key: cord-0020140-1921hwng
authors: nan
title: Abstracts of the 53rd ESPN Annual Meeting, Amsterdam, The Netherlands, September 2021
date: 2021-08-25
journal: Pediatr Nephrol
DOI: 10.1007/s00467-021-05210-9
sha: f39c266d251cbb66a051a527b37c7bec8b3f89ff
doc_id: 20140
cord_uid: 1921hwng

nan

Introduction: Circulating permeability factors (CPFs) involved in the pathogenesis of idiopathic focal segmental glomerulosclerosis (FSGS) can lead to early recurrence of FSGS and kidney failure after transplantation. Identification of FSGS patients with CPFs is clinically important as it can predict treatment response and prognosis. Currently, kidney biopsy is the gold standard diagnosis. Therefore, there is an increased demand for diagnostic assays to determine the presence of CPFs in the sera of FSGS patients. Using conditionally immortalized human podocytes as a substrate, we aim to demonstrate the presence of plasma-derived CPFs using series of in vitro assays. Material and methods: Podocytes and primary glomerular endothelial cells (GMVECs) were incubated with plasma from biopsy proven FSGS patients in relapse and remission as well as from steroidresistant nephrotic syndrome (SRNS), minimal change NS (MCNS), membranous nephropathy (MN), a non-renal control patient, and healthy controls. Cell viability, podocyte actin cytoskeleton architecture, and reactive oxygen species (ROS) formation in the presence or absence of ROS scavenger, dimethylthiourea, were investigated by CCK-8 assay, immunofluorescence staining, and CM-H2DCFDA probing, respectively. Results: We show that plasma of patients with FSGS causes a series of events in podocytes but not in endothelial cells. These events include actin cytoskeleton rearrangement, excessive formation of ROS, and eventually also cell death. These effects were solely observed in response to plasma of relapse FSGS patients, but not in response to plasma of kidney patients with SRNS, MCNS, MN and healthy controls. The co-presence of dimethylthiourea, abolished these effects. Conclusions: Altogether, we provide a panel of assays to measure podocyte injury and predict the presence of CPFs in FSGS plasma, providing a new framework for monitoring CPF activity that can be used for diagnostics or disease monitoring purposes. Moreover, our findings suggest that the inhibition of ROS formation or facilitating rapid ROS scavenging may exert beneficial effects in FSGS patients.

Introduction: Shiga-toxin related HUS (STEC-HUS) in pediatric patients is severe with at least 50% of affected children requiring dialysis. Mortality rates can reach 5% and long-term renal sequels occur in 30% of surviving patients. No specific treatment has proven its efficacy. Activation of the complement alternative pathway (CAP), a well known pattern of atypical HUS (aHUS) has been postulated in STEC-HUS patients. Eculizumab (EC), a monoclonal C5 antibody, which inhibits CAP activation has been proposed in STEC-HUS patients with conflicting results. Considering the lack of therapy in STEC-HUS, controlled study of EC efficiency was mandatory. Material and methods: We conducted a multicentric, single blinded, versus placebo trial of EC in pediatric STEC-HUS patients. Patients under 18 years were randomized in a 1:1 ratio to receive either EC or placebo during 4 weeks. Follow-up lasted for 1 year after treatment. Primary end point was the occurrence of a dialysis >48h. Secondary end points included renal, hematological and other organs involvement. Safety was assessed throughout the course of the trial. Results: Of 100 patients who underwent randomization, 14 did not complete the trial. Among the 86 analyzed patients (42 in the placebo and 44 in the EC group) demographic characteristics were similar. There was no difference in the occurrence of a dialysis >48h between the 2 groups (43% in the placebo and 57% in the EC group). No difference was found in the general course of acute renal failure or in the occurrence of mid-term renal sequels (6 and 12 months after the treatment phase). Hematological involvements as well as extrarenal manifestations of the HUS were also similar between the 2 groups. Conclusions: In pediatric STEC-HUS patients, treatment with EC is not associated with either an improvement of the course of neither the acute phase of the disease nor a prevention of midterm renal sequels.

phosphate deposition in the arterial medial layer causes vascular calcification. Structural changes in the vessels perhaps lead to arterial stiffness, in turn causing increased left ventricular pressure load and left ventricular hypertrophy. Our aim was to examine structural and functional CV changes in a young cohort with CKD. The skeleton continues to mineralize until the third or fourth decade of life, perhaps acting as a protective calcium buffer. Material and methods: 79 children & 21 young adults with CKD stages 4-5 and on dialysis aged 5-30 years underwent cardiac CT for coronary artery calcification(CAC), ultrasound for carotid intima media thickness(cIMT), pulse wave velocity(PWV), echocardiography for left ventricular mass(LVMI,g/m 2.7 ). cIMT & cfPWV were expressed as zscores. The vascular measures were analysed as structural changes (cIMT, LVMI and CAC) & functional changes (carotid distensibility, and PWV). We examined carotid dilatation (lumen/wall cross sectional area) as a surrogate of the association between structural and functional changes. Results: 69.5% of CKD and 88.3% of dialysis patients had at least one structural or functional CV abnormality. The odds of having any structural or functional abnormality in dialysis was 17.3 times higher compared to CKD (95% CI 5.3 to 53.5, p<0.0001). Carotid dilatation was lower in patients with cIMT z-scores >2 compared to <1. The presence of more than one structural abnormality increased the odds of more than one functional abnormality by 4.5 (95% CI 1.3 to 16.6, p=0.045) .

Conclusions: There is a high prevalence of subclinical CVD in children and young adults with CKD4-5D. Functional changes indicative of arterial stiffness were more prevalent in dialysis. Our data suggests that patients with more structural abnormalities were more likely to have functional abnormalities. Longitudinal studies are required to determine the temporal association of structural and functional CV changes. home using the NxStage Dialysis System OneTM, we investigated the frequency and potential determinants of UF inaccuracy. Material and methods: This was a retrospective single centre observational study of all children under the age of 18 and undergoing HHD treatment using the NxStage System OneTM from 2011 to 2020. The primary event of interest was UF accuracy measurement. This was defined as the difference (in L) between the planned UF and the actual UF volume for each HHD session. In addition, we investigated associations between range of UF accuracy and machine-related as well as patientrelated factors.

The "HDF-Heart-Height" study showed that hemodiafiltration (HDF) is associated with better statural growth than conventional hemodialysis (HD) in children. We report a post-hoc analysis of the same study assessing the effects of dialysis modality on nutritional status. Material and methods: We included in the baseline cross-sectional analysis (T0) 107 incident and prevalent children, 79 of whom (43 HD, 36 HDF) completed a 12-month follow-up (T12). Height (Ht-SDS), weight (Wt-SDS), and body mass index (BMI-SDS) standard deviations scores, waist-to-hip ratio, normalized protein catabolic rate (nPCR), insulin-like growth factor-1 (IGF-1)-SDS, des-acyl ghrelin (DAG), adiponectin, leptin, insulin, and prealbumin levels were measured. Results: Compared to patients treated with HD, those on HDF had higher Ht-SDS both at T0 and T12 (-1.4 vs -2.4 ; p= 0.01, and -1.6 vs -2.6; p=0.009, respectively) and higher W-SDS at T12 (-1.5 vs -2.1; p=0.02), while no differences were observed for the other anthropometric or laboratory parameters. On univariate analysis, Ht-SDS positively correlated with IGF1-SDS and inversely with adiponectin and DAG, Wt-SDS positively correlated with IGF-1 SDS and leptin and negatively with DAG, while BMI-SDS correlated with leptin and insulin. On multivariable linear regression analyses, higher Wt-SDS at T12 was positively associated with HDF modality (beta=0.47 vs HD; 95%CI 0.12-0.83; p=0.01) and inversely with T0 DAG (beta=-0.18 per 500 higher; 95%CI -0.32, -0.05; p=0.006). Similarly, higher T12 Ht-SDS was associated with HDF modality (beta=0.20 vs HD; 0.44; p=0.11) and lower T0 DAG (beta=-0.13 per 500 higher; 95% CI -0.22, -0.04; p=0.004). Conclusions: Although children treated with HDF have better growth than those receiving HD, and growth is independently associated with DAG levels, the effect of dialysis modality on growth does not appear to be related to an improvement in the measured nutritional parameters. Further studies are needed to assess the mechanisms linking HDF to improved growth.

Introduction: NEK8/NPHP9 encodes a protein that localizes to the inversin compartment of the primary cilium. Biallelic NEK8 variants are known to cause multiorgan developmental defects including renal cystic dysplasia and extensive extra-renal defects, with heterozygous carrier parents being asymptomatic. This autosomal recessive inheritance is the most common inheritance mode for ciliopathies. Complementary to this, we now propose a dominant-negative effect for certain heterozygous NEK8 missense variants in the kinase domain resulting in an autosomaldominant ciliopathy. Material and methods: Genetic testing was performed in patients from several medical centers. To further explore the consequences of the identified NEK8 variants we are performing cilia staining assays in both patients skin fibroblast and kidney cells, as well as in mIMCD3 kidney cells overexpressing the identified variants. Results: We identified three distinct heterozygous NEK8 variants in seven families (table 1) , all leading to missense alterations in the kinase domain. Interestingly the p.Arg45Trp variant is a recurrent variant we detected in five unrelated families. All patients have a kidney phenotype that varies from mild FSGS to prenatal presentation with polycystic kidneys. Some patients have end-stage kidney disease at varying ages of onset. In all patients we thoroughly checked whether a variant could be found on the second allele. Furthermore, the large symptomatic family and the de novo occurrences are also in favor of a dominant mode of inheritance. Our preliminary results from functional studies show normal localization of the NEK8 protein to the Golgi region, but abnormal primary cilia formation, in serum starved patient derived cellsa finding consistent with pathogenicity.

Introduction: Central venous lines (CVLs) for haemodialysis (HD) in children are associated with frequent complications leading to inadequate dialysis and change of devices in nearly half the patients. Computational fluid dynamics (CFD) can be used to characterize the haemodynamic of CVLs. We studied CVLs commonly used in children to investigate the correlation between fluid-dynamics parameters and clinical outcomes. Material and methods: Four models of CVLs of varying design and sizes (6.5F, 8F, 10F and 14F) were reconstructed from microCT images. CFD analyses were set up to simulate CVL working conditions in anatomical models of superior vena cava. Haemodynamic features including velocity fields, shear stresses, and platelet lysis index (PLI) were analysed, and CFD simulations compared to clinical data on catheter dysfunction from our Centre. Results: Analysis of velocity fields identified presence of jets through the side holes ( Figure 1a ) and areas of recirculation and stagnation in all the designs, especially when used in arterial configurations. Side-holes played a crucial role in fluid exchange in all the design but in the 8F design. In this case area of stagnation were found in proximity of the side-holes. Highest presence of shear stresses >10Pa were also found in the 8Fr CVL while highest PLI in the 10F model. The anatomical model showed an increased disturbance of the flow ( Figure 1b ) and wall shear stresses. CFD results were in accordance with the clinical data which showed a higher recurrence rate of complications for the 8Fr and 10Fr CVLs (Figure 1c) . Conclusions: This study provides novel characterization of fluiddynamics of CVLs that may guide future improved CVL design. (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) (2018) OF 46 CHILDREN WITH TINU SYNDROME: WE HAVE TO BE CAUTIOUS.

Introduction: Dent's disease type 1 (DD1) is a rare X-linked nephropathy characterized by proximal tubule dysfunction, including low-molecular-weight proteinuria (LMWP), hypercalciuria, nephrolithiasis, nephrocalcinosis and often progressive renal failure (RF). A broad phenotypic variability has been reported, with no genotype-phenotype relationship and limited long-term knowledge. The prevalence of DD1 is unknown. Geographic dispersion of the few diagnosed cases makes epidemiologic and clinical studies difficult. Material and methods: A physician-based anonymous survey supported by ERKNet, ESPN and ERA-EDTA, either distributed via post mail or e-mail, was conducted. Questions were aimed to assess the prevalence and disease traits in the target population. Results: 73 nephrologist from 63 hospitals in 22 European countries participated in this survey. 230 patients with DD1 were reported. Demographic and clinical data were available for 152 male patients with confirmed mutations in CLCN5 gene. Median age at diagnosis was 6 years [IQR, and the main sign leading to diagnosis was proteinuria (see Figure 1 ); 11.5% had positive family history. All patients showed LMWP, 66.9% nephrocalcinosis, 44.4% hypercalciuria and 25.6% kidney stones. 60% patients had progressed to chronic kidney disease with estimated glomerular filtrataion (eGFR) <90 ml/min at last follow-up. Eight patients presented RF at 35 years [IQR, [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] . Patients < 18 years at last follow-up showed hypercalciuria more frequently than those older (51.4% vs. 22.7%; p<0.001), less glycosuria (8.9 % vs. 43.2%; p<0 .01) and better eGFR (90 ml/min [IQR, vs. 58 ml/min [IQR, ). Conclusions: Large registries are important to increase the knowledge of this probably under-diagnosed disease. LMWP, the hallmark of DD1, should be measure in males with proteinuria, nephrocalcinosis, lithiasis or bone disease although the phenotype is very variable and evolves with age and loss eGFR. Our results confirm DD1 manifestations described in smaller cohorts and show long-term outcomes with less percentatge of renal failure.

Amina El Amouri 1 , Kato Delva 1 , Aurélie Foulon 2 , Charlotte Vande Moortel 2 , Koen Van Hoeck 3 , Griet Glorieux 2 , Wim Van Biesen 2 , Johan Vande Walle 1 , Evelien Snauwaert 1 , Sunny Eloot 2 , Ann Raes 1 1 Paediatric Nephrology, Ghent University Hospital, 2 Nephrology, Ghent University Hospital, 3 

Introduction: Life-threatening hyperkalaemia is the most dreaded metabolic complication in children with chronic kidney disease (CKD). However, direct evidence in support of the widespread practice of dietary potassium restriction for the prevention and management of hyperkalaemia is lacking. Furthermore, the resultant lower fibre exposure from avoiding potassium-rich fruits and vegetables may deprive CKD patients from potential health benefits. Therefore, we examined whether potassium and fibre intake correlate and investigated associations between dietary potassium, fibre intake and serum potassium levels in paediatric CKD. Material and methods: This study is a longitudinal analysis of a 2year, prospective, multi-institutional study, following children with CKD at 3-month intervals. 24-h recalls and 3-day food records were used to assess dietary potassium and fibre intake and coupled to serum potassium concentrations. Associations between dietary potassium intake, dietary fibre intake and serum potassium concentrations were determined using linear mixed models. Results: 52 patients (7 transplant recipients, none on dialysis) aged 9 [4;14] years with an estimated glomerular filtration rate (eGFR) of 49[25;68] mL/min/1.73 m 2 , were included. For every g/day decrease in dietary potassium intake, the estimated mean daily fibre intake was 5.1g (95% confidence interval(CI), 4.3 to 5.9g/day; p < 0.001) lower. Regarding potassium intake, the relative contribution of fruits and vegetables was 16 [12;33] %, while non-nutritious sources (fastfood, sugar…) accounted for 29 [11;45] %. Neither dietary potassium intake (p = 0.403), nor dietary fibre intake (p = 0.432) were associated with circulating potassium in a model adjusted for time point, eGFR, treatment with a renin-angiotensin-aldosterone system blocker, serum bicarbonate concentration and body surface area. Conclusions: Dietary potassium and fibre intake are closely related and were not associated with circulating potassium levels in paediatric CKD. If downward adjustments of potassium intake are necessary, the focus should shift from mere potassium content to potassium sources to safeguard fibre intake.

Introduction: In renal proximal tubule (PT) cells, bone derived fibroblast growth factor (FGF) 23 activates the FGFR1/Klotho/ERK1/2 signalling to reduce the type II sodium phosphate transporters NaPi-2a and NaPi-2c in the apical brush border membrane (BBM) causing lower serum phosphate levels. In the presence of high extracellular phosphate, the type III sodium-dependent phosphate transporters PiT-1 and PiT-2 activate ERK1/2 in bone cells in vitro. It has been shown that PiT-2 is responsible for the phosphate-mediated osseous FGF23 secretion. Yet, it is unknown if phosphate sensing plays a role in renal PT cells and thereby regulates its own excretion. Thus, we aimed to analyse renal actions of phosphate in the setting of chronic high phosphate loading independent of FGF23. Material and methods: C57BL/6N male mice were fed a 0.8% normal phosphate diet (NPD) or a 2% high phosphate diet (HPD) for 6 months, phosphate homeostasis was determined and kidneys were analysed by qPCR, immunoblot and histology. Cultured murine PT cells were treated with phosphate or FGF23 with or without the phosphate transporter inhibitor Foscarnet followed by analyses. Results: Elevated plasma FGF23 levels in HPD-fed mice resulted in reduced TRP and increased FEPi with still enhanced serum phosphate levels compared to NPD. HPD diminished renal Klotho protein, while Fgfr1 was unaltered. Although ERK1/2 activation was inconsistent, NaPi-2a mRNA expression was significantly reduced in HPD-fed mice compared to NPD. Analysing BBM vesicles and immunofluorescence staining confirmed NaPi-2a internalization from the apical BBM. HPD-fed mice showed increased PiT-2 expression and enhanced accumulation on the basolateral membrane of PT. In cultured murine PT cells, Foscarnet prevented the phosphatemediated PiT-2 upregulation and ERK1/2 phosphorylation but not the FGF23-induced effects. Conclusions: In the setting of high phosphate-mediated renal resistance of FGF23/Klotho signalling, phosphate itself may stimulate its urinary secretion via PiT-2/ERK1/2-mediated downregulation of NaPi-2a resulting in hyperphosphaturia FGF23-independent.

Introduction: Primary hyperoxaluria (PH) is a rare genetic condition characterized by recurrent kidney stones and Chronic Kidney Disease. Oxabact® (O.formigenes) is a commensal, gram-negative, anaerobic gut bacteria with the ability to metabolise and remove excess oxalate from the body. The main objectives of the ePHex study were to evaluate efficacy and safety of Oxabact® in patients with PH, an estimated glomerular filtration rate (eGFR) < 90 ml/min/1.73 m 2 and total plasma oxalate (Pox) concentration ≥ 10 μmol/L. Material and methods: This international 52-week study evaluated the treatment effect of Oxabact® versus placebo on Pox as the primary endpoint, and kidney function and kidney stone events as key secondary endpoints. Other endpoints included 24-h urinary oxalate (Uox) excretion, stool count for O. formigenes, nephrocalcinosis grade, safety labs and adverse events in patients (≥ 2 years of age) with any type of PH. Subjects receiving vitamin B6 were required to receive a stable dose prior to screening and were not allowed to change the dose during the study. Pre-study kidney function and kidney stone events were collected. Subjects were randomised in a 1:1 ratio to either twice daily Oxabact® or placebo and stratified based on PH type and 24-h Uox excretion. During the study, Pox, eGFR, kidney stone events and safety labs were assessed every 8weeks. Cardiac function was determined with echocardiography (traditional and Speckle Tracking) and kidney stones with ultrasound. Stool samples and 24-h urine were collected at regular intervals, and adverse events monitored throughout the study. Results: Twenty-five subjects were randomized in the study. The results from the study will become available early/mid June 2021 and will be presented for the first time during the ESPN 2021 conference. Conclusions: The ePHex study represents the longest placebo-controlled phase 3 study with the objective to investigate efficacy and safety of Oxabact® in the treatment of patients with PH.

Lucy Plumb 1 , Anna Casula 1 , Manish Sinha 2 , Carol Inward 4 , Stephen Marks 3 , James Medcalf 1 , Dorothea Nitsch 1 1 Uk Renal Registry, 2 Evelina London Childrens Hospital, 3 University College London Great Ormond Street Institute Of Child Health, Nihr Great Ormond Street Hospital Biomedical Research Centre, London, UK, 4 

Introduction: Few national datasets describe the epidemiology and outcomes of childhood AKI. Since 2014, all NHS laboratories in England are required to issue electronic (e-)alerts for AKI based on changes in serum creatinine. The UK Renal Registry receive these data which are linked to electronic health record data. The aim was to describe a national cohort of children who received an AKI ealert and their clinical course. Material and methods: AKI e-alert data from 01/01/2017-31/12/ 2017 are described. Linkage to Hospital Episode Statistics data was undertaken to describe outcomes of hospitalised AKI including length of stay (LOS) and critical care admission (CC). Risk associations with CC (hospitalised cohort) and 30-day mortality (total cohort) are examined using age-and sex-adjusted multivariable logistic regression models. Results: Over the study period, 7,788 children (52% male, median age 4.4 years, IQR 0.9-11.5) experienced 8,927 AKI e-alert episodes; 8.2% occurred during birth admissions. Children aged under 5-years accounted for half of all episodes. Of 5,582 children with hospitalised AKI episodes, peak AKI stage 2 was noted in 20.8% and stage 3 in 13.2%. CC occurred in 1,402 (25%) : children of Asian ethnicity, in the youngest (<1) or oldest (16-18) age-bands (reference 1-5 years), and Introduction: Given the improved life expectancy and the limited survival of kidney allografts, children and young adults undergo sequential periods of dialysis and transplantation over their lifetime. Most studies focus on access to transplant or allograft survival but fail to study patients' complete KRT trajectories. This study aims at developing a tool able to simulate the impact of medical practices or healthcare interventions on these care trajectories. Material and methods: Data from all ESKD patients starting KRT before 30 years old in France between 1995 and 2015 were included (N=9402). A multistate model was used to study patients' trajectories between 15 states and transition rates were estimated using a Poisson model. Results: Over the 20 years following KRT initiation, patients spent on average 4.6 years on dialysis and 13.1 with a functioning transplant. The restricted mean survival was 18.5 years. The tool allowed us to assess the impact of the rate of preemptive waitlisting, the rate of living donation and the number of HLA mismatches (A/B/DR) overall and in specific age subgroups. As an example, increasing preemptive listing and transplant from living donors to 50% only resulted in a slight decrease of the time on dialysis (3.6 months over 20 years) in children (<18) while a significant reduction of 18 months would be expected among young adults. Conclusions: The final aim of this tool is to guide clinicians and help health policy makers by assessing the impact of changes in clinical practices or healthcare policies. Such tools may help identifying strategies to maximize the time spent with a functioning transplant and minimize the time on dialysis.

Introduction: For children with relapsing steroid sensitive nephrotic syndrome (rSSNS), previous studies have shown that giving daily lowdose prednisolone for 5-7 days during an upper respiratory tract infection (URTI) may reduce risk of relapse. It is unclear if these findings are generalisable to a large multi-ethnic population on different maintenance treatments. Material and methods: A randomised, double-blind, placebo-controlled trial was carried out in 122 UK paediatric units.365 children with rSSNS (7.6 ± 3.5 years) were randomised by background treatment to receive 6 days of prednisolone 15 mg/m 2 or placebo at the start of an URTI. Primary outcome was incidence of first URTI-related relapse (URR) following any URTI. Secondary outcomes included measures of corticosteroid adverse effects and quality of life (QoL). Cost-effectiveness analysis used trial data and a decision-analytic model to estimate 1-year Quality-Adjusted-Life-Years (QALYs) and costs, which were then extrapolated over 16 years. Results: The number of patients experiencing a URR was 56 (42.7%) and 58 (44.3%) in prednisolone and placebo arms respectively (adjusted risk difference: -0.024, 95% CI: -0.14 to 0.095; P=0.7). There was no evidence that treatment effect differed according to maintenance treatment. There were no significant differences in secondary outcomes between treatment arms. In apparent contrast, the economic evaluation found that daily prednisolone at the time of an URTI increased QALYs and decreased overall costs, a finding that was robust to sensitivity analysis. Conclusions: PREDNOS 2 has shown no clinical benefit to 6 days of daily low-dose prednisolone at the start of an URTI in reducing relapse risk. The apparent conflicting economic result illustrates the cost implications associated with background treatment and the costs and reduced QoL associated with relapses when balanced against a cheap treatment. Literature in this area is sparse and more work is needed to evaluate the QoL and economic impact of SSNS relapses.

Introduction: Molecular defects in genes encoding nucleoporins (NUPs; components of nuclear pore complexes), such as NUP93, have been recently reported to cause steroid-resistant nephrotic syndrome in childhood. Here we collected clinical and genetic information on 31 patients, including 20 unpublished, to further characterize the associated phenotype. Material and methods: The patients were recruited from the international PodoNet Registry clinical registry for patients with persistent subnephrotic proteinuria/overt steroid-resistant nephrotic syndrome and/or identified through systematic literature review. Clinical data were collected through a standardized questionnaire. The shared background haplotypes were determined and compared to general population; genetic clock methods were used to estimate the age of a mutation. Results: Median age at onset was 4.4 (0.3-16) yrs. Most patients presented with overt nephrotic syndrome and 5 (16%) in end-stage kidney disease (ESKD), which was attained at a median age of 6 years. Extrarenal manifestations were present in a minority of cases and most commonly comprised cardiac disorders (19%) including severe dilated cardiomyopathy in 3 pts during peritoneal dialysis, eye abnormalities and vision difficulties (15%) and neurodevelopmental problems (7%). The c.1772G>T variant was found in 21 (including 10 homozygous) patients from Central and Eastern Europe (Poland, Czech, Germany, Hungary, Russia, Serbia) and Turkey. Patients homozygous for c.1772G>T had a milder disease course then other NUP93 cases with later median age at onset (5.0 vs 2.9, p=0.05) and at ESKD (11.0 vs 4.9 yrs; p=0.04) . Analysis of the haplotype background composed of SNPs surrounding the variant revealed a common segment of at least 360 kb. Preliminary estimation of the nonrecombined haplotypes suggests that the mutation occurred 600-1,500 years ago. Conclusions: The study enabled us to delineate the phenotype of NUP93 glomerulopathy, including a homogeneous group of SRNS patients of Central/Eastern European ethnicity who harbor a single founder mutation associated with a milder phenotype.

Introduction: The aim of this nationwide cross-sectional cohort study was to determine the prevalence of and risk factors for tubular dysfunction in childhood cancer survivors (CCS). Material and methods: For the Dutch Childhood Cancer Survivor Study (DCCSS) LATER cohort part 2; clinical visit & questionnaire study; RENA project, 1,024 CCS (≥5 years after diagnosis), aged ≥18 years at time of study, treated between 1963 and 2001 with potentially nephrotoxic therapy (i.e. nephrectomy, abdominal radiotherapy, total body irradiation, cisplatin, carboplatin, ifosfamide, high-dose cyclophosphamide(≥1g/m2 per course or ≥10 g/m2 in total), or bone marrow transplantation participated. Five-hundred age-and sex matched controls were used from the Lifelines cohort study. Renal electrolyte loss was defined as low serum levels in combination with increased renal excretion, or receiving electrolyte supplementation. α1microglobulin:creatinine ratio >1.7 mg/mmol was considered as lowmolecular weight proteinuria (LMWP). Chi-Square analysis was used to compare the prevalence in both groups. Multivariable logistic regression analyses were performed to assess risk factors and expressed as odds ratio (OR) with 95% confidence interval (95%CI). Results: Median age at diagnosis was 4.7 years (interquartile range [IQR] 2. 4-9. 2), at study 32.5 years , and follow-up time 25.5 years . Risk factor for magnesium loss was cisplatin (OR 10.1, , for potassium loss these were ifosfamide ) and cisplatin ) and for phosphate loss ifosfamide ). LMWP was associated with ifosfamide ). Overall prevalence of renal losses in CCS (magnesium 5.6%, potassium 4.5%, phosphate 5.5%) was not higher compared to controls, while LMWP was significantly more prevalent (CCS 20.1% versus controls 0.4%, p<0.001). Conclusions: After a median follow-up of 25.5 years CCS had an increased prevalence of LMWP compared to controls, but not of renal electrolyte losses. Ifosfamide and cisplatin were associated with tubular toxicity over time. Introduction: Over 25% of pediatric kidney transplants (KTs) are lost within 7 years necessitating return to dialysis or retransplantation. Knowledge regarding the long-term outcomes after pediatric retransplantation is limited. Using ERA-EDTA Registry data, we investigated kidney retransplantation outcomes from childhood into adulthood. Material and methods: Patients on kidney replacement therapy (KRT) between August 1979 and December 2016 were studied. Multivariable Cox regression models were applied to study access to KT.Death-censored graft survival was analyzed and retransplantation outcomes were assessed using cumulative incidence competing risk analysis. Results: A total of 4871, 1126 and 259 children having received at least one, two and three KTs, respectively, were included. Median age at first, second and third KT was 12.6, 20.0 and 24.9 years old, respectively and median follow-up was 23.2 years. Starting KRT at younger age (0-4 years old) was associated with a lower access to first KT [adjusted HR (aHR) 0.45; 95%CI 0.41-0.49]. Children receiving their first KT between 10-14 years old had lower graft survival rates compared to other age groups. Patients with recurrent diseases showed a lower access to KT regarding their first and second KT (aHR 0.79; 95%CI 0.73-0.86 and aHR 0.85; 95%CI 0.73-0.99, respectively). Regarding access to subsequent KT according to the type of previous KT, the likelihood of receiving a second KT was significantly lower when first KT was from a deceased donor (aHR, 0.79; 95%CI 0.68-0.92). The 10-year graft survival rate was 63.1%, 51.3% and 46.4% for the first, second and third KT, respectively, and graft survival was significantly better for first and second KT with living donor kidneys. Conclusions: First KT had better overall survival compared to subsequent KTs. Survival rates are better for living donor recipients for first and second KT but comparable to DD for third KT. Having received a DD as first KT decreases the chances for further KTs.

biological fluids, such as urine. Due to their high degradability, miRNAs are often carry by extracellular vesicles (EV), lipid nano-bound particles release from all types of cells. Particularly the study of urinary extracellular vesicles (UEVs) and their miRNAs content could be helpful to reflect directly the condition of the kidney. For this reason, we try to identify a miRNAs profile from UEVs samples useful to prevent subclinical kidney rejection in pediatric transplanted patients. Material and methods: The miRNAs were extracted from UEVs of 20 pediatric transplanted patients, with a stable condition or kidney rejection at one-year post-transplantation. The UEVs were isolated from urine samples by the ultracentrifugation method. The vesicles concentration and size were identifying by electron microscopy and scattering analysis (Nanosight 3000). The extracted miRNAs were enriched before sequencing with the Illumina sequencer.

Results: The miRNAs sequencing shows about 522 different miRNAs and 48 of them were differentially expressed between patients with subclinical rejection or stable condition. UEVs characterization show a concentration of 2,79 x 10 11 -9,56 x 10 11 particles with a size diameter of about 197 ± 7 nm. The miRNAs concentration was between 197 -907 pg/μl. Conclusions: These results emphasize the relevance of vesicles miRNAs as useful biomarkers lead to the evaluation and prevention of subclinical kidney rejection in pediatric transplanted patients. Introduction: Outcome of kidney transplantation (KT) from donors after circulatory death (DCD) in adults is comparable to KT from donors after brainstem death (DBD). DCD now account for nearly 30% of the total KT performed in the UK. Limited data exists for DCD KT outcomes in children. This study reports the outcome of DCD KT in children compared to age and sex matched children who received DBD KT around the same time period in the NW of England. Material and methods: Retrospective review of case records. Results: From January 2013 to December 2020 10 children underwent DCD KT. All children received steroid minimisation immunosuppressive regimen with tacrolimus and MMF maintenance therapy from day 5. Mean age at KT was 11.8 years (7.0 -17.0) for DCD recipients and 10.7 years (4.9-17.3) for DBD recipients, with mean cold ischaemic times of 12.3 (8.5-18.2) and 12.3 (8.4-18. 3) (p=0.97) hours, respectively. Average length of stay was similar (DCD 13.7 v DBD 13.3 days) . There was a trend towards increased delayed graft function (DGF) in DCD recipients compared with DBD recipients (7/10 v 3/10, p=0.07). eGFR was not significantly different at discharge for DCD compared to DBD (mean 50.7 vs 63.5 ml/min/1.73m 2 , p=0.36), at 6 months (mean 70.7 vs 77.7 ml/min/1.73m 2, p=0.53) or at 12 months (mean 75 vs 72.8 ml/min/1.73m 2 , p=0.87). There was no significant difference in incidence of hypertension -DCD 2/10 vs DBD 6/10, (p=0.07) at mean follow-up of 43.9 and 39.2 months respectively. Biopsy proven acute rejection episodes were similar in the 2 groups (DBD 1, DCD 2). Mean Z score change for height since KT in DCD and DBD patients at latest follow-up was +0.24 and +0. 11 (p=0.83) . Conclusions: Although children who receive DCD KT have a trend towards increased risk of DGF, the long-term graft function and outcome is similar to DBD recipients.

Thurid Ahlenstiel-grunow 1 , Xiaofei Liu 2 , Raphael Schild 4 , Christina Taylan 3 , Lutz Weber 3 , Jun Oh... 4 , Hagen Staude 5 , Anika Großhennig 2 , Lars Pape 1 1 University Of Essen-duisburg, 2 Hannover Medical School, 3 University Of Cologne, 4 University Of Hamburg, 5 

Introduction: Pharmacokinetic monitoring alone is insufficient to estimate the intensity of immunosuppression after kidney transplantation. Levels of virus-specific CD4 T cells(CD4Tvis) have been shown to identify overimmunosuppression. The IVIST trial has demonstrated that additional steering of immunosuppressive therapy by CD4Tvis levels is safe and reduces exposure to immunosuppressants with significantly lower trough levels but without increasing the risk of acute rejections. Material and methods: In the multicenter, randomized controlled IVIST trial, 64 pediatric kidney recipients were randomized 1:1 to a control group with trough level monitoring of immunosuppressants or to an intervention group with additional steering by CD4Tvis levels against adenovirus(ADV), cytomegalovirus(CMV) and herpes simplex virus(HSV). The immunosuppression consisted of cyclosporine A, everolimus and glucocorticoids. CD4Tvis were quantified by cytokine flow cytometry in 20 visits during the two-year study period. In the intervention group we have analyzed the CD4Tvis levels and the number of Tvisbased dose adjustments of immmunosuppressants. Results: At time of transplantation, ADV-CD4Tvis were detectable in 30/31 patients from the intervention group, CMV-CD4Tvis and HSV-CD4Tvis only in 12/31. No significant ADV-or HSV-DNAemia was found; only two patients showed transient CMV-DNAemia based on CMV-reactivation. Five primary CMV-infections with seroconversion and boost of CMV-CD4Tvis were observed without significant CMV-DNAemia. The mean level of ADV-CD4Tvis was 1.63(SD1.25), 2.03(SD1.8), 2.18(SD2.51) and 1.97 cells/μl(SD1.34) 1,6,12 and 24 months after transplantation. In case of CD4Tvis <2cells/μl 125 dose reductions of immunosuppressants (96% based on ADV-CD4Tvis) were performed in 28/31 children with a median of 4 Tvis-based dose reductions (range 0-10) per patient. 48% of the Tvis-based dose reductions were carried out in the first six months, 36.8% between month 7 and 12 and 15.2% in the second year after transplantation. Conclusions: Under the intensified immunosuppression during the initial post-transplant period low ADV-CD4Tvis levels were observed with subsequent increase after dose reduction of the immunosuppressive therapy. ADV-CD4Tvis are most suitable for immune monitoring because of their high prevalence (even in children) and stability combined with absence of ADV-DNAemia. Routine monitoring of ADV-CD4Tvis is recommendable especially in the first post-transplant year to prematurely identify overimmunosuppression. children, improving access to LDTx is of high importance. In this study, we describe the characteristics and outcomes of pediatric transplants performed through KPE. Material and methods: We studied 5,022 pediatric LDTx (2/2008-12/ 2019) , including 128 National Kidney Registry (NKR) transplants, using the Scientific Registry of Transplant Recipients (SRTR) linked with the NKR database. We compared death-censored graft failure (DCGF) and mortality between NKR recipients and three control groups (1) all non-NKR SRTR living donor recipients, (2) all non-NKR unrelated SRTR living donor recipients, and (3) all non-NKR SRTR KPE recipients. Results: There were 352 pediatric KPE transplants during the study period (36% participated in NKR). Among NKR pediatric recipients, 44% were female, 23% were African American (AA), 14% were Hispanic, and the median age was 16. Compared to SRTR controls, NKR pediatric participants were more often AA (23% vs 9%, p<0.001), less likely to receive preemptive transplant (28% vs. 38% p=0.02), more often had a previous transplant (27% vs. 9%), and more often had a PRA>80 (23% vs. 4%, p<0.001). NKR participants experienced longer cold ischemia times (median 8 vs. 1 hour) but did not experience increased risk of delayed graft function (4% vs 3%, p=0.6), 5-year DCGF (5% vs. 0.5%, p=0.1), or 5-year mortality (1.7% vs. 1.9%, p=0.2) . Conclusions: The use of KPE to improve access to LDTx in children increased over the last decade. This especially benefited children with traditionally lower access to LDTx such as AA and highly sensitized patients and demonstrated good patients and transplant outcomes similar to non-KPE LDTx. Introduction: The pathological condition underlying nephrocalcinosis in children is not always evident and requires a detailed history and workup. Most commonly it is not associated with specific symptoms, while only a small number of children can present with recurrent urinary tract infection (rUTI). Yet, when accompanied with hypercalciuria and hypomagnesemia, it should raise a suspicion of an inherited disease, and therefore genetic testing is warranted. Material and methods: Case report. Results: We report a case of sister (11 years) and brother (7 years) born to nonconsanguineous, healthy parents. The girl initially presented rUTI at the age of 4, while renal ultrasound revealed bilateral nephrocalcinosis. A screening renal ultrasound was performed in her brother at the age of 4 months with the same findings. Further evaluation revealed hypercalciuria, hypomagnesaemia, hypermagnesuria, hyperparathyroidism, hyperuricemia and decreased GFR in both siblings, with no other extrarenal manifestations. Finally, targeted gene sequencing (Blueprint Nephrolitiasis panel with 35 genes) identified a novel heterozygous frameshift variant c.332_333del, p.(Thr111Lysfs*15) and a heterozygous missense variant c. 358T>C, p.(Cys120Arg) in CLDN16 gene, confirming the diagnosis of Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC) . Conclusions: FHHNC is is a rare autosomal recessive tubular disease caused by mutations in CLDN16 and CLDN19 genes encoding for the tight-junction proteins expressed in the thick ascending limb of Henles loop, where they form an essential complex for the paracellular reabsorption of magnesium and calcium. Many patients display a marked decline in GFR at the time of diagnosis, and about one-third progress to chronic renal failure during adolescence. While most of them harbor loss-of-function mutations in both alleles, phenotypic variability has been shown even in siblings with the same homozygous mutation, emphasizing the likely contribution of epigenetic factors to the disease development. In this context, to achieve a wider health impact, reporting of novel diseasecausing mutations is of high importance in order to establish phenotypegenotype correlations, facilitate appropriate treatment and inform disease outcome. Introduction: The first step in the management of the syndrome of inappropriate antidiuretic hormone (SIADH) is fluid restriction. This can be challenging, as patients with SIADH not only tend to be thirsty but may occasionally not tolerate restriction due to coexisting medical conditions. Data on the safety of pharmacological approaches are needed to guide clinical care in paediatric SIADH. Our objective was to review the efficacy and safety of tolvaptan and urea in paediatric patients with a clinical diagnosis of SIADH. Material and methods: Patients were identified from pharmacy electronic records based on their tolvaptan and urea prescriptions. The prospectively collected electronic patient records during the inpatient stay were reviewed and relevant information and laboratory results were extracted. Results: We identified 14 patients who had received tolvaptan and /or urea as part of their routine clinical care for treatment of SIADH. The majority of patients were under the care of the paediatric oncology team (12/14, 86%) . Tolvaptan use led to plasma sodium normalisation in 10/13 (77%) within six days (median 2.5 days, range [1, 6] ) with a median change of sodium concentration of 7mmol/L (-1,14) within the first 24 hours of treatment. Urea use led to sodium normalisation in 5/6 (83%) patients. Median number of days to normalisation with urea was 2 (1, 10) with a median change of plasma sodium concentration of 2 mmol/L (-1,6) within 24hours. All patients tolerated tolvaptan and urea without reported side effects. Sudden sodium concentration changes in 3 patients were not associated with clinical signs or symptoms. Conclusions: When fluid restriction is challenging in managing paediatric SIADH, tolvaptan and urea appear to be safe and effective therapeutic options.

tubular disorders underwent NGS. Variants were classified as per American College of Medical Genetics (2015) guidelines and pathogenic / likely pathogenic variants were considered significant. Results: 77 index cases (median age 46, IQR 18 to 10 months; male 74% n=57) underwent NGS. Phenotypic classifications were as follows: Distal Renal Tubular Acidosis i.e. RTA (n=24), Bartter (n=19), Isolated hypophosphatemic rickets with phosphaturia (n=6), Proximal RTA (n=12), Nephrogenic Diabetes Insipidus (n=7), Kidney stone / Nephrocalcinosis (n=5) and Miscellaneous (n=4). Among them 58 children (75%) had 53 pathogenic or likely pathogenic variants (33 novel) detected. Percentage NGS yield was noted to be in 80's for most of the phenotypes except distal RTA (71%) and stone /nephrocalcinosis (20%). NGS resulted in a new diagnosis in 9 children including non-tubulopathy disorder mimicking as tubulopathy in 7 children (Cystic fibrosis presenting with Bartter phenotype; n=4 and one each of Cong chloride diarrhea with Bartter phenotype, Nephronopthisis with Nephrogenic Diabetes Insipidus phenotype and Hypo-parathyroidism, sensori-neural deafness and renal dysplasia phenotype mimicking miscellaneous tubulopathy). Additional change of diagnosis happened in two children (Bartter phenotype to Gitelman syndrome and Nephrogenic Diabetes Insipidus phenotype to distal RTA). Conclusions: In our cohort of suspected tubulopathy from Eastern India NGS had a yield of 75%, identified a large number of novel variants and resulted in 12 % (n=9) new diagnosis. Our finding underscores the clinical utility of NGS for suspected tubulopathy and also highlights the unique mutation spectrum in Indian population and need for larger Indian studies.

Laurence Dubourg, Manon Aurelle, Laurence Chardon, Sacha Flammier, Sandrine Lemoine, Justine Bacchetta Centre De Référence Des Maladies Rares Du Calcium Et Du Phosphore, Hospices Civils De Lyon, France

Introduction: The assessment of phosphate homeostasis in clinical practice relies on circulating phosphate levels but also on phosphate tubular reabsorption, ideally assessed using the Tubular maximum Phosphate Reabsorption per Glomerular Filtration Rate (TmP/GFR). TmP/GFR reference values were established before the onset of IDMS-standardized creatinine assays, and thus need to be updated with these modifications in assays and laboratory standards. Our objective is to provide reference values for TmP/GFR from childhood to adulthood, using the gold-standard of GFR assessment and IDMS-standardized creatinine values. Material and methods: We retrospectively analyzed all the inulin and iohexol clearances (mGFR) performed in children in our unit since the beginning of IDMS-creatinine assays, as well as the clearances performed in adults screened for a living-donation. TmP/GFR was calculated on a fasting sample, using the conventional formula without correction for TRP in subjects below 19 years of age. Results: A total of 2051 subjects (1711 children and 340 adults), aged from 1.9 to 73.4 years with normal GFR, normal phosphate and normal calcium levels, was included for TmP/GFR analysis. As expected, there was a progressive decrease along puberty in both genders of plasma phosphate and TmP/GFR, the decrease occurring earlier in girls. After the age of 19, there was a stabilization of plasma phosphate and TmP/ GFR levels until the age of 55, phosphate levels and TmP/GFR being slightly lower in men than in women. Conclusions: We present here the largest cohort describing TmP/ GFR reference values in the era of IDMS-standardized creatinine assays. We believe that these data will help physicians to better diagnose and manage patients with abnormal phosphate metabolism in daily clinical routine. Introduction: There is an over-incidence of obesity in X-linked hypophosphatemia (XLH), but the underlying pathophysiological mechanisms are not yet known. The objective of this study was to evaluate whether FGF21, another endocrine FGF involved in the regulation of carbohydrate-lipid metabolism, could be involved. Material and methods: We performed a prospective multicenter crosssectional study comparing circulating FGF23, Klotho and FGF21 levels in teenagers with XLH compared to healthy controls (HC, VITADOS cohort) after a 1:1 matching on age, gender and puberty (XLH21, NCT03596554; VITADOS NCT01832623). Non-parametric tests were performed, results are presented as median (min-max). Results: A total of 40 teenagers with XLH (N=20 with standard of care, SOC, N=20 with burosumab) were included. Whilst patients receiving burosumab displayed decreased SDS for height and increased BMI as compared to patients receiving SOC, systolic blood pressure expressed as percentile progressively and significantly decreased when comparing the three groups: 77 in SOC, 47 in burosumab, and 28(0. in HC (p=0.007) . When compared to patients receiving SOC, patients receiving burosumab displayed significantly increased phosphate, 1-25-D and Klotho levels. No differences were found for either carbohydratelipid biomarkers or FGF21 between the three groups. In HC, FGF23 and FGF21 were positively associated (R=0.586, p=0.002), but this association was lost in XLH patients. A total of 21 XLH patients (53%) had insulin-resistance (HOMA>2.4, N=10 SOC, N=11 burosumab); there were no differences for FGF21, phosphate and Klotho levels between these two sub-groups. Conclusions: FGF21 does not explain obesity/overweight in XLH teenagers. This study was performed in France in 2018-2019, early after the approval authorizing the treatment of patients with burosumab only in case of severe XLH despite SOC. As such, the data on systolic blood pressure highlighting a possible impact of burosumab to decrease blood pressure deserve further studies given their potential impact on long-term cardiovascular risk. Objectives: Renal tubular dysfunction in children with Sickle Cell Disease (SCD) is one of the earliest manifestations of the disease, but there is a lack of data. Sickle Cell Nephropathy (SCN) is defined by hyperfiltration followed by microalbuminuria. Our aim was to compare tubular function between SCD patients with and without glomerular involvement.

Methods: This was a retrospective, single-center, cross-sectional study of all children with SCD admitted for comprehensive renal functional assessment at Lyon University Hospital, France, over a period of 18 years (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) . Glomerular and tubular dysfunction was ascertained by collecting the following data: the measured glomerular filtration rate (mGFR) by inulin clearance, albuminuria, urine osmolality, reabsorption rates of chloride, sodium, potassium, calcium and magnesium as well as the tubular maximum re-absorption of phosphorus per unit volume of GFR (TmP/GFR). Results: Eighty-six children were included, aged from 2 to 20 years old (mean age of 10.6 years, 53% girls). Thirty-six children (42%) presented SCN including 22 (26%) with hyperfiltration (median mGFR 177 ml/ min/1.73m 2 [IQR 166; 182] and 29 (34%) with albuminuria (median 5.5 mg/mmol [IQR 3.7; 6.7] ). There was not a statistically significant difference between SCN and non-SCN groups regarding urinary osmolarity, calcium reabsorption rate and TmP/GFR. However, the mean chloride, sodium and magnesium reabsorption rates were significantly higher in the group with SCN, with respectively 99.06 vs 98.74 (p-value = 0.01), 99.51 vs 99.31 (p-value < 0.01), 97.98 vs 97.49 (p-value = 0.04). The mean potassium reabsorption rate also tended to be higher in the SCN group: 91.72 vs. 89.95 (p-value = 0.05). Conclusions: Children with SCN seem to have a greater tubular reabsorption activity compared to those with normal glomerular function but exhibit similar renal concentrating ability, and urinary calcium and phosphorus excretion.

Aurélia Bertholet-thomas 1 , Michael Acquadro 2 , Catherine Guittet 3 , Sophie Joukoff 3 , Maria A. Manso-silván 3 , Victor Navas 3 , Alexia Marrel 2 1 Hospices Civils De Lyon, France, 2 Icon Plc, Ireland, 3 

Introduction: Patients with distal renal tubular acidosis (dRTA) have negative impacts on growth, bone and kidney, sometimes with hearing loss, which may significantly affect their quality of life (QoL). This study explores their lived experience about QoL linked to dRTA and its treatment. Material and methods: Individual 1-hour interviews (n=19) were performed to gather the impressions of patients with dRTA, (and/or their parents) 5 years after enrolment in a clinical study. ADV7103 (potassium citrate and potassium bicarbonate prolonged-release granules, twice daily) was compared with the standard of care (SoC) taken before study entry. Interviewers trained in qualitative research conducted the interviews using a semi-structured interview guide and performed thematic analysis with MAXDA software. Results: The main QoL domains impacted by dRTA and its treatment were difficulties studying, social challenges, and negative emotional and physical impacts. Difficulties associated to hearing impairment remained, but switching from previous SoC to ADV7103 was experienced as "life-changing" by patients/parents (Table 1) :

& The emotional burden of disease perceived was relieved in the absence of treatment-related invasive questions from others, & Difficulties at school due to burdensome administrative issues and need to explain disease and treatment disappeared, facilitating parents who had stopped working to return to work, & Social/family issues improved: travel and holidays became easier to organise, patients/parents stopped thinking about managing treatment daily/nightly, reducing tension in the family/couple, & Bad taste and gastro-intestinal adverse events improved with ADV7103. Better compliance led to milder physical impacts and less fear to be hospitalised.

Mean satisfaction score with ADV7103 vs. SoC was 9 out of 10 and ADV7103 exceeded or met the expectations of 82% patients. No more organisation problems for families at school and work, 13 paediatric patients (100%)

Social functioning and family problems, 6 patients (31%) Improved family functioning, 18 patients (95%) Health and product acceptability issues, 16 patients (84%) Improved health and product acceptability, 18 patients (95%)

Conclusions: Qualitative interviews show that dRTA and its treatment have a significant impact on QoL of patients and parents and that ADV7103 helps improve daily-life and reduces treatment burden, resulting in greater overall patients' and parents' satisfaction.

Introduction: Polyuria in children may become a diagnostic challenge since it may be seen as presenting symptom of an underlying renal or systemic disease. Material and methods: An adolescent boy, who did not have any known illness, was presented with polyuria. The detailed history revealed the findings of learning difficulty, speech impairment, unsteady gait and an operation of polydactyly. He had consanguineous parents and a brother who had abruptly diagnosed with the end-stage renal disease at the age of 21. These clues pointed to genetic background. Results: On physical examination, he had pectus excavatum, atypical facial appearance, dysarthria, hypotonia, rotatory nystagmus, impaired tandem walk, hyperpigmented retinal irregularities. Laboratory examinations showed Stage-4 chronic kidney disease accompanied by tubulopathy. Ultrasonography detected cystic lesions on the corticomedullary junction. Thus, the patient had diagnosed Juvenile-Nephronophthisis. During further examinations, Molar Tooth Sign was detected in cranial MRI imaging. All these clinical and radiological findings indicate the spectrum of Joubert-Syndrome-Related-Disorders (JSRD). Genetic analysis of the patient and his brother revealed homozygous NPHP1 deletion. Distinctly from literature, they both had hematological involvement in the form of persistent thrombocytopenia. Conclusions: Genetic heterogeneity and phenotypic variability of nephronophthisis are major challenges. Although NPHP1 deletions are mostly identified in isolated nephronophthisis, they have also been described in complex ciliopathy syndromes such as JSRD. This case is also specific due to haematological involvement additional to kidney, retina, skeleton, neurological. We think, this case may shed light on future genotype-phenotype studies.

Background: Dent disease is an X-linked renal proximal tubular disorder characterized by low-molecular-weight (LMW) proteinuria, hypercalciuria and nephrocalcinosis/nephrolithiasis that frequently develops chronic kidney disease (CKD) over time. The aim of this study is to describe the long term outcome of patients with Dent disease.

Methods: This is a retrospective, observational study including affected male patients who were diagnosed during childhood. We measured urine and blood parameters related to the expected evolution of the disease and registered radiological findings, estimated glomerular filtration rate (GFR) and the treatment they received.

Results: Seven male patients were included, all of them carrying CLCN5 gene pathogenic variants. They were referred to the Pediatric Nephrology Service at the median age of 3 years (range 11months-13years) due to proteinuria (3patients), proteinuria and hypercalciuria (1), kidney failure (1) and familial study (2) . The median rate follow-up time was 9 years (range 2-20.5 years). All of the patients have, at last follow-up, LMW proteinuria and 5 patients have hypercalcemia and nephrocalcinosis. None of them have nephrolithiasis or hematuria. Additional manifestations of proximal tubular dysfunction are also present with variable frequencies, such as hypokalemia (3patients) or glycosuria (1) . Three patients have hypophosphatemia, low bone mineral density and take phosphate supplements from the adolescence. One patient showed growth failure and received Growth Hormone Therapy. At diagnosis, the median estimated GFR was 96ml/min/1.73m 2 (range and one patient had CKD. During follow-up period, 4 patients developed CKD (II-III), median GFR 82ml/min/1.73m 2 (range 51-157) with the median age of 18years (range [13] [14] [15] [16] [17] [18] . Four patients need thiazide and amiloride combination drugs, 5 receive potassium or phosphate supplements and 3 vitamin D supplements. Conclusion: Dent disease is a rare condition with poor long-term prognosis that progress to CKD at early adulthood and may develop hypophosphatemia with risk of osteomalacia. Genetic diagnosis is essential for the study of relatives.

Maduri Raja 1 , Mushfequr R Haq 2 , Bhumita Vadgama 2 , Arvind Nagra 2 , Rodney D Gilbert 2 , Evgenia Preka 3 Objectives: Drug-induced tubulointerstitial nephritis (DI-TIN) remains an underappreciated cause of AKI in children with delays in diagnosis and treatment contributing to further renal sequelae. Although corticosteroids are widely used in severe DI-TIN cases, knowledge of its efficacy in children is limited with no valid data from large randomised controlled trials. In order to reach generally accepted policies for these patients, all successful experiences should be reported. Methods: Retrospective review of case notes and analysis of kidney function data (from admission up to 12 months) alongside review of current literature. Results: A 6- year-old girl presented with oliguric acute kidney injury (AKI) [eGFR 11ml/min/1.73m 2 ] requiring continuous veno-venous haemofiltration (CVVH). History suggested recent use of ibuprofen, paracetamol and ceftriaxone following a positive urine culture with enterococcus. She had a previous history of recurrent urinary tract infections associated with self-limiting AKI episodes and both times she was given regular NSAIDs and antibiotics. Kidney biopsy showed a mixed interstitial infiltrate of lymphocytes, plasma cells and eosinophils with patchy tubulitis and neutrophil casts. Ophthalmology review was normal. Despite 4 days of daily CVVH, discontinuing potential nephrotoxic drugs and subsequent improvement in urine output, her eGFR remained between 14-16ml/min/1.73m 2 . A tapering steroid regime was started on day 6 and reduced over 6 weeks [initial prednisolone dose 1mg/kg/ day]. The eGFR improved to 49.7ml/min/1.73m2 after the first 4 doses and normalised 1 month after commencing prednisolone. DMSA and MCUG at 6 months follow-up were normal. Her latest eGFR at 12 months follow-up is 100.6ml/min/1.73m 2 .

Conclusion: Based on current literature and our case report, we suggest that early diagnosis and timely administration of corticosteroids in severe DI-TIN cases can lead to full recovery despite a critical initial presentation. Large randomised prospective studies are needed to determine bestpractice recommendations for DI-TIN treatment in children. Objective: Kidney transplantation (KTx) is the best treatment option for renal replacement therapy in pediatric patients with end-stage renal disease (ESRD). However, especially in very small children KTx can be a challenging procedure with a higher risk of peri-operative complications and poorer outcome. The aim of this study is to to analyze the outcome of KTx recipients weighting under 15 kg, focusing on surgical and infectious complications. Methods: We reviewed our retrospective database for recipients of KTx between January 2018 and April 2021 with body weight under 15 kg. Results: In the period between 1 January 2018 and 31 March 2021, 86 paediatric KTxs were performed at İstinye University Liv Bahçeşehir Hospital. 32 (37,2 %) of these 86 children had a body weight of <15 kg at the time of Ktx. Twenty-seven of 32 children who had detailed followup data were included in the study. There were 13 females (48.1 %) and 14 (51,9 %) males. Mean weight of the patients was 11.69±2.16 kg and mean age was 3.60±1.59 years. Median follow-up was 9.5 (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) months. The most common cause of ESRD was nephrotic syndrome (26.9 %). Six (22 %) patients were on hemodialysis whereas 9 (33%) were on peritoneal dialysis treatment. In 12 (44%) patients Ktx were performed preemptively. The only postoperative complication was ileus (3 patients Introduction: The long-term outcome of combined liver and kidney transplantation (CLKT) in a 13-year-old boy with end stage kidney disease secondary to homozygous protein C deficiency (PCD). Material and methods: Retrospective review of case notes, kidney function and protein C (PrC) levels from birth to 13 years of age (10 years post-transplantation); Cost comparison pre and post CLKT.

Results: This is the first report of 10-year post-CLKT outcome in a child with PCD born with bilateral renal venous thrombosis resulting in end stage kidney disease. He had worsening kidney function due to recurrent thrombotic episodes secondary to undetectable PrC levels. On PCD diagnosis at 7 months of age he started activated PrC infusions (levels maintained >0.25IU/ml) to prevent thrombosis. He received a deceased donor CLKT at age 3 years. PrC levels were maintained above 100IU/ml peri-operatively to prevent thrombosis and were discontinued 48 hours post-CLKT when levels were 1.03IU/ml. 10 years post CLKT they remain normal (0.79IU/ml) with no thrombotic episodes since CLKT and he has had no further requirement for exogenous PrC. Kidney function: His creatinine improved rapidly from 350μmol/l pre-CLKT to 30μmol/l post-CLKT. Kidney function remained stable but deteriorated 6 years post-CLKT secondary to antibody mediated rejection. This responded to increased immunosuppression. Cost analysis: Pre-CLKT PrC infusions cost £182,000/year. The cost of the CLKT was approximately £130,000 for the first year. 10 years post-CKLT, over £1,000,000 has been saved on PrC infusions alone and no requirement for long-term dialysis.

Conclusions: CLKT in PCD with early renal involvement restores hepatic synthesis of PrC and provides definitive renal replacement therapy. CLKT has few long-term complications and is a cost-effective treatment option. This first reported case suggests CLKT should be considered as a treatment option in similar cases of PCD. and bladder within 3 days after transplantation. Concentrations at 3, 6 and 12 hours post-reperfusion were compared with the half-life of serum creatinine at reperfusion (T1/2Creat) as measure of graft recovery, and with the estimated glomerular filtration rate (eGFR) after 3 months.

Results: At all time-points post-transplantation, the median graft uNGAL concentration was lower than the bladder concentration, whereas the median graft uIL-18 concentration was structurally higher than the bladder concentration. After reperfusion, the graft uNGAL and uIL-18 concentrations peaked within 6 hours, then gradually declined. The graft uNGAL and uIL-18 concentrations at 3, 6 and 12 hours post-reperfusion correlated with the rate of graft recovery, and predicted slow graft function, with higher ROC-AUCs for uNGAL than for uIL-18. The graft function at 3 months posttransplant was only weakly predicted by the uNGAL and uIL-18 concentrations at the early time-points. Conclusions: uNGAL and uIL-18 concentrations in urine directly drained from the graft in the hours after reperfusion are associated with graft recovery after transplantation. Thus slow graft function can be anticipated by measuring these tubular injury markers and therefore prevent us to perform more invasive diagnostic interventions in pediatric kidney recipients.

Cheryl Lim , Manish Sinha , Nabil Melhem Evelina London Children's Hospital, United Kingdom

Introduction: Thrombosis is a rare but catastrophic complication in the context of paediatric kidney transplantation. Whilst thrombophilia is often implicated, there are few data to support this association. We describe the prevalence of thromboembolic events (TEs) in paediatric kidney transplant recipients and assess the clinical utility of pre-operative thrombophilia screening. Material and methods: Single-centre, retrospective study of all paediatric kidney transplant recipients aged 1-18 over a 5 year period. Results: 84 children included with a mean age of 11.1 ± 5.2 years. 54(64.3%) boys, 59(70.2%) white-Caucasian, and 48(57.1%) with CAKUT. 61(72.6%) were receiving dialysis at time of transplantation. All participants underwent thrombophilia screening pre-transplantation to identify inherited and acquired abnormalities of coagulation. Abnormal thrombophilia screen was recorded in 37(44.0%) with 20(23.8%) showing persistent abnormalities upon repeat testing. 11 (13.1%) had anticardiolipin (AC) antibodies, 11(13.1%) lupus anticoagulant (LA) antibodies, 2(2.4%) elevated homocysteine, and 5(6.0%) were heterozygous for thrombophilic gene mutations. 21(25.0%) started prophylactic unfractionated heparin post-operatively as per haematologist advice pre-transplantation and 10(11.9%) following intraoperative decision by transplanting surgeon. Overall, TEs occurred in 10(11.9%) patients. 6(7.1%) pre-transplant of whom only two had LA antibodies. A further 4(4.8%) TEs occurred post-transplant of whom one had abnormal screening (AC antibodies and protein S). Graft loss did not occur following TEs. There was no association between pre-operative thrombophilia screening and pre or post-transplant TEs (p=0.70). Dialysis and non-White ethnicity was associated with abnormal thrombophilia screening (p=0.04 and p<0.01 respectively). Conclusions: We found a high prevalence of thrombophilia in our pre-transplant population, particularly in those on dialysis and of ethnic minorities. Despite high prevalence of abnormal tests, we observed lack of significant predictive value of detailed testing. Risk stratification could improve our approach to transplant thromboprophylaxis, with focus on patients with previous TEs and on dialysis.

Introduction: BK virus nephropathy (BKVAN) is a clinicopathological entity that negatively affects graft function in kidney transplant recipients.

In this study, we aimed to evaluate the efficacy of leflunamide treatment compared to cidofovir in patients with BKVAN.

Material and methods: The medical records of kidney transplant recipients with BK viremia between 2004 and 2019 were reviewed retrospectively, and those with a diagnosis of BKVAN were included in the study. Serum BK virus level above 10 4 copies was accepted as BK viremia. BKVAN was defined as the detection of BK virus SV40 antigen in renal graft tissue by immunochemistry staining and accompanying signs of tubulointerstitial nephritis or the presence of high serum creatinine in addition to BK viremia. Results: Of 304 kidney transplant recipients, 53 had persistent BK viremia; and 36 of these patients (61.1% male) were included in the study with the diagnosis of BKVAN. Median age at the time transplantation was 12.23 years. Anti-thymocyte globulin was administered in 52.8% of patients for induction therapy, and tacrolimus was used in 80.6%. As a first-line treatment; MMF dose was reduced in 34 (94.4%) patients, MMF was switched to azathioprine in 9 (25.0%), calcineurin dose was reduced in 29 patients (80.5%). Ciprofloxacin was given to all patients. 12 patients (33.3%) received cidofovir and 14 (38.8%) received leflunamide. Plasma BK virus load and graft functions were similar between the groups. Median viremia clearance time after treatment was lower in the leflunamide group compared to cidofovir (3.0 vs 4.0 weeks, p=0.032). Graft failure occurred in 5 of 12 patients treated with cidofovir and 3 of 14 patients treated with leflunamide (p=0.310). There were no advers effects associated with leflunamide and cidofovir, leading to a discontinuation of treatment.

Conclusions: Leflunamide is an effective and safe treatment option that can be used in kidney transplant recipients with BKVAN. Introduction: In pediatric kidney transplantation, adequate perfusion of adult-sized grafts demands significant hemodynamic changes in small recipients. Hypoperfusion can shorten graft survival by loss of kidney mass and function, especially in donor-recipient size mismatch. In order to adequately perfuse the transplanted adult-sized kidney, young recipients are hypothesized to develop a supraphysiological hemodynamic state. Our primary objective is to enhance knowledge and insight in hemodynamic responses after pediatric kidney transplantation with a living, adult donor. By comparing Magnetic Resonance -Arterial Spin Labeling (MR-ASL) with transabdominal and intra-operative ultrasound (US), our secondary goal is investigating the reliability of non-invasive techniques in monitoring donor kidney perfusion after transplantation.

Material and methods: Twenty children (including donors) with a maximum age of 15 and a maximum weight of 40kg will be included in this prospective clinical pilot study with 12 months of follow-up. Perioperative hemodynamics are monitored closely, including cardiac output measurements. We measured volume of the kidney graft (MR), whole organ kidney perfusion (MR-ASL) and afferent blood flow (US and MR) before, during and 6 months after transplantation. We present the first three patients with complete series of imaging in follow up.

Results: MR-ASL perfusion imaging yields good quality images and reproducible perfusion values. Kidney graft volumetrics and perfusion showed a decrease after transplant, and a subsequent compensatory increase at 6 months. Afferent flow measurements comparing US and MR are corresponding, and in line with our hypotheses. Introduction: Despite the significant improvement in immunosuppressive therapy over the years, graft rejection remains the leading cause of graft loss in kidney transplanted children. The aim of this study was to identify which are the acute rejection (AR) at major risk for nonresponding to anti-rejection treatment. Material and methods: A retrospective analysis of all the AR diagnosed in our Hospital (Jan 2015-Aug 2020) in kidney-transplanted children, who completed the anti-rejection treatment and a follow-up biopsy after the AR treatment, was done. The immunohistochemical characterization (IC) of the cellular infiltrate with anti-CD3/CD20 antibodies was performed on all the biopsies. Results: 73 AR (53% subclinical) in 52 children: 33 males, median age 9 years, 19% pre-emptive, 30% living donor, 10% 2 nd kidney transplant. The Banff-17 criteria classified 54% cellular, 38% antibody-mediated and 8% mixed rejections. At the IC 84% had a mixed CD3-CD20 infiltrate. Cellular AR received pulse methylprednisolone (386 mg/mq, 293-488) and ATG in 7 cases. The antibody-mediated AR: 88% pulse steroid, 94% immunoglobulin, 62% plasmapheresis and 68% Rituximab. After treatment, a follow-up biopsy proved: 32% Banff1, 42% persistent AR and 26% IFTA. At the univariate and multivariate analysis, children at risk for non-responding to AR treatment were those at the 2 nd transplant, previously dialyzed, with a poor graft function at discharge from transplant, older at the time of AR. AR, if diagnosed by a protocol biopsy, or treated with a major pulse methylprednisolone dose or switched to Tacrolimus, had a better outcome. A predominant CD3 infiltrate increased risk of nonresponding to treatment (OR 10.11, .

Conclusions: The protocol biopsy, the pulse steroid dose and the switch to Tacrolimus are the only modifiable variables that correlate with a better response to the anti-rejection therapy. The implementation of IC of the inflammatory infiltrate could be an additional tool to identify patients most likely to not respond to therapy.

Introduction: The objective of this study was to explore immunological causes of inferior graft survival in renal transplant recipients during late adolescence and young adulthood in comparison to other age categories.

Material and methods: This study is part of the larger multicentre cohort study Adolesce-NT and investigates the relationship between T cell subsets and pubertal stage in patients with end-stage renal failure, renal transplant recipients and healthy controls. Participants, with age 8 to 30 years at time of inclusion, were divided in a pre-transplantation, post-transplantation and healthy control group. Exclusion criteria: no informed consent, pubertas praecox, prior treatment with immunomodulating agents. Patients had two study visits one year apart, healthy controls had one study visit. Participants were classified as pre-pubertal, early pubertal, late pubertal or post-pubertal according to skeletal age, Tanner stadium and/or testis volume. Using 8-color flow cytometry, mean cell counts of recent thymic emigrants (CD4+CD31+CD62Lhi and CD8+CD31+CD62Lhi) and naïve and memory T cells (CD4+ and CD8+ Temro, Temra and Tcm) were determined. Results: In total 267 participants were included in the analysis. The increased numbers of recent thymic emigrants showed a trend towards a higher thymic T cell output during the late pubertal period in both patient groups compared other age groups (pre-transplantation group p=0.053, post-transplantation group p=0.054). Memory T cells showed a higher cell count during the post-pubertal stage, being CD8+ Temra in the pre-transplantation group (p=0.014) and CD4+ Temro in the healthy control group (p=0.027) compared to other age groups.

Conclusions: The current study shows a trend towards a more active immune system during the late pubertal and post-pubertal stage in transplant patients. These observations form an important starting point to further explore the possible causes of the poorer kidney transplant survival during late adolescence and early adulthood.

Introduction: We aimed to analyze the effect of pretransplant recombinant human growth hormone (rhGH) and corticosteroid withdrawal on longitudinal growth in the 1 st year after kidney transplantation (kTx) and to identify factors associated with final height (FH) in pediatric kTx recipients.

Material and methods: Patients who underwent kTx between 1996 and 2018 in 5 Belgian and Dutch centers before the age of 18 yrs were included in this retrospective study. We analyzed the differences between height SDS at kTx and 1 year post kTx (D height SDS) in children who were and were not treated with rhGH before kTx (rhGH+ and rhGH-) and those with and without corticosteroids at 1 year (CS+ and CS-). Univariate and multivariate linear regression analysis was performed to identify factors associated with height SDS at 1 year post kTx, D height SDS and FH SDS.

Results: 179 patients were included, with a median age at kTx 9.27 years. The median height SDS before kTx and 1 year after kTx in the CS-/ rhGH-, CS+/rhGH-, CS-/rhGH+ and CS+/rhGH+ groups were respectively -1.42/-0.80, -0.90/-0.62, -1.35/-1.20 and -1.30/-1.60 (p=0.001).

Corticosteroid use at 1 year post kTx was the only factor associated with D height SDS on multivariate analysis (p=0.003). Median FH SDS, available in 124 patients, was -0.80 (range:-7.30 -3.10). There was an association between FH and D height SDS at 1 year (p<0.001). Of 96 patients with height SDS <-1 at 1 year, 64 had FH <-1 SDS. Corticosteroid dose at 1 year was associated with FH on multivariate analysis (p=0.014).

Conclusions: Growth in the first year post kTx was highest in the CS-/ rhGH-group and lowest in the CS+/rhGH+ group. The use of corticosteroids at 1 year post kTx is the most important factor associated with growth in children in the 1 st year after kTx and their final height.

Introduction: Kidney transplant candidates and recipients have a high risk for infectious diseases which are preventable with vaccination.

Monitoring the serology in pre-and post-transplant periods may guide during follow-up, as these patients vaccine responses have decreased due to existing renal failure and immunosuppressive treatments. The aim was to determine the course of Hepatitis-B titers in pediatric renal transplant recipients.

Material and methods: A retrospective analysis of the patients was performed in a single center. The Hepatitis-B surface antibody (Anti-HBs) titer >10 mIU/mL was considered positive. The most recent pretransplant titer and the lowest post-transplant titer during follow-up were compared.

Results: A total of 30 patients were involved. Transplantation age was 9.5±4.4 years, and current age was 15.5±5.8 years. Male/female ratio was 2. Cadaveric transplantation was performed in 40% of them. There was a significant decrease in Anti-HBs titers after transplantation. No relationship was found between the Anti-HBs titers and primary disease/donor type. The ratio of positive serology was similar in pre-and post-transplant periods (86.7% and 70%, respectively). Pre-transplant positive patients(n=26) were divided into two groups as "titer >100 mIU/mL" and "titer between 10 and 100 mIU/mL". The second group had significantly lower titers after transplantation, while the first group had similar titers. Six(23%) of pre-transplant positive 26 patients had became negative in a mean of 24±28 months, and it took less than 5 years to become negative in 70% of them. Also, five patients had pre-transplant titers below 100 mIU/mL. Pre-transplant Anti-HBs was negative in four patients (13.3%) . After Hepatitis-B vaccination, the Anti-HBs became positive in three of them. However, on follow-up, it became negative again in two patients. Conclusions: After kidney transplantation, a decrease of Anti-HBs titers may be observed in recipients, especially in those with titers below 100 mIU/mL. Therefore, monitorization of the serologic responses, even after repetition of vaccine may be helpful. Introduction: This study was performed to evaluate the usefulness of the estimated glomerular filtration rate at one month after transplantation (eGFR-1M) in predicting the change of graft function in paediatric living renal transplant recipients. Material and methods: The 43 paediatric recipients were classified as those with eGFR-1M ≥ 90 ml/min/m 2 (n = 19; Group A) and those with eGFR-1M < 90 (n = 24; Group B). In Group A and B, changes in eGFR were evaluated for five years after renal transplantation retrospectively. Results: The mean recipient age at transplantation in Group A / B was 6.1±3.4 / 7.8±4.0 years (P=0.14). In both groups, more than 50% of the recipients had congenital anomalies of the kidney and urinary tract (CAKUT) as their primary diseases. The mean eGFR-1, 12 and, 60 M (ml/min/1.73m 2 ) in Group There were no significant differences in donor age, the number of recipients with CAKUT as primary disease, acute rejection and BK nephropathy between both groups.

Conclusions: The eGFR-1M could be useful in predicting the change of graft function in paediatric living renal transplant recipients. Our study also suggested an interesting finding that body size mismatch between donor and recipient could affect graft function up to five years after transplantation. Introduction: Height-adjusted total kidney volume (htTKV) is a validated prognostic measure for adult ADPKD e.g. to categorize disease severity and progression according to the Mayo classification. Recently, our group has implemented a novel 3D ultrasound (3DUS) method to measure htTKV in pediatric ADPKD. We aim to develop a pediatric ADPKD imaging classification wherein 3DUS htTKV functions as a prognostic parameter.

Methods: Genetically-confirmed pedADPKD patients were evaluated between 2015-2020 in a tertiary hospital, and htTKV was assessed using 3DUS manual contouring. htTKV values were plotted according to patient's age. Slopes of renal growth were defined into five approximately equal-sized severity classes. The borders delineating the different slope areas were defined using y=A*(1+B)^x (applied from the MAYO classification), with "A" the starting htTKV at age 0 and "B" the yearly htTKV % increase.

Results: 67 genotyped patients (32 female, 35 male) underwent in total 232 3DUS assessments. Age (mean+/-stdev) at first evaluation was 10.5+/-4.8years (range: 0. 2-19.2) , height 143+/-29cm (59-198) , and htTKV of 187+/-101mL/m (74-630). Extrapolating the MAYO curves (A=150mL/m, B=1.5, 3, 4.5 and 6%/year) below the age of 15 years strongly overestimates htTKV in children, even with correction for patient height. Therefore, we optimized renal growth cut-off lines with respective values A=70, 80, 90, 100 and B=6, 7.5, 9, 10 .5%, splitting the 232 scans into 5 subgroups with 47, 94, 42, 27 and 22 patients, respectively. We demonstrated an accelerated growth after the age of 10 years comparing to the expected kidney growth in children.

Conclusion: Extrapolating htTKV cut-off growth curves of adults to pediatric patients, we developed an optimization of the previous adult model to a pediatric ADPKD population with 3DUS. This provides a tool to stratify disease severity and progression from a young age, which is a novelty in pediatric ADPKD.

Charlotte Duneton 2 , Roshan George 1 , Mandy Ford 1 , Pamela Winterberg 1 1 Emory University, Atlanta, USA, 2 Robert Debré Hospital, Paris, France

Introduction: Despite improved patient and graft outcomes with CD28-CD80/86 costimulation blockade, increased early acute rejection has hindered the widespread use of belatacept (CTLA-4Ig) for kidney transplant. Our group has previously reported lower pre-transplant frequencies of CD28 + CD4 + effector memory helper T cells (CD4 + T EM : CCR7 -CD45RA -) with decreased functional capacity in adults that were subsequently free from early rejection on belatacept. We aimed to determine if a similar T cell phenotype is detectable in children awaiting kidney transplant.

Material and methods: We analyzed existing flow cytometry data of unstimulated blood cells collected from children on dialysis (n=30) or healthy children (n=18) and examined expression of markers of costimulation (CD28), senescence (CD57, PD1), activation (CD38) and cytotoxicity (Perforin, Granzyme B) on memory CD4 + T cells.

Results: None of the children had CD28 + CD4 + T EM frequencies as low as those we have previously observed in adults that were rejection-free on belatacept. However, 8 children on dialysis (27%) had CD28 + CD4 + T EM frequencies (median 92.56%, 05) below the minimum value (96%) observed in healthy children (99.82%, 99.46-99.91; p<0.0001) . Patients with this "stable-like" T cell phenotype had higher frequency of CD4 + T EM cells bearing senescence markers (CD57 + PD1 + , p=0,011) and cytolytic effectors (Granzyme B, perforin, p=0,0004) but decreased activation markers (CD38 + , p=0,003) compared to the rest of the dialysis patients. Conclusions: Despite their young age and limited antigen experience, a subset of children on dialysis accumulate CD4 + T EM cells that have lost CD28 expression and bear markers suggestive of impaired function, a phenotype reminiscent of adults with decreased risk for early rejection on belatacept. The functional capacity of these cell populations in children needs further study.

Introduction: Inflammaoma complex (NOD-like receptor protein 3 (NRLP), apoptosis-associated speck-like protein (ASC), inactive butchipase-1) is a part of the innate immune system has recently been shown as the responsible mechanisms that lead to kidney damage in kidney stone disease. According to the one of the mechanisms responsible for this process, crystal structures such as oxalate enter the cell and cause mitochondrial damage. Then reactive oxygen species resulting from the damage cause the formation of the inflammasome complex. Elamipretide is a drug containing peptide in aromatic cationic structure and it has been shown that acute tubular necrosis prevents the development of chronic damage in the kidneys by reducing the formation of inflammasome. In this study, it was investigated whether the use of Elamipretide for the first time reduced the activation of the inflammatory pathway caused by oxalate crystals and the occurrence of kidney damage Material and methods: In this study, 40 C57BL6 mice at 10-12weeks of age were used (8 controls, 32 experimental groups). The study group was administered 200 mg / kg sodium oxalate intraperitoneally (IP) for 4 days. No application was made to the positive control group after the 5th day. Phosphate buffer saline was administered to the placebo group on days 0-9, and elamipretide at a dose of 5 and 7.5 mg / kg / day was administered via IP to the drug groups. On days of 0,5 and 10, the mice were weighed and urinated. The experiment was terminated on the 10th day and the mice were bled and their kidneys removed. Serum kreatinine was measured.

Histopathological evaluation was made in the kidney tissue. The mRNA expression levels of genes and proteins involved in the formation of the inflammasome complex were measured and protein levels were determined by western blot. This study supported by the Erciyes University Scientific Research Center (TOA-2018-7752) Results: When the mice were evaluated in terms of weight changes between the 0th and 5th days, weight gain was observed in the negative control group, while weight loss was detected in the other groups and the difference was statistically significant. Serum creatinine level was lower in negative control and elamipretide groups. It was observed that urine oxalate values on day 5 increased significantly in all groups compared to the negative control group (p = 0.037). Histologically, it was observed that kidney damage was less and mitochondrial damage was reduced in elamipretide groups. When the groups were compared in terms of IL-11, it was found that the gene expression in the placebo group was statistically significantly higher than the other groups and that caspas 1, caspas 9, caspas 11 and NLRP3 gene expression were significantly lower in the negative control group compared to the other groups. There was no significant difference in terms of caspas 1, caspas 9, caspas 11 and NLRP3 gene expression between treatment groups (plasebo vs elamipretid).

Conclusions: In this study, it has been shown that elamipretidine reduces mitochondrial damage, and with increased caspas1 and NLRP3 mRNA expressions, the inflammatory pathway is active in oxalate nephropathy, but elamipretide is not effective in suppressing this pathway

Introduction: Apolipoprotein L1 (APOL1) variants, G1 and G2, increase the risk of various non-diabetic kidney diseases in the African population.

To date, the precise mechanisms by which APOL1 risk variants induce injury on podocytes and other kidney cells remain unclear. Trying to unravel these mechanisms, most studies used animal or cell models created by gene editing. Material and methods: We developed conditionally immortalized human podocyte cell lines from urine of a donor carrying APOL1 high-risk genotype (HRG), G2/G2. As control, APOL1 wild type (G0/G0) podocytes previously generated from a Caucasian donor were used. The APOL1 G2/G2 cell lines were characterized for podocyte markers at both the mRNA and the protein levels, using real-time quantitative PCR and Western blot, respectively. APOL1 expression was induced upon exposure to 50 μg/mL polyinosinicpolycytidylic acid (poly(I:C)). Validation of the functional features of APOL1-induced podocyte dysfunction such as cell detachment, cell viability, cell death, autophagy, cytoskeleton organization and podocyte permeability were assessed. Results: We successfully generated for the first time APOL1 G2/G2 podocyte cell lines isolated from urine of a human donor carrying APOL1 high-risk genotype (HRG). Upon exposure to poly(I:C), G2/G2 and G0/G0 podocytes upregulated APOL1 expression regardless of the APOL1 genotype. This resulted in podocytes detachment, decreased cells viability and increased apoptosis rate in a variant-independent manner. Nevertheless, G2/G2 podocyte cell lines exhibited altered features, including upregulation of synaptopodin, alteration of cytoskeleton, reduction of autophagic flux and increased permeability in an in vitro model under continuous perfusion.

The human APOL1 G2/G2 podocyte cell model is a useful tool for unraveling the mechanisms of APOL1-induced podocyte injury and the cellular functions of APOL1. Genotype rs4293393 TC (TC) was present in 10 pts, 9 (90%) had scars; genotype rs4293393 TT (TT), the most frequent in the general population, was found in 21 patients, 7 (33%) had scars. Among children with scars, those with TC compared to those with TT were younger (mean age 77 vs 101 months), their reflux grade was lower (2,5 vs 3,6) , the number of FUTI was lower (2.9 vs 3.7 per patient). Objectives: Bladder schistosomiasis is a rare cause of hematuria. We present three patients with different evolution, highlighting the importance of this pathology in the differential diagnosis of persistent hematuria. Methods: Case 1: A 9-year-old male from Mali with macrohematuria for 4 months. The physical examination and the renal ultrasound were normal with a negative urine culture. The urine test showed hematuria, leukocyturia and proteinuria. Blood tests just showed anemia. In the microbiological urine study, Schistosoma haematobium (SH) eggs were observed. He received three doses of Praziquantel. One month later, he still had microhematuria and SH eggs in the urine, so another praziquantel cycle was repeated. Case 2: A 10-year-old male from Guinea. He presented intermittent episodes of macrohematuria with hypogastric pain. She received antibiotic therapy for suspected acute cystitis. He had hematuria, leukocyturia, and moderate proteinuria. Renal ultrasound showed a bladder with thickened walls and inflammatory appearance, compatible with cystitis and distal ureteritis. The microbiological study showed eggs of SH. He received three doses of Praziquantel. 3 weeks later he had a normal urine, but SH eggs persisted, so the treatment was repeated. Case 3: A 11-year-old male from Senegal. In Spain for 3 months. He presented a 1-month of macroscopic non-painful hematuria. The urine test showed proteinuria in the nephrotic range, hematuria and leukocyturia. The renal ultrasound showed a thinned bladder without calcifications. In the urine we found SH eggs. He received three doses of praziquantel with urinary normalization in 2 weeks. Results and Conclusions: SH has a special tropism for the perivesical plexuses. In chronically affected patients, the eggs may persist after treatment, requiring an other cycle of praziquantel at 4 weeks. If the clinic persists, we must rule out scar lesions or subsidiary granulomas of surgical resection.

Objectives: Extremely low birthweight (ELBW) infants suffer from poorer outcomes in later life, including lower estimated glomerular filtration rate (eGFR). We aim to identify the perinatal factors influencing these outcomes, as previously reported for neurodevelopmental outcome, enabling targeted renal follow-up. Methods: As part of the PREMATCH study, we evaluated and compared eGFR in 59 ELBW children and 71 controls at age 11. Adverse renal outcome was defined as presence of chronic kidney disease (CKD) stage 2 (eGFR <90 ml/1.73m 2 /min). We investigated perinatal factors associated with this adverse renal outcome to develop a proof-of-concept model to predict the proportional risk of CKD stage 2 in ELBW children.

Results: We confirmed that ELBW children suffer from lower average eGFR than controls (94.1 vs. 106.5 ml/1.73m 2 /min, p<0.001). Amongst ELBW children 34.5% progressed to CKD stage 2. ELBW children with CKD stage 2 were more frequently male (75% vs. 47.7%, p=0.055), were ventilated significantly longer post-birth (17 vs. 9 days, p=0.006) and suffered more commonly from intraventricular hemorrhage (IVH) (40% vs. 15.8%, p=0.056). In contrast, birthweight, gestational age, steroids/ ibuprofen use, duration of oxygen therapy, retinopathy of prematurity and bronchopulmonary dysplasia showed no significant association to renal function in adolescence. In our model, we developed a score (0-3) to determine the risk of CKD stage 2 based on the cumulative perinatal risk factors sex (male), ventilation duration (>10 days), and IVH. We found this risk to increase linearly from 0% to 80%, delineated as follows -0 points: 0%; Introduction: Percutaneous kidney biopsy is considered a safe procedure in the diagnosis and management of paediatric kidney disease. We aimed to study complications to percutaneous kidney biopsies made in children in our centre and to target potential risk factors to the procedure. Material and methods: We retrospectively studied kidney biopsies performed during a five-year period in the Swedish regional centre of Queen Silvia Children´s Hospital. Our study included both native and transplanted kidneys, with exclusion of oncological biopsies. All biopsies were performed by a paediatric radiologist under general anaesthesia using ultrasound-guidance. Most of the elective biopsies followed a protocol enabling discharge after six to seven hours of observation. Complications were divided into minor, moderate and major events, where minor complications were classified as events not in need of further investigation nor intervention.

Results: 232 biopsies were performed in 198 individuals, 116 (59%) boys and 82 (41%) girls. The median age was 10.8 (1.4-18.4) years. Nephrotic proteinuria or minimal change disease was the most common indication, followed by non-nephrotic proteinuria or haematuria and investigation of kidney transplants. One major complication with the need of blood transfusion occurred. The complication was identified as a large renal hematoma during the procedure. We found the most common complications being minor complications, involving minor reduction of haemoglobin, renal hematomas and transient macroscopic haematuria. Identification of 75% of complications was made by <6 hours and 95% by <12 hours. Increased number of needle passes and low diastolic blood pressure was significantly associated with moderate to major complications. Conclusions: Kidney biopsy in children is a low-risk procedure. The number of needle passes and low diastolic blood pressure were associated with the risk for more serious complications in children. . For a start concentration of e.g. 3000μmol/L in a 3kg patient, time to reach 400μmol/L was 315min (QB30) and 190min (QB50) with 4008/FXPaed. The CarpeDiem machine could not decrease ammonia concentrations below 400μmol/L within 4h for start concentrations >800μmol/L. Simulations with CarpeDiem or 5kg patient resulted in longer time intervals. Our institution-specific protocol therefore prescribes 4008/FXPaed for start concentrations >400μmol/L. To calculate the time needed to decrease start ammonia concentration C start to target C target , the following algorithm can be used: from patient's total body water (V) (Wells formula) and dialyzer clearance (K) (by single measurement of ammonia at dialyzer inlet and outlet), time (T) to target T=(-V/K)•LN(C target / C start ).

Conclusions: By implementing these formulae in a simple spreadsheet, medical staff can draw its institution-specific flowchart for patienttailored treatment of hyperammonemia. Due to some made assumptions in kinetics, our own institution-specific protocol will be applied and studied in a prospective study to validate the present results. Introduction: The evidence from individual studies to support the maturational pattern of measured glomerular filtration rate (GFR) in healthy term born neonates is inconclusive. This hampers the delineation between normal and abnormal kidney development as well as the diagnosis of acute kidney injury (AKI). Thus, we aimed to describe GFR maturation in the first month of life using an individual participant data meta-analysis (IPDMA) of measured GFR data. Material and methods: The Pubmed and ClinicalTrials.gov databases were searched to identify studies reporting mGFR as measured by exogenous markers or creatinine clearance (CrCL) in healthy term born neonates.

Articles were subsequently reviewed using Rayyan by two individual researchers. The relationship between postnatal age and clearance was investigated using penalized splines with generalized additive linear mixed models on individual data, taking into account clustering by study. Data from aggregated results were simulated to exactly reflect the reported mean/median and SD. Acute clinical course, duration of renal replacement therapy (RRT) and extra-renal involvement were reviewed. 12-month and 5-year follow-up data (kidney function, proteinuria, antihypertensive requirement and neurodevelopmental outcomes) were analysed using descriptive statistics and compared to an O15:H7 HUS case cohort. Results: Median age at presentation was 3 years; 60% were male. 9 (90%) had bloody diarrhoea. STEC O55:H7 serology positive in 5 (50%); Stool culture positive for STEC O55:H7 in 9 (90%). Mean acute dialysis duration was 17 days with 9 children requiring more than 10 days of RRT. Neurological involvement was seen in 7 (70%); 3 (30%) had cardiac involvement. At 12-month follow up, 6 (60%) were on a single antihypertensive agent; 8 (80%) had raised urine albumin/creatinine ratio; the median formal GFR of the O55:H7 cohort was significantly lower (50-92ml/min/ 1.73m 2 ) than that of the STEC O157:H7 HUS group. At 5 years post-HUS, 50% of the O55:H7 cohort had formal GFRs corresponding to CKD stage 2 (G3a 1 /G2 Objective: We present a patient with initial manifestation of rapidly progressive acute renal failure with macrohematuria. We consider the differential diagnosis between immunological diseases, post-renal obstructive pathologies and glomerulonephritis among other patologies. Methods: A 10-year-old female patient with a one-week clinic of abdominal pain and diarrhea. Tests showed a creatinine of 0.6 mg/dl, microhematuria and an abdominal ultrasound without signs of acute abdomen. Five days later, he presented a clinical worsening: macrohematuria with asthenia, anorexy, and isolation of Campylobacter in stool culture. Physical examination and blood pressure were normal. She presented: an increase in creatinine 4.5mg/dL (GFR 12.64 mL /min/ 1.73m2), urea: 204 mg/dL, hemogram without anemia or thrombocytopenia, no ionic alterations, hematuria>100xc and Protein/Creatinine index (P/Cr): 0.21mg/mg. Autoimmunity: ANA, ANCA, anti-basal membrane, Anti PLA2R, negative. C3: 1403mg/L, C4: 315mg/L, IgA: 4209mg/L, ASLO <200U/mL. Renal ultrasound showed bilateral renal hyperechogenicity without signs of lithiasis. Corticosteroid boluses at 30 mg/kg were started every other day due to clinical suspicion of rapidly progressive glomerulonephritis, followed by oral prednisone. He presented progressive improvement, with preserved diuresis. He was discharged seven days after admission with creatinine 0.74 mg/dL (GFR 76 mL/min/ 1.73m2), microhematuria 10-25xc and P/Cr 0.29mg/mg. The renal biopsy revealed 7 glomeruli with slight mesangial expansion, doubtful hypercellularity, tubular atrophy and mixed inflammatory infiltrate, some dilated tubules and numerous blood casts. Immunofluorescence staining: weak mesangial positivity for C3 (+), irregular focal mesangial positivity for IgA (+). We diagnosed him with acute kidney failure due to IgA nephropathy. At six months of evolution, he presented normal kidney function with negative proteinuria: creatinine 0.53 mg/dL (GFR 109mL/min/1.73m2), cystatin C:0.94mg/L, microhematuria 0-10xc and P/Cr: 0.1mg/mg. Conclusions: We want to highlight the rare presentation of a well-known pathology, where the compromise of renal function is justified by the intrarenal obstruction itself, caused by the hematic casts as well as by the tubulo-toxicity generated by hemoglobin and some of its degradation products (hematin). Objectives: Anti-glomerular basement membrane (GBM) disease is characterized by circulating anti-GBM antibodies with immunoglobulin deposition (Ig) G along the GBM. It manifests as rapidly progressive glomerulonephritis (RPGN) with crescentic proliferation with or without pulmonary hemorrhage. Early diagnosis and prompt treatment are essential to preserving kidney function. We present an eight -years -old boy who presented with macroscopic hematuria and was diagnosed with anti-GBM.

Case presentation: An 8-year-old boy was admitted to his primary care clinic with macroscopic hematuria. He had no other complaints such as fever, dysuria, cough, dyspnea, or abdominal pain. He was initially treated outpatient with antibiotics and with symptomatic therapies. Despite that, his macroscopic hematuria persisted for ten days, and he was referred to our department when his kidney functions were high. Upon admission, vital signs and physical examination were normal. Initial lab. work was significant for anemia, elevated creatinine (2.2 mg/dL), ESR (greater than 160 mm/hr, ref 0-30 mm/hr) and CRP (65 mg/dl ref less than 0.5 mg/dl). Urine analysis was remarkable for macroscopic hematuria -glomerular origin (numerous dysmorphic erythrocytes, erythrocytes cast). The chest graphic was normal. Renal and bladder Ultrasonography, complement analysis, was normal. He underwent a renal biopsy which showed necrotizing and crescentic glomerulonephritis with positive linear IgG along the GBM. Treatment included plasma exchange, intravenous high-dose methylprednisolone, and cyclophosphamide as a mainstay medication was stared. Anti-GBM antibody level was high of >200 u/ml (ref less than 20 U/ml). The treatment was effective with an immediate decrease in anti-GBM titers and creatinine levels.

After two weeks of plasmapheresis, plasmapheresis was interrupted because the negative anti-GBM titer was negative. On day 7, the anti-GBM antibody came back positive. The patient was started on plasmapheresis shown to improve outcomes and survival for patients with anti-GBM nephritis.

Results: During the follow-up, he received a 15 mg/day steroid and the second monthly dose of cyclophosphamide, and the last creatinine value was 0.7 mg/dl. Conclusions: Anti-GBM disease leads to RPGN since prompt diagnosis and early treatment are essential to improve outcomes. As seen in our case, timely diagnosis led to aggressive therapy, which ultimately translated into a favorable prognosis for our patient. Introduction: The incidence of acute kidney injury (AKI) after paediatric allogeneic haematopoietic cell transplantation (HCT) varies widely (21-53%) and its pathogenesis remains unclear. Material and methods: All paediatric patients who underwent HCT in 2015-2017 at our hospital were retrospectively assessed. Clinical and laboratory parameters including plasma creatinine (P-Cr) levels (pre HCT, peak value and at, or as close as possible to, 100 days) were recorded. AKI was defined as a ≥ twofold increase in P-Cr (KDIGO ≥ II).

Results: Sixty-one HCTs were done in 56 patients (66% boys) with a mean age of 7.5 years (0. 1 -17.4) . Most patients (51%) had non-malignant indications. Reduced intensity conditioning was more frequent (52%), as was cyclosporine as post-HCT immunosuppression (98%). Median P-Cr was significantly higher at 41 μmol/L 100 days post-HCT compared to 24 μmol/L pre-HCT (p<0.001), corresponding to an eGFR of 96 and 158 ml/min/1.7m 2 , respectively. AKI was observed in 66% of the patients and 7% of the patients had developed eGFR < 60 ml/min/1.7m 2 at the last follow-up. No patient needed renal replacement therapy. AKI incidence was significantly higher in unrelated donor (URD) HCTs compared to other donor-type HCTs (78 vs. 52%, p<0.05). Age was negatively associated with AKI. There was no association between acute GVHD, conditioning, HCT indication, infections, sex or toxic cyclosporine levels and AKI. Occurrence of AKI did not affect eGFR 100 days post-HCT or three-year survival. Conclusions: AKI seems to be a very common complication to HCT. However, in this study, AKI was not associated with a worse outcome as measured by eGFR at 100 days or three-year survival. The high pre-HCT eGFR in this study suggests that plasma creatinine may overestimate GFR pre-HCT, which makes diagnosing AKI challenging. The observed association between URD-HCTs and AKI is intriguing and advocates further investigation addressing immunological mechanisms in the pathogenesis of AKI after HCT. Introduction: Chronic kidney disease (CKD) is a devastating illness with profound impact on the child and their families. To our knowledge, there are currently no national registries reporting epidemiology of pre-dialysis or non-dialysis stages of CKD in children.

The objectives of this study were (i) to describe the demographic characteristics of children <16 years with stages 3-5 of CKD in South East of England; (ii) to describe the recent trends in incidence and prevalence; (iii) to describe age, gender and ethnicity-specific incidence; (iv) to compare trends with a previous 5-year period. Material and methods: This was a retrospective study of all children <16 years with an estimated glomerular filtration rate of <60ml/min/ 1.73m 2 , who were followed up at Evelina London Children's Hospital between 2012 and 2016. Incidence and prevalence were calculated based on data from the 2011 Census. Results were compared with data from a previous 5-year period (2005-2009) . Results: There were 292 patients in the study. Renal dysplasia (39.3%) and obstructive uropathy (21.6%) remained the most common causes of CKD. The mean incidence and prevalence of CKD amongst <16 years were 16.7 per million age related population (pmarp) and 110.0pmarp respectively. The incidence of CKD was higher in males (10.5pmarp) compared to females (6.1pmarp Introduction: Children and young people (CYP) with kidney diseases may face adverse impacts of chronic kidney disease (CKD) on their developing dentition, alongside increased risk of adverse side-effects from dental treatment. Those who are immunocompromised are at increased risk of severe orofacial infections which can lead to pain and poor quality of life. Our objective: To highlight the main orofacial manifestations of kidney disease and provide guidance on improving dental care and maximising oral health outcomes in CYP with kidney disease. Material and methods: A joint dental-kidney service for CYP with CKD was piloted at our centres. Patients with CKD (IV-V) and those undergoing renal replacement therapy (RRT) are offered specialist dental reviews as part of their regular kidney out-patient clinics, or during incentre haemodialysis therapy.

Results: Enamel defects are prevalent in patients with CKD. They can result in poor aesthetics alongside pain, and breakdown of molar teeth. Drug-induced gingival overgrowth is a side-effect of ciclosporin, tacrolimus and calcium-channel blockers. It can lead to disfiguration and increased risk of periodontal disease. Other orofacial manifestations of kidney disease may include oral soft tissue changes, xerostomia, salivary stones, opportunistic infections, increased risk of malignancy and radiographic changes in those with renal osteodystrophy. This joint service ensures CYP receive dental care by dentists with appropriate experience within paediatric dentistry to manage these more complex conditions. Furthermore, it also minimises the personal and financial burden patients and families face from attending excessive health care appointments. Conclusions: The Kidney MDT is in a pivotal position to advocate oral health and reinforce regular dental reviews. Equally, the dental team may require support from the kidney team regarding additional precautions such as antibiotic prophylaxis, steroid cover, altered prescribing, and haemostatic measures during dental treatment. By working together, nephrology and dental teams can maximise oral health and quality of life for their patients. Results: The eGFR decreased from median 148 to 116 ml/min/1.73m 2 between pre-HSCT and ten years after HSCT. CKD, defined as an eGFR <90ml/min/1.73m 2 and/or albuminuria (KDIGO stage ≥G2 or ≥A2) occurred in 17% of patients. In multivariate analysis, severe prolonged stage ≥2 acute kidney injury (AKI), with an eGFR <60ml/min/1.73m 2 and duration ≥28 days, was the main risk factor for CKD (HR 9.5, . Stage ≥2 AKI with an eGFR ≥60ml/min/1.73m 2 and stage ≥2 AKI with eGFR <60ml/min/1.73m 2 but recovery within <28 days were not associated with CKD. Furthermore, hematological malignancy as HSCT indication (HR 3.5, ) was an independent risk factor for CKD. One third of patients with CKD had both an eGFR <90ml/min/1.73m 2 as well as albuminuria, one third had isolated eGFR reduction and one third only had albuminuria. Hypertension was observed in 27% of patients with CKD compared to 4.4% of patients without CKD. Tubular proteinuria was present in 7% of the subgroup of patients (n=71) in which β2-microglobulinuria was measured. Conclusions: In conclusion, a significant proportion of pediatric HSCT recipients developed chronic kidney disease within ten years after HSCT. Our data stress the importance of structural long term monitoring of eGFR, urine and blood pressure after HSCT to identify patients with incipient CKD who can benefit from nephroprotective interventions.

Objectives: Large studies in adults with CKD have shown that arterial stiffness measured by PWV is associated with CKD progression but the association was not consistent. The association of PWV with risk of CKD progression has not been studied in children with CKD. Methods: Post-hoc analysis of the Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study that prospectively followed children aged 6-17 years with CKD stages 3-5. PWV was measured with an oscillometric Vicorder device and standardized according to sex and height (PWVz). CKD progression was defined as a composite endpoint of (i) 50% decline in baseline estimated glomerular filtration rate (eGFR), (ii) eGFR < 15 ml/min/1.73 m 2 or (iii) start of kidney replacement therapy (KRT Introduction: Estimating glomerular filtration rate (eGFR) in adolescents and during the pediatric-to-adult transition period is challenging since performance of specific pediatric or adult equations is poor. Some authors suggested to use the average of pediatric and adult creatininebased eGFR in young adults whereas others proposed equations designed to cover the whole life span. The aim of this study is to evaluate the performance of these various methods of GFR estimation in adolescents and during the transition period, namely between 13 and 25 years. Material and methods: Measured GFR (mGFR) was assessed in 1861 adolescents and young adults at various CKD stages (mean age 16.0 ±0.1years) by a reference method (inulin or iohexol clearance); plasma creatinine (Pcr) was determined by an IDMS-standardized assay. Mean mGFR was 87.0±0.7mL/min/1.73m 2 [range12-209] . The performance of Schwartz2009 (1), Schwartz-Lyon (2), CKDEPI (3), average(Schwartz2009-CKDEPI)(4), EKFC (5), CKDEPI40 (6), LMR18 (7), CKiDU25ct and CKiDagedep (8) the accuracy of these formula is highly dependent on the creatinine assay method used. Our study aimed to assess the concordance between the original and the updated Schwartz formula applied to creatinine, regardless of the measurement method used, and the cystatin C formula used as the reference, in healthy children living in the Democratic Republic of Congo (DRC). Material and methods: In a cross sectional study conducted from February to December 2019, a random sample of 515 children (aged 6 to 16 years) were recruited using a multistage sampling, from 17 schools in Kinshasa, the capital of the DRC. Using kappa coefficient and Bland-Altman method, we evaluated the agreement between eGFR from the original Schwartz formula applied to Jaffe-based uncalibrated creatinine, from the updated Schwartz formula applied to both Jaffe-based uncalibrated creatinine and enzymatic based-creatinine, and cystatine C-based formula.

The results showed a strong agreement between eGFR from the original Schwartz formula applied to Jaffe-based uncalibrated creatinine versus cystatine C-based formula (kappa=0.95), and the updated Schwartz formula using enzymatic based-creatinine versus cystatine Cbased formula (kappa=0.96). However, there was a significant gap between eGFR from updated Schwartz formula applied to Jaffe-based uncalibrated creatinine with eGFR from cystatine C-based formula (kappa=0.45).

Conclusions: The significant difference between the updated Schwartz formula applied to Jaffe-based uncalibrated creatinine and cystatine Cbased formula reveals that the new Schwartz formula should be used with caution, especially in low-income countries, like DRC, where Jaffe method for determining creatinine remains the most commonly used. In this setting, the use of the original Schwartz formula is more appropriate.

Introduction: Kidney function assessment and urinary screening are useful for identifying occult kidney diseases in asymptomatic children and might be an important initial step in prevention of chronic kidney disease (CKD). Our study aimed to determine the prevalence of urinary abnormalities and to assess the kidney function through the estimated glomerular filtration rate ( [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] 5] . Most of patients (75%) were treated using a 5Fr CVC (4Fr in 10%, 4.5Fr in 5% and 6.5Fr in 10%). Circuits were primed with 5% albumin in 16 patients; no one received blood priming. Downtime occurred in 2.3% of total time of treatment; the most common cause was clotting. Survival at CRRT discontinuation and hospital discharge were 95% and 50% respectively (4 patients were discharged in peritoneal dialysis and 6 without need of renal replacement therapy The median prescribed Qb was 23 (14-35) mL/min. Circuits were primed with NaCl 0.9%, using heparin anticoagulation (10 to 12UI/kg/h) in all patients. Only two sessions were stopped secondary to a filter clotting. CVVH efficaciously allowed blood purification and fluid balance without hemodynamic instability in all neonates. No survival was reported secondary to basal neonate pathology. Conclusion: CARPEDIEM is feasible, accurate and safe even in preterm neonates; it has the potential enhance the clinical management of very low birth weight neonates with multisystemic organ dysfunction.

Introduction: Identification of patients with altered renal function after cardio-pulmonary bypass is often delayed due to lack of accurate methods for evaluation of glomerular filtration rate (GFR). We compared GFR measurement by the gold standard technique plasma iohexol clearance (mGFRiohex) with estimated GFR based on the routinely used Schwartz formula (eGFRschwartz) in pediatric patients after cardiac surgery. Material and methods: Children who underwent cardiopulmonary bypass surgery were included. After IV iohexol bolus injection, plasma iohexol clearance was calculated from the plasma concentration-time curve over a 360-minutes interval. Volumetric absorptive microsampling was used for iohexol blood sampling. Pearson's correlation coefficient for mGFRiohex and eGFRschwartz was determined and agreement between the methods was assessed visually using Bland-Altman plots. Accuracy of eGFRschwartz was determined as the percentage of GFR estimates within ± 30 % of mGFRiohex (P 30 hours. In our experience, metabolic acidosis was more common than metabolic alkalosis, the most common metabolic complication was hyponatremia (defined as Na < 135 mmol/L), reflecting more the clinical conditions of these patients rather than complications of RCA. We found only a few episodes of hypocalcaemia, never clinically relevant, and treated with changes in calcium compensation. Only two patients presented citrate accumulation (CA), defined as a calcium ratio > 2.5, but neither of them presented clinical signs of CA with serum bicarbonate and lactate in order. Survival rate of our patients was 62 %. No patient developed treatment-related bleeding complications. Conclusions: In our experience regional citrate anticoagulation was safe and effective in preventing circuit clotting. RCA can be used for CRRT in children, even in the ones with very low body weight. Introduction: The incidence of acute kidney injury (AKI) in pediatric patients following cardiac surgery varies between 15 % and 64 %, with a mortality rate of 10-89 % among those requiring dialysis. This variation in the incidence and mortality of AKI across studies are due to the inconsistent definitions used for AKI. Material and methods: We evaluated the incidence of AKI using the KDIGO criteria in 150 infants and children undergoing cardiac surgeries between 2015 and 2017. Post operatively, all patients were admitted to the Pediatric Intensive Care Unit (PICU) at a tertiary care center in a developing country. This is a retrospective chart review in which data collected included: age, gender, type of heart disease, prior cardiac surgeries, RACHS-1 category, and pre-and post-operative creatinine levels.

Neonates were not included in this study.

Results: Six percent of the studied patients were below one year of age, 84%, 1-10 years and 10%, 10-18 years. Fourteen patients (9.3%) developed AKI. Patients with cyanotic heart disease were more prone to develop AKI (78%) compared to those with noncyanotic heart disease (44%). Children with AKI had a higher length of stay in PICU, 2.56 ± 1.44 vs 4 ± 2.66 (p-0.02). Serum lactic acid was higher in patients who developed AKI with a mean value of 6.8 ± 6.9 vs. 2.85 ± 1.55 in the non-AKI group (p-0.03). Lower hemoglobin levels and hyperlactic acidemia were significantly more prevalent in the AKI group. There were 5 death in this series (3.3%) and 4 of those (80%) were in the AKI group. Conclusions: Using KDIGO criteria, the incidence of AKI in infants and children following cardiac surgery was 9.3%. This is slightly lower than previously published studies which range between 15% and 64%. Children with cyanotic cardiac disease, hyperlactic acidemia and anemia were more prone to develop AKI. Identifying patients at risk might help in decreasing the risk of postoperative AKI. week, yet remained higher than before the procedure. The raise of urine IL-18 values was also delayed by 2 weeks, although by the 4th week it decreased below the pre-transplantation records.

Conclusions: Tubular damage is present already before alloHSCT and aggravates after the procedure. Urine markers are more specific in the assessment of tubular function than the corresponding serum concentrations. Urine NGAL seems the most promising parameter in the early detection of tubular damage, although further investigation on a larger group is required.

Nabil Melhem, Sarah Roy, Heidi Ramsey, Manish Sinha Evelina London Childrens Hospital Introduction: N-terminal pro B-type natriuretic peptide (NT-proBNP) is a biological marker of ventricular dysfunction secondary to fluid overload. Few data describe NT-proBNP concentrations and its potential utility for intravascular fluid assessments in the paediatric haemodialysis population. We describe demographic and clinical associations of NT-proBNP concentrations in children on established haemodialysis (HD). Material and methods: Retrospective cohort study including all prevalent children on HD, with preserved cardiac function aged <18yrs between 2018 and 2019. Stepwise multiple regression analysis was performed to assess potential predictors of post-dialysis logNT-proBNP and repeated measures ANOVA performed to analyse change in concentrations from baseline to 3 and 6 months.

Results: 24 of 31 children [14 (58%) white-Caucasian], mean age 10.3 ±5.8yrs of whom 16 (67%) were boys; 8 (33%) had congenital abnormalities of kidneys and urinary tract with 16 (66.7%) polyuric and remainder oligo-anuric (<150ml per day) at baseline. Amongst all participants, there were 161 post-HD measurements with median (IQR) NT-proBNP 2046 (794, 5275) ng/L and following log transformation normalised data with mean logNT-proBNP 3.34 ±0.58ng/L. 130 (80.7%) had an elevated of NT-proBNP defined as a concentration above 598ng/L as previously described in a non-renal population. Multiple regression analysis identified post-dialysis systolic BP z-score (β=0.15, P<0.01), haemoglobin (β=0.01, P<0.01) and non-White ethnicity (β=0.10, p=0.02) as positive predictors of logNT-proBNP, whilst residual urine output of >150mls (β=-0.28, P<0.01) was a negative predictor of logNT-proBNP concentrations in this population. On longitudinal assessment, the mean logNT-proBNP at baseline, 3 and 6 months were 3.32±0.47ng/L, 3.23±0.55ng/L and 3.19±0.61ng/L respectively (p=0.50).

Conclusions: Elevated NT-proBNP were observed in the majority of children on haemodialysis with preserved cardiac function with a dominant effect of blood pressure and residual urine output. These data demonstrate both modifiable and non-modifiable risk associations with higher NT-proBNP and highlight potential clinical relevance when fine-tuning the clinician's intravascular fluid assessments for children on chronic haemodialysis. Conclusions: More than half of the patient cohort met the composite renal outcome at the age of 12. Nearly one fifth of the patients were obese or overweight, which was found to be the only predictive factor for hypertension, although not predictive of the other studied renal outcomes. While screening and follow-up of adult patients' relatives during childhood remains controversial, these results support the need to identify and monitor these patients closely since childhood.

Introduction: One of the perceptions cilia are involved in is the sense of smell. Motile cilia are equipped with odorant receptors and play a critical role in odor transmittance and detection. As a consequence, genetic defects disrupting the functional or structural integrity of these cilia may cause olfactory dysfunction. One of the ciliopathies that has already been associated with hyposmia is Bardet-Biedl syndrome (BBS). BBS is a multivisceral syndromic disorder caused by genetic defects located at the ciliary base. However, reports of olfactory dysfunction in other hereditary kidney diseases that are also caused by mutations in genes located at the cilium (nephronophthisis, polycystic kidney diseases) are sparse.

Here we provide a systematic survey on olfaction in a large cohort of children, adolescents and adults displaying genetically determined ciliopathies. Material and methods: We performed a match-controlled systematic olfactory evaluation in a group of 75 patients with a defined genetic background using age adapted and validated odour identification tests. However, when the serum levels of vaccine antibodies were measured, significantly lower antibody titers were observed in patients in the HD-PD group compared to healthy controls and children with stage 3-4 CKD (p = 0.034). In the control group, the percentage of positive antibodies to measles vaccine and antibody titer were found as significantly higher than the patients with CKD (p = 0.02 and p = 0.0001, respectively). Healthy children can produce a better antibody response to Rubella vaccine than patients with CKD (p = 0.03). No statistically significant difference was found between the patients with CKD and the control group for mumps and chickenpox antibody titers (p>0.05). Positive antibody response percentages with hepatitis A vaccine were found as significantly higher in the control group than the patients with CKD (p= 0.03). Conclusions: It has been shown that antibody response to vaccines occurs in most children with CKD, but these values were lower for some vaccines compared to healthy children and therefore these children should be followed closely. Children with CKD should receive ageappropriate vaccines and vaccination schedules must be checked in clinical visits. 12-2.59 ]) were more likely to be initiated on HD. As compared to patients in HD, those treated with PD exhibited an increased but non-significant mortality risk ]; p=0.28) and a higher prevalence of dialysis-related complications during DAGF course (p=0.03) Conclusions: Patients entering DAGF in more recent years are more likely to be initiated on HD.

Introduction: Italy was one of the most affected Countries by COVID-19 pandemic. Children with immunosuppression and chronic kidney disease (CKD) are considered at greater risk of infections. We aimed to assess the clinical impact and the seroprevalence of SARS-CoV-2 infection in an Italian cohort of children with CKD or immunosuppression. Material and methods: The Italian Society of Pediatric Nephrology performed a nationwide observational study to identify patients with severe COVID-19, defined as death, admission to intensive care unit, mechanical ventilation, and the need to change immunosuppressive treatment. Patients aged <18 years and affected by glomerular disease requiring immunosuppression, CKD stages 3-5, dialysis, or kidney transplant were enrolled. Data were collected by a phone-based questionnaire between April 13 and 24, 2020, and referred to the period February 20 th - Introduction: During the initial COVID-19 pandemic, young United Kingdom (UK) kidney patients underwent lockdown and those with increased vulnerabilities socially isolated or 'shielded' at home. The experiences, information needs, decision-making and support needs of children and young adult (CYA) patients or their parents during this period is not well known. Material and methods: UK wide online survey co-produced with patients was conducted in May 2020 among CYA aged 12-30, or parents of children aged <18 years with any degree of chronic kidney disease.

Participants answered qualitative open text alongside quantitative closed questions. Thematic content analysis using a three-stage coding process was conducted. Results: 118 CYA (median age 21) and 197 parents of children (median age 10) responded. Predominant concerns from CYA were heightened vigilance about viral (68%) and kidney symptoms (77%) and detrimental impact on education or work opportunities (70%). Parents feared the virus more than CYA (71% vs 40%), that their child would catch the virus from them (64%) and adverse impact on other children at home (65%). CYA thematic analysis revealed: strong belief of becoming seriously ill if they contract COVID-19, lost educational opportunities, socialisation, and career development, and frustration at public for not following social distancing rules. Positive outcomes included improved family relationships and community cohesion. Only a minority (14-21% CYA and 20 -31% parents, merged questions) desired more support. Subgroup analysis identified greater negative psychological impact in the shielded group.

Introduction: A small but significant proportion of children with COVID-19 or Multisystem Inflammatory Syndrome in Children (MIS-C) is severely ill, therefore we aimed to describe the incidence of Acute Kidney Injury (AKI Results: Signs of anxiety (SCARED scores) was present in 26(32.5%) patients and 4(13.3%) controls, and significantly higher in children with CKD and KTx recipients (p=0.03). Sixty-nine children and all controls have a depression scale of >19 and control group showed significantly higher depression scores than the patients (mean±SD,51.6±2.8 vs. 47.5±11.1; respectively, p=0.009). Thirteen (16.3%) patient and 2(6.7%) controls have high SDQ-Dysregulation Profile(SDQ-DP) scores. SDQ-DP scores of the patients were significantly higher than the controls (9.6±5.3 vs. 7.2 ±5.8, respectively; p=0.000). There was no significant difference of mothers in coping with difficulties, anxiety and depression scores between the groups(p>0.05). Higher degree of anxiety of the patients was significantly associated with higher anxiety and depression symptoms of the mothers in the patients group (r=0.5, p=0.000 and r=0.435,p=0.001;respectively ),whereas there was no relationship between the SDQ-DP of the patients and Beck anxiety and depression scores of the mothers Conclusions: The COVID-19 outbreak causes increased anxiety in children with CKD and KTx and increased depression in healthy children. We may speculate that higher depression scores in healthy children may be due to sudden lifestyle restrictions during the pandemic compared to CKD patients who already have certain restrictions. The association of the increased anxiety of the patients with the depression and anxiety of the mothers has shown the necessity of more attention from mental health practitioners. Identifying affected children as early as possible and providing professional psychological and behavioral interventions will ensure a better mental health for children with chronic kidney diseases and their caregivers during the pandemic. Introduction: During the first wave of the COVID19 pandemic all paediatric renal transplant recipients (pRTR) in the UK were required to shield driving a reduction in their face to face outpatient clinics and an increase in virtual reviews in our centre. Re-configuration of the transplant service was required to enable effective monitoring of pRTRs. We describe a testing method set up responsible for reducing some hospital or primary care visits. Material and methods: Collaboration between 2 UK paediatric nephrology centres and 2 laboratories enabled setting up of a home testing method (finger prick sample) to measure creatinine and tacrolimus level using Mitra tips which could be undertaken by pRTRs and their parent/carer. The samples are then posted to the tertiary centre.

Results: Mitra tip finger prick method measures creatinine(umol/L) and tacrolimus(ug/l). Extensive testing was carried out by our biochemistry colleagues to set up the assays, ensuring results comparable to standard laboratory testing used in our centre.

To date this home-testing has been used for 1. Monitoring between outpatient visits to reduce frequency of visits in stable pRTRs 2. Enabling monitoring of tacrolimus levels after dose adjustment 3. Facilitating early creatinine re-check if graft function elevated from baseline at routine clinic visit 4. Checking an accurate 12h trough tacrolimus level in pRTR who is unable to do this in clinic.

Conclusions: Home testing to measure creatinine and tacrolimus levels in pRTRs using Mitra tips allows increased flexibility with respect to the monitoring of transplant function we are able to offer. Though it was established in our centre through collaboration during the pandemic, it will be used going forwards to facilitate some of the patients' monitoring enabling a reduction in missed school days for patients and less time off work for their families. We hope it can be used in other patient groups receiving tacrolimus therapy. -19) , many factors such as the high rate of spread, unpredictability and uncertainty of the prognosis, physical and social restrictions due to the measures taken, have caused people to be psychologically adversely affected in our country as well as in the world. This study aimed to assess anxiety levels during COVID-19 in children with chronic kidney disease (CKD), including nephrotic syndrome (NS) and kidney transplantation (Tx). Material and methods: A case-control, cross-sectional study was conducted with children aged of 10 to 18 years, who had been followed with diagnosis of CKD, NS, Tx in Izmir Tepecik Training and Research Hospital, Turkey, between April and July 2020. Healthy control group was recruited age and gender-matched children. A questionnaire with printed and online version is designed in three parts: demographic characteristics, opinions about the pandemic, Turkish version of The Revised Child Anxiety and Depression Scale-Child Version (RCADS-CV). Results: Total of 88 children completed the questionnaire. The patient and control groups were similar by gender, age, household members and history of psychiatric treatment. Both groups stated that coronavirus is a risky disease for children (63.6%), they were afraid of contagion (69.3%).

Only half of them were receiving realistic and informative answers from family members. In RCADS-CV, 66% of them get high score from at least one subscale. Social Phobia (SP) scores of the control group was higher, although the high-scoring ratios were similar. The ratio of highscored participants was higher in CKD patients for Panic Disorder, and was lower in immunosuppressive agent group for SP. Conclusions: The current COVID-19 pandemic is a disaster that children encounter for the first time in their lives. It does not exclusively cause anxiety among children with chronic kidney diseases, but also healthy children. Introduction: Kidney involvement and histological findings have been rarely reported in pediatric SARS-CoV-2 infection. Acute tubular necrosis is the most common histological finding in adults, but the exact mechanism of kidney involvement is unclear. Material and methods: We describe clinical, laboratory and histological findings of two pediatric cases with an almost exclusive renal involvement by SARS-CoV2 without pre-existing diseases. Results: A 10-years-old girl with IgA vasculitis nephritis underwent a renal biopsy, showing a diffuse and segmental mesangial-proliferative glomerulonephritis. A steroid therapy was started (methylprednisolone, prednisone). After few weeks, clinical conditions worsened (weight gain, nephritic-nephrotic syndrome) and an atypical skin rash appeared. A SARS-CoV-2 infection was diagnosed. An electron microscopy evaluation revealed cytoplasmatic blebs and virus-like particles in tubular cells.

After few days, SARS-CoV-2 infections was cleared and cyclophosphamide was added to prednisone for 10 weeks. A second kidney biopsy was performed showing a crescentic glomerulonephritis with jalinosis, while virus-like particles were no more present. The second patient was a 12-year-old girl with a 3-week history of progressive weakness and weight loss. A mild rhinitis was reported the month before. No medications were taken. Blood and urine analysis revealed rise in serum creatinine (1.8 mg/dL), hypouricemia (1.8 mg/dl), severe low molecular weight proteinuria, low urinary gravity (1008), glycosuria, and proteinuria (uPCR 0.5 mg/mg). Patient showed a high SARS-CoV-2-IgG titre (195 AU/ml). A kidney biopsy was performed, showing features of acute tubular-interstitial nephritis. On EM, no images suggestive for virus-like particles were observed. Steroid therapy was started and resulted effective to restore a normal renal function.

In both cases RT-PCR was negative for SARS-CoV-2 on renal tissue. Conclusions: Kidney involvement is uncommon in children and related histological data are lacking, being reported only in two children with SARS-CoV-2-associated AKI. The diagnosis was acute necrotizing glomerulonephritis in both cases. RT-PCR for SARS-CoV-2 tested negative while EM was not performed. We firstly completely describe renal histological and clinical finding in SARS-CoV-2 positive children. We can speculate that in both cases SARS-CoV-2 played a major role as inflammatory trigger of the renal damage. We suggest investigating the potential kidney damage by SARS-CoV-2 in children and that SARS-CoV2 can be included among infectious agents of pediatric acute tubular interstitial nephritis. Introduction: Pulse wave velocity (PWV) is the gold-standard for non-invasive assessment of arterial stiffening in patients with hypertension. Adult studies have shown that PWV is mainly determined by blood pressure (BP) and age. We aimed to systematically analyze determinants of PWV in studies involving children with primary hypertension (PH). Material and methods: 196 articles retrieved from PubMed according to a predefined search strategy were screened for eligibility. 38 articles identified by title/abstract review underwent full-text screening by 2 reviewers and 12 were selected for the analysis if (i) measured carotid-femoral PWV (PWVcf); (ii) reported on risk associations using regression models; and (iii) included BMI and BP in the model. Results: The total population included >3700 children with normal and elevated BP. 25% studies used indirect methods for PWVcf estimation and 17% analyzed standardized PWVcf. Higher PWVcf in hypertensive vs non-hypertensive children was reported in 75% studies. 92% and 75% included age and sex, in regression models. In 83% studies PWV was positively associated with BP, whereas BMI associated with PWV in 25% only (positive 3 and negative association in 1). Age was positively associated in 18% and no studies reported any significant associations with sex. Association of race were reported in 2 studies only (direct effect of non-white race in 1). Models including BP among other covariates (biochemical, anthropometric and other BP parameters) explained 12-88% of PWVcf variability (R 2 not reported in 25% of studies). Conclusions: BP is the predominate contributor to PWV, compared to the inconsistent or lesser contributions of BMI, age, sex or other CV risk factors during childhood. Additional studies are needed to determine whether increased PWV is a reflection of primary arterial disease or a secondary phenomenon. Our data also highlights the need of standardization and reporting of confounders, such as age and sex. Objectives: Serum levels of biomarkers associated with CV stress are increased in children with CKD and after kidney replacement therapy (KRT). We aimed to evaluate the diagnostic performance of traditional (TnT and BNP) and novel (GDF15 and ST2) CV biomarkers to detect subclinical CV disease (CVD) in children with CKD and under KRT.

Methods: Biomarker levels were measured in 120 children with CKD stage 3-5, 95 of whom started KRT (n=53 dialysis and n=42 kidney transplantation (KTx)). CV endpoints were defined as left ventricular hypertrophy (LVH, left ventricular mass index >45 g/m 2.16 ), increased carotid intima-media thickness (cIMT; >95 th percentile) and increased pulse wave velocity (PWV; >95 th percentile). Logistic regression with ROC analysis using sum maximization was applied to assess diagnostic performance in each subgroup (non-KRT, dialysis and KTx) crosssectionally.

Results: TnT and BNP in the non-KRT group was associated with higher odds of LVH, BNP in the dialysis group was associated with increased PWV, while GDF15 associated with LVH in the KTx group. The ability of the biomarkers to discriminate patients with the presence of subclinical CVD was poor-to-fair. (Table) Conclusions: Serum biomarkers of CV stress (TnT, BNP and GDF15) are associated to a varying extent with higher odds of LVH or increased PWV in children with CKD and under KRT. Their sensitivity and specificity to detect subclinical CVD, however, is relatively poor. Introduction: Angiotensin-converting enzyme (ACE) and angiotensin-converting enzyme 2 (ACE2) are key enzymes of the renin-angiotensin-aldosterone system (RAAS), an important regulator of blood pressure (BP). Their relationship with BP during childhood has not been clearly established. We aimed to compare ACE and ACE2 activities between body mass index (BMI) groups in a sample of prepubertal children, and to characterize the association between the activity of these enzymes and BP. Introduction: Childhood hypertension (HT) is a chronic disease that requires careful and delicate follow-up. Many data obtained from ambulatory blood pressure monitoring (ABPM) guide us in the management of HT. The purpose of evaluating these measurements is to obtain the most accurate and earliest prediction for the severity of HT and end organ damage. Material and methods: Files of 269 children who were followed up with the diagnosis of HT were evaluated retrospectively. The presence of end organ damage was recorded together with the ABPM data of the patients at the time of diagnosis. Z scores were obtained from the ABPM outputs using the statistical LMS method and the relationship to end organ damage was investigated.

Results: Left ventricular hypertrophy (LVH) and hypertensive retinopathy were found in 18% and 9% of the patients who underwent cardiological and ophthalmological examination, respectively. The relationship of ABPM data Z scores and blood pressure (BP) loads with LVH is given in Table 1 . 24-hour, day and night mean systolic BP Z scores of the patients with LVH were found to be significantly higher as compared to the patients without. In addition, systolic day and night BP loads were significantly higher in the group with LVH. It was calculated that one unit increase in the mean daytime systolic BP Z score increases the risk of LVH by 1.35 times and ten percent increase in systolic BP load increases the risk 1.16 times.

Conclusions: These results show that evaluation of the ABPM data in childhood hypertension through the incoming studies will increase the chance of early diagnosis and treatment. At this point, the real question is what should be the ABPM cut-off points to prevent organ damage. Objectives: Chronic kidney disease (CKD) can cause atherosclerosis and cardiac diseases. Echocardiographic measurement of the elasticity and distensibility of the aorta is useful in detecting early vascular changes. These measurements may be affected by dialysis efficiency and fluid load. In our study, we aimed to evaluate arterial functions by echocardiography in patients with CKD and investigate its relationship with clinical findings and bioimpedance measurements which are indicators of hydration status. Materials and Methods: Twenty six patients with CKD followed-up in our Pediatric Nephrology and Cardiology outpatient clinics were evaluated for aortic elasticity. Demographic, clinical and laboratory findings, echocardiographic measurements, 24-hour ambulatory blood pressure values, bioimpedance measurements were recorded. Aortic strain, distensibility, aortic stiffness index were compared by a correlation analysis with CKD duration, dialysis time and type, overhydration status (bioimpedance analysis), systolic and diastolic blood pressures, hemoglobin and creatinine levels. A p value of <0.05 was considered statistically significant.

Results: Ten patients (38.5%) were female. Mean age was 13.5±3.6 years, CKD duration was 4.9±3.2 years. Sixteen patients (61.5%) were pre-dialysis patients, 10 patients (38.5%) were on renal replacement therapy. The systolic and diastolic blood pressures of the patients were 121.13 ± 11.27 mmHg and 79.07 ± 12.57 mmHg, respectively. Mean hemoglobin levels were 11.54 ± 2.22 g/dl, mean creatinine levels were 4.33 ± 3.09 mg/dl. Left ventricular functions were normal in all of the patients. Aortic valve pathology was detected in 3 patients. Ascending aorta stiffness index, strain and distensibility were 8,26±9,67,-1,62±1,15, 0,47±0,57 respectively. A positive correlation between CKD duration and stiffness of aorta was found (p values were 0,039 and 0,030 for arcus aorta and abdominal aorta respectively). No correlation was found between overhydration, blood pressure, hemoglobin, creatinine levels and aortic strain, distensibility, stiffness index. Conclusion: We found that the duration of CKD and the deterioration in arterial functions were parallel. CKD may accompany aortic valve pathologies. Evaluation of arterial functions in the long-term follow-up will be useful for patients with CKD.

Objectives: About 5-25% of arterial hypertension in children is caused by renovascular hypertension. Children suffering from this condition often show now significant clinical symptoms. Methods: We hereby introduce a 2 years old patient with sever hypertension due to renal artery stenosis showed only in catheter angiography.

The patient showed no symptoms and no abnormalities in the clinical examination. The blood pressure measurements showed pressures over the 95 th percentile. Blood work, urine screening, echocardiography and kidney ultrasound showed normal results. In the MRI-Angiography no vascular abnormality could be seen, however the left kidney was smaller than the right one. Moreover, because of persisting high blood pressure despite 3 anti-hypertensive medications, a digital subtraction angiography has been done and showed a high-grade stenosis of the left renal artery with a string-of-beads appearance. A renal scintigraphy was conducted and showed a leading right kidney and a left kidney with a slightly delayed renal perfusion.

Conclusion: Secondary arterial hypertension should always be considered in children with elevated blood pressure levels. If renal and endocrinologic causes can be ruled out, stenosis of vessels close to the heart and renal vessels is the most common reason for a secondary arterial hypertension. Comprehensive diagnostic should be considered to rule out renal artery stenosis. As presented in our case, MR angiography cannot always detect arterial blood vessel abnormalities. Therefore, catheter angiography should be taken in consideration to confirm the diagnosis of renal arterial stenosis. Objective: Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is the most frequently prescribed antihypertensive therapeutic in the paediatric population, despite being used off-label (1). The SAFEPEDDRUG project studied lisinopril exposure and blood pressure effects in a dose-escalation pilot study, envisioning safe and dose-optimized usage of lisinopril in children with primary or secondary hypertension including patients with mild renal impairment, corresponding to the vast majority of the day-to-day clinical paediatric population (2) . Methods: The SAFEPEDDRUG lisinopril pilot study included 13 children with primary/secondary hypertension who received oral lisinopril once daily, doses ranging from 0.05 mg kg -1 to 0.2 mg kg -1 . A total of 46 peak and trough plasma samples were collected. Patients were aged between 1.9 and 17.9 years (median: 13.5 years) and had a total body weight between 9.62 and 97.2 kg (median: 53.2 kg). eGFR was measured between 55.5 and 180 mL/min/1.73m 2 (median: 99.9 ml/min/1.73m 2 ). All data were analyzed using Monolix version 2020R1 (Lixoft®, France) and R version 3.6.2.

Results: A one-compartment model with 1 st order absorption and 1 st order elimination optimally describes the analyzed data. Significant covariate effects include total bodyweight on elimination clearance and distribution volume and eGFR on elimination clearance. The effects of total bodyweight are parametrized in terms of fixed allometric exponents (0.75 for clearance, 1 for volume), centered around a total body weight of 70 kg (3) . The effects of eGFR on the elimination clearance are optimally described by a power law parametrization centered around 105 mL/min/ (2004-2009, 2009-2014 and 2014-2019) . Cox regression analysis and Kaplan Meier procedure were used to analyze the data. Results: Overall graft survival rates at one and five year post-transplant were 97% and 88%, respectively. Both one-and five-year graft survival of the most recent cohort (transplants of 2014-2019) were 100%, both for living and deceased donors. Out of ten independent variables that were analyzed, occurrence of rejection within the first year after transplantation (HR 2,86; p-value 0,020) and deceased donors were found to be the strongest negative predictors of graft survival (HR 2,79; p-value 0,029). We found an unequal proportion of deceased donors allocated to black patients. Detailed investigation of this finding was beyond the scope of this research, but should be further investigated in order to limit possible racial gaps. Conclusions: 1-and 5-year graft survival rates improved substantially over the last 16 years in our center. Rejection within the first year after transplantation and deceased donors were significantly associated with worse graft survival in our data.

Louise Kipping , Helen Jones , Grainne Walsh , Nick Ware

Introduction: For half a century, paediatric renal transplant recipients (pRTRs) have been exclusively followed up in face to face(F2F) clinic in our tertiary centre. During the COVID-19 global pandemic adaptations were made to minimise travel/exposure for all pRTRs by re-structuring the clinic and utilising local services, for monitoring traditionally carried out by the tertiary centre. A virtual(video) transplant clinic overseen by the paediatric transplant team was developed together with postal packs to enable immunosuppression drug level and viral load monitoring in conjunction with laboratory colleagues. Material and methods: Retrospective review of F2F versus virtual pRTR outpatient follow-up appointments 6 months before the COVID-19 pandemic, after 6 months and 1y into it in a single paediatric nephrology centre.

Results: 97 pRTRs under follow up included in the study. Due to COVID-19 the transplant program was suspended for a period where no new pRTRs were added to the cohort until the end June 2020. Median number of reviews per pRTR was 5 F2F and 0 virtual before, 3.5 F2F and 2 virtual 6 months into and 3 F2F and 2 virtual 1 year into the pandemic. To facilitate the virtual reviews pRTRs had monitoring blood tests, anthropometry, blood pressure and urinalysis at the tertiary centre (57%), in primary care (15%), children's community nursing team (14%) and at their local hospital (12%).

Conclusions: Developing a virtual transplant clinic enabled a reduction of F2F visits during the COVID-19 pandemic. We hope to further develop this service by strengthening our links with local services as well as empowering pRTRs and families to carry out some of their own monitoring (weight, blood pressure, urinalysis and finger prick blood tests) in the home environment and evaluate the outcome including patient feedback of these changes. Introduction: In the smallest recipients (<15 kg) with end-stage-renaldisease (ESRD), kidney transplantation is a delicate task. We recently conducted a systematic review in which we showed that after an increase in graft survival in the early era, a stabilisation of graft survival is seen in recent years (under review). Although the better immunosuppressants have given great improvement in graft survival in the past, we hypothesize that their side effects (e.g. nephrotoxicity and infections) prevent further improvement. The current study investigates the clinical outcome of small children in the Netherlands, focussing on long-term post-transplantation complications (e.g infection, immunosuppression side effects and rejection) and relate these complications to the immunosuppression protocol used. Material and methods: All children having received a renal transplantation in the Netherlands with a weight of 15 kilograms or less were included. Data regarding graft survival were obtained from the Dutch Organ Transplantation Registry. Other variables were extracted from reviewing medical charts. Results: We included 73 transplantations performed from 1989 through 2020, of which 37 received a corticosteroid-sparing-protocol (TWIST) and 46 received a TRIPLE-immunosuppression-protocol. Overall, 5years graft survival improved from 46% in the 70-80's, to 84% in the 90-00's and 96% in most recent era. Our analysis will focus on factors that are potentially associated with the recent stabilisation in graft survival (infections rate, immunosuppression side effects and rejection) and will be analysed for both immunosuppression groups. Abstract: One of the major issues in organ transplantation is graft immune tolerance. The balance between the risk of acute/chronic rejection and infectious complications generated by immunosuppressive therapy tends to minimize their use. In the rare cases of solid organ transplantation following hematopoietic stem cell transplantation (HSCT) for immune deficiency from the same donor, a natural graft tolerance is theoretically expected. We report herein the case of a 17-year-old girl who underwent kidney transplantation in our center. She suffered from Fanconi aplasia and received a first HSCT from an unrelated HLA-identical donor at the age of 8 years. The outcome was very poor and she received a second HSCT from her haploidentical mother two months later. This procedure was successful despite numerous infectious complications, and liver and skin graft-versus-host disease. The outcome was favorable with complete maternal chimerism (100%) nine years after HSCT. Unfortunately, she progressed to kidney failure from multifactorial origin requiring peritoneal dialysis. The mother was a candidate for living-donor kidney donation. Since the recipient was 100% chimer with the donor's bone marrow following HSCT, we decided to perform a living-donor kidney transplant without any induction nor maintenance immunosuppression with the mother's kidney. The cross-match was negative. The renal transplantation was successful with immediate recovery of graft function and no immediate postoperative complications. Nine months after kidney transplantation, she had normal kidney function (creatinine 60μmol/L, eGFR: 97mL/min/1.73m 2 ) with no medication except for phosphorus supplementation.

To our knowledge, this is the first report of a kidney transplantation after HSCT from the same donor without any immunosuppressive therapy. It demonstrates that this strategy is conceivable when stem cells and kidney are from the same donor with a complete donor chimerism. Material and methods: Data were collected from the ESPN/ERA-EDTA Registry. All patients younger than 20 years of age starting KRT after malignancy treatment between 1980 and 2018 were included. Cancer patients were divided in two groups: (group 1) malignancy as a primary renal disease (PRD) and (group 2) history of malignancy but another PRD. Two non-cancer controls were selected for every patient matched on age, sex, year of KRT and country macro-economics.

Results: 130 patients in group 1 and 108 patients in group 2 were identified. Patients in group 1 were significantly younger (4.4; 1.7-8.7 years) at start of KRT than patients in group 2 (13.0; 6.1-17.5 years). The median time to kidney transplantation (KT) was longer in the malignancy groups than in the control groups. Five-year access to KT was 72.4%, 76.8%, 66.5% and 78.2% in group 1, their controls (group 3), group 2 and their controls (group 4), respectively. The 5-year mortality was higher in among malignancy patients: 14.7% (group 1), 10.7% (group 2), 6.6% (group 3), and 6.8% (group 4). In group 1, 36.4% of deaths were caused by the malignancy itself, whereas infection predominated in group 3.

Five-year mortality was higher in malignancy groups, mainly due to mortality caused by malignancies. Patients with malignancies spent longer time on dialysis before receiving KT, but access to KT was much more similar at 5-year follow-up. Background: Phosphate is critical for skeletal development and mineral metabolism. Phosphate deficiency leads to e.g. muscle weakness and rickets or osteomalacia. Several inherited and acquired causes of renal phosphate wasting can lead to hypophosphatemic rickets (HR). X-linked hypophosphatemia (XLH) is the most common form of HR with an estimated prevalence of 1:20.000. The prevalence of chronic hypophosphatemia in the Netherlands and the clinical manifestations are currently unknown.

Purpose: ORPHOS-NED has been developed to identify and evaluate patients with XLH and other forms of chronic hypophosphatemia within a registry in the Netherlands. Methods: ORPHOS-NED is a web-based registry that has been set up by a group of medical specialists, who are affiliated to the Dutch Federation of Nephrology (NFN) and the Bone Network of the Dutch Society of Endocrinology (NVE). Dutch endocrinologist and nephrologists are approached for eligible patients. Children and adults with chronic hypophosphatemia are considered for inclusion. After informed consent, a chart review is performed to collect data on several aspects of the disease: initial presentation; symptoms; radiological, genetic and laboratory examinations; treatment; and follow up. Furthermore, questionnaires are sent out to assess health-related quality of life including the Brief Fatigue Inventory, the Brief Pain Inventory, RAND36, the Health Assessment Questionnaire and the Pediatric Outcomes Data Collection Instrument. Results: Currently, 107 pediatric and adult patients from 4 academic hospitals have been included in this registry. Inclusion of patients is ongoing. The data from this registry will lead to more insight in the prevalence, natural history, treatment and its effects on HR, quality of life, and into genotype-phenotype relations in the different genetic forms. Conclusion: A Dutch nationwide registry is being set up for genetic and acquired forms of chronic hypophosphatemia, which will lead to improved insight in prevalence, causes, disease manifestations and therapy.

Introduction: The objective of this study is to describe the incidence of pediatric ESKD in metropolitan France, according to the level of social deprivation.

Methods: This study included all patients who initiated a kidney replacement therapy (KRT) from 2010 to 2015 in metropolitan France. Data were collected from the French Renal Epidemiology and Information Network (REIN registry). We used a validated ecological index of deprivation, the 2011 French version of the European Deprivation Index (EDI). Mapping has been carried out to describe the distribution of deprivation and the incidence of ESKD in France. We then estimated crude and standardized incidence as well as standardized incidence ratio (SIR) according to the quintiles of EDI.

Results: 613 patients were included (58.6% males, 44.9% starting KRT between 11 and 17 years and 30.2% with CAKUT). Children from the most deprived areas represented 38.8% of the sample. Although no trend could be identified geographically, a clear social gradient was found in the incidence (crude, standardized or SIR) of KRT. For example, the standardized incidence rate (per 1,000,000 children-years) increased from 5.11 (95% CI 3.96-6.26) in the least deprived quintile to 7.81 (95% CI 6.80-8.81) in the most deprived quintile of EDI.

Conclusion: This study is the first to show that in France, there is a relationship between the incidence of pediatric ESKD and deprivation, showing that the higher the level of deprivation the higher the incidence. Introduction: Kidney length measurement and its interpretation is an integral part of the diagnosis of pediatric nephrology diseases. The most widely used kidney length norms, published in 1984, are based on an American study including 203 non-necessarily healthy patients.

Material and methods: The aim of the study was to develop ultrasoundbased normative values of kidney length in European healthy children and adolescents aged 0-18 years.

Our study included 1769 patients aged 0-18 years (877 boys; 50%), with normal glomerular filtration rate, no history of urinary tract infections, no kidney abnormalities in abdominal ultrasound, recruited in schools and kindergartens as well as in pediatric units in Poland and Lithuania. The examination was conducted in accordance with the standards of the Polish and European ultrasound societies.

Results: Based on the ultrasound measurements, kidney length nomograms (including 2.5 th ; 25 th ; 50 th ; 75 th ; 90 th and 97.5 th percentiles) for patients aged 0-18 years were developed using quantile regression. There were no sex-related or patient position (supine or prone) differences in renal size. The median difference between the left and right kidney across all age categories was -1.00 mm (5 th percentile = -6.7 mm, 95 th percentile=+3.6 mm). Out of age, weight, height, body surface area and body mass index, the height was the most significant predictor or renal length (T=9.21, p<0.0001, relative importance = 25.8%). We also developed a formula to calculate the average kidney length (50 th percentile) and the cut-off values for small (<2.5 th percentile) and enlarged kidney (>97.5 th percentile) using the patients height. Introduction: Children with established kidney failure may have additional medical conditions that impact upon care and outcomes for their kidney disease. This data is often not collected as part of a core dataset by kidney registries, resulting in data capture of variable completeness and accuracy. The aim of this study was to audit data on coexisting disease held by the UK Renal Registry (UKRR) against national electronic health record data using Hospital Episode Statistics (HES).

Material and methods: The study population comprised English children aged <18 years receiving kidney replacement therapy (KRT) for >90 days on 31/12/2016. The proportion of children coded for co-existing disease variables as captured by the UKRR were compared to relevant ICD-10 diagnostic codes in HES. Results: Linked HES data was available for 808 (62% male) children at the end of 2016. The median age was 12.0 (IQR 7.8-15.3) years. Using UKRR data, 23.1% of children had no additional diagnoses. Higher proportions of disease were noted in the UKRR dataset for most disease variables (9/12); higher proportions of cerebral palsy (12 versus 4%) and congenital anomalies (73 versus 47%) were recorded by HES. HES data offered a more comprehensive picture of co-existing disease not currently captured by the UKRR dataset: a strong male preponderance was noted among gastrointestinal, genetic, respiratory, and perinatal disease. UKRR data showed a female predominance for malignancy and chromosomal anomalies while prematurity, congenital anomalies and congenital heart disease affected males more frequently.

Conclusions: This is the first study to report the spectrum of co-existing disease for UK children with established kidney failure using registry and electronic health data. Electronic health record data offers a comprehensive overview of all disease groups, which will help facilitate future audit and research of this cohort. (3.1) . Highest prevalence of relatives with stones appeared in COM (100%), lowest in MAP (36%). Urinary tract abnormalities ranged between 40-44% in HAP and MAP respectively, and 12-14% in the rest. Past urinary infection appeared from 69% in MAP to 13% in COM. HAP had much more frequently multiple stones at diagnosis (73%) with the lowest spontaneous passage (55%). Lowest urine volumes were observed in COM (0.7 [0.6-1.1] mL/kg/h), highest urine pH in HAP (7,0 [7,0 -8,5] ). Hypercalciuria prevalence was similar among all groups (38-50%) except COM (17%). Hypocitraturia was more common in COM (50%), COD (36%) and HAP (29%). Calcium/citrate ratio>0.33 mg/mg was more frequent in COD (60%) and HAP (57%).

Conclusions: COM showed more frequently low urine volumes, hypocitraturia and stones in relatives. MAP and HAP were associated to urinary tract abnormalities, COD and HAP with high calcium/citrate ratio. HAP had higher urine pH. Objectives: Hydroxyapatite stones are more frequent in pediatric patients. Hypocitraturia, hyperphosphaturia, high urine pH, urine stasis, and distal renal tubular acidosis (dRTA) are related factors. We describe our cohort. Material and methods: A national pediatric renal lithiasis registry is active since January 2015, sponsored by the national pediatric nephrology association. Stones are analyzed by a specialized laboratory. Clinical and analytical data are provided by clinicians. We describe clinical variables in hydroxyapatite stone-formers and compare their metabolic urinary profiles with other types of calculi (struvite excluded).

Results: In september 2018, 83 stones from 69 patients had been included. In 11 stones (13%) from 10 patients, main component was hydroxyapatite. Male:female ratio was 2:1. Age at diagnosis was 3,1 [1,4 -13,7] vs 9,4 [4,2 -13,0] (p=0,10). Family history of kidney stones was present in 6 (67%), past urinary tract infection (UTI) in 5 (46%), preterm delivery in 2 (19%). Structural or functional abnormalities of the urinary tract appeared in 4 patients (40%): one (two stones) with ureterovesical junction obstruction, one duplicated collecting system and one neurogenic bladder. Nine stones (73%) showed multiple localizations in image evaluation. Six stones (55%) passed spontaneously. No urinary solute concentration (calcium, phosphate, citrate) nor solute/creatinine ratio showed significant differences compared to the rest of stones but pH did (7,0 [7,0 -8,5] vs 6,0 [6,0 -7,0], p=0,02). dRTA was demonstrated in 2 patients (incomplete form), discarded in 4 cases and had not been evaluated in another 4 ones.

Conclusions: Hydroxyapatite stones appeared at an early age with multiple localizations. Patients frequently had past UTI, abnormalities in urinary tract and relatives with lithiasis. The most significant urinary metabolic difference was higher pH. dRTA was insufficiently evaluated.

Taniya Khan, Surupa Basu, Shakil Akhtar, Subhankar Sarkar, Rajiv Sinha

Objectives: Corticosteroid is the standard therapy for first episode nephrotic syndrome (FENS). Daily divided dose (DD) prednisolone is still commonly prescribed despite early morning single dose (SD) hypothetically having less hypothalamic-pituitary-adrenal axis (HPA) suppression and better medication adherence. Controlled study confirming these hypotheses are scarce. We conducted a randomized controlled trial with the primary objective to compare HPA axis suppression between SD and DD steroid at completion of 6 weeks of daily steroid before reduction. Secondary objective included comparing side effects, time to remission, time to first relapse, and frequency of relapse Methods: Children with FENS were randomized to receive prednisolone 2 mg/kg per day, either as SD (n=26) or in two DD (n=27) for 6 weeks, followed by single alternative daily dose of 1.5 mg/kg for 6 weeks. After completion of 6 + 6 weeks of steroid therapy follow up continued for 6 months. HPA axis was assessed by short synacthen test (SST) on completion of 6 weeks of daily steroid. Results: In both groups all patients were steroid responsive without differences in time to remission [SD: 9 days (IQR 8-12.5) and DD: 10 days (IQR 7.5-12)], relapse rates [SD: 35%, n=9 / DD: 37%, n=10], adverse event or medication adherence. In SD group 20% (n=5) passed SST vs 0% in DD group (p =0.01). Time to first relapse was longer in SD (115; IQR 40.5 to 126) than in DD (60; IQR 32 to 68) but did not reach statistical significance. Conclusion: Our finding suggests that SD is equally effective as DD prednisolone in FENS with less HPA axis suppression. Further studies are required to assess role of HPA axis suppression on relapse of nephrotic syndrome.

Subhankar Sarkar 1 , Arpita Ray Choudhury 2 , Samartya Pulai 2 , Saugat Das Gupta 2 , Rajiv Sinha 1 1 Institute of Child Health, India, 2 IPGMER, India

Introduction: About one third of children with steroid resistant nephrotic syndrome (SRNS) have underlying genetic origin and majority of them have poor response to immunosuppressant. Western data suggest high incidence of NPHS 2 (podocin) mutation among childhood SRNS (cSRNS) but there is scarcity of data among Indian population.

Material and methods: Retrospective multicentre cross-sectional study to evaluate genetic causal association of SRNS. cSRNS (3 months to 18 years age) who had undergone genetic analysis utilising next generation sequencing between May 2016 and December 2020 at four tertiary centers across Eastern India. Results were classified according to American

College of Medical Genetics and Genomic criteria. Pathogenic / likely pathogenic variants were taken as significant.

Results: During the study period 70 cSRNS (33 female, 51 primary SRNS, median age of onset of nephrotic syndrome: 56 months; IQR: 10 to 66) underwent genetic analysis. 48 variants were identified out of which 19 were significant, distributed among 17 children giving a positive yield of 24% among our cohort. Just over a third (37 %) of the variants identified were in COL 4 genes (COL4A5 x 4, COL4A4x 1, showed response to immunosuppressant in contrast to 40% (21 /53) among whom significant variants were not found.

Conclusions: Similar to international reports; a quarter of SRNS in our cohort were genetic in origin, majority of them were primary SRNS and had poor response to immunosuppressant. Important highlight was our high incidence of COL4 variants which is in sharp contrast to western literature. Objectives: This study explores whether higher levels of deprivation could influence rates of relapse and treatment in childhood nephrotic syndrome (NS) , and if additional support from social services could improve outcomes in these patients.

Methods: A retrospective cohort study of 27 patients with childhood NS treated at Alder Hey Children's Hospital was conducted. Inclusion criteria included a Liverpool postcode, steroid responsive NS, and age 1-18 years. Records were searched over a 24-month period and data collected on number of relapses, hospital admissions, Did Not Attend (DNA) appointments, courses of rituximab and second line immunosuppressive agents. Patients were grouped into deciles according to their postcode using the Index of Multiple Deprivation (IMD) 2019. Univariant analysis and the Mann-Whitney U test were used to assess the associations between the IMD decile and outcomes. Results: 19 (70%) of 27 of patients resided in the top 20% most deprived areas. 13 (93%) of 14 admissions occurred in these patients, which was statistically significant (0.68 vs 0.13, p=0.048). 47 (81%) of 58 relapses also occurred in these patients. 9 (90%) of 10 rituximab courses and 18 (95%) of 19 DNA appointments occurred in patients living in the top 10% most deprived areas. There was no statistically significant association for number of relapses or use of second line immunosuppressants. Conclusions: Social deprivation was associated with increased number of hospital admissions in childhood NS in a small cohort of patients residing in Liverpool, one of the most deprived regions in the United Kingdom. More research is needed to understand how deprivation may influence outcomes and therefore management of childhood NS. Introduction: To study the effectiveness and relapses-free persistence of different treatment groups in 107 patients with corticodependent nephrotic syndrome (CDNS) Material and methods: Retrospective study in patients with CDNS (2011-2019) who have received treatment with cyclophosphamide(CF), mycophenolate(MMF), cyclosporine(CyA), rituximab(RTX) and/or ofatumumab(OFA), establishing homogeneous groups based on the number of drugs received and the introduction order, thereby defining 7 groups. In group 1 those with only CF. Group 2a those who received CF+MMF. Group 2b those who received CF+CyA. Group 3 those with 3 drugs, subdivided into 3a(CF, MMF and CyA) and 3b(reversing order of MMF and CyA). Finally, group 4(CF-MMF-CYA-RTX) and group 5(CF-MMF-CYA-RTX-OFA) included monoclonal antibodies. The variables analyzed were age at diagnosis, initial treatment, relapses after last treatment, time without relapses and without treatment since the last immunosuppressant.

Results: Of the total cohort, 63 patients were included (excluding those who did not the criteria of any groups). The mean age at diagnosis was 3.49 years. The distribution was: 62%(group 1), 17%(2a), 8%(2b), 1.5%(3a), 6.3%(3b), 3.1%(4) and 3.1% (5) . The mean free time (years) of relapses was: 3.69 (group 1), 1.33 (group 2a), 3.39 (group 2b), 3.7 (group 3a-b), 4.22 (group 4) and 1.04 (group 5). The percentage of patients without relapses after the last treatment was 70%, 100%(2a-b), 75%(3a-b), 100%, 100%, respectively. Currently, within group 1, 83% are without treatment, 10% in 2a, 80% in 2b, 75% in 3b, 50% in 4 and 5 and none in 3a Conclusions: 62% of the SNCDs were controlled only with the administration of CF. Of those who received more than one drug, the group that received MMF as a second immunosuppressant had a higher mean relapses-free time than the CyA group ( Introduction: Long term steroid treatment in children is known to cause obesity and negatively affect growth. The objective of this study was to determine the prevalence of obesity and overweight and analyze linear growth in children with nephrotic syndrome. Also, we aimed to investigate possible positive effects of steroid sparing drugs and low-dose steroid regimens on these parameters. Material and methods: Our study was a retrospective analysis of patients treated at Great Ormond Street Hospital with a diagnosis of idiopathic nephrotic syndrome (NS) Introduction: Calcineurin inhibitors (CNIs) remain the first-line immunosuppressive therapy in children with steroid-resistant nephrotic syndrome (SRNS). This study aimed to identify the frequency of CNI-induced nephrotoxicity (CNIT) and its clinical and histological features in children with SRNS due to focal segmental glomerulosclerosis (FSGS). Material and methods: We studied 35 children (21F/14M) aged at onset of SRNS due to FSGS 6.0 (IQR: 3.0; 9.9) years. The eGFR before cyclosporine (CsA) treatment was 97.5 (86.4; 113.8) ml/min/1.73m 2 . The initial CsA dosage was 4.6 (4.0; 5.0) mg/kg/day to blood trough level of 80-150 ng/ml. CNIT was defined as rise in serum creatinine ≥25% from baseline level. The follow-up was 54.0 (35.0; 80.0) months. Results: 24/35 (68.6%) children with SRNS due to FSGS developed CNIT in 7.0 (5.3; 16.5) months of CsA treatment. There were no significant differences in age at onset of SRNS, albumin and serum uric acid levels, proteinuria, disease duration before initiating of CsA treatment, baseline eGFR, CsA dosage and C0 blood levels in patients with CNIT compared with individuals without CNIT (р>0.05). Histological findings at the 1 st kidney biopsy did not differ among the groups including rate of global and focal glomerulosclerosis, interstitial fibrosis and tubular atrophy (р>0.05). After 6 months of CsA treatment children with CNIT compared with patients without CNIT had significantly higher serum uric acid level: 0.37 (0.29; 0.41) vs. 0.31 (0.26; 0.33) mmol/l (p=0.041) and lower eGFR: 86.8 (65.6; 91.2) vs. 85.2 (82.9; 123.8) ml/min/1.73 m 2 (p=0.044) without any differences in C0 CsA and albumin serum levels, proteinuria and rate of response to CsA treatment (р>0.05).

Conclusions: We conclude that CNIT occurred in 68.6% of children with SRNS due to FSGS. Increased serum uric acid level and decreased eGFR in 6 months of CsA treatment were found in patients with CNIT. Identification of biomarkers of tubular dysfunction might be useful for early detection and prevention of CNIT to improve outcome of SRNS due to FSGS in children.

Introduction: Schimke immunoosseous dysplasia (SIOD; OMIM #242900) is an autosomal recessive multisystem disorder characterized by spondyloepiphyseal dysplasia, T-cell deficiency, and nephrotic syndrome (NS) progressing to ESKD during childhood. The aim of the study was to investigate clinical and molecular characteristics in Russian children with SIOD.

Methods: Retrospective analysis of phenotype and genotype of 10 children (6M/4F) with SIOD was conducted. Kidney biopsy performed in two subjects revealed FSGS. The median follow-up period was 14.5 (IQR: 11.8; 24.5) months. SMARCAL1 mutations were identified by direct Sanger sequencing (n=5) and NGS (n=5). Results: Low birth weight (LBW) resulted from intrauterine growth restriction (IUGR) had 10/10 (100%) children with SIOD. The median age at onset of NS was 49.0 (IQR: 38.0; 51.0) months. Among patients with SIOD NS, spondyloepiphyseal dysplasia and T-cell deficiency had 10/10 (100%) children, cerebral ischemic events had 5/10 (50%), hematological abnormalities and CAKUT had 4/10 (40%), respectively. Pathogenic homozygous (n=5) or compound heterozygous (n=4) nonsense variant с.2542G>T (p.Glu848*) in the SMARCAL1 gene was identified in 9/10 (90%) of individuals. One child had compound heterozygous SMARCAL1 variant c.994delA (p.R332fs); c.2070+2dupT. The median age of genetic diagnosis of SIOD was 54.0 (IQR: 44.0; 58.0) months. At the last follow-up of patients aged 5.5 (IQR: 4.5; 6.4) years progression to CKD was found in all children, including stage 2 CKD in 4/10 (40%) subjects, stage 3 CKD in 2/10 (20%), stage 4 CKD in 1/10 (10%) and ESKD in 3 (30%) individuals. Conclusion: We conclude that Russian children with SIOD characterized by LBW due to IUGR, NS, spondyloepiphyseal dysplasia, immunodeficiency, and common SMARCAL1 pathogenic variant с.2542G>T (p.Glu848*). Introduction: Nephrotic syndrome is one of the most common glomerulopathies in children. Approximately one third of children with steroid-resistant nephrotic syndrome (SRNS) carry pathogenic variants in one of the nowadays almost 70 causative genes. WT1 gene, being one of the most frequent ones and coding the transcription factor WT1, is known to cause SRNS, which may be associated with disorder of sex development and nephroblastoma (i.e., Denys-Drash syndrome). This study aimed to characterize the DNA-binding affinity of WT1 mutants. Material and methods: Eight distinct exonic WT1 variants were found in the national genetic database of children with SRNS. Wild type and mutant WT1 proteins were produced and the binding affinity of these proteins to the EGR1 DNA target sequence was analysed by microscale thermophoresis. Results: Whereas three WT1 mutants (p.Arg439Pro, p.His450Arg and p.Arg463Ter) showed decreased binding affinity, other three mutants (p.Gln447Pro, p.Asp469Asn and p.His474Arg) revealed increased binding affinity and two mutants (p.Cys433Tyr and p.Arg467Trp) showed no change of binding affinity when compared to the affinity of the wild type WT1. No correlation was found between the binding affinity and the phenotype.

Conclusions: The WT1 mutants found in children with SRNS presented with variable DNA-binding affinity, with no association with the phenotype of the patients. Further investigation is needed to clarify the impact of the WT1 mutants on gene expression and changes in the numerous target signalling pathways. This might help to discover the underlying mechanisms and potentially allow for individualised treatment of the so far unfavourable disease prognosis. Objectives: We report on a newborn with primitive hyperoxaluria type 1 (PH1) treated with lumasiran early in life after prenatal diagnosis (familial screening). Methods: At birth, the child displayed increased circulating oxalate levels and urinary oxalate/creatinine ratio (Uox/creat), respectively at 36 μmol/L (N <5) and 1263 mmol/mmol (N <280). Renal function was normal.

Results: Given the familial history of end-stage renal disease at the age of 4 months, it was decided to perform the first subcutaneous injection at day 9. According to the product information template, he received monthly lumasiran (3 injections of 6 mg/kg, and subsequent tapering to 3 mg/kg). Uox/creat further increased at 2850 mmol/mmol 15 days after the first injection and then started to decrease (1500 at month 1 and 1060 at month 2). However, despite an early initiation of lumasiran, decreased circulating oxalate levels (12 μmol/L at 3 months) and persistent normal renal function, the evolution was not completely satisfying. Indeed, renal ultrasounds performed after 2 months of lumasiran therapy revealed nephrocalcinosis stage 3, with a stabilization of Uox/creat between months 2 and 3 around 1000 mmol/mmol. Of note, hyperhydration and potassium citrate were associated with lumasiran from the beginning. Conversely, tolerance of lumasiran was good without any side effect: it was therefore decided to restart injections at 6 mg/kg in order to try to lower Uox/creat below the threshold of 300 mmol/mmol. Conclusion: To our knowledge, this is the youngest child treated with lumasiran worldwide. Despite satisfying clinical and biological tolerance, the initiation of lumasiran early during the neonatal period associated with conventional management did not prevent the onset of nephrocalcinosis. The specific hepatic immaturity in this age group could justify to maintain a 6 mg/kg regimen per injection, but this hypothesis deserves to be confirmed.

Cristina Martin-higueras 1 , Gesa Schalk 2 , Bernd Hoppe 3 1 German Hyperoxaluria Center, Germany, 2 Kindernierenzentrum Bonn, Germany, 3 Dicerna Pharmaceuticals, USA Introduction: The primary hyperoxalurias (PH) are three ultra-rare, autosomal recessive genetic disorders characterized by oxalate overproduction in the liver. Hyperoxaluria induces recurrent kidney stones, nephrocalcinosis, progressive renal impairment, and systemic oxalosis, especially in PH1. Nedosiran is an investigational RNAi therapeutic administered monthly by subcutaneous injection. It reduces hepatic LDHA protein thereby inhibiting the final step responsible of oxalate production in all PH. Material and methods: We report on two PH1 patients, a 40 year old woman (a) on hemodialysis (HD) 6 x 3 hours weekly, and a 6.5 year old boy (b) receiving 5 x 5 hours HD, both homozygous for AGXT c.508G>A and treated with pyridoxine. In patient (a), global longitudinal strain (GLS), an index of left ventricular contractibility, was impaired (-13 %; normal ≤ -18% Conclusions: Clinics improved and Pox declined over the six months of treatment. Pox was influenced in (b) by severe oxalate osteopathy and therefore possibly dissolving oxalate and in (a) when dialysis regimen was reduced to 4 x 3 hours at month 6. We cautiously conclude, that liver transplantation may be avoidable in PH1 patients treated with Nedosiran. ( -Two patients had salivary stones in the parotid gland, found in a routine x-ray of the jaw before orthodontic treatment.

Conclusions: Although this is currently only data of a small cohort, systemic oxalate deposition may also occur in PH3. Of course, data in more patients are needed to elucidate the true risk of systemic oxalate deposition and we therefore recommend to screen all known PH3 patients.

Cristina Martin-higueras 1 , Julia Pick 2 , Bernd Hoppe 1 1 German Hyperoxaluria Center, Germany, 2 University Hospital Bonn, Germany

Introduction: Three different enzyme defects in primary hyperoxaluria (PH) lead to endogenous oxalate overproduction and extremely elevated urinary oxalate excretion (UOx), which induces recurrent urolithiasis, nephrocalcinosis and chronic kidney disease, the latter especially in PH1. Uox and plasma oxalate (Pox) are used as biochemical markers for diagnosis, treatment decisions and outcome parameters. We were interested in their long term follow up related to kidney function, hemodialysis (HD) or transplantation (Tx). Material and methods: We retrospectively analyzed biochemical data taken in genetically confirmed PH1 patients over the last 15 years. Both urine and plasma were analyzed for oxalate, glycolate (UGlyc/PGlyc) and creatinine (Crea). Data was examined by means of correlation/regression analysis within groups of different renal function (normal, CKD 1-5; n=56 patients), HD (n=26), post Tx (n=32), and over time.

Results: Pox remained equivalent between stages of kidney function (median Pox 17 μmol/l). Until CKD 3-4 only 17% Pox values and 33% in CKD 5 were > 30. Highest Pox was found in HD (91) and HD post liver Tx (46 μmol/l) in sequential procedure. PGlyc was elevated in all groups of kidney function and significantly higher in HD (211 μmol/l). Abstract: Primary hyperoxaluria type 1 (HP1) is a rare autosomal recessive disorder caused by biallelic pathogenic AGXT variants. The gene defect results in dysfunction of the liver-specific peroxisomal enzyme alanine amino-transferase (AGT) and consequently nephrocalcinosis, kidney stones, kidney failure and systemic oxalosis despite supportive care. Until recently, the only specific treatment was liver-kidney transplantation. Therapeutic prospects, notably with interfering RNA, would aim at reducing the substrate by upstream oxalate enzyme blockade. Stiripentol is an anti-epileptic drug registered in pediatric Dravets syndrome and well-tolerated in young children. It inhibits the lactate dehydrogenase 5 enzyme, the key enzyme of the last step in the hepatic production of oxalate. It is therefore hypothesized to reduce hepatic oxalate production and urinary excretion, thereby preventing progression to kidney failure and systemic oxalosis in HP1. We report the case of a 18 month-old girl diagnosed with HP1 with bilateral kidney stones who received stiripentol from the age of 21 months with adjunctive measures. Her urinary oxalate/creatinine ratio quickly decreased from 0.48 to 0.07 mmol/mmol and was followed by complete normalization of the kidney ultrasound after 11 months of treatment. No side effect was noted. We suggest considering a trial of stiripentol in children with HP1, alone or in combination with other therapeutic strategies such as RNA interfering drugs where available. Abstract: Primary hyperoxaluria type 1 (PH1) is a rare inherited disease associated with excessive liver oxalate production and consequent systemic accumulation and severe organ involvement. Treatment consists in nychthemeral hyperhydration, crystallization inhibitors, pyridoxine and eventually kidney-liver transplantation. This treatment has a high negative impact on quality-of-life, even before transplantation, especially nocturnal hyperhydration on a G-tube. Recently, ARN interference therapy (Lumasiran) was shown to significantly decrease oxaluria in PH1. There are however no recommendations about the discontinuation of the burdensome supportive measures. We present here 2 patients with PH1 who stopped the nocturnal hyperhydration with promising outcomes. Patient 1, a 16 yo girl, and Patient 2, a 14 yo boy, were diagnosed with PH1 at the age of 6 months with bilateral nephrocalcinosis, elevated urinary oxalate/ creatinine ratio, whewellite urinary crystals and AGXT variants. They were prescribed hyperhydration via a G-tube, crystallization inhibitors and pyridoxine. This allowed disappearance of crystals in the urine, reduction of urinary oxalate/creatinine ratio and regression of nephrocalcinosis. Patient 1 had adherence difficulties and psychological distress and decided to stop nocturnal hyperhydration at the age of 12 and nephrocalcinosis and bilateral lithiasis reappeared at the age of 14. Lumasiran was begun at the age of 15 years and 13 years, respectively. We rapidly observed normal oxaluria/creatininuria and calciuria/creatininuria, negative crystalluria and regression of lithiasis (patient 1) or persistently normal kidney ultrasound (patient 2). We decided to withdraw nocturnal hydration after 6 months in Patient 2 due to difficult-totolerate enuresis. 3 months after withdrawal, oxaluria, calciuria and crystalluria remain normal. The control kidney ultrasound is pending. Lumasiran seems very efficient to normalize oxaluria even in patients with no nocturnal hyperhydration because of non-adherence or in order to improve the quality-of-life. Additional data and longer follow-up are needed to guide updated treatment recommendations.

Introduction: Patients with end-stage kidney disease (ESKD) are known to have higher plasma concentrations of metabolic waste products than healthy individuals. Patients with Primary Hyperoxaluria (PH), a rare congenital cause of ESKD, suffer from hepatic overproduction of the metabolic end product oxalate. Plasma oxalate (POx) levels are determined in the diagnostic and therapeutic work-up for PH. Remarkably, correct interpretation of these values is hampered by the absence of knowledge concerning POx levels in patients with ESKD due to common causes. Material and methods: In this observational study, we obtained POx values in patients with ESKD due to another cause than PH, to establish reference values in this patient group. We collected blood samples from 118 patients with eGFR < 15 mL/min/1.73 m2 who required maintenance hemodialysis or peritoneal dialysis at the Amsterdam UMC. In addition, we collected 15 blood samples from adults with chronic kidney disease (CKD) stage 4 and 5 who received no renal replacement therapy. Results: While there was a wide variation in patients with ESKD, the median POx level was 50 umol/L and lowest values were twice the upper reference limit that applies to healthy individuals (6.7 umol/L Introduction: Primary Hyperoxaluria type 1 (PH1) is a rare, inherited metabolic disorder of glyoxylate metabolism characterized by oxalate overproduction, leading to end-stage kidney disease (ESKD) in more than half of all patients. As renal function deteriorates the ability of the kidneys to excrete the excess of oxalate is increasingly compromised resulting in elevated concentrations of oxalate in the blood and progressive systemic deposition of calcium-oxalate crystals in virtually all tissues, a situation referred to as systemic oxalosis. A wide spectrum of cardiac abnormalities are reported in PH1 patients, including pre-symptomatic myocardial disease early in the disease course. We aimed to further determine cardiac manifestations in a heterogenous cohort of PH1 patients by conventional and speckle tracking echocardiography (STE). Material and methods: Data from 38 genetically confirmed PH1 patients were included in this two-centre study and compared to age-and sex-matched controls. Comprehensive echocardiographic analysis (including STE) was performed. PH1 patients were subdivided in three groups based on stage of chronic kidney disease (CKD) and transplantation status (CKD1-4 (n=24), CKD5 (n=7) and post-liver transplantation (n=7)). Introduction: Primary hyperoxaluria type 1 is a rare autosomal recessive disease caused by mutation of the AGTX gene responsible for derangement of hepatic AGT enzyme. It accounts for 1 to 2% of cases of pediatric end-stage kidney disease (ESKD). Aim of the study was to evaluate the outcomes of patients with primary hyperoxaluria who received combined or sequential liver-kidney transplantation.

Material and methods: We retrospectively evaluated 10 patients with oxalosis who received a liver-kidney transplantation, with a median age of 5.6 years (range: 2.2-17.0) at kidney transplant. Five patients received a combined transplant. In five, the kidney transplant was postponed by a median time of 8 months (range 4-20) to achieve a lower oxalate burden for the graft. One of the patient died just after intervention and was excluded from further analysis. Median follow up was 3.2 years (range 1.6-11). All patients were on hemodialysis treatment at transplantation. Results: Median eGFR at 6 and at 12 month was 81.2 (range: 45.7-108.8) and 79.3 ml/min/1.73m 2 (range 54.7 -112.1) in patients who underwent combined transplant, and 45.7 (range 34.5-86.7) and 38.3 ml/min/1.73m 2 (range: 29.9-77.5) in those with sequential transplant (p:NS). In children with sequential transplant, serum oxalate before liver transplantation compared to pre-kidney transplant values showed a median drop of 51% (range 14-73%).

Sixth-month protocol biopsy showed the presence of oxalate crystals in all patients except one, demonstrating the recurrence of deposition in spite of the delay between liver and kidney transplant.

Conclusions: Liver and kidney transplant is currently the only possible option in patients with oxalosis. A delay between liver and kidney transplant does not appear to improve the final prognosis. (29%), brushite 6 (5%), amorphous calcium phosphate 3 (3%)], struvite 5 (5%), cystine 4 (4%), uric acid 2 (2%), and ammonium acid urate 2 (2%). A total of 20 (18%) stones were pure and 24 (22%) were infectious. Carbapatite stones were the most frequent in patients < 2 years and calcium oxalate stones in patients > 2 years old. Metabolic abnormalities (most frequently hypercalciuria) were found in 50% of tested patients and in 54% of patients with infectious stones. Congenital anomalies of the kidney and/or urinary tract (CAKUT) or neurogenic bladder was present in 9/24 (38%) patients with infectious stones and 12/16 (76%) patients with bladder stones.

Conclusion: This study confirms that calcium oxalate stones are the most frequent among pediatric patients, which could reflect the nutritional habits of predisposed patients. In contrast, infectious stones are less frequent and occur mostly in association with anatomic or metabolic favoring factors.

Katharina Hohenfellner 1 , Julia Quitmann 2 , Stefanie Witt 2 , Kaja Kristensen 2 1 Romed Klinikum Rosenheim, Germany, 2 University Medical Center Hamburg-Eppendorf, Germany

Introduction: Despite the impairments experienced by patients with cystinosis, very few studies investigate health-related quality of life (HrQoL) in this patient group and disease-specific HrQoL measures are lacking. Thus, the aim of this study is to develop a Patient-Reported Outcome measures (PROM) for children and adolescents with cystinosis. This instrument will capture the HrQoL from both the child/adolescent and parent perspectives. Material and methods: Based on international guidelines the PROM will be developed simultaneously in six countries (US, UK, Ireland, Germany, Spain & France). The study will take place in four phases within 24-months. Patients and parents will be recruited by clinicians and patient organizations. A first, the state of research on cystinosis and HrQoL will be examined in a systematic literature review. In phase 2, focus interviews with patients and their parents will be conducted to create preliminary questionnaire items. In phase 3, this preliminary questionnaire will be psychometrically tested in a pilot test. Subsequently, a cognitive debriefing will be conducted to examine the comprehensibility, completeness, and cultural applicability of the preliminary version from the patients and parents perspectives. In the fourth phase, the final questionnaire will be applied in a field-and re-test to evaluate its psychometric properties.

Results: The final product will be a cross-cultural, psychometrically validated, practically feasible, and conceptually suitable instrument for children and adolescents with cystinosis. It will be available in English, German, French and Spanish. With further international collaborations, this tool can be linguistically validated and cross-culturally adapted for use in a wide range of countries. And while this project refers to the development of a PROM for children, the development of a PROM for adult patients is planned as a follow-up project.

Conclusions: First results will be presented and critically discussed.

Claire Dossier 1 , Christelle Moreau 2 , Theresa Kwon 1 , Anne Couderc 1 , Alexandra Cambier 1 , Veronique Baudouin 1 , Anne Maisin 1 , Julien Hogan 1 1 Pediatric Nephrology, Robert-debre Hospital, Aphp, Paris -France, 2 Pharmacy, Robert-debre Hospital, Aphp, Paris -France

Introduction: B-cell depletion with rituximab (RTX) induces sustained remission in children with Steroid-Dependent or Frequent Relapsing Nephrotic Syndrome (SD/FRNS). However, most patients relapse after B-cell recovery and some do not achieve B-cell depletion. We report our experience of low dose Obinutuzumab (OBI), a 2 nd generation anti-CD20 antibody in this population.

Material & Methods: This is a retrospective study of children with FR/ SDNS and resistance or relapse after rituximab, treated at Robert-Debre hospital, with a single infusion of 300mg/1,73m 2 of OBI, and >6 months follow-up. Oral immunosuppressors were discontinued within 2 months. Results: 32 patients were included. Median ages at INS onset, first RTX and first OBI injection were 3.9, 8.8 and 10.7 years old, respectively. Indication for OBI were: no B-cell depletion (n=7) or short depletion <3 months (n=2), Antirituximab Antibodies (n=1) or relapse after B-cell recovery following RTX (n=22). B-cell depletion was achieved in all patients, with a longer duration compared to prior RTX. At last follow up (median 18 months), Bcell recovery had occurred in 27 patients after a median depletion of 8.3 months [IQ 6.1-12.3]. 8 patients relapsed (25%), after a median time of 16 months. Mild infusion reactions occured in 5 patients and neutropenia grade 2-3 in 7 patients. IgM were low in 7 patients at baseline, and 21 during followup. One patient was hospitalised for infectious pneumonia and another for Acute-Lung Injury with complete recover. Conclusion: A single low-dose of obinutuzumab is effective in children with FR/SDNS, including those resistant to rituximab. Tolerance profile is comparable to that of Rituximab but long term monitoring of Immunoglobulin levels is mandatory as well as a face to face trial with rituximab.

Floor Veltkamp, Leonie Rensma, Antonia Bouts Amsterdam University Medical Centers, University of Amsterdam, Emma Childrens Hospital, Department of Pediatric Nephrology, Amsterdam, The Netherlands

Introduction: Idiopathic nephrotic syndrome (INS) in children is, although the most common glomerulopathy in paediatric nephrology, a rare disease in children. Corticosteroids are the cornerstone of the treatment of the first episode, however, relapses occur in the vast majority of children causing considerable morbidity. Differences between ethnicities have been suggested, yet the incidence nor the risk for relapse have been systematically reviewed. Therefore, the objective of this systematic review and meta-analysis was to estimate the overall pooled weighted incidence and risk for relapse of INS in children.

Material and methods: Using a comprehensive search strategy, MEDLINE and Embase were searched for eligible studies until December 2020. All studies reporting incidence (per 100,000 children/ year) and/or risk for relapse (proportion of total of patients who experience at least one relapse) of INS in children (<18 year) were eligible. After quality assessment, the following data were extracted: study (design, localisation, sample size) and patient (age, sex, steroid response, ethnicity) characteristics, incidence, and risk for relapse. The overall pooled weighted estimates were calculated using random-effects metaanalysis, as heterogeneity among studies was expected. In addition, metaregression was used to test if there was a change over time in incidence and risk for relapse. Sources of heterogeneity were explored by separate subgroup analyses. To test the robustness of the results, subsequent sensitivity analyses were performed. Results: After screening, a total of 73 studies (27 incidence, 54 relapse) were included for analysis. The results will be presented during ESPN 2021.

The manuscript was accepted for publication by Pediatrics and its results and conclusions are still under embargo.

Background: Idiopathic nephrotic syndrome in children is a rare disease. In the Netherlands, the estimated incidence is 1.52 new cases per 100,000/ year (2006) (2007) (2008) (2009) . During the inclusion phase of an ongoing randomised controlled trial (LEARNS study), the number of new cases per year did not meet this estimate. Furthermore, during the Covid-19 pandemic, it seemed that even fewer new cases were identified, yet this needs to be confirmed. We hypothesise that the latter may be due to lower exposure to (viral) infections as a result of social distancing, school closings, and other lockdown measures. Methods: Two separate online surveys were sent to all paediatricians in the Netherlands and Flanders, Belgium on two occasions: May 2020 and June 2021 (planned). Paediatricians were asked to report any case of new onset INS in a child (1-18 years) (n=4), corticosteroids (n=5) and from age-matched healthy controls (n=6), prior and one-month post PCV13. Peripheral Mononuclear Cells (PBMCs) were isolated. For the identification of PS1-and PS9V-specific B-cells, PBMCs we stained using chemically-biotinylatedpolysaccharides bound to anti-biotin-coated beads and PE-conjugated anti-biotin antibodies along with CD10-APC-AlexaFluor-750, CD20-ECD, CD19-PC7. PS-specific B-cell counts were calculated by multiplying the CD19 + CD20 + CD10 -PS + event frequencies derived from cytometry and a total B-cell count measurement. Cytometric data were analyzed using Kaluza 2.1. Mann-Whitney U-test and Wilcoxon-rank test were performed. Results: At baseline, patients under CsA demonstrated lower antigen-specific B-cell counts than controls for both serotypes (p=0.019 for PS1 and p=0.0105 for PS9V), while no significant differences were found between children under corticosteroids and controls. After PCV13, patients under CsA demonstrated lower antigen-specific B-cell counts compared to controls for both serotypes (p=0.0105 for PS1 and p=0.0105 for PS9V), while no significant differences were found between children under corticosteroids and controls. Comparing pre-and post-PCV13 PS-specific Bcell counts in each group, no significant increase was found in children under CsA, while significant increases were detected in controls (2-fold increase for PS1 and 2.57-fold increase for PS9V, both p=0.0277) and patients under corticosteroids (1.82-fold increase for PS1 and 2.32-fold increase for PS9V, both p=0.043).

These results indicate a negative effect of CsA on PSspecific B-cell responses to PCV13. This Flow-Cytometry method assisted the detection of these differences, despite the small sample. It remains to determine the potential correlation of these differences with the achievement of protective antibody titers. Introduction: Our aim was to report the response to different treatments and the renal prognosis in a cohort of patients with corticosteroid-resistant nephrotic syndrome (CRNS). Material and methods: Retrospective observational study in patients with CRNS. For this, the results of the histology, the different treatment guidelines used in each case and the evolution of renal function were collected, determining the results in terms of remission and renal survival in the different groups.

Results: Of the initial cohort of 37 patients, 33 were included, excluding 4 patients with Finnish-type genetic CRNS. The mean age at diagnosis was 6.1 years. 54.5% were women. Regarding the initial biopsy, 45.5% corresponded to minimal changes (15 patients), 27.3% (9) focal and segmental glomerulosclerosis, 15.1% (5) diffuse mesangial proliferation and 12.1% (4) others. The mean follow-up was 53 months (3-115 months) . 27 patients (84.4%) received cyclosporine (CyA), 66.7% (18) of them presented complete remission and 22.2% (6) partial response. Of the patients in complete remission, 33% had at least one relapse after 17 months of treatment (7-27 months) . Rituximab was administered in 12 patients (37.5%), of which 7 had not previously responded to immunosuppressants. 100% of frequent relapsers presented complete remission after administration of Rituximab, although 3 had subsequent relapses (60%) after 21 months of treatment (12-34 months) . 57% of the patients who did not respond to immunosuppressants did not respond to Rituximab either, with Ofatumumab allowing complete remission in one of them. When relating the results with the histology, we saw how the remission in minimal changes and diffuse mesangial proliferation was 100% and 80%, respectively, although it was 33.3% in focal and segmental glomerulosclerosis. Similarly, renal failure was more frequent in patients with focal segmental glomerulosclerosis (77.7%). Of the remissions (24; 72.7%), 3 were partial (9.1%) and 6 (18.2%) did not respond to any immunosuppressive treatment, with the need for kidney transplantation in 2 of them (6%) and with 1 deceased due to an infectious cause (3%).

Conclusions: Histology and especially focal and segmental glomerulosclerosis, plays a prognostic role in the CRNS, with a lower remission rate and a greater deterioration in renal function and the need for associated kidney transplantation.

Introduction: Autoantibodies targeting factor H (AB-FH), which is a crucial alternative pathway (AP) of complement regulatory protein, have been described in 1-3% of C3 glomerulopathy patients. It may be hypothesized that in their presence, which leads to uncontrolled AP activation, B cell depletion with rituximab may be effective Material and methods: .. Results: CASE REPORT: A 10-yr old girl was admitted to our department for an occasional finding of proteinuria (protein/creatinine ratio 2.32 mg/mg), microscopic hematuria (60-150 blood cells per field) and anemia (9,2 g/dl). She had no history of serious illness or any recent evidence of upper respiratory or gastrointestinal tract infection. Her physical examination was normal. Laboratory findings revealed normal renal function, absence of nephrotic syndrome. Low levels of C3 (3 mg/dl) and C4 (6 mg/dl) were observed with elevated sC5b9 (2270 ng/ml), ANA and anti-dsDNA were normal. The first kidney biopsy revealed a membranoproliferative glomerulonephritis with a full house immunofluorescence pattern. A low-salt diet, oral prednisone and mycophenolate were immediately started. A second biopsy, performed 3 months later showed a more proliferative pattern with mainly granular deposit of C3 detected by immunofluorescence. Treatment with 3 methylprednisolone pulses were added. Screening for complement abnormalities showed no genetic mutations in the genes coding for FH, FI, MCP, THBD, C3, C5, CFHR1-5, FB and DGKE. However, AB-FH (1069 AU/ml, upper limit of normal >127 AU/ml) was found to be positive and Rituximab infusion (375 mg/m2) was administered. Interestingly, AB-FH titer was not significantly reduced by Rituximab (739 AU/ml at 4 months) without any effect on proteinuria in the following months Conclusions: To the best of our knowledge, this is the first report on the use of Rituximab in a patient with AB-FH-associated C3 glomerulopathy. Large collaborative studies are needed to elucidate the best therapeutic strategy for this ultra-rare disease.

Introduction: IgG4-related disease is a fibroinflammatory disorder characterized by IgG4-positive plasma cell infiltration and fibrosis. We present a case of isolated IgG4-related kidney disease (RKD) with tubulointerstitial nephritis (TIN) and several glomerular lesions. Material and methods: A 6-year-old boy was admitted to the emergency room with nausea, vomiting and fatigue that started 5 days ago. He had a body weight of 21.4kg (25-50p), a height of 118.5cm (25-50p), blood pressure of 158/100mmHg (>95p+12), and (+1) pretibial pitting edema. Laboratory tests revealed urea 198mg/dL(N:10-38); serum creatinine 6.9mg/dL(N:0.5-1.2); uric acid 6.4mg/dL(N:2-5.5); albumin 2.3g/ dL(N:3.5-5.5); sodium 130mmol/L(N:134-150), potassium 4.91mmol/L(N:3.5-5.5), calcium 7.7mg/dL(N:8.8-10.8), phosphorus 6.6mg/dL(N:4-7), erythrocyte sedimentation rate(ESR) 108mm/h(N:0-20); parathormone 248ng/L(N:18.5-88); total IgE 24600IU/mL(N:0-90), total IgG:8.44g/dL(N:7-16), IgG4:2.91g/dL(N:0.012-1.699), pH 7.13, HCO3 11.6mmol/L, and BE-16.7mmol/L. His urine output was 0.3 cc/kg/h. Urinalysis revealed specific gravity 1018; glucose+2; pro-tein+3; erythrocyte+2. Spot urine protein/creatinine was 24.4. Serum C3-C4 were normal; ANA and anti-dsDNA were negative. The kidney biopsy was consistent with chronic TIN. There was global sclerosis in 3, cellular/fibrocellular crescents in 4, ischemic collapse in 10-11 of the 43 glomeruli. IgG (+2) and IgM (+1) staining were observed in immunofluorescence microscopy. There were ≥10 IgG4 stained cells/hpf. The patient was diagnosed with IgG4-RKD and USG, CT, MRI and PET-CT were performed to detect other organ involvements. There were no signs of malignancy or extrarenal symptoms. Hemodialysis was initiated. Results: He received 6 doses of pulse methylprednisolone followed by 2 doses of intravenous cyclophosphamide 15 days apart and Rituximab. Serum creatinine decreased to 1.7 mg/dL and he had no need for dialysis anymore. The treatment was supposed to be personalized due to laboratory tests in the follow-up.

Conclusions: IgG4-RKD is should be kept in mind in patients with high IgE levels and chronic TIN even in childhood. Our case is the smallest patient with IgG4-RKD and the first child with isolated IgG4-RKD.

Introduction: Nephrotic syndrome (NS) is a syndrome characterized by nephrotic proteinuria, hypoalbuminemia, edema and hyperlipidemia. These patients have been shown to have a higher risk of cardiovascular disease (CVD), obesity, and dyslipidemia. The aim of this study is to evaluate the epicardial adipose tissue that plays an active role in the development of CVD and atherosclerosis by secreting inflammatory substances in patients with nephrotic syndrome. The study was conducted with the inclusion of pediatric patients aged 0-18 years with NS who were followed up in the Pediatric Nephrology Outpatient Clinic of SBU Tepecik Training and Research Hospital. Retrospectively, from the file data of these patients, age of diagnosis, current disease status (remission, attack), treatments used, findings of biopsy, weight, height, BMI, mean blood pressure, presence of edema, laboratory parameters and ECHO findings were recorded (Group 1). Healthy, screening ECHO cases were taken as the control group (Group 2).

Material and methods: The study and control groups consisted of 32 patients (20 males) and 15 patients (7 males), respectively. There was no difference between the groups in terms of gender, age, BMI, systolic and diastolic blood pressure. In Group 1, there were steroid dependent NS patients with 37.5% (12) . The mean age at diagnosis was 80.0 ± 57.8 (17.0-207) months. 22 patients were clinically in remission. Biopsy diagnosis was present in 23 patients and 10 of them (43.5%) were compatible with MLH. There was no patient with ascites. Six patients were clinically edematous. Results: The demographic and clinical characteristics of Group 1 are shown in Table 1 . When both groups were evaluated in terms of ECHO findings, a significant difference was found between the groups in terms of IVSD, LVWD, epicardial steatosis (viewed from the right ventricle and parasternal short screen in the parasternal long axis) ( Table 2 ). In addition, there were significant differences between the patient and control groups in terms of parameters indicating repolarization in ECG evaluations in both groups (Table 3) . Conclusions: Cardiovascular morbidity and mortality are high globally in renal diseases and early diagnosis of cardiovascular diseases is important in this group of patients. Measurement and tracking of EYD can give us information in this sense as a non-invasive parameter. Objectives: An international research collaboration recently found that NPHS1 is also known as disease-susceptibility gene for steroid-sensitive nephrotic syndrome. Mutations in NPHS1 gene could occur in both SRNS and SSNS patients.

We report on a 11-year old Surinamese-Creole male patient who presented since the age of 2 11/12 years with a steroid sensitive frequently relapsing nephrotic syndrome (SSFRNS). Kidney biopsy showed minimal change disease (MCD). He was treated first with the classical schedule steroids with tapering. After a steroid-free period of 6 months he developed 4 flares, for which cyclosporine was added. He remained without relapses for 2 years. Then frequent relapses were seen on tapering off his medication. Rituximab was started. Patient remained in remission for 14 months and then 2 flare-ups occurred each time after a viral infection. Steroids and cyclosporine were restarted. A second rituximab treatment was given at the age of 10 with subsequent tapering of steroids and retention of cyclosporine. Currently: (GFR: 101.9 ml/min/ 1.73 m 2 ), no hematuria, normal C3 and C4.

Results: Because of the SSFRN a genetic study was carried out. A heterozygosity was found for 2 variants in NPHS1: c.2734 G>A(p.(Ala912Thr)) and c.1747 G>A(p.(Gluc583Lys)).

Conclusions: The association of these variants has been previously reported as novel and potentially pathogenic variants by Bierzynska A. et al in 2017 . Variations in heterozygous variants are not adequate to make structural damage and so are manifested with a milder phenotype. To conclude it is advisable to perform a genetic analysis, especially in SRNS, in familial cases of NS, but also in SSFRNS like in our case.

Introduction: Congenital nephrotic syndrome (CNS) is a heterogeneous kidney disorder characterized by early onset of symptoms caused by genetic defects in specific podocyte proteins disrupting the integrity of the filtration barrier. The most common genetic defects involve NPHS1 gene, which encodes nephrin and causes the Finnish type CNS. Material and Methods: Herein we report the case of two Chinese sisters with the same mutations but different clinical severity. The younger sister was referred at three months because she developed diffuse oedema associated with massive proteinuria (max 11,6 g/L), hypoalbuminemia (min 14 g/L, range 38-54 g/L), hypothyroidism and hypertension. Renal biopsy showed mesangial hypercellularity and diffuse microcystic dilation of the proximal tubules and ultrastructural analysis showed complete foot process effacement and villous transformation of podocytes with endothelial swelling. On the suspect of CNS, NGS analysis was performed. The girl was treated with albumin, antithrombin III and immunoglobulin supplements, ACE-inhibitor (ACE-i) and antihypertensive drugs. In her family history, parents were healthy and not consanguineous, but her older sister was diagnosed with proteinuria at the age of 2 and was treated with ACE-i in China. At 9 years of age, she had mild proteinuria (1 g/day) and her renal biopsy showed mild mesangial hypercellularity, little microcystic dilation of the proximal tubules and foot process effacement. The genetic test was extended to her.

Results: NGS analysis highlighted the Fin-minor mutation c.3325C>T (p.Arg1109Ter) and the missense mutation c.928G>A (p.Asp310Asn) in compound heterozygous state in both sisters.

Conclusions: In CNS is emerging evidence of the possibility of a variable phenotype despite the same genetic variants. Our case highlights profound differences both in clinical presentation and evolution and in histological features between sisters with similar environmental exposure and the same compound heterozygous mutations in NPHS1. Response to intensive immunosuppressive treatment was favorable, leading to the reduction of endocapillary and extracapillary proliferation lesions. High levels of immune IgG/IgA complexes, reduction of proteinuria and gradual eGFR stabilization argued against Alport syndrome. Nevertheless, COL4A3-cIgAN patients seem predisposed to more serious IgAN presentation compared to the non-COL4A3-cIgAN group, with more glomerulosclerosis and a lower eGFR over time. One of the four patients was kidney transplanted with subsequent IgAN recurrence.

Conclusions: Predisposition factors for developing serious cIgAN flairs should be considered for cIgAN with COL4A3 pathological heterozygous variants. COL4A3 variants, usually responsible for Alport syndrome in adults, should not automatically exclude an immunosuppressive regimen in cIgAN. Moreover, evidence of an ACMG class 4/5 COL4A3 variant in early stage cIgAN could be a helpful tool for stratifying severity of cIgAN beyond the Oxford classification.

Introduction: Disease-causing variants in COL4A3-5 are known to be associated with type-IV-collagen-related nephropathy, comprising Alport syndrome (AS) and thin basement membrane nephropathy (TBMN). Initial symptoms of individuals with AS are microscopic hematuria (MH) followed by proteinuria leading to end-stage renal disease (ESRD). Extrarenal manifestations like hearing impairment and eye abnormalities can additionally be observed in AS. In contrast, individuals with TBMN mostly present with MH, only some of these individuals develop ESRD. Digenic inheritance has been proposed as causative for type-IV-collagen-related nephropathy and discussed as a possible aggravating factor of the phenotype in type-IV-collagen-related nephropathy. However, up to now only little and inconclusive information concerning this topic can be found in the literature. Material and methods: 60 index cases, in whom exome sequencing had been performed and with (likely) pathogenic variant(s) in COL4A3-5 (summarized to "disease-causing variant"), were reanalyzed for additional (likely) pathogenic variants in COL4A3-5. Moreover, a Mendelian genomics database (Munich Exome Server) comprising 22,000 exomes was scrutinized for individuals with a combination of disease-causing variants in at least two of the three collagen genes COL4A3, COL4A4, or COL4A5. Results: Of 60 reanalyzed individuals, 83% had AS phenotypically, 12% TBMN and 5% had focal segmental glomerulosclerosis. No additional disease-causing variants were identified in one of the alternate COL4A3-5 genes in these individuals. In the Munich Exome Server, only one individual with a non-renal phenotype and a combination of a heterozygous disease-causing variant in COL4A4 and COL4A5, respectively, was identified.

Conclusions: In this study, no clear indication for digenic inheritance could be observed implicating that this phenomenon might be very rare and not that common than postulated in the literature. Future research on digenic inheritance in type-IV-collagen-related nephropathy should focus on statistic evidence from case-control studies and experimental proof of functional impact of digenic variants in COL4A3-5. Conclusions: We conclude that following careful evaluation in this contemporary cohort of C&YP with ADPKD, the incidence of mitral valve prolapse is significantly lower than previously reported in both children and in adults with ADPKD. Those with variants of normal anatomy may represent early signs of developing MVP in this population and longitudinal studies are needed. Objectives: Cystic kidney diseases such as autosomal recessive or dominant polycystic kidney disease (ARPKD and ADPKD) are associated with high prevalence of arterial hypertension. On the contrary, studies on hypertension in children with renal cysts and diabetes (RCAD) syndrome caused by abnormalities in the HNF1B gene are rare. Therefore, the aim of our study was to investigate the prevalence of hypertension in children with RCAD syndrome due to HNF1B gene abnormalities and to search for possible risk factors for development of hypertension.

Methods: Data on all children with genetically proven RCAD syndrome from three pediatric nephrology tertiary centers were retrospectively reviewed (office blood pressure (BP), ambulatory blood pressure monitoring (ABPM), creatinine clearance, renal ultrasound, echocardiography, albuminuria/proteinuria). Hypertension was defined using the current ESH 2016 criteria and/or by the use of antihypertensive drugs. Results: Thirty-two children with RCAD syndrome were investigated. Three children received ACE-inhibitors for hypertension and/or proteinuria. Hypertension was diagnosed using office BP in 22% of the children (n=7) In the 7 performed ABPM (one in a child with office hypertension and five with normal office BP) only one child (14%) was diagnosed with hypertension by ABPM. Creatinine clearance, proteinuria, albuminuria, body mass index, enlargement or hypodysplasia of the kidneys and prevalence of HNF1B-gene deletion or mutation were not significantly different between hypertensive and normotensive children.

Conclusions: Hypertension is rare in children with RCAD syndrome. The low prevalence of hypertension seems to be the hallmark of the disease. Objectives: Schimke immuno-osseous dysplasia (SIOD) is a rare autosomal recessive disease (SMARCAL1 variants) characterized by T-cell immunodeficiency and steroid-resistant nephrotic syndrome progressing to kidney failure with early mortality mainly due to infections and stroke. Indication and modalities of kidney transplantation (KTx) and bone marrow transplant (BMT) are not standardised. We described the management proposed by our unit. Methods: Retrospective, observational, single-centre study including paediatric SIOD KTx recipients followed between January 2002 and January 2021.

Results: Eight patients of 7 year median age (3) (4) (5) (6) (7) (8) (9) (10) at deceased donor KTx time were included. Seven patients required chronic dialysis of 6 month median duration (3) (4) (5) (6) before KTx. Induction treatment was basiliximab and steroids (6 patients Our data show that the risk of disease recurrence after kidney transplantation is extremely low in case of identified NPHS2 causal variants. These data are consistent with the pathophysiology of the disease due to structural defects of the glomerular filtration barrier in the native kidney and with recent data highlighting that the rare reported cases of post-transplant proteinuria in patients with NPHS2 variants are probably multifactorial. All together, these data reinforce the possibility of kidney donation from living donors in individuals carrying the NPHS2 p.R138Q variant in the heterozygous state.

Introduction: Alport syndrome (AS) is a hereditary nephritis characterized by progressive renal failure. There is increasing evidence that renin-angiotensin-aldosterone system (RAAS) inhibition slows progression to chronic kidney disease (CKD) in AS patients. On the other hand, the effectiveness of immunosuppressive (IS) therapy and the number of studies is limited. This study aimed to analyze the outcomes of RAAS inhibitors and IS therapy in pediatric patients with X-linked AS (XLAS). Material and methods: A total of 74 pediatric XLAS patients were included in this multicenter study. Data from medical records were collected retrospectively, other centers were requested to fill out a questionnaire which includes data regarding patient demographic features, clinical and laboratory characteristics, treatment, and follow-up results.

Results: A total of 74 pediatric patients with XLAS (41 male, 33 female) were studied. The median age at first presentation was 6.0 years (interquartile range (IQR) 3.4 -9.9). The median follow-up duration was 4.0 years (IQR 1.7-7.3). Fifty-two (70.2%) patients received only RAAS inhibitors, 11 (14.9%) patients received RAAS inhibitors and IS, and 11 (14.9%) patients were followed up without treatment. During follow up, glomerular filtration rate (GFR) decreased below 60 ml/min/1.73 m 2 in 7 (9.5%) of 74 patients (1 female, 6 male) at the median 16.2 years (IQR 15. 2 -16.6) . The patients who were followed up without treatment did not progress to CKD, however, the follow-up period was significantly shorter than other groups (p=0.02). The median age at onset of RAAS inhibitor therapy were significantly higher in patients who progressed to CKD than those who did not ( Background: Sulfate is an important mineral for cartilage metabolism and hepatic detoxification. Like other ions, sulfate is absorbed via dedicated transporters in the gut and in the proximal tubule. As sulfate is not commonly measured in clinical medicine, sulfate deficiency is not recognized and little is known on the phenotype of sulfate deficiency. This is the first report describing hyposulfatemic hypersulfaturia caused by a homozygous nonsense variant in the SLC13A1 gene, encoding the sodium-sulfate cotransporter, which is responsible for intestinal and renal sulfate (re)absorption.

Case description: The boy presented at 4 months with enlargement of the knees. X-ray revealed spiky widening of all metaphyses, ovoidshaped vertebral bodies, slightly delayed epiphyseal ossification, irregular tarsal bones and flared ribs, which improved over the years. At the age of 11 years, he has broad knees and elbows, winged scapulae, a relatively shorter trunk with reduced movement of the lumbar spine and knees. He has a normal cognitive development, and no kidney or liver dysfunction. Trio-based Whole Exome Sequencing showed a homozygous g.122839967G>A (Chr7 (GRCh37) Objectives: To assess kidney function and clinical features of renal involvement in tuberous sclerosis complex (TSC), including glomerular filtration rate (GFR), albuminuria, and blood pressure (BP) levels in children, adolescents and young adults.

Methods: Patients with a confirmed TSC diagnosis followed up at the Paediatric Neurology department of a tertiary hospital were included in the current cross-sectional study. All participants had kidney imaging within six months of ambulatory blood pressure and GFR assessment.

Data on demographics, history, genotype, kidney function at diagnosis and last imaging were also collected.

Results: The median age of the patients was 15 years (IQR range 9 to 18). 23.5% of the participants had ambulatory BP hypertension. Significant positive association of GFR DTPA with systolic BP values was noted despite the absence of hyperfiltration. Greater increase in GFR from initial TSC diagnosis to assessment date resulted in higher GFR levels in childhood and adolescence in those that developed hypertension and possibly in those with angiomyolipoma or cysts. All patients with ambulatory BP hypertension had angiomyolipomas or cysts on renal imaging studies.

Conclusions: Hypertension may be prevalent in young patients with TSC-related kidney disease. Routine ambulatory BP measurement could be part of the annual clinical assessment of the TSC population. Introduction: Cystinosis is a rare, incurable autosomal recessive disease caused by mutations in the CTNS gene, which encodes for the cystine transporter cystinosin leading to lysosomal cystine accumulation in all cells, with kidneys being the first affected organs. Treatment with cysteamine decreases the cystine accumulation, but does not reverse the renal Fanconi syndrome, glomerular injury or loss of renal function. We have developed a zebrafish larvae model having truncating mutation in ctns, which recapitulates kidney phenotype of cystinosis. In this study, we characterized the adult cystinosis zebrafish model to evaluate the long term effects of cystinosis on kidney and extra renal organs. Material and methods: Cystinosis (ctns -/-) zebrafish of 18 months and control (WT) zebrafish were studied. Histological studies of kidneys and extrarenal organs were performed. Cleaved caspase-3 staining was used to evaluate apoptosis in the kidney. Cystine accumulation was evaluated via liquid chromatography-mass spectrometry and toluidine blue staining. For the fertility studies, the number of total eggs and fertile eggs produced by breeding female and male ctns -/zebrafish compared to WT zebrafish was evaluated.

Results: ctns -/zebrafish show cystine accumulation, glomerular hypertrophy and proximal tubular accumulation of hyaline-like eosinophilic droplets and vacuolated cytoplasm. Moreover, the cystinotic zebrafish show increased apoptosis in proximal tubules. In addition, instead of the typical striped pattern, ctns -/zebrafish presents an altered melanin skin pigmentation resulting in spotted skin. Lastly, male ctns -/zebrafish presents spermatogenic cysts enriched in spermatozoa in the testis, while female presented increased percentage of unfertilized eggs.

The ctns -/zebrafish model reproduces several human phenotypes of cystinosis such as cystine accumulation, altered kidney morphology, impaired skin pigmentation and decreased fertility. This model may be useful for studying long-term effects of cystinosis and for testing novel drugs for correcting cystinosis phenotype. Results: We identified six themes: struggling with daily restrictions (debilitating symptoms and side effects, giving up valued activities, impossible to attend school and work, trapped in a medicalized life, overprotected by adults, and cautious to avoid health risks); lagging and falling behind (delayed independence, failing to keep up with peers, and socially inept); defeated and hopeless (incapacitated by worry, an uncertain and bleak future, unworthy of relationships, and low self-esteem and shame); reorienting plans and goals (focusing on the day to day, planning parenthood, and forward and flexible planning); immersing oneself in normal activities (refusing to miss out, finding enjoyment, determined to do what peers do, and being present at social events); and striving to reach potential and seizing opportunities (encouragement from others, motivated by the illness, establishing new career goals, and grateful for opportunities).

Conclusions: Young adults encounter lifestyle limitations and missed school and social opportunities as a consequence of developing CKD during childhood and as a consequence lack confidence and social skills, are uncertain of the future, and feel vulnerable. Some re-adjust their goals and become more determined to participate in "normal" activities to avoid missing out. Strategies are needed to improve life participation in young adult 'graduates' of childhood CKD and thereby strengthen their mental and social wellbeing and enhance their overall health. Introduction: Tertiary centers of pediatric nephrology in Belgium provide multidisciplinary care for children with chronic kidney disease (CKD). This care is essential as studies have shown that CKD has an impact on the psychosocial development of these children and their families. Many studies have focused on QoL. However, less is known about the illness-related stress of parents and its relation with child psychosocial functioning. Therefore the aim of the study was to investigate (1) illnessrelated stress in parents of children with CKD with and without kidney transplantation (Tx) and (2) Introduction: Little is known about the impact of pediatric chronic kidney disease (CKD) on the parents. This study aims to explore the psychosocial functioning in this parent group. Material and methods: Fourthy-four parents (32 mothers) of children with CKD completed our psychosocial questionnaires. Parental stress was evaluated by the Parenting Stress Index -Short Form (PSI-SF), anxiety and depression were measured using the Hospital Anxiety and Depression Scale (HADS). The Child Vulnerability Scale (CVS) and Parent Overprotection Measure (POM) were used to explore parents' perception of child's vulnerability and protective behavior, respectively. A matched control group of parents of healthy children was used for comparison. Results: Since the CKD diagnosis, 47% of the parents perceived a deterioration of their own health, and in 38% of the families at least one of the parents reduced work activities. Averagely parents took 17 days of work leave in the last 6 months because of the child's treatment. Compared to our control group, parents of children with CKD reported higher stress levels (59.6 versus 43.5; p < 0.001; normal range 43 -61) and more symptoms of anxiety (7.8 versus 5.1; p < 0.05; normal range 0-7) and depression (5.3 versus 3.7; p< 0.05; normal range 0-7). Significantly higher scores on child vulnerability perception (8.6 versus 2.5; p< 0.001) and protective behaviour (41.7 versus 36.8; p< 0.05) could be measured in parents of children with CKD. Conclusions: Parents of CKD patients report more health problems and a significant professional impact. Compared to parents of healthy children, a higher presence of stress, anxiety and depression symptoms can be seen. Also, these parents perceive their child as more vulnerable and use more protective behavior towards their child. As the impact of CKD goes beyond the child and affects the entire family, a multidisciplinary family-based therapy should be recommended.

Introduction: DSTYK encodes dual serine/threonine and tyrosine protein kinase. DSTYK has been associated with autosomal dominant congenital anomalies of the kidney and urinary tract and with autosomal-recessive hereditary spastic paraplegia. Here we report a father and his two dizygotic twin sons with a novel, heterozygous variant in DSTYK, all presenting with voiding dysfunction due to functional urinary bladder disturbance. Materials and Methods: We performed whole exome sequencing of the family. All three presenting clinically with hesitancy, abnormal voiding pattern and night incontinence till adolescence. In the sons cystoscopy excluded urethral valves but showed hypertrophy of the bladder neck and trabeculated bladder. Additionally, both sons were diagnosed with epilepsy. Based on the pedigree, filtering of exome data focused on rare (MAF<0.01%), autosomal-dominant variants, predicted to be deleterious, Introduction: Urinary system infections (UTI) are one of the most common bacterial infections in childhood. UTI should be diagnosed quickly and treatment should be initiated as soon as possible due to its significant morbidity and mortality. In this study, we aimed to investigate the diagnostic value of Pro-adrenomedullin in children with UTI and compare with Procalcitonin, C-Reactive Protein and blood leukocyte count. Material and methods: In this prospective study we enrolled 106 children (62 girls) with a diagnosis of UTI and 31 (21 girls) controls. Urinalysis, complete blood count, Procalcitonin, C-Reactive Protein, BUN, creatinine and, urine culture was done. Venous blood samples for the analysis of Pro-adremonedullin were obtained from all patients before starting antibiotic therapy and one week later.

Results: The patients with UTI had higher Pro-Adrenomedullin levels compared to control group (p=0.001). The diagnostic accuracy for predicting the UTI, reflected by the area-under-the-curve of receiver operating characteristics (ROC) were: Pro-adrenomedullin 0,91 (95% CI 0,861-0,971) and, procalcitonin 0,94 (95% CI 0,904-0,989). The ROC analysis showed a cut-off value of 11679 pmol/l for Pro-adrenomedullin. We showed that the risk of UTI was 33,8 times higher in children with Pro-adrenomedullin level above 11679 pmol/l. Based on the cut-off values obtained for Proadrenomedullin and Procalcitonin, we demonstrated that the probability of predicting the diagnosis of UTI was 189.8 times higher when both biomarkers were used. Also, Pro-adrenomedullin levels at initial diagnosis were well correlated with Procalcitonin (r=0,470, p=0.001), CRP (r=0.395, p=0,001) and leukocyte count (r=0,387, p=0.001). Although Procalcitonin, CRP and leukocyte count decreased one week after treatment (p=0,001), there was no statistically significant difference in terms of Pro-adrenomedullin levels (p>0.05).

Conclusions: Our results demonstrated that Pro-adrenomedullin is a powerful biomarker in the diagnosis of UTI and increases the probability of predicting the diagnosis when used with other biomarkers but not useful for follow-up.

Introduction: We aimed to evaluate the effects of non-E.coli or extended-spectrum beta-lactamase-producing bacterial (ESBL-PB) growth in the first febrile UTI of infants Material and methods: The data of patients aged between 2-24 months and were followed up for at least 6 were retrospectively analyzed. Ultrasonography was performed in all cases at the time of the infection and dimercaptosuccinic acid ( Introduction: We aimed to evaluate the accompanying urological and urinay anomalies including vesicoureteral reflux(VUR), hypoplasia, urinary tract infection(UTI), hematuria and proteinuria and long-term results of patients who were followed up with a diagnosis of ectopic kidney (EK). Material and methods: The files of the patients with EK followed up between 2008-2020 in the outpatient clinics were retrospectively reviewed. Gender, age at presentation, complaints, urinary findings (hematuria, proteinuria), and radiological imaging of the patients were evaluated. Results: The mean age at presentation of 78 cases (F/M=41/37) was 53.42 ±58.5 (0-274.03) months. 45%(n=35) of the patients were diagnosed incidentally, while 22% (n=17) presented with abdominal pain, 15% (n=12) had antenatal history, 12%(n=9) had UTI and %6.5(n=5) of them applied for voiding disorder. 69%(n=54) of the cases had pelvic, 11%(n=9) had cross EK, and 19%(n=15) had horseshoe kidney. 24%(n=19) of the patients had recurrent UTI. VUR was detected in 9 of these cases. In 35% of the patients (n=25), EKs were hypoplastic. The frequency of hematuria was statistically significantly higher in patients without pelvic EKs (p=0.039). No significant difference was found in terms of age at presentation, follow-up time, current age, size difference between two kidneys on USG between patients with and without hematuria and between those with and without proteinuria. The fractional functions of the kidneys in DMSA were similar between patients with and without hematuria, while having> 10% difference between the two kidneys in DMSA was significantly higher in patients with proteinuria (p=0.023).

Conclusions: Recurrent UTI and VUR can be seen in patients with renal ectopia. Hematuria in non-pelvic EKs and kidneys with high differential difference in DMSA are more common in patients with proteinuria. ). 8% routinely perform a cystogram to investigate contralateral vesicoureteric reflux. 62% would undertake routine renal function assessment with frequency ranging from once only (62%) to "every two years". Nephrectomy thresholds quoted were: "still present at 3/4 years", "still present at 5 years", "3cm at 5 years", and "6cm at 6 years". 25% recalled MCDK nephrectomy within the previous five years. Respondents voiced concerns that national guidance may result in an overcautious approach but could (1) balance between consensus and safe variation, and (2) Introduction: The identification of vesico-ureteral reflux (VUR) in children with congenital solitary functioning kidney (CSFK) identifies patients at risk of kidney injury but exposes to radiations and pain. VUR may be associated with renal dysplasia and reduced renal length (RL). Our hypothesis was that RL>2 standard deviation score (SDS) in the first months of life (renal hyperplasia) could identify patients with CSFK with lower probability of presenting VUR. We also hypothesized that the utility of RL in selecting patients with lower risk of VUR is limited to the first months of life because -later-the compensatory renal growth of CSFK could not allow to distinguish patients with renal hyperplasia from those with renal hypertrophy. We aimed testing our hypotheses. Introduction: A precise assessment of glomerular filtration rate is key to delineate the care of children with a solitary functioning kidney (SFK). Data regarding measured GFR (mGFR) in this population is restricted to a single study of 77 individuals, which suggested that a GFR estimation (eGFR) method based on creatinine and cystatin C (eGFR-CKiD2) performed better than Schwartz's equation (eGFR-Schwartz). Material and methods: We measured GFR in 210 consecutive adolescents (7 to 22 years old) with a SFK referred to our institution between 2014 and 2019 and in 43 young candidates to kidney donation (18 to 25 year old). We compared the distribution of mGFR in both groups and determined the factors associated with reduced mGFR in adolescent with a SFK. We further compared different eGFR formulas with mGFR and assessed the association of mGFR and eGFRs with PTH and FGF23, two early indicators of GFR reduction. Results: While adolescent with a SFK had a similar median mGFR than healthy controls (103±24ml vs 107±12 ml/min/min/1.73m 2 ), the fraction of individuals with a mGFR below 90ml/min/1.73m 2 was higher in patients with SFK (23% vs 5 % in controls; P=0.005). Multiple linear regression identified older age, ipsilateral abnormalities of the urinary tract, lack of compensatory hypertrophy and treated hypertension as independent factors associated with reduced mGFR. Conclusions: Our findings demonstrate that renal injury is present in children with SFK at early age. Kidney functions of these patients start to deteriorate over years starting from young age. Kidney protective approaches should be taken at follow-up of these children. Conclusions: Although US findings cause concern for the doctor and parents in MU cases without reflux and obstruction, we could be interpreted to these cases having a low risk of causing problems in terms of UTI, parenchymal damage and growth. Introduction: Duplicated renal collecting system is one of the congenital anomalies of the kidney and of the urinary tract (CAKUT), which are the most common cause of chronic renal disease in children.

Material and methods: S. is a 7-month-old male infant, born at term with an antenatal diagnosis of bilateral, complete duplex system. Renal ultrasound at birth confirmed the diagnosis and antibiotic prophylaxis with amoxicillin-clavulanate was started in the first week of life. A month later, voiding cystourethrography was instead normal, with no evidence of passive or active vesicoureteral reflux (VUR). Abdominal MRI showed an ectopic outlet into prostatic urethra of both the upper ureters, leading to an obstruction of urine flow and to a massive dilatation of these systems, associated with normal bilateral lower systems. A Technetium-99m-MAG3 Scan detected a good function of upper bilateral mojety. Results: Corrective elective surgery was performed at 6 months of age by carrying out a right termino-lateral ureteroureterostomy with stent placement. Due to a multiresistant P. aeruginosa urinary tract infection though, S. was admitted to hospital to remove the ureteral stent and to start IV antibiotic therapy with meropenem. Renal function and BP were within normal range. Contralateral hydropyonephrosis required an invasive approach with percutaneous nephrostomy, left in place until left ureteroureterostomy was carried out. Clinical conditions improved and no other intercurrent episode of UTI occurred. Conclusions: The most common complications of duplex kidney are obstruction of the upper moiety and VUR from the lower one. S. did not present the latter, but the severity of the first one required surgical intervention. Upper ureteroureterostomy is a safe and conservative alternative to upper pole heminephrectomy. Prenatal diagnosis is of crucial importance as it allows to plan a multidisciplinary intervention with diagnostic workup, and, if needed, elective corrective surgery. In our case, an early start of antibiotic prophylaxis allowed us to have a safer surgical timing. Abstract: Shiga toxin-producing Escherichia coli (STEC) is the leading cause of hemolytic-uremic syndrome (HUS) in children. Patients with STEC HUS are generally ill-appearing at presentation and have the biological triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure. A previously healthy 7-month-old girl presented to the emergency room with periumbilical inflammation. An abdominal ultrasound revealed the presence of a urachal cyst. Blood workup showed: hemoglobin 8.7 g/dl, white blood cell count 6 300/ mm3, platelet count 287 000/mm3, C-reactive protein 3 mg/l, serum creatinine 101 μmol/l; peripheral blood smear found no schizocytes. The infant had no history of recent infection or toxic exposure. She had a normal urine output, no edema and normal blood pressure. Renal ultrasound was normal. Urinalysis revealed leukocyturia, mixed proteinuria and hematuria. Further laboratory tests were conducted and found normal values of serum albumin, LDH, haptoglobin, liver and pancreatic enzymes. Immunologic workup found normal complement levels and negative antinuclear antibodies. Creatinine levels did not decrease after IV hydration. A percutaneous kidney biopsy was performed and was in favour of a thrombotic microangiopathy. The urachal abscess was drained and culture was positive for Escherichia coli. Polymerase chain reaction identified the strain as producing shiga toxin-2. Stool samples were negative for STEC. No genetic mutation of atypical HUS was found. Evolution was favourable: at 6-month followup, the patient had a normal clinical examination and an improved renal function with a serum creatinine of 50 μmol/l. The abdominal ultrasound found no sign of urachus remnants. The patient is closely monitored every three months and receives an anti-proteinuric treatment with ACEi. This very atypical case raises awareness of the possibility of STEC HUS following E. Coli abcess. Our patient had no prodromal diarrhea, no signs of hemolysis, a normal platelet count, a fortuitous discovery of renal failure and STEC was identified in a urachal abscess and not in stool. Material and methods: 124 children with primary IgAN were enrolled in a retrospective study. 75 children were followed up more than 2 years (the median follow-up was 28 months). The median age of onset was 11.0 years (IQR is 7.0-13.5). Patients were divided into 2 groups: group #1idiopathic IgAN (n = 92), group #2 -Shenlein-Henoch purpura (n = 32). The age of onset and primary admission, the level of proteinuria and glomerular filtration rate (GFR) at the onset, after 12, 24 months, at the end of follow up, mean blood pressure, medications before nephrobiopsy were analyzed. Nephrobiopsy data were classified according to the Oxford Scale. 70 children, followed for at least 2 years, showed disease progression (assessed by the GFR decline curve and the presence of persistent proteinuria), underwent next generation sequencing (NGS). Single nucleotide polymorphisms (SNP) were assessed according to the IgAN panel (panelapp.genomicsengland.co.uk/panels/156/). Progression was estimated by a decrease in GFR less than 60 ml/min/1.73 m2. Outcomes were classifyed into absence or presence of remission. A search for factors influencing GFR after 24 months of observation was carried out. Comparison and analysis of data was performed using Students t-test, Mann-Whitney, χ2, Fisher, linear regression model, Cox regression model. Results: Unlike adults, the predictive value of the Oxford scale in children has not been proven and is not associated with a decrease in GFR <60 ml/min/1.73 m2. GFR at the end of follow-up was lower in the first group than in the second. The level of GFR at the onset, mean blood pressure and the age of primary admission turned out to be independent factors helping detect children with an expected decrease in GFR less than 90 ml/min/1.73 m2 within 2 years. Analysis of SNP, their associations did not have a statistically significant effect on the clinical, morphological data of patients, outcomes. Perhaps the NGS results may not be representative due to the limited statistical power of the sample.

Conclusions: The influence of morphological and genetic factors on the outcome and course of primary IgA nephropathy has not been proven. The use of multiple linear regression predicts GFR on average after 24 months of observation. . 108 (30%) patients received oral steroids alone and 207 (51%) patients received three methylprednisolone pulses followed by oral corticosteroids, 44 patients (12.5%) did not receive steroids. Thirty-four children treated with oral steroids alone were compared with 34 matched control patients who did not receive steroid. IgAVN remission proportion was not different between these two groups: 76% versus 77% respectively. Ninety children treated with oral steroids alone were compared with 180 matched patients treated with three methylprednisolone pulses followed by oral corticosteroids. IgAVN remission proportion was not different between these two groups: 76% versus 73% respectively. Conclusions: The benefit of oral steroids alone and methylprednisolone pulses could not be established based on our findings. Randomized controlled trials are thus required to determine the efficacy of stroids in IgAV with nephritis. Results: Thirteen children included, 54% girls. Initial findings were one or more episodes of macroscopic hematuria in five (four linked to respiratory tract infection, two with microscopic hematuria in-between); one had persistent microscopic hematuria and nephrotic proteinuria one year before admission. Seven children had no previous complaints. The average age at the time of biopsy was 11±4.4 years. In the six children with previous symptoms, biopsy was performed on average 25 (5-60) months. At that time, seven patients had nephritic syndrome, associated to nephrotic proteinuria (three), significative nonnephrotic proteinuria (two) and nephrotic syndrome (one); two had nephrotic syndrome with microscopic hematuria; one had macroscopic hematuria and nephrotic proteinuria; two had microscopic hematuria and nephrotic proteinuria; one was diagnosed with stage 4 chronic kidney disease. Histopathologically, ten children had glomerular crescents and/or interstitial fibrosis. Of these, nine received corticoids and angiotensinconverting enzyme inhibitor (ACEI), five with cyclophosphamide association (persistent nephrotic proteinuria or relapse of nephritic syndrome).

One child had only ACEI (spontaneous resolution). Mean follow-up was 3.94 (0.6-11.7) years. At last evaluation, seven children (54%) had normal blood pressure, unchanged sediment, no proteinuria and normal renal function. The child with stage 4 chronic kidney disease did not worsen and five children maintained hematuria and/or proteinuria (nephrotic-three).

Conclusions: IgA nephropathy is the most common glomerulonephritis with a high clinical and histological variability and an important cause of end-stage renal disease.

Our results show that outcome is good, however some patients need immunosuppressive therapies and careful long-term observation is required. Results: Twenty-nine patients were analyzed (male = 59%). The median age at diagnosis was 3 days [1; 7] and 3 patients (10%) were diagnosed antenatal. Thirteen patients (45%) were premature. In 26 patients, diagnosis was suspected based on at least one of the three cardinal signs of RVT: palpable mass in the flank (62%), hematuria (62%) and thrombocytopenia (69%). Only 9 patients (31%) presented with the full triad at diagnosis. In all patients, diagnosis was confirmed by ultrasound. All patients had at least one known obstetrical or neonatal risk factor: birth by cesarean section (69%), perinatal anoxia (41%) or maternal diabetes (21%). NRVT was unilateral in 21 infants (72%), involving the left renal vein in 52%. NRVT was associated with inferior vena cava thrombosis in 21 cases (72%) and with adrenal glands hemorrhage in 11 patients (38%). Prothrombotic abnormalities were found in 12 patients (41%), 11 patients (92%) had factor V Leiden mutation. Among 27 treated patients, 20 received low molecular weight heparin, 2 unfractionated heparin and 4 fibrinolysis. The median length of treatment was 8 weeks [4; 12] . Most patients achieved partial repermabilization (59%). After a median follow-up of 4 years and 5 months [1; 7 years], 16 patients (55%) had lost function of their kidney, 1 (3%) had chronic kidney disease (CKD) and 2 (7%) had high blood pressure (HBP).

Conclusions: NRVT remains a challenging condition, which need to be early diagnosed to avoid CKD and HBP.

Introduction: Acute kidney injury (AKI) is a global clinical problem, affecting almost one third of critically ill children. The conventional diagnostic criteria of AKI are based on serum creatinine and urinary output. However, changes in serum creatinine lag behind changes in glomerular filtration rate (GFR), which might take several days. It does not allow early intervention. Therefore, extensive effort is put into searching for more reliable biomarkers allowing early detection of kidney impairment before rapid decrease of kidney functions. A potential non-specific marker of tissue damage is extracellular DNA (ecDNA). ecDNA is present in various body fluids, where enters from disintegrated cells in processes of apoptosis and necrosis, or during inflammatory damage -NETosis. The aim of our study was to assess concentrations of ecDNA in animal model of AKI and cohort of pediatric patients. Material and methods: In the first part of the study, 93 Wistar rats were used. To induce AKI, glycerol-induced rhabdomyolysis was performed (n=58). Healthy controls received saline (n=35). Blood and urine were collected 1, 3 and 24 hours after AKI induction. In the clinical part of the study, 20 children ( of the procedures had a RACHS-1 score of 6. Other risk factors included inotrope requirements (75%), fluid overload (56%) and low cardiac output syndrome (34%). No pre-existing renal abnormalities were identified. The reasons for initiating dialysis were fluid overload (61%), hyperkalaemia (22%), uraemia (11%) and acidosis (6%). Mortality within this group was 17%. At discharge from PICU 93% had recovered from AKI. There was minimal nephrology input into AKI -5% of patients were discussed. Conclusions: Our cohort had similar incidence of AKI to published reports. We identified the same risk factors for AKI post cardiac surgery including younger age, lower weight, and longer bypass time. AKI resolved in the majority of patients but there was no renal follow up, despite national AKI guidance. We need a drive to institute follow up for these high-risk patients to improve quality of care. Introduction: Cystic fibrosis (CF) is characterized by increased sodium and chloride losses related to defects in the CF transmembrane conductance regulator gene. The circulating volume, electrolyte as well as acid-base homeostasis in CF are constantly challenged in basal conditions, activating compensatory mechanisms in different renal functions. Current guidelines on monitoring sodium status in CF patients are based on fractional sodium excretion (FENa), which is unpractical since it requires paired blood and urine samples. The aim of this study was to identify urinary parameters as a surrogate for sodium-status in different age-groups. Material and methods: Blood and urine samples for electrolyte status determination were collected and analyzed retrospectively from 214 patients followed at the Ghent University Hospital CF-center. Results: The urinary sodium/creatinine ratio (UNa/Creat) showed a strong correlation with FENa (r = 0,93). The target FENa of 0.5 -1.5% corresponded to a UNa/Creat of 13,125 -38,575 mmol/mmol. However, the correlation between FENa and UNa/Creat did differ significantly between different age-groups. There was no association found between a decreased FENa (< 0,5%) and several clinical characteristics.

Conclusions: The strong correlation between FENa and UNa/Creat in a population of 214 CF patients implies that UNa/Creat would be a more practical and less invasive marker to follow the sodium status in this patient population compared to the current gold standard FENa. In addition, we showed that there were clear age differences which highlights the need for different reference values according to age.

Tomsa Anamaria Magdalena 1 , Rachisan Andreea Liana 1 , Pandrea Stanca Lucia 2 , Benea Andreea 2 , Junie Lia Monica 1 1 "iuliu Hatieganu" University Of Medicine And Pharmacy, Clujnapoca, Romania, 2 "prof. Dr. Octavian Fodor" Regional Institute Of Gastroenterology And Hepatology, Cluj-napoca, Romania Introduction: Kidney disease represents a burden for the health system worldwide. As the prevalence continues to rise, discovering new biomarkers of early kidney damage becomes acute. Oxidative stress (OS) represents one of the main factors involved in the early stages of many syndromes leading to kidney damage, therefore it must be studied in detail. So far, many studies focused on OS in advanced stages of acute kidney injury, with great success. The purpose of our study was to determine if even mild renal function impairment can be linked to specific systemic markers of OS and systemic antioxidants in order to pinpoint certain biomarkers for early kidney damage. Material and methods: We used male rats (Rattus norvegicus) in which we induced kidney damage by injecting gentamicin for 7 days. Blood was collected 24 hours after the last dose of gentamicin. Urea, creatinine, 3nitrotyrosine (3NT), nitric oxide (NO), malondialdehyde (MDA), thiols (TS), total oxidative stress (TOS), interferon-γ (IFN-γ) were measured. Also, for the antioxidant status we measured total antioxidant capacity (TAC) and interleukin-10 (IL-10).

Results: Our results show that our rats had mild renal impairment consistent with a pre-AKI stage due to the nephrotoxic effect of gentamicin. However, TOS, MDA and NO were significantly higher in the gentamicin group compared to the control group. Also, TAC was higher in the control group.

Conclusions: Oxidative stress markers reach higher levels even in the pre-AKI stage and might potentially be used as markers of kidney damage when mild renal function impairment occurs. Introduction: Autoimmune lymphoproliferative syndrome (ALPS) is an immune dysregulation syndrome characterized by chronic, nonmalignant lymphoproliferation and autoimmunity due to defective lymphocyte apoptosis. Clinical features include lymphadenopathy, splenomegaly, and cytopenia; glomerulonephritis occurred in 3%.

We present a patient with ALPS phenotype who developed an overlap syndrome of ANCA-associated crescentic glomerulonephritis with immune complex-mediated glomerulopathy as a case report.

Results: 14-year-old male with a 5-year history of hepatosplenomegaly, presented to emergency department with tea colored urine. There was no history of infection or dysuria and rash. Laboratory analysis showed pancytopenia and acute kidney injury; creatinine 1.55mg/dl. Urinalysis showed dysmorphic erythrocytes and proteinuria (4728mg/day). Ultrasound showed hepatosplenomegaly and echogenic kidneys. Haptoglobulin was low (2mg/dl), direct coombs was 2+ C3 and C4 were at 49mg/dl (79-152) and 12mg/dl (16-38), respectively. IgG was elevated (2860mg/dl). ANA, anti-dsDNA, anti-GBM were negative; c-ANCA, p-ANCA were positive. Double negative T cells were high as 3.8%. Viral markers were negative except for Ebstein-Barr virus (EBV) PCR (750 copies/ml) which was increased to 11500 copies/ml one week later. He was diagnosed as probable ALPS. Renal biopsy showed diffuse proliferative glomerulonephritis with IgG deposition. Also, the presence of glomerular basement membrane fracture and fibrinoid necrosis was interpreted in favor of a second glomerular disease in the form of a necrotizing glomerulonephritis when evaluated together with the patients positive ANCA serology. Induction treatment consisted of intravenous pulse methylprednisolone for five days and rituximab; which was preferred considering the positive EBV titers. In addition, five sessions of plasma exchange were performed. During the maintenance phase, oral steroids and mycophenolatemofetil were given. After these treatments, serum creatinine has normalized (0.53 mg/dl); his proteinuria and hematuria were significantly reduced and pancytopenia improved. Conclusions: ALPS should be considered in the differential diagnosis of a patient presenting with hematuria, proteinuria, acute kidney injury and pancytopenia and hepatosplenomegaly. Introduction: Aims to identify the aetiologies of paediatric rhabdomyolysis and explore the medium to long term renal consequences. We describe a single centre's experience of paediatric rhabdomyolysis over 10years. This is the largest dataset reported on in children with the condition. Material and methods: Retrospective, single-centre review of children presenting to a tertiary children's hospital with rhabdomyolysis as defined by a laboratory measured creatinine kinase (CK) of greater than 1000 IU/ litre. Exclusion criteria applied (children post cardiac surgery, cardiomyopathy, HIE). Results: 232 children met inclusion criteria for the analysis. Age at presentation was 8.4years. Median follow-up was 6.3 (interquartile range +/-43.1) months. Infection (28%) and trauma(18%) were the most common causes of rhabdomyolysis. There was no association between aetiology and severity of the condition. Acute kidney injury (AKI) was present in 32% of cases. Children with AKI tended to be younger with higher peak CK and active urinary sediment on urinalysis at presentation (p = 0.001 to <0.0005). The 38% of cases defined biochemically as having 'severe' disease (CK >5000 IU/ litre) were no more likely to require admission to the Paediatric Intensive Care Unit (PICU) than the rest of the cohort. AKI and need for renal replacement therapy were associated with a prolonged hospital stay (p<0.0005). Over the period of the study, 9% of children died and 2% met criteria for a diagnosis of chronic kidney disease (CKD). . The main study group was divided into two subgroups: I nonimmune (n=13) and II immune (n=25) kidney disorders.

Results: In subgroup I the concentration of the sAPO-1/FAS factor was from 0,046 to 0,24 ng/ml (normal value of 0,023±0,002 ng/ml) in serum of 12 children (92,3%). The AnV level in this subgroup was normal. In subgroup II the concentration of sAPO-1/FAS was significantly higher (from 0,2 to 0,24 ng/ml) than normal in all specimens. In 7 patients (28%) from this subgroup, values of AnV were increased too -1.1-1.2 times (7, (5) (6) (7) (8) 49 ng/ml) in 6 cases and 3 times (21,06 ng/ml) in one patient with IgA-vasculitis. In CAKUT group the concentration of both biomarkers was in the reference range. Expression of sVCAM-1had variations from 0 to 1.2 ng/ml (normal 0,7-0,9 ng/ml) in 10 children (40%) of subgroup II. Quantity of sVCAM-1 in subgroup I and CAKUT remained normal. The level of sICAM-1 in all groups was in the normal range from 50 to 67 ng/ml. Conclusions: Increased levels of sAPO-1/FAS are present in the majority of patients with GP and aren't detected in the CAKUT group. The AnV is elevated only in some children with immune GP. Increased expression of VCAM-1 in the blood of some patients with immune nephropathies was revealed. Results: Hypertension was confirmed in 26% of patients and high normal pressure in 28% of patients. In 43% of patients there was a discrepancy between the records -in 85% of them (37% of total) blood pressure in the second measurement was significantly lower.

In the whole group, the second measurement showed significantly lower systolic blood pressure during the day (128 vs 125 mmHg, p=0.03) and at night (115 vs 111 mmHg, p = 0.04) and a slower heart rate at night (69 vs 66, p = 0.005). The diastolic, mean and central blood pressure did not differ. The drop in blood pressure in the second measurement was significant mainly in the overweight group, especially in boys. The mean blood pressure during the day in the group of overweight boys was 94 and 85 mmHg (p = 0.009) in the first and second measurement, and 85 and 75 mmHg at night (p = 0.007), respectively. A significant change was observed in all blood pressure values Conclusions: The results of the study indicate that the first result of blood pressure monitoring may be confusing -in more than 1/3 of patients it gives an overestimated result. This is significant especially for overweight boys.

The study shows that the 24-hour blood pressure monitoring results should be verified with the second measurement, especially in overweight boys. Introduction: Vitamin D is very important element in human organism and plays a key role in many physiological as well as pathological processes. The purpose of this study was to find potential correlations in serum levels of vitamin D (25(OH)D) in overweight children with hypertension (group A ) and normal-weight children with hypertension (group B) compared to healthy control group (group C). Material and methods: The parameters we determined in all groups of children were serum 25(OH)D levels, anthropometric measurements (weight, height, body mass index (BMI)), age, sex and blood pressure (BP). We have analyzed the results with the help of SPSS statistic tool (independent t-test and Pearson correlation test).

Results: The study included 120 children between 4 and 18 years of age. The results obtained showed distinction in values of serum 25(OH)D in group A compared to group B, although the difference was not statistically significant (p=0.084). There was statistically significant difference in values of serum 25(OH)D between group A and group C (p=0.001). Results also showed differences in 25(OH)D levels between group B and group C, but it was not significant (p=0.117). We have also managed to prove the correlation between serum vitamin D levels and systolic BP values (r=-0.288; p=0.01) as well as between serum vitamin D levels and body weight (r=-0.155; p=0.045). The correlation between vitamin D levels and systolic BP was most apparent in group B (r=-0.338; p=0.033).

Conclusions: The pilot study shows that there are differences in serum vitamin D levels between investigated groups, most significant in the group A compared to group C. The biggest correlation was observed between vitamin D levels and systolic blood pressure values. We conclude that the obtained results show that vitamin D supplementation is needed in pediatric patients with hypertension and obesity. Introduction: Acute tubulointerstitial nephritis (ATIN), a rare cause of acute kidney injury in children, is characterized by inflammation of the tubulointerstitial region in the kidneys. In this study, it was aimed to evaluate the clinical features, etiology, treatment and prognosis of pediatric patients with ATIN who were diagnosed by biopsy and followed up at our center. Material and methods: The patients who underwent kidney biopsy between January 1th 2008 and December 31th 2020 at our hospital were reviewed and patients diagnosed with ATIN were included in the study. The demographic and clinical characteristics of the patients were obtained from records. Results: Twenty-one patients who were diagnosed with ATIN out of 325 patients (6.5%) having biopsy were included in the study. 11 were boys (52.4%), the mean age was 13.6 years (2-17 years) and median follow-up period was 27 months. All patients had acute kidney injury at presentation; mean creatinine was 4.36 mg/dl. Nephrotoxic drug usage was observed in 11 (52.4%) patients: NSAID in four, paracetamol in two, and pseudoephedrine, benzoyl peroxide and gentamicin-containing cream, gingko biloba, heroin, and chemotherapeutic drugs in one patient each. Etiology was not detected in the remaining 10 patients, who were accepted as idiopathic ATIN. Renal functions were improved in 6 patients (28.6%) spontaneously within a few days. 9 patients (42.9%) were treated with corticosteroids and 4 patients with both corticosteroids and azathioprine. At follow-up, 6 patients had eGFR lower than age-appropriate values, three of whom progressed to end-stage renal failure, all of whom were in idiopathic group. Chronic renal failure did not develop in any patient with ATIN due to nephrotoxic medications. Conclusions: ATIN develop mostly due to nephrotoxic drug usage. Early diagnosis and treatment is important, because it may lead to chronic renal failure.

C O N T I N U O U S M E M B R A N E O X Y G E N A T I O N A N DCONTINUOUS

Mehmet Çagri Özkara, Mustafa Koyun, Elif Çomak, Gulsah Kaya Aksoy, Sema Akman Akdeniz University Medical Faculty, Department Of Pediatrics

Introduction: Lower urinary tract dysfunction (LUTD) is a common problem in children. The risk factors is not well defined. In the present study, we aimed to investigate the risk factors such as voiding position (standing, sitting and squatting in boys, sitting and squatting in girls) and age and duration of toilet training on the development of LUTD. Material and methods: 150 children who had a diagnosis of LUTD and 300 healthy children above 5 years of age were included in the study. The data was collected by questionnaire in the control group whereas the data of the patient group were evaluated retrospectively. The patients with anatomical or neurological problems were excluded. Results: The mean ages of the patient and control group were 8.1±2.5 and 9.2 ±3.1 years, respectively (p>0.05). Girls were more in patient than control group (64% vs 51%, p=0.009). Age at toilet training were similar between the groups, whereas having >1 month of duration of toilet training was more common in patient than control group (86.7% vs 51.0%, p<0.001). The ratio of boys who void on standing was more in patient than control group (64.8% vs 40.8%, p=0.006). Also, the ratio of girls who void on squatting position was more in patient than control group (40.6% vs 17.6%, p<0.001). On logistic regression analysis, boys who void on standing had 4.9 fold and girls who void on squatting position had 3.2 fold increased risk for LUTD (95% CI: 1.9-12.5, p=0.001 and 95% CI: 1.8-5.7, p <0.001); also, having >1 month of duration of toilet training had 6.7 fold increased risk for LUTD (95% CI: 4.0-11.4, p <0.001).

Conclusions: In this study, we found that duration, rather than age, at toilet training affects the development of LUTD. Also, standing voiding in boys and squatting position in girls increased the risk of LUTD. Hypothyroidism, vitamin D deficiency and antithrombin III deficiency were diagnosed and treated. Antiproteinuric treatment was started with captopril, hydrochlorothiazide and aldactone and he could be discharged at 86 days of life. Edema was controlled and no albumin infusions were required, although the biochemical pattern of nephrotic syndrome was maintained. After 6 months, a progressive rise in serum albumin was observed, with a parallel decrease in proteinuria until normalization at 18 months (figure). Antiproteinuric treatment could be withdrawn at 2 years of age. At present he is 5 years old and remains asymptomatic, without proteinuria and minimal albuminuria (72.6mg/g creatinine).

Conclusions: FNS is a rare entity, genetically determined, progressing unavoidably to end-stage renal disease in the first years of age. Multiple complications are expected; spontaneous remission is exceptional. Clinical presentation and genetical study confirm FNS diagnosis but the evolution has been surprisingly good. The development of genetics will lead to the discovery of new variants, which will identify the prognosis of the disease. Introduction: Neurologic involvement is the most threatening complication of the diarrhea-associated hemolytic uremic syndrome (D+HUS). We presented two cases with severe initial neurologic involvement that occurred in the course of D+HUS. Material and methods: Case I. A 3.5- year-old female patient was followed up for five days with bloody diarrhea and referred to our clinic for high creatinine levels and oliguria. Midazolam was administered because of a generalized seizure during the referral. On physical examination, she exhibited fluctuating levels of alertness. Initial laboratory evaluation showed hyponatremia and the triad of HUS. Supportive treatment and peritoneal dialysis initiated for hyponatremia and renal failure. In admission, she had severe neurological symptoms, with convulsions and decreased consciousness; cranial MRI showed signal increases in the basal ganglia. One dose of Eculizumab was administered. Plasmapheresis was started for diffuse encephalopathy findings and ongoing focal seizures in EEG. After five sessions of plasmapheresis and two doses of Eculizumab, urine output begun on the 25th day of hospitalization. Enterohemorrhagic and EPEC PCR were positive in stool examination. On the 40th day of her admission, she was discharged. One week later, in the outpatient clinic control, creatinine value was 0.67 mg/ dl, and hematological parameters were normal. Case II: A 6-year-old boy presented with bloody diarrhea, fever, and diffuse abdominal pain. Physical examination revealed a fever of 38.6 C, tenderness, and defense in the abdomen. No pathological findings were found in abdominal ultrasonography and non-contrast abdominal MRI. HUS was diagnosed, and hemodialysis was started. On the third day of hospitalization, we checked the acute phase levels due to ongoing fever and abdominal pain. High levels of ferritin, triglyceride, LDH, and decreased fibrinogen, sedimentation values with hemophagocytic cells in the bone marrow suggested macrophage activation. IVIG and steroid were initiated. Two times COVID (PCR) test was negative. Hypertension (180/110 mm hg) and seizure were observed at the third dose of pulse steroid. Diffusion Cranial MRI was normal. Hypertension was controlled with the Ca channel blocker. Two days later, he had a newonset headache and convulsion with a fever. Intracranial hemorrhage was detected and drained. Ferritin values increased to 36.000 ng/ml under plasmapheresis and Eculizumab. Enterohemorrhagic, EPEC, and EAgEC PCR tests were positive in stool examination. Twenty days after the initial presentation, the patient died due to cardiac failure combined with neurological impairment.

Results: Neurological involvement in STEC-HUS; may develop due to uremia, hypertension, electrolyte disturbances, and thrombotic microangiopathy in cerebral microcirculation. Conclusions: These two cases aimed to emphasize the neurological involvement of STEC-HUS with high mortality and morbidity.

Introduction: HUS is actual problem of pediatrics and nephrology. There is not enough data of damage of gastrointestinal tract (GIT) in children with HUS. The aim of the study is to determine the state of GIT in children with HUS.

We examined 20 children with HUS in age from 9 months till 6 years old. There were 2 groups: 1 -children who underwent RRT (n = 10), 2 -children whose AKI was stopped without RRT (n = 10). Results: Patients under 3 years old are prevailed (70%). Thrombocytopenia, hemolytic anemia, AKI were found in 100% of children with HUS. Typical form of HUS had damage of GIT with diarrheal syndrome in 100% , haemocolitis in 45% (n = 9), vomiting syndrome in 75% (n = 15), liver damage with increasing of transaminases in blood -80% (n =16), and hepatomegaly -55%, abdominal syndrome -25% (n = 5). Damage of GIT in 1 group had more often hemocolitis syndrome (60%, p˂0.01), liver damage (hepatomegaly 60%, increased transaminases in blood, 100% Introduction: Botryroid Wilms' tumor is located in the intrapelvic region of the kidney, often presenting with hematuria and rarely with anuric renal failure. We present an infant who presented with anuric renal failure and was diagnosed with Botryroid Wilms tumor. Material and methods: A 13-month-old boy was admitted with anuria lasting for 24 hours and periorbital swelling. He had no fever or any other systemic complaint. His anthropometric measurements were normal (height: 50 percentile, weight: 25-50 percentile) and blood pressure was 100/60 mmHg (95th percentile 102/54 mmHg). On physical examination, a generalized diffuse edema and abdominal distention was seen. Laboratory tests were as follows: Blood ure nitrogen 60 mg/dL, serum creatinine 3.77 mg/dL, sodium 137mEq/L, potassium 7.7 mEq/L, serum phosphorus 6.9 mg/dL and serum uric acid 8.5 mg/dL. Results: An ultrasonography yielded enlarged kidneys with renal parenchymal thinning and increased echogenicity; renal calyces were dilated and deformed; multiple masses originating from the lower pole of both kidneys extending to renal pelvis, the largest being~6 cm. On tomography, polypoid mass lesions, with a size of 40x40x45 and 47x38x32 mm at right and left kidneys, filling renal pelvis extending to the whole calyceal system and to the proximal part of the ureters were observed. As hyperkalaemia and anuria persisted, dialysis was started. The patient was diagnosed with Botryoid Wilms' tumor based on imaging findings, and neoadjuvant chemotherapy (doxorubicin, actinomycin and vincristine) was given. Urine output began 48 hours after chemotherapy, and serum creatinine decreased to 0.4 mg/dL on the 5 th day after chemotherapy.

Conclusions: Botryroid Wilms' tumor should be considered in the differential diagnosis of a child with renal failure and a mass in the kidney. Introduction: The prevalence of hypertension in children population is estimated at about 4%. It is different depending on the region of the world because of various definitions of hypertension and methodology of measuring. The available epidemiological data shows that essential hypertension concerns the group of teenagers and adolescents. However, observations in recent years have shown, that this type of hypertension is more common among increasingly young children. The aim of the study was to evaluate the current epidemiology of hypertension in children from central Poland. These patients were either suspected of hypertension or have already been diagnosed with hypertension.

Material and methods: The study was retrospective. The data of 471 patients aged 5 to 18, who were hospitalized in 4 pediatric departaments dealing with hypertension in central Poland in the period 2017-2019 were analyzed.

Patients' medical records were analyzed in the study. The primary criterium for qualifying the patient to the study group was the suspicion of hypertension in outpatient conditions or during hospitalization. The analysis covered: age (patients were divided into 2 age groups -5-10 years of age and 11-18 years of age), gender, residence, anthropometric data (absolute and percentile), clinical symptoms of hypertension, data obtained from an Ambulatory Blood Pressure Measurement, family history, presence of complications of hypertension and treatment.

Results: The study group consisted of 175 girls (37%) and 296 boys (63%) (p <0.001).

Hypertension was confirmed in 42.5% of patients (61% of boys, p = 0.62), high normal blood pressure was diagnosed in 36.5% and normal blood pressure in 21%. 61% children were overweight or obese, as far as the group with confirmed hypertension or high normal blood pressure is concerned, 63% children were overweight or obese (62% boys, p = 0.61). More than half of the patients (55.5%) did not present clinical symptoms of hypertension. The most common symptom reported by patients in the whole group was headache (132 patients, 63%). Among patients who reported headaches, the most common diagnosis was normal blood pressure (43.5%).

In both age groups secondary hypertension was the rarest diagnosis-6% in younger and 1,5% in older children. High normal blood pressure was diagnosed in 53% of younger children and 34% of older children and primary hypertension in 29% and 42%, respectively. Conclusions: Hypertension was confirmed in less than half of the patients. We found no specific clinical symptoms indicative for hypertension in this group. Essential hypertension is more often confirmed than secondary hypertension in both age groups. Introduction: By creating nephrotoxicity models with cisplatin, vancomycin and gentamicin in HK-2 (human renal proximal tubule cell) and HEK293T (human embryonic kidney epithelial cells) cell lines, we aimed to evaluate the effect of cilastatin on recovery of cell damage after toxicity occurred.

Material and methods: In the first phase of the study, the doses of cisplatin, vancomycin and gentamicin (50% inhibitive concentration; IC 50 ) were determined. In the second phase, the effective dose of cilastatin against these drugs was determined, and IC 50 doses of nephrotoxic agents were administered simultaneously. In the third phase of our study, to evaluate the possible therapeutic effect of cilastatin after toxicity occurs; Analyzes of cell viability, apoptosis, oxidative stress and expression of kidney injury molecule-1 (KIM-1), neutrophil gelatinase associated lipocalin (NGAL) were performed.

Results: In the second phase of the study, it was observed that cilastatin increased cell viability when treated simultaneously with a nephrotoxic agent. In the third phase, cilastatin provided a significant increase in cell viability. We determined that after treatment with each agent for 24 hours, adding cilastatin to the medium had an effect on the recovery of cell damage by increasing cell viability, reducing apoptosis, and oxidative stress. The expression of KIM-1 and NGAL increased when nephrotoxicity occurred and decreased with the addition of cilastatin to the medium. To provide insight into the mechanism of LMS, we studied its immunomodulatory activity on in vitro cultured human T-cells.

Material and methods: Untouched human T-cells were isolated from three healthy donors. The effects of LMS on CD3/CD28-induced T-cell proliferation were assessed by the CFSE dilution assay in a three-day culture experiment. T-cell activation was determined by flow cytometry staining for the early activation marker CD69 and cytokine production by real-time PCR.

Results: Treatment with LMS decreased expression of CD69 in all donors after two and three days of activation. LMS treatment showed an average 5.0-fold decrease of CD69 expression at day 2 and 3.0-fold decrease at day 3. No differences were seen in CD4 and CD8 frequencies between treatment groups. LMS-treated CD4+ T-cells showed an average 5.4-fold decrease of CD69 expression at day 2 and 3.0-fold decrease at day 3. LMS-treated CD8+ T-cells showed an average 3.6-fold and 2.2fold decrease at day 2 and day 3, respectively. In agreement with the dampening effect on T-cell activation, we found that proliferation was decreased in LMS-treated T-cells with an average 9.9-fold decrease in division index (DI) at day 3. An average 10.9-fold decrease in DI was calculated for LMS-treated CD4+ T-cells, compared to 7.7 for CD8+. Finally, LMS-treated T-cells showed a decrease in IL-2 transcription. Conclusions: Our preliminary findings indicate that LMS acts as an immunomodulatory drug that directly affects the activation and proliferation of T-cells. Further experiments are necessary to identify the exact mechanism.

John Tolliday 1 , Shuman Haq 1 , Ramnath Balasubramanian 2 , Evgenia Preka 1 1 University Hospitals Southampton; 2 Guys And St Thomas Nhs Foundation Trust

Introduction: Haematuria represents a presenting feature in a wide range of conditions in children. In many cases the cause is benign or transient. However, haematuria may be the sole presenting feature in serious pathology. This guideline looks to aid clinicians in the investigation of haematuria in addition to providing guidance regarding referral to tertiary services. Material and methods: During the guideline creation process we reviewed latest evidence and practices regarding the investigation and management of haematuria in children in order to formulate pathways based on clinical presentation. Following review by the paediatric nephrology team this was sent to paediatric nephrourology leads in the hospitals within the region for further input. Further guidance was added particularly regarding management of microscopic haematuria ahead of publication on the Paediatric Innovation, Education and Research (PIER) network website, providing guidance for the Wessex region. Results: We formulated an investigation and referral pathway based on four different clinical scenarios. These were macroscopic haematuria with altered or with fresh appearance of blood and microscopic haematuria which was transient or persistent. We also included further guidance where a specific diagnosis was suspected and where a referral to a tertiary centre was recommended.

Conclusions: We hope that the collaborative approach to guideline creation will provide pragmatic support to clinicians in the region to investigate and refer cases of haematuria in children appropriately and therefore improve the patient journey. Our aim is to standardise practice in a safe manner and utilise investigations effectively. Our guidance will be updated based on feedback from hospitals in the region in parallel with updated evidence. When dedifferentiated, podocytes detach from the glomerular basement membrane, while TECs stimulate surrounding cells to transdifferentiate into myofibroblasts, thus resulting in glomerulosclerosis and tubulointerstitial fibrosis respectively. Our laboratory has identified a protein called Smad Anchor for Receptor Activation (SARA) as a key factor for maintaining cellular phenotype in the face of fibrogenesis. Here, we aim to determine if SARA overexpression in podocytes and TECs can prevent their dedifferentiation and reduce fibrosis in mouse models of glomerular and tubulointerstitial disease. Material and methods: SARA podo and SARA TEC mice that overexpress SARA selectively in podocytes or TECs respectively and SARA negative littermates (Ctrl podo and Ctrl TEC mice) were used. SARA/Ctrl podo mice were treated with Adriamycin to induce glomerulosclerosis, and SARA/Ctrl TEC mice with aristolochic acid to induce tubulointerstitial fibrosis. Urine, blood, and kidneys were harvested for histological and molecular analysis. Results: SARA podo mice showed less glomerulosclerosis histologically and less proteinuria than Ctrl podo mice after Adriamycin treatment. In SARA TEC mice, upregulation of markers of fibrosis and tubular injury (measured by qPCR) was less apparent than in Ctrl TEC mice after AA treatment. Expression levels of markers specific for podocytes and TECs will be measured to confirm that SARA maintained cellular phenotype. Gene expression profiles of podocytes isolated from SARA/Ctrl podo mice by flow cytometry are being analyzed by RNA sequencing. Kidneys from SARA/Ctrl TEC mice were digested into single cell suspensions for single cell RNA sequencing. These high throughput analyses will provide insight into the mechanisms by which SARA maintains cellular phenotype and protects against renal fibrosis.

Conclusions: SARA overexpression in podocytes and TECs protects against glomerulosclerosis and tubulointerstitial fibrosis respectively.

Elucidating the mechanisms by which SARA functions will help unearth new molecular targets for therapies directed at renal fibrosis. There were no significant differences between the groups in respect to the MOXO-CPT total and z scores. Attention and timeliness z scores were significantly higher in girls (p=0.004 and p=0.008, respectively). Attention and timeliness total scores were also significantly higher (p=0.006 and p=0.047) and hyperactivity total scores were significantly lower in older patients (12-18 years) compared to the younger ones (6-12 years, p=0.017).

Conclusions: Similar MOXO-CPT scores in all groups was attributed to presence of long CKD duration in all groups as well as presence of allograft dysfunction in the majority of RTx group. Regardless of the groups, older age and female sex were associated with better performance in respect to attention and timeliness, besides hyperactivity was found to be decreased as time passes. Results: In 6 out of 20 cases, the fitting methods on the full concentration-time curve resulted in very different reported GFR-values, mainly because some methods were not able to fit the data, or methods resulted in GFR-values ranging from zero to 120mL/min. The reported GFR-result therefore strongly depends on the fitting method making the full concentration-time method less robust than expected. Compared to a consensus reference GFR, the late sample models did not show fitting issues and may therefore be considered as more robust. Also the onesample methods showed acceptable accuracy.

Conclusions: The late sample methods (using 3 time-points) provide robust and reliable methods to determine GFR. Introduction: The glomerular filtration rate (GFR) used in the diagnosis, follow-up and evaluation of renal diseases is considered to be the best indicator of renal function. Beta-trace protein (BTP) is a low molecular weight protein produced in the cerebrospinal fluid. Our aim in this study is to investigate the serum and urine levels of BTP in children with chronic kidney disease (CKD) and to examine its relationship with impaired GFR and development of end-stage renal disease. Material and methods: 136 children with CKD stage 1-4 were included in the study. The control group consisted of 43 healthy children. In addition to serum creatinine, BUN, cystatin-C, spot urine creatinine, microalbumin, 24-hour-urine creatinine, protein and microalbumin were measured. Both serum and urine samples for BTP and beta-2 microglobulin (B2M) measurements were also taken at the same visit. Serum-BTP (S-BTP), urine-BTP (U-BTP), BTP/creatinine (U-BTP/creatinine) and fractional clearance of BTP (FEBTP) were calculated. Results: S-BTP level was significantly higher in the patient group compared to the control group (0.36±0.14 vs 0.29±0.13, p:<0.001). U-BTP/ creatinine and FEBTP demonstrating U-BTP excretion were significantly higher in the patient group compared to the control group (87.69±107.9 vs 21.47±30.41, p:<0.001 and 0.44±0.71 vs 0.04±0.06, p:<0.001, respectively). S-BTP, U-BTP/creatinine and FEBTP were detected to be elevated as the stage increased in children with CKD. Especially, U-BTP/creatinine and FEBTP were detected to have strong negative correlation with GFR (p:0.000, r:-0,690 and p:0.000, r:-0.784, respectively), and positive correlation with cystatin-C and urine protein, microalbumin and B2M excretions. In multiple regression analysis, it was found that the U-BTP/creatinine was mostly affected by the microalbumin excretion in the urine (p:<0.001, t:5.670). GFR and S-BTP were other factors affecting U-BTP/creatinine levels.

Conclusions: Serum and urine BTP levels are increased in children with CKD and it is thought that it may be an ideal marker demonstrating deterioration in GFR. Introduction: Hematopoietic stem cell transplantation (HSCT) is often performed in various oncologic and other diseases. The renal function assessment is obligatory for safe treatment. Material and methods: eGFR variability was assesed in 40 children (av. 8,6 yrs) treated with HSCT (11 autologous, 29 allogenic) in one year period. The eGFR was estimated before, one week, 1, 6 and 12 months after HSCT based on: cystatin C-eGFR(cysC); Schwartz bed-side -eGFR(BS) and Schwartz trimarker -eGFR (3M) with our correction and with creatinine clearance -eGFR(U24h). The Iohexol method eGFR(IOH)-reference method was performed before, 6 and 12 months after HSCT.

Results: eGFR values -in ml/min/1,73m2. The mean value of eGFR(IOH) was in normal range before: (131,8 ±35,7) and in 6 months (104,2±45,6, p=0,024) and 12 months after HSCT (109,6±33,0; p=0,052). One year after HSCT eGFR were lower statistically according to all but one equation (eGFR-U24h) with mean difference from 14,2 to 31,2. One week after HSCT increase of eGFR was observed with mean difference (15,9 to 27,9) . 1 month later eGFR decreased of mean difference (6,4 to 31,8) ; then in 6 months from 16,4 to 27,9. One year later eGFR was higher compared to 6 months eGFR (mean difference 6,4 to 31,2). The highest variability of GFR was seen during first 1 month after procedure. In 25% if children eGFR was < 90 one year after HSCT. The eGFR(3M) showed the best concordance with Iohexol method, the lowest agreement was noted for eGFR (U24h) Conclusions: The renal function in 12 months after HSCT is well preserved with non clinically significant decrease in eGFR. The temporary deterioration of eGFR was confirmed in 1 up to 6 months after with improvement tendency in 1 year . We suggest to use trimarker formula for eGFR estimation. Introduction: Growth failure in the context of chronic kidney disease in children is related to low quality of life, low self-esteem and worse school performance. Growth retardation in this case is multifactorial. Knowing the modifiable factors and establishing strategies that can improve care for these children is of utmost importance. Here we described growth pattern in children with chronic kidney disease and associated risk factors for short stature. Material and methods: We retrospectively analyzed anthropometric, epidemiological, birth weight, prematurity and laboratory data (bicarbonate, hemoglobin, serum bone biomarkers), from medical record of 43 children and adolescents with non-dialysis chronic kidney disease.

Results: Short stature was present in 63% of children at the beginning of the follow-up, which remained 51% at the end of the study period (p = 0.096). There was an improvement in serum bicarbonate levels (18.2 ± 4.5 and 20.7 ± 4.0 mEq / L, p = 0.005), and hemoglobin (10.2 ± 1.68 and 11.5 ± 1, 97 mg / dl, p = 0.001) throughout the follow-up period. Despite the improvement in laboratory data, 60% of children maintained metabolic acidosis (bicarbonate <22mEq / L) and 34.9% still had anemia (hemoglobin <11mg/dL). When comparing children with adequate stature and short stature, we observed lower serum levels of bicarbonate in the latter group, respectively, 22.0 ± 3.1 and 19.4 ± 4.5 (p = 0.03). There was an increase in PTH levels over the follow-up period (p = 0.029), but when compared PTH levels >2xUNL in both groups (adequate and short stature), there was no difference (p=0.9). Hemoglobin, bone disease markers, birth weight and gestational age did not show any association with short stature in our population. Conclusions: We observed a high prevalence of short stature which was associated with low serum bicarbonate levels. Our results point out the need for better control of metabolic acidosis.

Introduction: HUPRA syndrome is a rare mitochondrial disease characterized by hyperuricemia, pulmonary hypertension, metabolic alkalosis and, renal failure in infancy. This syndrome was previously described in five patients with a homozygous mutation in SARS2, encoding the mitochondrial seryl-tRNA synthetase. The principal affected tissue in HUPRA syndrome is the kidney. Material and methods: We report here a girl, who presented with hyperuricemia, increased urea and creatinine values for her age and diagnosed HUPRA syndrome.

Results: A two years old girl was admitted to our emergency department with nausea, vomiting and fever. She had previous history of recurrent admissions to emergency department with similar manifestations. Family history was significant for a similar presentation of a cousin who died at seven years old age. Blood tests showed renal failure, anemia, mild acidosis, hypomagnesemia and, hyperuricemia. Echocardiography revealed pulmonary hypertension. Genetic analysis showed homozygous mutation in SARS gene (c.515A>G (p.N172S) resulting in p.Asn172Ser). She was investigated for other system involvements and hyperthyroidism and immunodeficiency were diagnosed. She had cranial MRI imaging which demonstrated Arnold-Chiari Type 1 malformation. On last visit, our patient was 4 years and 4 months old age and she had stage 3b renal failure. She was under the treatments of allopurinol for hyperuricemia, sodium bicarbonate for acidosis, vitamin D for low vitamin D levels, alpha lipoic acid, Coenzyme Q10, and L-carnitine for their antioxidant effect and to improve mitochondrial enzymes, thyromazol and propranolol for hyperthyroidism and darbepoetin for anemia of chronic kidney disease.

Conclusions: In conclusion, our patient had important renal failure, severe pulmonary hypertension, hyperuricemia and other extrarenal malformations which were not reported yet. HUPRA syndrome is a multisystem fatal mitochondrial cytopathy and children with this syndrome must be checked for other system involvements.

Introduction: Anemia is one of the most important cause of morbidity in chronic kidney disease (CKD). Erytropoesis stimulating agents (ESAs) are the mainstay of the therapy. In this paper we aimed to analyse the risk factors associated with ESA hyporesponsiveness in children receiving renal replacement therapy (RRT). Material and methods: We evaluated 33 clinically stable ESRD patients (14 males, 19 females) on hemodialysis or peritoneal dialysis. EPO hyporesponsiveness evaluated at the last visit by eritropoesis resistance index (ERI). We also evaluated serum hemoglobin, iron, ferritin, total iron binding capacity, transferrin saturation index, folic acid, vitamin B12, platelet, WBC, parathyroid hormone (PTH), calcium, phosphorus, magnesium, alkaline phosphatase, 25-OH vitamin-D, albumin, blood pressure and body fluid volume (overhydration) measured by bioimpedance spectroscopy. Then, we analysed the correlation between ERI and all of the parameters related to CKD above. We also divided patients into two groups by the median value of the ERI as high ERI group (>16) and low ERI group (<16) and compared the parameters between two groups. Results: The mean follow-up time was 4.83±4.37 (range: 0.3-14.1) years. ERI was positively correlated with serum phosphorus level (p=0.016) and although not statistically significant, presence of hypertension was also found to be correlated with ERI (p=0.058). When two groups were compared mean serum phosphorus levels were found to be significantly higher in high ERI group than low ERI group (6.61±1.67 vs 5.14±1.14 mg/dl respectively, p=0.007). Mean PTH levels were also higher in high ERI group than low ERI group but it was not statistically significant (599±351 vs 392±320 pg/ml respectively, p=0.088). Presence of hypertension was significantly higher in high ERI group than low ERI group (p=0.041) in the presence of comparable body fluid volumes of two groups. Conclusions: ERI seems to be associated with secondary hyperparathyroidism and hypertension in children with ESRD receiving RRT. 

Introduction: Polyuria is a common problem in patients with tubular diseases, especially for those with and Fanconi syndrome and chronic kidney disease (CKD). There are currently no guidelines on how to treat debilitating polyuria. Vasopressin is usually not effective. Material and methods: A 13- year-old female with idiopathic Fanconi syndrome and CKD stage II had an estimated glomerular filtration rate (eGFR) of 69 mL/min/1.73 m 2 and was severely affected by polyuria of 5 L per day (voiding at least 11 times during the day and up to 8 times at night), impacting her mood (RCADS-child) and academic performance at school. In the absence of guidelines and with literature discouraging the use of indomethacin in this condition, we nonetheless attempted indomethacin treatment because of its effect on reduction of sodium wasting. RCADS scores were obtained before and during treatment. Sodium-23 ( 23 Na+) MRI of her thigh was performed at 18 months on treatment.

Results: Indomethacin was started at a dose of 1 mg/kg every 12 hours. The patient's urine output dropped to 2.5L and this was accompanied by a substantial decrease of her sodium wasting from 24.6 to 7.7 mmol/kg/ day. Over the course of 18 months, her eGFR dropped temporarily to 60 mL/min/1.73 m 2 and recovered to 68 mL/min/1.73 m 2 at last follow up. However, MRI revealed ongoing moderate sodium decrease in her skin substantial Na+ decrease in her muscle (z-score -2.5 when compared to age-matched peers with normal renal function). The self-reported RCADS-Child survey and academic performance improved significantly. Conclusions: We report the successful use of indomethacin in an adolescent female with idiopathic Fanconi syndrome, which was safe and substantially improved the urinary frequency. We also demonstrated a substantial reduction of the Na+ wasting with indomethacin while the patient's muscle Na+ concentration remained substantially depleted, suggesting no further role with Na+ intake reduction. Introduction: Children diagnosed with chronic kidney disease(CKD); have more risk for the incidence and severity of infections due to immune deficiency, repeated dialysis sessions, and frequent contact with medical care facilities. With its seasonal epidemic, influenza creates a high risk of mortality and morbidity for children with CKD. We aimed to evaluate the knowledge and opinions of the parents of children who were followed with CKD. Material and methods: A seasonal influenza vaccine questionnaire was administered to a voluntary parent of patients with CKD who admitted to outpatient Pediatric Nephrology Clinic between November 2019 and February 2020, and those who completed the questionnaire were included in the study. Results: Parents of 64 patients diagnosed with CKD completed the questionnaire. 44(68.8%) participants were informed about the vaccine. 54 participants who had not had their child vaccinated were asked about the reasons for not getting vaccine. The most frequent reason was reported as insufficient information about vaccine(33.3%) requirement and the second reason was the fear of possible side effects of the vaccine (14.8%). There was no significant difference about the rate of vaccination between the two groups of patients who use and did not use immunosuppressive drugs (71.4% and 40% respectively) The knowledge about influenza vaccine of parents of children with kidney transplantation was significantly higher than other CKD (p:0,006). All participants were informed about infections caused by influenza and flu vaccines. Athough information 18(28.1%) participants did not want to vaccinate, 17 (26.6%) participants stated that they still have no idea.

Conclusions: In our study, the most common cause of having no vaccination was lack of knowledge about vaccination. Therefore, influenza vaccination rates can be can be increased by informing parents about influenza infection and vaccination in pediatric nephrology clinics. Material and methods: We report the case of a child with end stage kidney disease and nephrotic syndrome complicating AA-type amyloidosis secondary to FMF. Results: A first degree consanguineous six-year-old boy presented for progressive onset of generalized oedema and poor urine output. The family reported a three years history of recurrent fever and abdominal pain treated symptomatically. First assessment found hypertension, oliguria, and pallor. His height was less than -2 standard deviations. He has microscopic hematuria on dipstick. Laboratory assessment found kidney failure, microcytic anemia, acidosis, hyperkalemia, hyperphosphatemia, hyperparathyroidism, hypoalbuminemia, and nephronic proteinuria. Renal ultrasound found large dedifferentiated kidneys. Furosemide, nicardipine and bicarbonate were started. After four hours, the child was still oliguric and his blood pressure raised. Hemodialysis was soon started, and prednisone was prescribed. Renal biopsy showed AA-type amyloidosis. Genetic testing found mutation of the MEFV gene in favor of FMF. Colchicine was soon started. Evolution was marked by persistent nephrotic syndrome and inflammation despite a course of four weeks high-dose steroids. Anti-interleukin 6 (tocilizumab) was then started at 8 mg/kg/month by IV route. After three months, the child had no more abdominal pain, arthritis. Also, laboratory tests showed no inflammation, normal albumin, and less proteinuria. At the same time, his blood pressure normalized, his GFR increased by 75%, and he was dialysis free for two years.

Conclusions: Tocilizumab should be used as a first line therapeutic option in renal AA-type amyloidosis complicating FMF. Results: A-six-month-girl was admitted to the hospital because of a recurrent urinary tract infection. The facial features of the child seemed dysmorphic, microcephaly, facial hirsutism, hypertelorism, microphthalmia, nystagmus, thick bushy eyebrows, phocomelia. Laboratory examination revealed normal whole blood count, serum biochemistry. Urinary ultrasound demonstrated a horseshoe kidney. CdLS was considered in the patient who was investigated for dysmorphic findings. A prophylactic antibiotic was administered because of a recurrent urinary tract infection. The voiding cystourethrography revealed bilateral grade 3 reflux. DMSA renal scintigraphy determined horseshoe kidney with bilateral renal scars. Despite the antibiotic prophylaxis, the patient who underwent recurrent urinary tract infection was operated for VUR. During the follow-up period, it was observed that the patient had an increase in creatinine with a decrease in the eGFR. At the last visit, the seven-year-old patient has been followed up with the diagnosis of CRF with a 36 ml/dk/1.73m2 eGFR.

Conclusions: Various urinary tract pathologies such as pelvic dilation, horseshoe kidney, VUR, renal dysplasia have been reported in CdLS. The urine and biochemistry analysis, urinary ultrasound should be regularly performed in CdLS.

Introduction: Prenatal screening rules out majority of renal agenesis, however up to 38% cases are diagnosed postnatally. Glomerulopathy occurring in solitary kidney may result in rapid kidney function loss. Material and methods: 16-year-old male with solitary kidney was hospitalized due to accidentally discovered erytrocyturia and proteinuria. Ultrasound exam revealed absence of left kidney. Renal scintigraphy confirmed its null function. Laboratory tests presented with eleveated IgA level and serum creatinine. Prednisone and antihypertensive therapy with enalapril were started. A few weeks later patient presented with nephrotic-range proteinuria and erythrocytes found in urine sediment. His GFR corresponded to the II stage of CKD. Follow-up ultrasound shown hyperechogenity of renal parenchyma and indistict border between renal medulla and cortex of the right kidney. Antineuthrophil cytoplasmic antibodies were found. Granulomatosis with polyangitis was suspected, therefore the patient underwent a CT scan of sinuses -resulting in polyps and mucosal thickening. To finally verify the diagnosis, biopsy of patient's solitary kidney was performed. The histopathological report shown features of proliferative glomerulopathy with IgA deposits. Methylprednisolone and cyclophosphamide were the implemented in therapeutical protocol. Enalapil was converted to ramipril, beta-blocker was added.

Results: Kidney function, serum cANCA levels normalized, the patient no longer presented with signs of nephrotic syndrome, renal sonogram returned to normal, blood pressure remained within limits. Low-range proteinuria occured, cyclophosphamide was discontinued and cyclosporine was administered. Since then patient has presented with no abnormalities in urinalysis and urine sediment and his filtration rate is stable. at the start of treatment and after 12 mths and 24 mths were -2.1, -1,5, -1,3 respecitively. The median rate of growth was 8 cm/year . During first-year rhGH treatment GV was significantly faster compared to the second year (median 9.5cm/year and 7.6cm/year, p < 0.001, respectively). There were no differences according to the stage of CKD. We found no significant relation between GV and sex, cause of CKD, hemoglobin, total protein, albumin, urea, creatinine, calcium, phosphorus, Ca x P, PTH and alkaline phosphatase.

The median eGFR at onset of the treatment group was 25ml/min/1.73m 2 , after 1 year of treatment 22.1 and after 2 years of treatment 23.3ml/min/ 1.73m 2 , respecitively. Conclusions: 1. Treatment with rhGH is effective in children with every stage of CKD 2. Early initiation of rhGH treatment in patients with CKD allows for long-term treatment and enables the children to reach the prognostic growth percentile. Introduction: Anemia in chronic kidney disease (CKD) is correlated to a decrease in erythropoietin (EPO) production due to kidney dysfunction . Erythropoiesis-Stimulating Agents (ESAs) are very capable drugs, targeting a significant hemoglobin (Hb) level. Polycythemia refers to an increased hemoglobin concentration in peripheral blood. Drug-induced polycythemia can occur with excess use of ESAs. On 12 January 2020, the World Health Organization (WHO) confirmed that a novel coronavirus was the cause of a pandemic respiratory illness. This pandemic has affected many countries including our country. Patients under risk were suggested to be isolated. In the present report, we describe a case of a CKD patient who developed polycythemia due to ESA overuse during COVID-19 isolation. Material and methods: A 12-year-old male was admitted to the hospital with a high hemoglobin level that was detected at routine outpatient evaluation. He had not been able to attend routine controls since he had been in isolation for 4 months after the COVID-19 outbreak. He had continued to take ESA at the dose of 100 U/kg/week that had been started upon the the diagnosis of anemia at a level of Hb 8.7 gr/dl, 6 months ago. On physical examination, his blood pressure was 140/80 mm Hg (he had been on an ACE inhibitor and a calcium channel blocker). Additionally, he had slight facial edema. Laboratory investigation revealed a Hb level of 20.8 g/dl, hematocrit level of 66%, creatinine level of 6.5 mgr/dl, urea level of 135 mg/dl, potassium level of 5.3 meq/L, and a parathormone level of 132 pg/ml. Venous blood gas analysis revealed ph:7.39 , bicarbonate 25.2 mEq/L. His previous Hb results were as follows: December 2019: 8.7 gr/dl, February 2020: 11.2 gr/dl. He was admitted to the hospital and underwent daily phlebotomy sessions (10cc/kg/session). During this period aspirin was also started (5mg/kg). After 5 sessions, his Hb level decreased to 14 gr/dl and hematocrit to 40%. He was discharged to return to the outpatient clinic for a check later. ESA was stopped until the time when anemia will re-appear.

Conclusions: During this pandemic,patients with CKD should be closely monitored by their family physicians at home by telephone, or by visiting them in person. In addition, as pediatric nephrologists, we should inform other pediatricians and family physicians for risks such as the one experienced by our patient.

Introduction: The kidney deterioration, which starts in childhood often leads to end-stage renal failure in the future. Therefore, searching for an early, sensitive and specific biomarkers became a paramount for chronic kidney disease diagnosis. The aim of the study was the appraisal of the usefulness of new markers: KIM-1, FGF-23, NAG, NGAL, uromodulin in predicting the development of chronic kidney disease in children.

Material and methods: 97 children (27 boys, 70 girls from 6 months to 17 years old) with kidney disorders, which had clinical indications for renoscintigraphy, were included in the study. The exclusion criteria were: chronic diseases and infectious diseases, acute kidney injury, previously diagnosed chronic kidney disease and prematurity. Firstly, the patients were divided depending on the result of renoscintigraphy (impaired uptake of the tracer corresponding to renal hypodysplasia or postinflammatory scars in renal parenchyma vs normal kidney picture). Secondly, depending on the level of estimated glomerular filtration rate (glomerular hyperfiltration vs normal filtration rate). Serum and urine concentration of KIM-1, FGF-23, NAG, NGAL and uromodulin were measured in all patients and compared between the groups. Results: There were no significant differences in the concentration of tested markers in blood and urine between the groups divided based on the result of renoscintigraphy. Statistically, significantly higher serum NAG and NGAL levels were found in children with glomerular hyperfiltration compared to children with normal glomerular filtration rate.

The results of the study do not allow to indicate new markers, which could be useful in the diagnosis of the early stage and prognosis of kidney damage visible in the scintigraphic examination. The study confirmed the possible usefulness of NAG and NGAL in detecting early stage of kidney disease associated with glomerular hyperfiltration in children.

Introduction: The aim of study was to determine frequency and structure of renal damage in children with DCTD. Material and methods: We examined retrospective 199 case histories of patients with Schönlein-Genoch vasculitis (SGV) and 326 case histories of patients with rheumatoid arthritis (RA) hospitalized in paediatric clinic of Orenburg medical university in period 2010-2020.

We detected renal damage in 31.5% patients with SGV (n = 60). Renal damaged was combined with skin, articular, abdominal syndromes. Renal damaged had microhematuria in combination with proteinuria (41.6%, n = 25), isolated microhematuria (35%, n = 21), isolated proteinuria (11.6%, n = 7). Nephrotic syndrome was in 1 child (1.6%). We diagnosed articular form of RA in 89.7%, systemic form in 10.3% of patients. We detected renal damage in 20.8% of patients (n = 68) with RA. Renal damage had isolated microhematuria (20.5%, n = 14), isolated proteinuria (19.1%, n = 13), microhematuria in combination with proteinuria (4.4% n = 3). Nephrotic syndrome was in 1 child (1.5%). Renal damage was more often in boys (63.3%, n = 38) than in girls ( Results: There was a significant difference in oral hygiene status and cytological changes in patients with CKD. Oral Fungal Infection was found in 32% of our patients on dialysis and oral lesions, defined as clinical signs associated with OFI such as erythematous oral stomatitis, membranous candidiasis, or angular cheilitis, were found in 37% of the patients with OFI, while 5% of the patients without findings of fungal infection presented oral lesions associated with OFI (p=0.0002). Furthermore, patients with self-reported mouth dryness were three times more likely (p=0.02) to be diagnosed with OFI.

Conclusions: Hemodialysis patients are found to have significantly more OFI than controls. Oral dryness and dental plaque formation also seem to be at risk of developing OFI. Detection of oral lesions associated with OFI should be combined with a histopathological diagnosis before antifungal treatment. The prevalence of oral candida in these cases isalarming and can be a predictor of a poor prognostic index. As medicine advances, oral health care professionals should have a holistic approach to the management of patients with complex medical problems especially to diseases of the renal system as it is pivotal in maintaining a stable internal environment and homeostasis. Introduction: Atypical haemolytic uraemic syndrome (aHUS) is a life-threatening disease, characterised by thrombotic microangiopathy (TMA), due to complement dysregulation. While C5 inhibition is effective, intravenous infusions impose a significant treatment burden. Crovalimab is a novel anti-C5 monoclonal antibody, with a 30-day half-life, allowing for small volume subcutaneous (SC) self-injection every 2 or 4 weeks (weight-based tiered dosing). Crovalimab has been studied in patients with paroxysmal nocturnal haemoglobinuria, another complement-mediated disorder, in the COMPOSER trial (Röth et al, Blood 2020), where crovalimab showed rapid complement inhibition and promising efficacy and safety. COMMUTE-p is a global Phase III single-arm trial evaluating the efficacy and safety of crovalimab in paediatric patients with aHUS. Material and methods: COMMUTE-p will enrol three cohorts of paediatric (aged ≥28 days to <18 years) patients with aHUS: 1) Naive: patients treatment-naive to complement inhibitors and with active TMA; 2) Switch: patients with controlled TMA switching from eculizumab or ravulizumab; and 3) Pretreated: patients who discontinued previous eculizumab or ravulizumab treatment. All cohorts will receive weight-based crovalimab loading dose(s), followed by self-injected SC maintenance dosing. The primary efficacy objective is to evaluate the effect of crovalimab in treatment-naive patients, measured by the proportion of patients with complete TMA response anytime from baseline to Week 25. Secondary efficacy endpoints for the Naive and Switch cohorts include change in dialysis status, changes in estimated glomerular filtration rate and haematological parameters, changes in chronic kidney disease staging and changes in fatigue, measured using age-appropriate Pediatric Quality of Life Inventory questionnaires. Safety will be evaluated, along with pharmacokinetics (including dose confirmation for patients <40 kg), immunogenicity, biomarker and treatment preference objectives.

Results: Enrolment will initiate October 2021.

Conclusions: COMMUTE-p will evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of crovalimab in paediatric patients with aHUS, a therapy which may reduce the treatment burden for these patients.

Introduction: Atypical haemolytic uraemic syndrome (aHUS) is a rare disease, the morbidity and mortality of which, has improved since the introduction of Eculizumab. Material and methods: Retrospective study of disease manifestation and outcome in a single-centre cohort. One patient has CKD, one died (no genetic mutations identified for either). Two further patients progressed to renal transplants (one has C3 mutation, the other CFHR1/3 deletion); aHUS recurred in one of these post-transplant, they continue on eculizumab for the past 7.4 years. Conclusions: aHUS is rare and patients can present very unwell. Introducing eculizumab resulted in noticeable improvement. There is still some way to go to further understand the genetic influence on outcomes. This study hopes to add to the growing knowledge of this rare disease.

Introduction: C3 glomerulopathy in children is a rare disease with an incidence of 1-2 per 1,000,000 population and a has a high risk of progressing to end stage renal disease (ESRD). Cluster hierarchical analysis has recently shown that patients tend to fall into four major subgroups. Each subgroup has their own different pathogenetic patterns and therefore may respond to anti-complement therapies differently. Current strategies involve treatment with RAAS blockade, immunosuppression and complement inhibition, albeit with a lack of randomised controlled trials for any of the above. The objective of establishing this clinic, designed to assess and manage children with C3 glomerulopathy, is to evaluate the efficacy of a harmonised treatment approach. Thereafter, attempt to define management therapies and review who may benefit from enrolment in clinical trials with complement inhibitors. Material and methods: Sixteen children with the diagnosis of C3 glomerulopathy were followed in the last two years at GOSH. Clinical, histological characteristics and biochemical analysis were assessed before and after treatment. Twelve were treated with oral prednisolone, five of whom also received mycophenolate mofetil (MMF) and one with cyclophosphamide. At twelve months of follow-up, all patients were on ACE inhibitors (ACEI) with improvement of albuminuria in all, except one. Six patients continue with prednisolone, eight with MMF and two commenced Tacrolimus. At present, three patients are in remission, two who were treated with immunosuppressive medication, the third was only treated with ACEI and had spontaneous recovery. One patient is in stage 3 CKD and two patients are in ESRD. These latter two were treated with Rituximab without success. Conclusions: Establishing this clinic, learning to identify which of these clusters the patients fall into and collating further data will help predict treatment response and therefore create more personalised management plans and guide prognosis.

Introduction: Atypical hemolytic uremic syndrome (aHUS) is a rare and severe disease characterized by hemolytic anemia, thrombocytopenia and acute renal failure. The dysregulation of the alternative complement pathway is caused by the mutations in the complement gene or acquired autoantibodies against complement regulatory proteins. Eculizumab, which is the first-line therapy in aHUS, blocks the formation of C5 convertase and inhibits the formation of terminal membrane attack complex. It is known that the treatment with eculizumab increases the risk of meningococcal disease 1000-2000 times. Material and methods: In this case report, we presented a case who developed meningococcemia under Eculizumab treatment despite vaccinations against meningococcus. Introduction: Atypical hemolytic uremic syndrome (HUS) is a chronic disease related to dysregulation and/or excessive activation of the complement system. Plasmapheresis/plasma infusion forms the basis of managing aHUS in absence of access to Eculizumab which is the first line treatment of aHUS. Material and methods: In this case report, we present two brothers who were diagnosed complement factor H related aHUS and successfully treated with two weekly plasma infusions. Results: Case1: An eight years old Syrian refugee boy had first aHUS attack when he was three years old age. He was treated with hemodialysis and plasmapheresis. His brother admitted on same day with similar symptoms. Genetic analysis was heterozygous positive for factor H mutation. Two years later he had second attack with neurologic involvement. Because of insurance problems eculizumab couldn't be administered and plasma infusion treatments were started. Two weekly plasma infusions were given without any adverse effect. Case 2: Ten years old boy had first TMA attack when he was five years old age. Genetic analysis was homozygous positive for factor H mutation. He had second TMA attack two years later and treated with plasma infusions. One year later he had experienced a third TMA attact after a one-week delay of plasma infusion. On follow up two weekly plasma infusions were continued and both patients did not experience a new event for two years and had hematological and renal remission. Both children were under enalapril treatment for persistent proteinuria.

Conclusions: The outcome of aHUS has improved after eculizumab treatment. If there is lack of availability of eculizumab, plasma exchange/plasma infusions are the preferred treatment. Both patients were successfully treated with plasmapheresis during aHUS attack and treatments were continued with regular plasma infusions without adverse effect and control of the disease.

Marion Ferri , Claire Dossier , Theresa Kwon , Julien Hogan Pediatric Nephrology Department, Robert Debre Hospital, Aphp, Paris Introduction: Previous guidelines suggest combining plasma exchange (PE) and immunosuppressive drugs to treat children with aHUS due to anti-CFH antibodies but the place of other treatments remains controversial. Material and methods: Since 2011, our treatment protocol combines eculizumab with corticosteroids and mycophenolate mofetil (MMF). Rituximab was added in patients >1year old and immunoadsorption (IA) in patients requiring dialysis. We report the clinical course and outcomes of 5 patients treated with this protocol. Results: Patients were aged 5 months to 12 years and anti-CFH antibodies titers varied from 14000 to 129500 IU/L. Median duration of Eculizumab treatment was 14 [5;23] months. All but one patient presented platelets count normalization within one week. Kidney function improved rapidly and only one patient did not recover a normal function at 1-year (eGFR=68.9 mL/min/1.73m 2 ). Anti-CFH antibody titers decreased rapidly over the first 3 months to reach titers below 3000 IU/L in 1 to 12 months in 4 patients. Only one patient reached titers below 1000UI/L after 2 years of follow-up. No increase in Ab titers was observed at B-cell reconstitution (median time to reconstitution 4 months). Immunosuppressant treatments were stopped in one patient (titers 2470 IU/L) and no relapse was observed 36 months after discontinuation. The youngest patient was only treated with ECZ for 6 months and IvIg infusions. Anti-CFH antibody titers remained low and no relapse was observed 40 months after ECZ discontinuation. No infectious complication was reported in this cohort.

Conclusions: These data suggest that ECZ can be safely used to induce rapid remission and that maintenance treatment with steroids and MMF. The benefit of B-cell depletion on relapse prevention and antibody titers remains to be demonstrated. Finally, treatment discontinuation seems possible despite antibody titers >1000UI/L and larger studies are needed to assess predictors of relapse in these patients. Introduction: In this case report, a case of Catastrophic Antiphospholipid Syndrome (CAPS) with Thrombotic Microangiopathy (TMA) that is accompanied by a genetic disorder in the complement system is presented. Material and methods: ... Results: A 13-year-old patient presented with menstrual bleeding and thrombocytopenia. On physical examination pretibial edema was present. Laboratory findings showed abnormal kidney function tests (creatinine: 3.97 mg/dL), anemia (Hb: 9.7 g/dL), thrombocytopenia (35.000/mm3), reticulocytosis (4%), low haptoglobin (<8 mg/dl), elevated LDH (1080 U/L) and low C3 levels. Anti-nuclear antibody (ANA) and direct coombs were positive. There were signs of hemolysis in peripheral blood smear. The patient was considered to have "TMA". Cortical necrosis was detected in the kidney biopsy that were consistent with clinical diagnosis of TMA. Lupus nephritis was not detected in the kidney biopsy. Three doses of pulse-steroid and intravenous immunoglobulin treatments were given and continued with oral high dose prednisolone. Plasmapheresis was initiated for antibody and complement-related TMA causes. Three doses of eculizumab and rituximab were also administered to the patient. In autoimmune antibody screening; anticardiolipin antibody (ACA) was negative, anti-beta-2-glycoprotein-I antibody (β2GPI) IgM and Lupus anticoagulant (LA) were positive. The patient was evaluated as "primary APS" with histopathology and antibody positivity. After a while, the patient presented with severe abdominal pain. Abdominal CT angiography images were consistent with mesentery, spleen and liver ischemia. In addition, deterioration was observed in kidney functions. With these findings, the patient was evaluated as "CAPS". Homozygous deletion in the Complement Factor H-Related 1 (CFHR1) gene was detected. She is still being followed up with anticoagulant and immunosuppressive treatments. Despite therapy, she eventually progressed to end stage kidney disease.

Conclusions: Antiphospholipid Syndrome should be kept in mind and investigated in patients presenting with TMA. Genetic mutations related to the complement system in CAPS patients may be responsible for the severe clinical course. The father has a debut of the disease at the age of 12, the children were diagnosed in their infancy (6 months for son, 7 months for daughter). The peculiarity of the course of the disease in all family members was the development of the classical symptoms of aHUS without extrarenal symptoms. The severity of clinical manifestations differed among family members: the father had 3 episodes of activity of complement-mediated TMA, the daughter -1, and the son -5. For father and daughter, the severity of hematological manifestations of aHUS prevailed over nephrological ones. For the son, this was observed only in the first 2 episodes. The severity of the disease was due to the severity of hemolysis over the remaining symptoms of TMA, and in subsequent relapses the severity was caused by the development of dialysis-dependent renal failure. All family members were plasma sensitive. Complement-blocking therapy (eculizumab) in children made it possible to achieve aHUS remission with complete restoration of renal function. The clinical diagnosis was supported by the results of a genetic study of the complement system that identified the C3 complement component gene mutation (p.Ile1157Thr) in a son and daughter. Conclusions: The presented clinical observation demonstrates the development of aHUS in three family members with indications of an autosomal dominant type of disease inheritance. Given that patients with aHUS have constant uncontrolled activation of complement, the risk of developing sudden complications persists throughout their lives, therefore, long-term therapy with eculizumab is recommended for such patients. Introduction: Haemolytic uremic syndrome (HUS) is a rare but known complication of infection by Streptococcus pneumoniae (SP-HUS), especially in children.

We report the case of a sixteen-months boy presenting COVID-19 infection with positive nasopharyngeal RT-PCR test and SP-HUS with neurological impairment. Streptococcus pneumoniae serotype 10A was found in blood culture and lombar puncture, realised after generalized tonic-clonic seizure. SP-HUS associated microangiopathic haemolytic anemia, thrombocytopenia and oligoanuric renal failure leading to continuous hemofiltration. After diagnosis of SP infection, antibiotherapy was also beginned. One single dose of eculizumab (ECZ) was administrated six days after admission regarding persistant complexe seizures with extended ischemic lesions at MRI. Results: Hemofiltration was stopped two days after eculizumab injection, renal function fully recovered within a few days with a normal serum creatinine and neurological condition gradually improved. Investigations into the cause of thrombotic microangiopathy found a normal ADAMTS13 activity. Analysis of plasma levels of complement factors showed an initial decrease of C3 antigen (483 mg/L) and a high level of plasmatic SC5b-9 (1222 ng/mL), involving an activation of the alternate complement pathway. Moreover, CH50 activity was low (20%). Other plasma levels of complement factors (C4 antigen, C1q antigen, factor H and factor I) were normal. Screening for anti-CFH, anti-CFB and anti-C3b was negative. Control of C3 complement factor was normal six months after HUS episode.

Conclusions: To date, only very few cases of SP-HUS treated by ECZ have been reported.

In this case, we report a co-infection with COVID-19 and Streptococcus pneumoniae complicated with HUS and severe neurological impairment.

Activation of complement alternate and classical pathways was found and ECZ was successfully use with recovery of renal condition. ECZ could provide a new therapeutic weapon for the most serious forms of SP-HUS with further studies required to document the benefit of complement blockade therapy in severe forms of SP-HUS. Introduction: Atypical hemolytic uremic syndrome (HUS) is an alternative complement pathway disease. One of the rare underlying genetic causes is the Diacylglycerol Kinase E (DGKE) gene mutation, and the optimal treatment strategy is still unclear.

Material and methods: A three-year-old boy was referred to our clinic because of vomiting and high creatinine level after using amoxicillin and paracetamol for fever and sore throat. Physical examination revealed no pathological finding other than edema. Laboratory evaluation showed the triad of HUS; anemia, thrombocytopenia, increased creatinine and hemolysis in peripheral blood smear. He was anuric. Supportive treatments, hemodialysis, and plasmapheresis were initiated. Adamts13 activity, complement three, four, H levels were in normal range. Enterohemorrhagic E. coli (verotoxin) PCR test were positive in stool. Treatment continued with fresh frozen plasma under premedication because of anaphylaxis after the third plasmapheresis. On the seventh day the first dose of Eculizumab was given. Urine output began on the 21st day. He was discharged with a 0,67 mg/dl creatinine value on the 36th day. He was followed up with enalapril for his proteinuria. There was a history of death due to DGKE mutation in the grandson of his fathers uncle. We also detected compound heterozygous mutation in the patient DGKE gene, exon 5: C. 1009C>T (p. R337X), heterozygous; exon 1: C.427C>T (p. Q143*), heterozygous. Creatinine decreased to 0.4 mg/dl. After four-dose, Eculizumab treatment was interrupted. 6 months after discharge, he presented with a second attack triggered by fever. He didn't need dialysis, achieved remission after eculizumab treatment. One week after the second eculizumab dose, he presented a widespread rash on the skin and mucous membranes. Skin biopsy was compatible with Stevens-Johnson Syndrome. His rashes regressed with intravenous immunoglobulin, steroid, and antihistamines. We discontinued Eculizumab due to its side effect. Results: In the follow-up, there was no new attack, creatinine was 0.4 mg/dl (GFR 103 ml/min/1.73m2), and hematological parameters were normal, urine protein was normal with enalapril. Conclusions: The optimal treatment strategy for patients with DGKE mutations is not clear. The attacks of our case were controlled with plasmapheresis and eculizumab treatments. , and immunologic abnormalities were more common in the group with proliferative lesions but without statistically significant correlations. Conclusions: Because proliferative LN is an aggressive disease that may lead to ESRD, it is important to identify to identify the predictive factors of its occurrence in order to establish a diagnosis as soon as possible and institute the appropriate treatment. Material and methods: .. Results: Patient 1 (male) presented with aHUS at 3 years-8 months of age, with abdominal pain without diarrhea, moderate kidney failure, proteinuria, macrohematuria, petechiae, anemia, and low C3. He did not have neurological involvement and STEC serology was negative. We administered Eculizumab with rapid normalization of kidney function, hemoglobin and platelets. After 3 months, results of positive high titer (>2000 AU/ml) anti-FH antibodies with homozygous deletion of CFHR1-CFHR3 were found. Immunosuppression was not started due to concomitant COVID-19 pandemic and parent refusal. Anti-FH antibody titers at 6 months were 1506 AU/ml, at 12 months 509 AU/ml with normalization of C3 and FH levels. Therapy with Eculizumab was discontinued after 14 months without concomitant immunosuppression. Patient 2 is a 6-year-old male with a history of HUS diagnosed in Albania with terminal renal failure requiring hemodialysis and neurological involvement associated with non-bloody diarrhea, positive for E.coli O:157. No treatment was given and after 8 weeks the family left Albania to seek treatment in our center. We performed a kidney biopsy, which showed thrombotic microangiopathy lesions. Kidney function improved spontaneously, and hemodialysis was stopped after 1 month. Complement analysis revealed a low positive titer of anti-FH antibodies (386 AU/ml) with homozygous deletion of CFHR1-CFHR3. Six months later antibody titers spontaneously reduced to 143 AU/ml. At last followup (+ 18 months), proteinuria was absent and kidney function only mildly reduced with no neurological sequelae. Conclusions: Complement FH is the main regulatory protein of the complement alternative pathway. Mutations in genes encoding for FH-related proteins are associated with autoantibodies against FH, which can cause aHUS. We describe two cases of anti-FH antibody-aHUS with a good outcome and, in both cases, spontaneous decrease in anti-FH antibody titer. Introduction: Hemolytic Uremic Syndrome (HUS) is diagnosed by microangiopathic hemolytic anemia, thrombocytopenia and kidney involvement. Thrombotic microangiopathy(TMA) is a well-known pathological renal involvement in HUS. In this study, a case of HUS is introduced with crescent formation in about 10% of glomeruli in renal pathology with minimal TMA that was treated with Eculizumab. Case presentation: Patient was a fourteen-month old boy presented with recurrent vomiting after breastfeeding and icterus and was suffering from anorexia and had discoloration of urine. In past medical history there was no sign of diarrhea or fever in last days. He was born full term and weighted 2.5 kilograms. His parents are second-degree relatives. He was pale and icteric in the physical exam. Laboratory data showed hemolytic anemia and thrombocytopenia with anisocytosis, schistocyte and burr cell which are the indicators of microangiopathy. Decreased level of C3 component of complement was detected. Urine analysis showed protein (1+), blood (3+) and many red blood cells. Ultrasound imaging showed mild increased size of kidney,increased corticomedullary echo pattern and differentiation for both kidneys. He was treated with methylprednisolone and intravenous immunoglobulin (IVIG). Because of unavailability of Eculizumab, plasma infusion was started. His hemolysis was improved but within 2 weeks his creatinine increased gradually from 0.5 to 0.9 mg/dl. His blood pressure increased severely and he started to have gross hematuria. Consequently, he underwent renal biopsy which showed focal proliferative, necrotizing glomerulitis and cellular crescents in 7 out of 75 glomeruli. Features of possible acute tubular damage was detected. Finally, Eculizumab was provided with difficulty. The patient received 300 mg Eculizumab in week zero, one and then every 3 weeks with penicillin prophylaxis. After 4 doses, he had only microscopic hematuria without hypertension and his creatinine dropped to 0.5 mg/dl. Conclusion: An unusual kidney biopsy in HUS was successfully treated with Eculizumab.

described, all of which only explain 10% to 20% of all patients with CAKUT, suggesting the presence of additional genes that cause CAKUT when mutated. Material and methods: Herein, we report two siblings of a consanguineous family with CAKUT, both of which rapidly progressed to chronic kidney disease in early childhood. Whole-exome sequencing (WES) was performed in the two affected boys, one unaffected boy and their parents. A homozygosity mapping was performed using WES data via HomSI software.

Results: WES identified 49.737 variants with the average 147x depth of coverage in affected individuals. Homozygosity mapping identified two variants and thereby two candidate genes; RNA binding motif protein (RBM19) and Homeobox A11 (HOXA11). The former has been detected in healthy individuals and has knock-out mice models without any urinary abnormality. On the other hand, knocking-out of Hoxa11 in mouse has been associated with CAKUT. Conclusions: We therefore showed for the first time an association between a homozygous HOXA11 variation with CAKUT in humans, expanding the genetic spectrum of the disease.

Hadas Shasha-lavsky 1 , Chen Nozik 2 , Irith Weissman 1 , Ziv Paz 1 , Ariel Berl 2 , Pierre Awadia 1 , Lama Majadla 2 , Shir Sivan 1 , Orly Yakir 1 , Tzipora Falik-zaccai 1 1 Galilee Medical Center 2 Bar Ilan University

Introduction: Chromosomal microarray analysis (CMA) is part of the prenatal evaluation of congenital anomalies . The prevalence of pathogenic CMA test results in cases of prenatal isolated renal malformations is unknown.

Objective: To determine the risk of pathogenic CMA results in fetuses with an isolated renal malformation compared to normal pregnancies and to fetuses with combined renal and extra-renal malformations. Material and methods: A single center, retrospective observational study based on medical records of pregnant women who were referred for a prenatal nephro-genetic consultation at the Galilee Medical Center, Israel, between the years 1997-2018. The rate of pathogenic CMA findings was compared between fetuses with isolated renal malformation and fetuses with combined renal and extra-renal malformation. Each group was then compared to the general population based on a national registry which includes 5541 CMA results of fetuses with a normal prenatal ultrasound.

Results: A total of 70 fetuses were included in this study. Of those, 38 fetuses had an isolated renal malformation and 32 had renal and extra-renal malformations. Pathogenic CMA test results were found in 8 cases (11.4%) with no statistically significant difference between the subgroups within our cohort [5 cases (13.2%) in the isolated renal malformation and 3 cases (9.4%) in the renal and extra renal malformations]. The risk for pathogenic CMA test result in isolated renal malformations was higher compared to the control group which represent the general population) 13.2% vs 1.4%, P<0.001) with a relative risk of 10.148 (95% CI 1.63-63.13).

The risk for a pathogenic CMA test result among fetuses with an isolated renal malformation is higher compared to fetuses with normal prenatal ultrasound. CMA test should be considered in cases of prenatal renal malformation.

Introduction: Congenital anomalies of the kidney and urinary tract (CAKUT) comprise a spectrum of structural malformations that form the major cause of end-stage renal disease in children. Despite the occurrence of familial cases that clearly suggest a genetic background, the exact patterns and mechanisms of inheritance have not been conclusive. Although 10-20% of CAKUT cases seem to have a monogenic background, disease etiology is probably more complex in most cases. We currently investigate a cohort of 30 cases with multicystic dysplastic kidney and their parents, using a whole genome sequencing-based approach to identify underlying molecular mechanisms. Material and methods: Patients and their parents were included in the AGORA data-and biobank. The selected cohort was phenotypically homogeneous in the sense that all patients presented with unilateral multicystic dysplastic kidney. All participants gave informed consent for whole genome sequencing (WGS). WGS was performed in 30 caseparent trios. First, WGS data was analyzed for single nucleotide and structural variants in known CAKUT genes. Next, potentially deleterious variants were listed and prioritized for further investigation using KidneyNetwork (https://kidney.genenetwork.nl/) based on phenotyperelated and tissue-specific expression data. Results: A de novo variant in the GREB1L gene was identified in a patient with unilateral multicystic dysplastic kidney and absence of the vas deferens. The variant was classified as pathogenic. The patient was referred for genetic counseling at the nephrogenetics outpatient clinic for children.

The upcoming integration of WGS data with KidneyNetwork will lead to the prioritization of high impact variants in new CAKUT-related genes for follow-up studies.

Conclusions: Case-parent trio WGS revealed one de novo diseasecausing variant in a known disease gene for CAKUT. This finding extended the phenotypic spectrum related to GREB1L gene variants. The integration of trio WGS, expression and phenotypic data will bring more insight into the genetic background of multicystic dysplastic kidney. Introduction: The management of asymptomatic infants with antenatal hydronephrosis (AHN) due to high-grade ureteropelvic junction obstruction (UPJO) remains controversial. In this retrospective study, we evaluated the infants with isolated unilateral UPJO, with special emphasis on the timing of surgical intervention. Material and methods: Pyeloplasty was performed at first presentation if the initial differential renal function (DRF) was ≤40% or if there was severe hydronephrosis on ultrasound along with poor drainage on diuretic renography. Surgical indicaitons at follow-up were worsening hydronephrosis on subsequent ultrasounds, persistence of obstructive curve on second renogram, and the presence of any symptom.

Results: A total of 45 infants (38 boys) were icluded. Of 45 infants, 28(62.2%) were followed only conservatively for median 23 months . Hydronephrosis resolved spontaneously in 19, improved in 8 and remained stable in 1. Surgical correction required in a total of 17(37.8%) infants with a median age of 5.8 months (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) , 4 infants at first presentation and 13 while on conservative protocol. In these 13 infants, pyeloplasty was performed at a median age of 6.7 months (1-12) before a decrease in renal function on second renogram or parenchimal thinning on subsequent ultrasounds occured. For all 17 patients, worsening hydronephrosis was the main indication for surgery. Conclusions: Pyeloplasty was performed after a short follow-up period in our center, based on many studies suggesting that early surgical aproach prevents renal impairment and even improves renal function in infants with antenatal UPJO. We think that this approach is effective and reliable in young infants. Introduction: Posterior urethral valve (PUV) is the main cause of bladder outflow obstruction in males. PUV is also the most common obstructive uropathy leading to chronic kidney failure. We aimed to identify the clinical course, kidney outcomes and prognostic factors in children with PUV. Material and methods: We retrospectively analyzed of 83 children with PUV who were follow-up in our tertiary center. We reviewed medical records of children with PUV and recorded demographic features, growth parameters, clinical course, laboratory and radiological data of the patients.

Results: The median age at diagnosis was 2.5 months (range 1 day-99 months). The median surgical intervention age was 3 months. The median follow-up period was 2.5 years and the longest was 20 years. Conclusions: Based on the current available evidence the use of continuous antibiotic prophylaxis for children with primary nonrefluxing megaureter selected for primary non-surgical treatment should be taken into consideration, at least in patients with urinary outflow impairment, higher grade of ureteral dilatation, and for children in the first months of life. However, there is an urgent need for high quality prospective studies.

Introduction: A 14-year-old boy with nutracker syndrome and a history of constant and intense periumbilical pain (pain scale, [8] [9] for the last 24 months was overviewed for surgical treatment. All clinical examinations and possible psychogenic upgrades were insufficient to explain the pains cause, including autoimmune thyroiditis as comorbidity.

Material and methods: Digital subtraction angiography revealed a segment of the left renal vein with reduced contrast filling immediately before its inflow into inferior vena cava and high-pressure gradient. The three-dimensional reconstruction model demonstrated that the LRV and the duodenum were contracted at the aortomesenteric angle, resulting in left renal vein compression from the abnormal high-level duodenal compartment. When duodenum coarses between the abdominal aorta and superior mesenteric artery (duodenal interposition), the left renal vein entrapment occurs even at < 90 aortomesenteric degrees.

Results: Three-dimensional PEEK printed extravascular stent was chosen to elevate the superior mesenteric artery and lower the duodenum position, thus relieving left renal vein compression. This extravascular application has significant advantages over open surgery, endovascular stenting and artificial vessel procedures with expanded polytetrafluoroethylene. It provides better cellular vitality by ensuring soft tissue proliferation. Such a stent has a distinctive personalized design, good stiffness, and durability that allows blood vessel growth, preventing stent migration and thrombosis. Therefore, it is suitable for both adult and pediatric patients. According to the abdominal ultrasound and MSCT scan, the post-operative follow-up results are satisfactory one year after surgery. The patient feels well, the blood flow in the left renal vein is not obstructed, and the blood flow velocity was average. The external stent is in place.

Conclusions: By reducing external acceleration and centrifugal force, a three-dimensional printed PEEK extravascular stent reduces adverse side effects. Surgical treatment of NCS should be considered for children whose conservative therapy has remained inefficient for more than 24 months or in children with severe pain, debilitating their everyday life. We believe that treating patients with nutcracker syndrome by the laparoscopic placement of a 3D printed PEEK extravascular stent around the compressed LRV is safe has advanteges over endovascular stenting. 3DP-PEEK extravascular stent is an effective method of treating nutcracker syndrome in children as it allows them to grow/expand their blood vessels. To our knowledge, this is th first european patient treated with such stent. Introduction: The recent multidisciplinary consensus on the classification of prenatal and postnatal urinary tract dilatation (UTD classification system) proposes that six ultrasound morphological parameters be assessed (J Pediatr Urol, 2014) . It is considered that anteroposterior pelvis diameters (APD) smaller than 10 mm should not be studied. Likewise, the study of renal function is also neglected. The objective of this work was to study renal function in children with mild-moderate dilatation of the urinary tract and to check whether the results are useful in deciding to order other imaging tests. Material and methods: A retrospective cross-sectional study included 102 infants (75V, 27M) with a APD between 5 mm and less than 20 mm at the first ultrasound; 88 were diagnosed in utero (86.3%).All had performed, in addition to ultrasonography before the age of one year, cystography and at least maximum urinary osmolality (UOsm) determined with desmopressin. When possible, the albumin/creatinine ratio value was collected. A renogram was performed in 33 cases. Results: Three patients were diagnosed with ureteropelvic junction obstruction (UPJ)(APD between 12 and 18.2 mm). Vesicoureteral reflux (VUR) was observed in 17 infants (16.8%) (1 grade I, 4 grade II, 10 grade III, 2 grade IV; APD between 5.6 and 19 mm). When distributed according to APD (5 to <10 mm, 10 to <15 mm, 15 to <20 mm) and excluding patients with VUR and PUS, significant differences in UOsm were observed (lower in the last of these subgroups, p=0.03 Results: Branchio-oto-renal syndrome, which is also known as banchiootorenal dysplasia, Melnick-Fraser syndrome, branchiootorenal spectrum disorders (BOS)[i] are all synonymous for a condition with a wide variability of clinical presentations that has head and neck, auditory and genitourinary variances. Head and neck variabilities range from hemifacial hypoplasia, cleft palate, branchial cysts, to lacrimal duct stenosis. Auditory abnormalities range anywhere from preauricular skin tags, hearing impairment either conductive or sensorineural, malformations of the external ear to incomplete partition of the cochlea. The scope of genitourinary involvement differs from each affected individual and can include renal steatosis, malrotation, collecting system abnormalities, vesicoureteral reflux, polycystic kidney dysplasia, renal agenesis or dysplasia[ii] and in some patients can even progress to end stage renal disease [iii] . The three cases discussed in this review presented due to renal malformations and were in end stage renal failure and were subsequently found to have preauricular pits and signs consistent with the BOR syndrome in contrast to those in review of the literature who presented initially with symptoms of auditory infections, preauricular pits, progressive hearing loss and branchial fistulae [iv] [v] [vi] .

Although approximately 90% of BOR cases are inherited in an autosomal dominant fashion, there can be vast differences in manifestations of symptoms and signs among those affected, even amongst family members [vii] . The breadth of the observed defects can be explained by variable expressivity of different genetic loci including, EYA1 , SIX1 and SIX5 [viii] . Around 40% of the with BOR have a mutation in the EYA 1 gene [ix] . A SIX1 mutation affects approximately 4% of people with BOR spectrum and a SIX5 mutation is present in about 5% of those affected [x] . The gene in approximately 50% of patients is unknown [xi] . The remaining 10% of affected individuals are due to the effect of de novo genetic mutations. The genomic defects can cause anomalous development of the genitourinary system along with abnormal development of the second branchial arch in the developing embryo which can cause the head and neck and ear abnormalities in the maturing fetus [xii] . In some individuals with BOR syndrome, no genetic mutation was identified in the EYA 1, SIX1 and SIX 5 genes [xiii] , therefore there are probably other gene mutations that have not been identified that can cause this syndrome [xiv] . The differential diagnosis can include but is not limited to: branchio-otorenal syndrome, branchio-oculo-facial facial syndrome [xv] / Goldenhar syndrome [xvi] , oculo-auriculo-vertebral spectrum [xvii] , CHARGE [xviii] , Treacher Colllins, Alport Syndrome [xix] and Towns Brocks syndrome [xx] . Euthyroid goiter *Only two major criteria are needed if the proband has two or more affected family members/ family history of brachial, otologic or renal anomalies. *Three major criteria or two major criteria and two minor criteria required if negative family history.

Those with a suspected or confirmed diagnosis of BOR require a multidisciplinary team approach that is tailored to each patient's needs. The team should comprise of a "geneticist, otolaryngologist, speech therapist, occupational therapist, radiologist and renal specialist, with the pediatrician coordinating the care" [xxiv] . An audiological evaluation is also required including computerized tomography of the ear and laboratory and radiological investigations for renal defects [xxv] . The treatment of those with BOR syndrome, depends on the degree of affection. Hearing aids and rehabilitation may be required for those with auditory deficit. Antimicrobial agents can be used to treat otitis media or inflamed branchial sinuses. Surgery may be beneficial for those with structural deformities of the pinna or those with branchial cleft deformities that can cause cysts or fistulae. Due to the incidence of renal involvement, it is recommended to involve a nephrologist to assess the patient for any renal impairment. The patient may require surgery, dialysis or renal transplant [xxvi] .

[i] "Branchiootorenal Syndrome." Genetic and Rare Diseases Information Center, U.S. Department of Health and Human Services, rarediseases.info.nih.gov/diseases/10147/branchiootorenal-syndrome.

[ii] Human Phenotype Ontology, hpo.jax.org/app/browse/disease/ OMIM:113650.

[iii] "Branchiootorenal/Branchiootic Syndrome -Genetics Home Reference -NIH." U.S. National Library of Medicine, National

Introduction: Patients with bilateral megaureter (BM) constitute the most severe group among congenital anomalies of the kidney and urinary tract (CAKUT-syndrome). Because its play a causative role of cases of end-stage renal disease, it is important to diagnose these anomalies and initiate therapy to minimize renal damage, prevent or delay the onset of ESRD, and provide supportive care to avoid complications of ESRD. Moreover, it's known that several genes and epigenetic factors have been implicated in the pathogenesis of renal malformations and CAKUTsyndrome is considered as monogenic disease.The aim of this study was to identify mutations in genes in patients with severe forms of bilateral megaureter with beginning-stage renal disease for possibility prognosis its development. Material and methods: 25 boys in the age of 3-16 years old with BM, complicated acute renal disease in infancy and preserved renal function at the moment of investigation. Next generation sequencing (NGS) includes the analysis of encoding sequences of 4812 genes and bioinformation analysis of founded mutations with the help of genetic data bases OMIM, ClinVar and MedGen. Results: All patients were operated step by step during the life. Among the treatment options the posterior urethral valve incision were done in 11, temporary urinary diversion (ureterostomy, nephrostomy, internal stenting) in 22, ureter reimplantation in 13 boys. Mandatory urological evaluation includes US, DMSA scanning, MAG3 dynamic scintigraphy, VCUG, and bladder urodynamic investigation. Abnormal mutations were found in 15 boys. Among them there were mutations which are known as pathological in different kidney or smooth muscle diseases in 18 genes: AGT, COL4A4, PKHD1, ACE, PKD1, CFH, CFHR2, COL9A3, COMP, NID1, EYA1, MYH9, FRAS1, TP63, ITGB4, MYLK, HNF1B, HSPG2. Each patient has from 1 to 3 mutations in these genes. Three of these genes: AGT, PKHD1 and ITGB4 were abnormal in not one of them. Moreover, the mutations, related to another diseases, were found in 4 from these 15 patients. There were mutations in well-known BRCA1, MAN2B1, MEFV and NSD1 genes. In 10 patients without any kidney or smooth muscles related mutations any others mutations also weren't founded. Conclusions: In 40% patients with clinical picture of CAKUT-syndrome on the background of bilateral megaureter genetic base of disease not confirmed and they must be assessed as malformation without dysplasia. We may suppose that nongenetic patients have better prognosis for renal function failure. Further investigations will help to understand the pathogenesis of malformation better.

Introduction: We describe a case of a child with hyponatriemic hypertensive syndrome (HHS) to emphasize the importance of early diagnosis and treatment of this condition Material and methods: A previously healthy 16 months old child was referred for vomiting, clouding of consciousness, polyuria. Blood pressure measured 150/110 mmHg. Laboratory tests revealed hyponatriemia, hypokalemia, and metabolic alcalosis. Urinalysis revealed proteinuria in nephrotic range, hypercalciuria, hyperuricuria, natriuresis (FENa 8.2%) and glycosuria. He was hydrated and his electrolytes were corrected by intravenous sodium and potassium replacement. Renal sonography showed small right kidney (3.14 SD below the mean) with normal left kidney. Angio-TC and arteriography both demonstrated bilateral duplication of renal arteries with stenosis of right ones so percutaneous transmural angioplasty was performed. Results: Symptoms and laboratory findings were completely reversed within 10 days after angioplasty and dual renin-angiotensin-aldosterone (RAA) blockade: blood pressure gradually normalized with resolution of polyuria and electrolyte imbalance (FENa<1%, resolution of glycosuria and proteinuria). Postoperatively, Doppler sonography showed increase in the size of the right kidney (0.5 SD below the mean) with improvement in renal parenchyma vascularization and normalization of renal arterial resistive index. Conclusions: HHS is characterized by unilateral renal artery stenosis, secondary systemic hypertension and activation of the RAA with glomerular and tubular dysfunction due to contralateral hyperfiltration. High levels of angiotensin II and subsequent "aldosterone escape" phenomenon are central to the pathogenesis of the syndrome. In our case the development of HHS allowed early detection and treatment of an underlying silent condition, so that irreversible renal damage was prevented. Although HHS has been reported often in adults, it is uncommon in children. This condition should be suspected in patients with severe hypertension associated with hyponatremia in the absence of other parameters of glomerular disease or tubulopathy. Introduction: Congenital anomalies of the kidney and urinary tract (CAKUT) are the leading cause of end stage renal disease in children. One of the variants of syndromic СAKUT is coloboma renal syndrome caused by PAX2 gene mutations. Material and methods: We describe a clinical case of renal coloboma syndrome identified by Next Generation Sequencing (NGS). Results: A 3-year-old boy was referred to our hospital with a history of chronic kidney disease. He was the second child of healthy and nonrelated parents. He was born full-termed, bilateral renal hypoplasia was detected by ultrasound in the third trimester. In the 1 month of life, ophthalmological examination revealed a coloboma of the optic disc, which was later confirmed by MRI. Laboratory findings included mild anemia, hypocalcemia, hypomagnesemia, hyperkalemia, increased creatinine values (80 μmol/l) with the estimated glomerular filtration rate (eGFR) 25 ml/min/1,73 m 2 . By the age of 3, eGFR had improved to 52 ml/min/1,73 m 2 , the electrolyte composition and blood hemoglobin were within the normal range, subcompensated metabolic acidosis, growth retardation (z: -1,2) and arterial hypertension (to 110/75) were noted. By performing NGS on a patient's blood sample we identified a previously undescribed heterozygous deletion in PAX2 gene c.226delG (p.G76Afs*6), which represents stopcodone mutation. This mutation is probably pathogenic, as it leads to the termination of protein synthesis. Conclusions: All children with renal hypodysplasia require an ophthalmologic examination, as approximately 10% have a point mutations in the PAX2 gene with accompanying eye abnormalities. Introduction: CAKUT are common pathology in paediatric nephrology and important cause of chronic kidney disease in children. The aim of our study was to find out the clinical presentation of our children with CAKUT, their treatment and complications Material and methods: 324 CAKUT patients with all the relevant clinical data available, were included in the study and clinically screened. In addition, cohort included patients, in whom, after parent consent, a blood sample for DNA isolation was taken, allowing further genetic studies to be compared to phenotype findings. Their clinical characteristics, diagnostic methods, treatment and complications were collected. Results: Commonest CAKUT was vesicoureteral reflux (VUR), diagnosed in 273 children (84.2%), followed by hydronephrosis due to pyeloureteral junction stenosis in 76 children (23.4%), dilation of pyelon in 43 (13.3%), megaureter in 27 (8.3%), duplex collecting system in 19 (5.6%) and hypoplastic kidney in 12 included children (3.7%). All other CAKUTs together were present less frequently, diagnosed in 32 cases (9.9%).

Regarding diagnostics, ultrasound was done in 100% of patients, voiding cystourethrogram in 316 (97.5%) and dynamic renal scintigraphy in 22 (6.8%) of them. Urologist was consulted in 137 (42.3%) cases. Regarding treatment, observation only was sufficient in 48 (14.8%) of patients, just antibiotic prophylaxis in 138 (42.6%), endoscopic treatment of VUR with injection of synthetic or natural materials in 109 (33.5%), classic surgical procedure in 29 (9%) patients. Complications were few, mainly before the year 2010. Reflux nephropathy was diagnosed in 19 patients (5.8%), hypertension in 17 patients (5.2%) and chronic renal disease in 11 patients (3,3%) . Conclusions: Commonest CAKUT diagnosed, was VUR. Diagnostic and treatment management was in accordance with newest global standards. Complications were rare, especially in the last decade.

Introduction: Congenital anomalies of the kidney and urinary tract (CAKUT) are the major cause of kidney failure in childhood and adolescence. Nevertheless, a substantially larger subset of individuals have a better prognosis of kidney function. This strong clinical variability highlights the need for accurate decision-making in the management of patients. Unfortunately, the largely unknown aetiology of CAKUT and the limited early predictability of kidney function currently hamper this. We have set up a nation-wide research frameworkthe ArtDECO Consortiumto define the genetic and environmental aetiology of CAKUT with the ultimate goal to improve the clinical management of patients. Material and methods: The ArtDECO consortium will establish a nation-wide data-and biobank for CAKUT based on the existing protocols, infrastructure, and licenses of the AGORA data-and biobank. ArtDECO will include 3,750 CAKUT cases with comprehensive data on clinical parameters and foetal environmental exposures as well as DNA collections. We aim to increase the diagnostic yield of genetic testing in CAKUT patients by identification of new monogenic causes by whole-exome sequencing in a subset of patients. Next, we will perform multi-angle analyses using environmental information from questionnaires as well as genome-wide microarray data to elucidate the complex multifactorial background of study participants without a monogenic cause. By associating potential genetic factors with identified environmental risk factors, we also aim to detect genetic variants and environmental exposures that are associated with the development of kidney injury among CAKUT patients. Finally, genetic and environmental factors will be functionally characterized by combining innovative modelling using patient-specific induced-pluripotent stem cells and human kidney organoids with tailor-made animal-based modelling. Results: N/A Conclusions: The ArtDECO study is a large-scale national multicentre study that integrates genetics, environmental exposures and clinical data for the identification of molecular causes of kidney and urinary tract malformations and potential prognostic factors for kidney injury.

Introduction: Perirenal fluid collection in children may be due to urinoma or lymphangiectasis. Renal lymphangiectasis is a rare disease that gives the appearance of a cystic mass characterized by malformation in the lymphatics. Urinoma is usually traumatic or iatrogenic; it is rare in newborns. A male patient with posterior urethral valve(PUV) who developed anuric acute kidney injury(AKI) due to perirenal cystic fluid collection is presented. Material and methods: A male newborn born in the neonatal intensive care unit at the 36 th week was admitted to the neonatal intensive care unit due to diffuse free intra-abdominal fluid and bilateral increased renal echogenicity in antenatal ultrasonography. The physical examination revealed birth weight of 2650g (50-90p), height of 50cm (90-99p), and head circumference of 34cm (90 percentile), and blood pressure of 62/39 mmHg (50/50-75p). He had 3cc/kg/h urine output. Renal ultrasonography revealed right perirenal anechoic cystic mass that compressed the kidney and was compatible with renal lymphangectasis. The renal parenchyma was normal with mild dilatation of the pelvis and calices. The right ureter could not be visualized. The left kidney had dilatation of the pelvis and calices. The left ureter was dilated and tortuous throughout its course. On postnatal day 3 rd , the patient suddenly had abdominal distention and anuria. Serum creatinine increased to 1.5 mg/dL. Results: The magnetic resonance urography (MRU) showed perirenal cystic mass with thin septations and bilateral hydroureteronephrosis (Fig1). There was also intra-abdominal free fluid and mild trabeculation and thickening of the bladder wall. Chemical analysis drained fluid was revealed as; cholesterol 1mg/dL, triglyceride 3mg/dL, total protein 0.6g/ dL, albumin 0.1g/dL, glucose 14mg/dL, sodium 54mmol/L and potassium 10.1mmol/L. The pH was 8, the density was 1019. It was urinoma. Urine output restarted after drainage and creatinine regressed to 0.9 mg/ dL. PUV was considered, since the patient with postrenal AKI had hydroureteronephrosis, increased bladder wall thickness was observed and the fluid sample in the perirenal area was compatible with urinoma. PUV was diagnosed by cystoscopy and resected. Urinoma did not recur after resection. Conclusions: Fluid sampling is important in differentiating urinoma and lymphagectasis. PUV, which requires early diagnosis and intervention, should not be forgotten in the differential diagnosis of male newborns with urinoma.

Introduction: Minimally invasive surgeries (MIS) are becoming more common due to the minimization of traumatic urinary tract injuries. Such interventions become especially relevant in childhood.

Recently, endoscopic methods of treatment of diseases of the upper urinary tract are being discussed more often. The issue of endoscopic correction of vesicoureteral reflux in children is widely covered in the modern medical literature. Successful use of minimally invasive endourological interventions in the valves of the posterior urethra is noted by many authors. Material and methods: MIS interventions for congenital pediatric urological diseases have been introduced on the basis of surgical departments of the Zhytomyr Regional Childrens Clinical Hospital since 2000. Pediatric models of endoscopic equipment are used for it. The range of surgical interventions is quite wide: laparoscopic pyeloplasty & nephrectomy, laparoscopic and retroperitoneal excision of renal cysts, correction of vesicoureteral reflux, introduction of Botulinum toxin A into the detrusor, removal / installation of ureteral stents, dissection / puncture of ureterocele, dissection of valves / strictures of the urethra, etc. Introduction: A boy of 16teen with Myelomeningocele never operated for, paraplegic with severe spine deformity which represents the natural evolution of spina bifida anomaly. Ever treated for his neurogenic bladder and bowel. Material and methods: Boys weight was 30kg, HC:56.5cm, length hands finger-finger:163cm, head-waist: 53cm, waist-foot 60cm. He was frightened for his health and life, never intended school but able to read and write. He had some blurred vision and loss of perception for a few seconds throw the day. And episodes of vomiting were frequent. He had severe bilateral inguinal hernia. Increased inflammatory parameters. Results: Scintigram: left kidney afunctional type. Right kidney increased size, decreased accumulation and prolonged parenchymal transport time and half elimination time. GFR:51.4ml/min. MR detected severe L/S angular kyphosis, positive "Baltalimani" on segments above and under the angulation, Cobb angle is >90°. Intraspinal structures (the thecal sac) through angulation are herniated, with tethered cord at L4-L5. Thecal-sac was intraabdominal. Severe sinistro-convex scoliosis. Siringomielia Th3-Th5. Modulla oblongata and cerebellum Herniation, 30mm though foramen magnum with obstructive hydrocephalus-Chiari II. A skin fistulation not clearly determined, was natural way to decompress the ICL. ENG: no amplitude of nerve conduction. EMG: fibrillation, fasciculation's and positive denervated waves. Abdominal MR: left kidney agenesis. Right kidney was enlarged with gr V hydronephrosis with severe megaureter. Bladder enlarged with diverticulosis and thick and hypervasculated bladder wall.

Cystometry and found noncompliance bladder with high pressures at 30ml of filling. Pressures at beginning of testing were 30cmH2O and at the end 57cmH2O. Low bladder capacity 90ml, incontinence at 75ml and residual 100 ml, no filling sensation, no voiding reflex. Bladder Cooling Test negative. Conclusions: Parents left this boy un-operated, as were told he will pass way soon after birth. Raising awareness that MMC anomalies could live a normal life if they get medical support early in life is important. Introduction: Data on COVID-19 infection in children with chronic kidney disease (CKD) is limited. We aimed to share the frequency and the clinical status of COVID-19 infection in patients with CKD at our center. Material and methods: Pediatric patients who were on the waiting list for kidney transplantation in February 2021 were included in the study. A questionnaire was applied to the patients or their parents who agreed to participate. The questionnaire sought information about demographic characteristics, primary kidney disease, transplantation status, renal replacement therapy, comorbid diseases, medications used, in the last 6 months COVID-19 contact and COVID-19 disease. Results: 44 children were included in the study; 28 (63.6%) were male, the median age was ). The most common cause of chronic kidney disease was CAKUT (n=15 34,1%). Seventeen (38.6%) of the patients were on hemodialysis, 21 (47.7%) peritoneal dialysis, and 6 (13.6%) were on CKD stage 4. Five (11,4%) had a history of previous graft loss. None of the patients were receiving immunosuppressive therapy. Hypertension was present in 26 (59.1%) of the patients. In the last 6 months, 19 (43.2%) of patients had symptoms that could be associated with COVID-19, the most common being fever (n=15 78,9%) and cough (n=7 46,7%). PCR test was applied to a total of 25 (56,8%) patients. PCR test was performed for 15 (34.1%) of the patients due to suspicion of COVID-19 and for screening in 18 (40.9%). Two patients (4,5%) had COVID PCR positive. None of them needed hospitalization and additional treatment was not required. Conclusions: The frequency of COVID-19 in children with chronic kidney disease was relatively low and the clinical symptoms were mild in those with dysfunction are severe complications of this infection, but such severity is rare in children. COVID-19 is also associated with a thrombotic state with increased risk of thrombosis and disseminated intravascular coagulation (DIC). However, there has not yet been definitive evidence linking COVID-19 with thrombotic microangiopathies(TMA) such as hemolytic uremic syndrome (HUS). In this case report, we aimed to report a pediatric patient with COVID-19 and HUS. This is a rare COVID-19 presentation of its kind. Material and methods: A three-year-old girl with fever and respiratory distress was admitted to the hospital. The patients COVID PCR test resulted positive; thus, hydroxychloroquine and favipiravir were added to the treatment. As her respiratory distress increased and blood gas indicated deep respiratory acidosis (pH:6.96, pCO2:91 mmHg, HCO3:22 mEq/L) on the 3rd day of the pediatric intensive care unit follow-up, the patient was intubated and ventilated. Thorax computerized tomography (CT) showed bilateral effusion and atelectasis. During her follow up, the pleural effusion resolved but there were marked consolidation areas and ground glass appearances compatible with COVID-19 on the followup CT. On the 10th day, she became anuric and developed progressive thrombocytopenia and persistent anemia, which were suggestive of HUS given a high creatinine level (1.9mg/dl), an undetectable haptoglobuline level, reticulositosis (%8), and a LDH level of 2540 U/L. Direct Coombs test returned negative. Examination of a peripheral blood smear revealed schistocytes. In the light of the available findings, we considered the patient to have HUS possibly triggered by COVID-19. Hence, plasmapheresis was performed with fresh frozen plasma (FFP). LDH values started to fall and blood pressure was reduced. Her platelet count also started to rise. After 4 weeks, she became completely asymptomatic, and her hemodynamic parameters normalized. Results: Conclusions: COVID-19 patients are at potential risk of HUS. To confirm this association, a renal biopsy can provide valuable information about the pathogenesis HUS in COVID-19 infection. Further research should be directed at assessing the role of complement in COVID-19 and its association with hyperinflammatory and prothrombotic states.

Introduction: We aimed to present incidence of COVID-19 in children with renal replacement therapy (RRT) and compare the severity and outcomes of the disease between the groups undergoing dialysis and kidney transplantation (KTx). Material and methods: This multicenter observational study was based on data collected from children receiving RRT, either chronic dialysis or KTx, diagnosed with COVID-19. All members of the Istanbul branch of the Turkish Pediatric Nephrology Association were requested to submit all their confirmed COVID-19 cases between April 1 and December 31, 2020. They were also asked to report the number of their prevalent patients on RRT under the age of 20. Results: A total of 46 RRT patients diagnosed with COVID-19 were reported from 12 centers. Of these, 29 were KTx recipients, and 17 were on dialysis (10 hemodialysis and 7 peritoneal dialysis). COVID-19 cases represented 9.3% of all prevalent dialysis patients and 9.2% of all prevalent KTx recipients. Twelve KTx recipients (41.4%) and three dialysis patients (17.6%) were asymptomatic (p=0.12). The hospitalization rate was higher in dialysis patients than KTx recipients (82.4% vs. 27.6%, p=0.001). Two patients, one in each group, experienced a severe disease course, and only one hemodialysis patient had a critical illness that required mechanical ventilation. Acute kidney injury developed in 36% of KTx recipients, but none of them required dialysis or lost their graft. In the entire cohort, one patient on hemodialysis with multiple comorbidities died. Conclusions: Although most of cases were asymptomatic or had a mild disease, children on RRT seem to have an increased risk for COVID-19.

Introduction: Coronavirus disease 2019 (COVID-19) is challenging for patients and medical staff. Radical changes were implemented for preventing disruptions in patient care as well as medical education. Material and methods: A web-based survey was sent to European Society for Pediatric Nephrology (ESPN) members via the ESPN mailing list to evaluate the effects of the COVID-19 pandemic on delivery of pediatric nephrology (PN) care and educational activities. There were ten questions and their subheadings. Results: Seventy-six centers from 24 countries were enrolled. Significant decreases in number of patients' admissions in the nephrology wards and outpatient clinics (2.2 and 4.5 times) were noted. Tele-medicine tools including telephone/visual calls, whatsapp/e-mail correspondences, electronic prescriptions and online applications for off-label drugs were used in 40-60% of the centers. Despite staff training and protective measures, 44% of centers reported COVID-19 infected staff, whereas 24% centers reported infected patients. Difficulties in receiving pharmaceuticals and health related products were reported in 19% of centers. Half of the centers suspended living related kidney transplantation and one third cadaveric transplantation. Hands-on education have been suspended in 84% of medical schools and face to face teaching almost completely replaced by online system (89%). Multidisciplinary training in PN was also largely affected. Results: The first case was a 23-month-old girl, who admitted to the hospital with watery diarrhea and vomiting. Her physical examination revealed fever, edema, and severe hypertension. She was anuric and required hemodialysis. The PCR test and IgG for SARS-CoV-2 were negative, but IgM was positive. The second case was an 8-month-old boy, who admitted with vomiting and focal seizure. He had a history of close contact with a family member with confirmed COVID-19. On admission, his physical examination was unremarkable, except a low-grade fever. The PCR test for SARS-CoV-2 was positive. On the third day of hospitalization, oliguria and anemia developed. Laboratory findings of both cases revealed non-immune hemolytic anemia, thrombocytopenia, and acute kidney injury. Their coagulation tests (prothrombin time and partial thromboplastin time), ADAMTS13 activity, and serum complement levels were within normal ranges. Stool tests for shiga-toxin producing Escherichia Coli were negative. Eculizumab was administered to the first case who had no response to plasmapheresis. Hemolytic episode stopped three days after eculizumab, kidney functions improved, and hemodialysis was discontinued on the 20th day of hospitalization. The second case was successfully treated with plasmapheresis. He did not need dialysis. At the last follow-up, both children had normal kidney functions without proteinuria or hypertension. Conclusions: As a result, COVID-19 infection can be a trigger for TMA like influenza and streptococcus pneumoniae.

Introduction: Coronavirus disease 2019 is declared as a pandemic and public health emergency all around the world. COVID-19 has nonspecific symptoms of upper airway and pulmonary system which can overlap with other diseases having respiratory system involvement. Granulomatosis with polyangiitis (GPA), is an uncommon ANCA associated vasculitis presenting with at least three of the following six criteria; granulomatous inflammation, upper airway, pulmonary, renal system involvement, laryngo-tracheo-bronchial obstruction and positive cytoplasmic ANCA. Both COVID-19 and GPA have a high morbidity and mortality rate, that indicates the importance of rapid diagnosis and treatment. Evaluation through real-time reverse transcriptase polymerase chain reaction (RT-PCR) is currently recommended method for the diagnosis of COVID-19. In addition to RT-PCR, antibody tests help to diagnose both previous and current infection. Material and methods: We present a a thirteen year old girl who was previously healty, presented with upper respiratory tract symptoms and pulmonary involvement and progressed to acute kidney failure. Computed tomography (CT) of the lungs depicted multiple nodules, cavities and ground glass opacities (GGOs) We collected upper respiratory nasopharyngeal swab on two alternate days and RT-PCR tests were negative for SARS-CoV-2. Because of progression of respiratory findings and subfebrile status, we searched immunglobuline levels for SARS-CoV-2 twice and found that IgM levels were positive (1+) in both consecutive tests and IgG level was negative in the first test and returned to weak positive in the second test whereas RT-PCR test repeated for the third time was negative again. According to positive c-ANCA, upper airway, pulmonary and renal involvement, she was diagnosed as GPA.

Conclusions: It is important to make a rapid differential diagnosis of COVID-19 infection with chronic diseases especially those presenting with respiratory symptoms like GPA. This report highlights that COVID-19 antibody tests can be false positive in patients with autoimmune disease including Granulomatosis with polyangiitis. Introduction: SARS-CoV-2 infection in children is less severe compared to adult population, expect from cases of Multisystem Inflammatory Syndrome (MIS-C). Sodium homeostasis imbalance is commonly described in COVID-19 patients, however, the possible correlation with MIS-C remains unclear in pediatric population. Material and methods: We conducted an observational single-center study. Children with confirmed COVID-19 were eligible. After hospital admission full blood count, serum biochemical profile and urine biochemical profile on urine sample was performed. Fractional excretions, blood/urine osmolarity and proteinuria were calculated. Length of hospital stay (LOS) was recorded. Results: A total of 30 children (20 males, median age 6 years), were studied, 23 were symptomatic (23.3%) and 5 presented MIS-C (16.7%). Moreover, 5 children were hyponatriemic (16.7%) while no other pathological blood or urine biochemical values were observed. All patients with hyponatremia were euvolemic with urinary osmolarity >100 mosm/kg (median level 285 mosm/kg) and urinary sodium >20 mEq/L (median level 112 mEq/L), indicative of syndrome of inappropriate antidiuretic hormone. Serum sodium was negatively correlated to maximum fever (r=-0.61, p=0.006) and LOS (r=-0.342, p=0.0750) and was negatively associated with subsequent diagnosis of MIS-C (OR 0.334, 95% CI 0.115-0.969, p=0.044). Hyponatriemia was strongly associated with the presence of MIS-C (p=0.001). Multiple regression analysis, showed that blood serum sodium values (p<0.001) and sex (female) (p=0.03) were independently associated with presence of MIS-C. Conclusions: Children with COVID-19 infection may present hyponatriemia, probably due to syndrome of inappropriate antidiuretic hormone, especially in case of MIS-C. Further research around the explanatory pathophysiological paths of this sodium balance disorder is indicated. (COVID-19) , which has affected all ages. We aimed to share the clinical characteristics of kidney transplant recipients diagnosed with COVID-19 at our center. Material and methods: Among pediatric kidney transplant recipients on follow-up, the patients with a diagnosis of COVID-19 confirmed by PCR in the nasopharyngeal sample were included in the study. The most common immunosuppressive modification was to increase the prednisolone dose with MMF dose reduction/withdrawn. Results: COVID-19 PCR was positive in 13 of 158 (8.2%) kidney transplant recipients who were followed up during the pandemic period. Nine (69.2%) of 13 patients were girls; mean age was 13.4±4.6 years. Three patients (23.0%) had a deceased donor; nine patients received induction therapy with basiliximab (n=3) or anti-thymocyte globulin (ATG) (n=6). 8 of 13 patients had mild symptoms; the most common symptom was fever (76.9%). Two patients had severe symptoms; one of them was 6year-old boy, who had at post-transplant 32 days at the diagnosis of COVID with living donor recipient; he had acute respiratory distress syndrome and multisystem inflammatory syndrome. MMF and tacrolimus treatment was interrupted, steroid dose was increased; however, as no response was observed, plasma exchange and intravenous immunoglobulin were administered. The other was a 17-year-old girl; COVID PCR positivity was detected on the 5th day after pulse methyl prednisolone and ATG treatment with a diagnosis of acute cellular rejection. High flow oxygen support was required to the patient with severe pneumomia. No graft or patient loss was observed; there was no difference between the eGFR before and at the time of COVID-19 diagnosis (83.54 ml/min/ 1.73m 2 vs 76.12 ml/min/1.73m 2 , p=0.168). Conclusions: COVID19 infection was present with mild symptoms in most of the pediatric kidney transplant recipients. Clinical findings may be severe in early post-transplant period. Early diagnosis and modification of immunosuppressive therapy may be important.

Houda Nassih, Rabiy El Qadiry, Aicha Bourrahouat, Imane Ait Sab B Pediatric Ward, Department Of Pediatrics, Child And Mother Hospital, Mohammed Vi University Hospital Center, Marrakesh, Morocco Introduction: We describe the clinical phenotype and evolution of kidney impairment (KI) related to COVID-19 in children Material and methods: A single center retrospective study of 13 children with KI related to COVID-19 Results: The mean age was of 9-year-old. Medical history found a Churg-Strauss syndrome, auto-immune hepatitis, CAKUT with stage 4 CKD, ARPKD with ESRD on hemodialysis, recurrent pancreatitis and nephrosis in one case each. Renal involvement was an anuria in 7.7%, oliguria in 23%, hemoglobinuria in 7.7%, proteinuria in 38.5%, hematuria in 46% (microscopic in 30.8% and gross in 15.4%), leukocyturia in 38.5%, and glycosuria in 7.7%. One child presented a relapse of his idiopathic nephrotic syndrome, and two had a nephritic syndrome. KI was caused by an acute urine retention in one case (CAKUT), dehydration in two cases, acute glomerulonephritis in one case, rapidly progressive glomerulonephritis in one case, acute tubulointerstitial nephritis in 6 cases, and thrombotic microangiopathy in one case. KI was classified according to the pediatric-RIFLE into kidney injury in 3 cases and kidney failure in 7 cases. Two cases had hypovolemia with isolated high uremia and one case of CKD had a decline of eGFR. Type 1 and type 2 renal tubular acidosis were present in one case each. Renal biopsy found features of a nonspecific pyelonephritis, hemolytic and uremic syndrome, acute glomerulonephritis with endocapillary deposits of IgG and C3, and chronic tubulointerstitial nephritis in one case each. Steroids were given IV in 7 cases and/or oral in 8 cases. Tocilizumab and immunoglobulins were given in one case each. Hemodialysis was started in three cases during the acute phase. One child had a remaining stage 2 CKD. Introduction: We have little experience of managing COVID-19 mortality in our cohort; therefore we must share our cases and learn from each other. Material and methods: We detail a case of COVID-19 mortality in a tertiary paediatric hospital, highlighting specific challenges. Results: Our patient was a 17-year-old male with Lowe's syndrome and severe learning difficulties, from a Punjabi speaking family. He presented with four days of cough. He was hypoxic and had bilateral pneumonia on x-ray and was positive for covid-19. He deteriorated, was admitted to intensive care and ventilated on maximal support. Unfortunately his parent also tested positive, his remaining family were symptomatic and prevented from visiting. Over the next four days he received dexamethasone, proning, inotropes and blood products. He deteriorated further, developing AKI 3, and coagulopathy. The multidisciplinary team did not believe renal replacement therapy was in his best interests and recognised that he was dying. The team communicated this to his family on a three-way telephone call with an interpreter. There was no advanced care plan. The palliative team and hospice were consulted and a care plan was made, to give him a "good" death, with family present virtually. A memory box was made including photographs, hand casts and footprints. He was compassionately extubated and passed away peacefully. Conclusions: COVID-19 has resulted in children presenting late, as may have been the case here. Although COVID-19 rarely causes critical illness in children, this patient could be considered high risk (male, ethnic minority, low socioeconomic background, learning disabilities). Paediatricians should discuss advanced care planning with families of patients at high risk of COVID-19 mortality. COVID-19 has brought a new challenge and pressure to caring for dying patients. We cannot be perfect under these extraordinary circumstances but technology can allow families to be involved at the end of life.

Introduction: Contrary to our initial expectations, the prolonged and fluctuating course of COVID-19 pandemic has a significant impact on our medical practice. Despite significantly lower disease transmission among children, cases have been increasing steeply. We aimed to evaluate demographic findings and outcomes of pediatric nephrology patients with COVID-19 in Turkey. Material and methods: An online survey was sent to all centers to collect the data. Results: Diagnosis of COVID-19 was made in 203 children with 114 infected family members. While the disease was most commonly seen in the age group of 10-15 years (37%), it was less common in children under 2 years (5,4 %) and those between 2-5 years of age (8,9%) . Renal transplantation (27,6%), hemodialysis (16,3%), and glomerulopathies (15,3%) were the most common diagnostic categories. At least one comorbid condition was observed in half of the patients, while 15 % had multiple comorbidities. Only 42,4% of patients were admitted to the hospital due to complaints and 43,8% were diagnosed with screening tests because of infected family members or, routine PCR test before hospital admission. The remaining 13.8% of the patients were diagnosed at another center. The primary method for diagnosis was SARS CoV-2 PCR test and it was positive in 84% of the patients. Other methods for diagnosis were SARS CoV-2 serology (5,9 %) , thorax CT (5,4 %) and high clinical suspicion (4,9%) . 60 % of patients were asymptomatic or had mild disease, while among 82 hospitalized ones, 23 (28% of hospitalized patients, 11,3% of all patients) required ICU care. Treatment regimens were highly heterogenous. Half of the patients (55%) were not treated, while remaining patients were mostly given favipiravir (20,7%), steroid (16,3 %) and hydroxychloroquine (11,3 %) . Some of the patients were treated with additional combination regimens of intravenous immunoglobulin, low molecular weight heparin or biologic anti-cytokine therapies. The patients were most frequently hospitalized for >3-7 days (35,4 %) and >7-14 days (31,7 %). Only seven patients required >30 days of hospitalization. Acute kidney injury developed in 20% of the hospitalized patients during the course of the disease. Five patients had the diagnosis of MIS-C and three of them died. Another two patients died due to COVID pneumonia, one post-COVID cardiac arrest at home after discharge and one COVID-unrelated reasons. Fortunately, 83% of the patients were discharged without any apparent sequelae. On the other hand, 108 health care staff including 42 physician (25 of them pediatric nephrologist), 15 secretary, 15 cleaning staff, 14 pediatric's nurse and 13 hemodialysis (HD) nurse were infected during the study period. Conclusions: COVID-19 was most commonly seen in patients with renal transplantation, undergoing HD and having glomerulopathy. Combined immunosuppressive therapy and exposure in-center HD may increase these patients susceptibility. A mortality rate of 3.4% and staff infections deserve more attention and further precautions. Objectives: To describe the clinical outcomes of pediatric kidney transplant (KT) recipients with COVID-19, followed in a pediatric KT center, and assess immunity to SARS-CoV-2. Methods: We performed a prospective study for 1 year (March/2020 to March/2021), with descriptive analysis of demographic, baseline and transplant characteristics; immunosuppression; comorbidities; clinical and laboratory data at diagnosis; intervention and follow-up, including SARS-CoV-2 serologic tests. Results: We report 5 cases of COVID-19 infection from a cohort of 55 KT recipients (median age at diagnosis: 13 years [7-16 years] ; four females; median follow-up of 2 months [2-9 months] ). Regarding the cause of chronic kidney disease: 1 was unknown, 2 had congenital anomalies of the kidney and 2 had steroid-resistant nephrotic syndrome. Cardiovascular disease was the most common comorbidity (5/5): all had hypertension, 1 left ventricular hypertrophy, 1 mild aortic regurgitation and 1 history of patent arterial duct surgically treated. Hyperuricemia was detected in 2. None had lung disease, diabetes, dyslipidemia or obesity. All were on immunosuppression with glucocorticoids, mycophenolate mofetil and tacrolimus. Median time after KT at COVID-19 diagnosis was 38 months [1 month-11 years] . The most common symptoms were fever (2/5), cough (2/5), rhinorrhea (2/5), myalgia (2/5) and headache (2/5) . None had signs of respiratory distress. One was asymptomatic. Laboratory findings at diagnosis were lymphopenia (2/5), thrombocytopenia (1/5) and slight increased creatinine (3/5) , which returned to baseline after infection. C-reactive protein was negative in all who were tested (3/5) . None needed hospital admission. The treatment was only supportive, with no need to reduce immunosuppression. There were no episodes of allograft loss. All had serological immunity [102-461 U/mL] at 3-6 months after COVID-19 infection. Conclusions: Unlike reports of COVID-19 infection in KT adults, in our series children were asymptomatic or had mild disease, being managed as outpatients. Despite the immunosuppression, short-term outcome was excellent.

Ece Demirci Bodur, Nurdan Yildiz, Serim Pul, Serçin Güven, Neslihan Çiçek, Özde Nisa Türkkan, İbrahim Gökçe, Harika Alpay Marmara University Pediatric Nephrology

Objectives: In this study,we aimed to evaluate the clinical course and outcomes of COVID-19 in children with kidney disease . Materials and Methods: Twenty five patients(14 male,11 female) with kidney disease followed-up in Pediatric Nephrology outpatient clinic and diagnosed with COVID-19 confirmed by nasopharyngeal PCR or COVID-19 IgM tests were evaluated retrospectively. Results: The mean age on admission was 12.5±5.8 years. Four (16%) patients were kidney transplantation (KTx) recipients, 8(32%) had end stage kidney disease(ESKD-4 hemodialysis, 4 peritoneal dialysis),4(16%) had chronic kidney disease(CKD) and 2(8%) had steroid sensitive nephrotic syndrome. Thirteen(52%) patients presented primarily through contact exposure with positive family members. Seven patients(28%) were asymptomatic,16(64%) had mild disease and 2(8%) had severe disease.The most common presenting symptoms were fever(44%) and myalgia(36%) followed by fatigue/weakness(20%) and headache(%20). Other symptoms included nausea, cough, chest pain and sore throat. Thirteen (52%) patients were hospitalized. Median of the hospitalization was 17(4 to 37) days. Acute kidney injury developed in 3 KTx recipients and 1 CKD patient, and completely recovered without dialysis. Chest tomography findings in 6 of 13 patients were consistent with COVID 19 pneumonia. One patient needed mechanical ventilation and one high flow oxygene support. Nine patients(36%) were using immunsupressive therapy. Mycofenolate mofetil was discontinued in one KTx patient, and the dose was reduced in one KTx patient. Commonly used therapies are antimicrobials in 10(40%), favipiravir in 5(20%), hydroxychloroquine in 5(20%), acetylsalicylic acid in 2(8%), steroids in 2(8%) and enoxaparin in 4(16%) patients. Patient with granulomatosis with polyangiitis was lost due to multiorgan failure and fungal sepsis in spite of aggressive treatment including ECMO. Conclusion: KTx recipients and ESKD patients receiving dialysis appear to develop mild COVID-19 disease. However, clinical course may be severe in those with pulmoner involvement. We suggest to perform diagnostic tests in the presence of contact exposure or suspicious clinical findings and to monitor closely to prevent complications in these patients. Results: 94 pRTRs under follow up at the start of the first national lockdown in our centre with 86 under follow up a year later. 18 patients transferred to 4 adult nephrology centres facilitated using video appointments enabling joint working between paediatric and adult teams which was previously conducted in person. 3 patients developed de Novo donor specific antibodies during this period (2 teenage with admitted non-adherence) all with evidence of rejection on allograft biopsy though only 1/3 had acute antibody medicated rejection (ABMR). 1 patient required plasma exchanged and immunoglobulin treatment for ABMR and all received pulsed steroids. 2 other patients (both teenagers) had borderline T cell mediated rejection during the course of the year. No graft loss recorded in those remaining under follow up in the paediatric setting and 1 graft loss secondary to significant non-adherence and haemodialysis commenced in adult nephrology centre. 1 patient was diagnosed with PTLD refractory to treatment in this period and sadly died. The transplant programme was suspended in March 2020 but resumed in June 2020 enabling 14 children to receive transplants in the period described (11 living donor including 1 via the UK kidney sharing scheme, 3 deceased donor). 10/14 followed up in our centre and no episodes of rejection to date. All new recipients shielded for 3 months post-transplant. 4 pRTRs tested positive for SARS-CoV-2 PCR DNA test (all male) and 1 requiring an inpatient stay but displayed no respiratory symptoms. None of the patients required a reduction in their background immunosuppression. Conclusions: We describe an overview of the pRTR cohort managed during the COVID19 pandemic. Despite the challenges our multidisciplinary team adapted and has strived to maintain seamless follow up for this patient group. in Wuhan, the dramatic outbreak of COVID-19 has spread globally in months. Although it usually affects children mildly, its most severe form, "Multisystem inflammatory syndrome in children" (MISC), may be seen in some rare cases. Fever is one of the indespensible symptom for the diagnosis of MISC. However, during the pandemic, other infections should also considered in the differential diagnosis of fever, besides MISC. Material and methods: An eight-year-old girl (Case 1) and an sixteenyear-old girl (Case 2) admitted to hospital with fever for three days. Both had headache, flank pain, vomiting and lethargy. They had no known COVID-19 contact. The COVID-PCR tests were negative for both cases. But Rapid COVID-19 antigen test was positive IgG and negative IgM in first case. Due to leukocytosis, high inflammatory markers and high Ddimer levels, they had diagnosed MISC. In first case, urine analysis showed microscopic hematuria without piyuria and urine culture showed no bacterial growth. Results: The second case had pyuria and Escherichia coli growth. However, on the physical examination, they both had persisted costovertebral angle tenderness. On the abdomen computed tomography with contrast, they had wedge-shaped hypodense multipl lesions. These lesions were present in both kidneys in Case 1 and in right kidney in Case 2. They diagnosed acute focal bacterial nephritis (AFBN). Conclusions:Acute focal bacterial nephritis is rare form of urinary tract infection which is considered between APN and renal abscess. It is characterized by localized renal inflammatory mass-like lesion. The common presenting symptoms are persistent high fever, flank and/or abdominal pain. It may considered in differential diagnosis. Introduction: The current COVID-19 pandemic has been an anxious time for children and young people (CYP) with end stage kidney disease and their families, particularly as they were identified as a vulnerable group. Many transplant programmes closed and reopening brought new concerns for patients and professionals. We report experience on being transplanted during the pandemic. Objectives: To obtain a better understanding of the concerns and experiences of CYP and families have about receiving a kidney transplant during the pandemic. Material and methods: A questionnaire was sent to patients and families of 10 paediatric patients transplanted in the first six months of reopening our transplant programme. One patient refused transplant and one lacked social support to proceed with transplant. Results: All participants felt that their questions were answered before transplantation and 75% felt well informed about the SARS-CoV-2 effects on transplantation. 62.5% reported feeling nervous, 37.5% were anxious, 25% scared and 12.5% relaxed about transplantation during the pandemic. The majority of participants reported surgical complications being their biggest fear; two participants were worried about catching SARS-CoV-2. 87.5% felt that care was delivered safely in inpatient and outpatient setting. 75% of participants found shielding easy. Overall, 87.5% of patients were glad to have received a kidney transplant during the pandemic with one patient struggling with feeling isolated. Conclusions: Receiving a kidney transplant can be a stressful experience, particularly during a pandemic. Our results show that a significant number of patients felt scared, that detailed counselling of CYP and families about risks and addressing their concerns related to SARS-CoV-2 contributed to a good patient and family experience on transplantation during the pandemic. Further studies are needed to look into the long-term effects of the pandemic on this vulnerable group of patients and strategies to mitigate them.

Case description: We present a case of a ten-year-old boy with multiple comorbidities who developed MIS-C after asymptomatic SARS-CoV-2 infection. The patient initially presented hematuria, persistent fever and elevated markers of inflammation, with no other sign of renal affection. Besides, he had a discrete erythematous maculopapular rash on the right lower leg. Within the next two days, his condition worsen despite the broad-spectrum antibiotic therapy. He started to vomit and developed abdominal pain, conjunctivitis, arrhythmia and mild left ventricular systolic dysfunction with hypotension and pleural effusion. High level of clinical suspicion for MIS-C was supported by laboratory findings (elevated ESR, CRP, proBNP, D-dimers and fibrinogen) along with positive IgG SARS-CoV-2 antibodies and negative microbiological cultures. The patient was given intravenous immunoglobulin (IVIG) at a dose of 2 g/kg and began to show instantaneous clinical improvement, including downtrend of fever and inflammatory markers.

Despite the growing reports of the MIS-C in the literature, there is still paucity of studies describing the various clinical manifestation and laboratory finding in this serious condition which can be easily mistaken for many others inflammatory diseases. Therefore, pediatric professionals must be aware of (many) unusual presentations of COVID-19 associated disease in order to early recognize and treat such challenging patients. Background & Aim: Hypertension consider as a risk factor for the severity of Covid-19 but there is no report of hypertension crisis as an earlier presentation of Covid-19 in pediatrics that is the aim of this study. Methods: This is a case series collected from March to February 2021. Confirmed SARS-Covid 2 defined by positive RT-PCR of nasopharynx swab, or antibody against it (IgG or IgM), or imaging pattern in favor of it on chest CT-scan . suspicious cases described by clinical sign (fever, diarrhea, cough) and laboratory tests (leucopenia, lymphopeia, rise of CRP, d-dimer, LDH, CPK-MBA, Ferritin, or ALT, with negative cultures for bacteria) and close contact with an infected person. Hypertensive crisis elucidated by acute rise of blood pressure more than stage 2 cut off with potential risk of end organ damage. Results: Four confirmed and two suspicious SARS-COvid-19 cases (4 males, 2 females) were reported. The mean age of patients was 4.2 (range, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] years. Four cases with newly diagnosis of nephrotic syndrome who were on 2mg/kg /day prednisolon developed rapid rises of blood pressure. The other two cases were suffered from Chronic kidney disease stage 5 being on regular dialysis with no edema or sign of fluid overload (HD and CAPD). The lowest systolic blood pressure at the time of admission was 160 mmHg and the highest was 200 mmHg. The diastolic blood pressures were between 100 -155 mmHg. All the patients had normal blood pressure prior to the admission. Three patients (two CKD) received anticovid 19 medications. All patients treated with labetalol infusion titrated to maximum dosage and continued for at least one week and because of poor control of oral antihypertensive medications were added. On follow up, one patient on CAPD died , patient on HD complicated with pericardial effusion, pancreatitis and chronic diarrhea. All nephrotic syndrome patients were resistant to steroid, went on renal biopsy, and calcineurin inhibitor started for massive proteinuria despite being on ARBS /ACEI. All children had resistant hypertention and their blood pressure controlled with four or five antihypertensive medications. Conclusion: Whether the virus itself can cause exacerbation of hypertension is not yet known but it seems that there is a correlation between COVID-19 infection and hypertension crisis in these cases. Further clinical research with a larger population would be required to determine the clinical significance of these findings.

Objectives: Autosomal recessive polycystic kidney disease (ARPKD) is a rare genetic disorder ciliopathy with an incidence estimated to 1:20,000. ARPKD is mainly caused by variants in the PKHD1 gene and rarely in DZIP1L. The disease presents with a phenotypical spectrum with high variation in severity that could lead to an early impact on child health. While there are defined criteria for the clinical diagnosis, the clinical variability can make it challenging to differentiate ARPKD from other genetic causes of cystic kidney diseases. In some of these cases of phenocopies genetic testing can lead to a change in the initial clinical diagnosis. Methods: Patients secondarily excluded from ARegPKD due to genetic diagnosis of another cystic kidney disease were analyzed. Variants found in phenocopy genes were evaluated using in silico pathogenicity prediction tools and classified using ACMG criteria. Initial and follow-up clinical presentation data in this cohort was then compared to ARPKD cases with detection of relevant PKHD1 variants (at least one variant ACMG class ≥3). Results: At the time of analysis 665 patients were included in the ARegPKD registry. 284 patients had relevant PKHD1 variants. We identified 32 individuals with variants in other cystic kidney disease-causing genes (18 PKD1, 5 TMEM67, 5 HNF1B, 2 NPHP3, 1 PKD2, 1 LRP5) but without detection of PKHD1 or DZIP1L variants. All variants identified in these genes showed in silico predicted disease-causing pathogenicity and compatible results in variant frequencies in the genome aggregation database. The majority of these patients presented prenatally or postnatally in the first year of life with 34% and 41%, respectively. Extrarenal manifestations were seen in 9 patients. 8 patients started kidney replacement therapy with a median age at onset of 4.4 years. Conclusions: Utilizing our international cohort, we extend the data on ARPKD phenocopies and present their genetic and clinical data. Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is a systemic disease involving cysts in the kidneys and abdominal organs as well as abnormalities in the heart and vasculature. Although it typically presents in adults, ADPKD has been diagnosed in foetuses, infants, children, and adolescents. The aim of this study was to describe the clinical features and outcomes of ADPKD among Tunisian children. Material and methods: Cross sectional observational study of the paediatric cases of ADPKD managed in the department of paediatrics in the University hospital (Sousse -Tunisia) Results: 21 patients, predominantly girls (57%) were included. Family history of cystic disease was positive in 80% of cases. Mean age of diagnosis was 11 years, however one patient was diagnosed at neonatal period. Half of our patient were symptomatic when the disease was diagnosed. Main symptoms were abdominal pain, fever and gross hematuria. Hypertensionwas found in 16% of patients. Renal function was normal at the diagnosis in 20 cases. One patient had End stage renal disease at presentation. Renal ultrasound showed renal enlargement with multiple cysts. For the extra renal manifestations, liver cysts were found in 3 patients and pancreatic cysts in one patient. The main complication was Hypertension in 20% of patients, and Urinary tract infection occurred in 3 cases. Management was based on ACE inhibitors.14% 3 patients progressed to end-stage renal disease requiring haemodialysis in 2 cases followed by renal transplantation, and one was on peritoneal dialysis. Conclusions: ADPKD in children is relatively rare in children, often asymptomatic, however symptoms may be observed during childhood, mainly hypertension and hematuria. Besides End stage renal disease can occur during childhood In this study, we described clinical, biochemical, imaging and genetic findings and investigated parameters that may influence renal prognosis in pediatric patients with autosomal recessive polycystic kidney disease(ARPKD).

Material and methods: Patients who were diagnosed before birth or during the first month were classified as perinatal presenters(9 patients), diagnosed later classified as non-perinatal presenters (10 patients). We also divided patients according to estimated glomerular filtration rates(eGFR) at last visit as patients with eGFR≥30 and eGFR<30 ml/ min/1.73m 2 . We analyzed clinical, demoghraphic findings, kidney dimensions adjusted to height, urinary protein excretions, liver functions, office blood pressures at diagnosis and at last visit, genetic analysis and genetic types. The correlation between time of diagnosis (perinatally or non-perinatally, eGFR at last visit(eGFR≥30 or eGFR<30 ml/min/ 1.73m 2 ) and other parameters were evaluated. Results: Seven patients(36.84%) were diagnosed antenatally, the mean follow up time was 7.7±5.21 years. Among six(31.6%) patients who reached stage-5-CKD, two had a renal transplantation. Eleven patients(57.9%) had hypertension and five(26.3%) had proteinuria. Liver disease was diagnosed in 13 patients(68.4%). Genetic tests of 15 patients were evaluated. Eleven patients had homozygous mutation in PKHD1 gene, 1 truncating and 10 non-truncating. Four patients had compound heterozygous mutation in PKHD1 gene. When two groups were compared, kidney dimension at diagnosis was higher in perinatal presenters(p=0.01) and although not statistically significant, eGFR at diagnosis was lower in perinatal presenters (p=0.065). Liver and spleen involvements were higher in nonperinatal presenters(p=0.04, p=0.033). When patients are compared according to eGFR at last visit, kidney dimension at diagnosis was higher in patients with eGFR<30 ml/min/1.73m 2 (p=0.045). Conclusions: In patient with perinatal presenters kidney dimension at diagnosis is higher. Kidney dimension is the parameter most associated with low eGFR at last visit. Non-perinatal presenters, on contrary, had more liver and spleen involvements. Introduction: In this study, we aimed to investigate clinical and genetic features of autosomal recessive polycystic kidney disease (ARPKD) and autosomal dominant polycystic kidney disease (ADPKD) in a group of Turkish patients. Material and methods: A total of 69 children with genetically confirmed ARPKD (10 females, 11 males) or ADPKD (28 females, 20 males) from seven pediatric nephrology centers were included in this study. Demographic features, family history, clinical findings at presentation and during 12 months intervals were collected. Results: For ARPKD patients, the median age at diagnosis was 10.5 (IQR; months. At the time of diagnosis, 14 (66.7%) patients had eGFR<90 ml/min/1.73 m 2 . Mean duration of follow-up was 4.1±3.7 years. At the last visit, median eGFR was 74 (IQR; 43-126) ml/min/ 1.73m 2 . Preparations for renal transplantation are made for the other patient. For ADPKD patients, the mean age at diagnosis was 5.5±4.6 years. At the time of diagnosis 11 (22.9%) patients had eGFR<90 ml/min/1.73m 2 . Mean duration of follow-up was 2.6±2.1 years. At the last visit, median eGFR was 114 (IQR; 98-135) ml/min/1.73m 2 . A total of 42 patients (87.5%) had a heterozygous PKD1 mutation while 6 (12.5%) had a heterozygous PKD2 mutation. The rate of growth retardation, hypertension at diagnosis and progression to chronic kidney disease (CKD) were higher in patients with bi-allelic PKHD1 mutation than the patients with heterozygous PKD1 or PKD2 mutation (p < 0.001, p < 0.001 and p = 0.001, respectively). In renal survival analysis, mutation type, growth retardation and malnutrition at presentation, increased renal echogenity in ultrasonography were found as independent risk factors for progression to CKD. Conclusions: Differentiation of polycystic kidney diseases and establishing the predictors for CKD development are important to provide appropriate management including choosing appropriate donor in renal transplantation.

Harika Alpay 1 , Neslihan Cicek 1 , Ceren Alavanda 2 , Sercin Guven 1 , Mehtap Sak 1 , Ozde Nisa Turkkan 1 , Ece Demirci Bodur 1 , Serim Polat 1 , Pinar Ata 2 , Nurdan Yildiz 1 , Ibrahim Gokce 1 1 Marmara University School Of Medicine, Department Of Pediatric Nephrology; 2 Marmara University School Of Medicine, Department Of Genetics Introduction: We evaluated pediatric patients with autosomal dominant polycystic kidney disease (ADPKD) and investigated the parameters that may influence renal prognosis. Material and methods: Thirty one patients (19 males, 12 females) with ADPKD are included in the study. We evaluated kidney outcome with estimated glomerular filtration rates (eGFR) at diagnosis, eGFR change (eGFRc) and urinary protein excretion (UPE). We analyzed clinical and demographic findings, kidney dimensions adjusted to height, office blood pressures at diagnosis and at last visit. The correlation between eGFR at diagnosis, eGFRc, UPE and other parameters were evaluated. We also evaluated patients' datas according to genetic types (PKD1 or PKD2, truncating or non-truncating) and subtypes (nonsense, misense, inframe, frameshift, splice-site). Results: The mean age at diagnosis and the mean follow-up time were 9.07±4.9 (0-16.6) and 6.51±4.7 (0.8-19 .3) years, respectively. Antenatal diagnosis was present in two patients (6.45%). The mean eGFR at diagnosis and annual eGFR change were 175.5±47.4 and 1.11±17.64 ml/min/ 1.73m 2 respectively. Only three patients (9.7%) had hypertension and five (16.1%) had proteinuria. Genetic tests of 28 patients were evaluated. Twenty-two patients had mutations in PKD1, 15 truncating, 7 nontruncating mutations. Six patients had mutations in PKD2, all of them were truncating. Eleven of the 28 mutations were novel. eGFR change was negatively correlated with age at diagnosis (p=0.039) and UPE was positively correlated with kidney dimension at last visit (p=0.015). eGFR at diagnosis was negatively correlated with kidney dimension at diagnosis, hypertension at diagnosis and antenatal diagnosis (p=0.002, p=0.015, p=0.015). When we compared the patients with PKD1 and PKD2 mutation, there was no significant difference in terms of all parameters. Introduction: Autosomal Dominant Polycystic Kidney Disease (ADPKD) is one of the most common inherited disorders, caused by PKD1 and PKD2 gene mutations, resulting in non-functioning polycistin-1(PC1) and polycistin-2(PC2), respectively. Mutations in GANAB, which encodes glucosidase II subunit α(GIIα), have recently been described in a small percentage of cases of ADPKD and usually presents with mild kidney disease. Material and methods: ... Results: We describe two 17-year-old patients with GANAB mutations, corresponding to 3.4% of our ADPKD paediatric cohort. Patient 1 presented with macroscopic haematuria since he was one-year-old. His family history was positive for nephrolithiasis, and he was initially diagnosed with nephrolithiasis. Patient 2 presented with flank pain and intermittent micro and macroscopic haematuria after renal trauma. He also had congenital partial deficit of factor XI and a positive family history for nephrolithiasis. Further investigation revealed bilateral renal cortical cysts and hypocitraturia in both patients. No hepatic involvement or hypertension were reported and the estimated glomerular filtration rate was normal. Next-Generation Sequencing revealed GANAB heterozygous mutations in both patients: c.1452+1G>A in patient 1 and p.Arg834Ter (c.2500C>T) in patient 2. Conclusions: Our patients presented with intermittent haematuria and hypocitraturia, not typically described in the literature. Further workup showed bilateral renal cysts with preserved renal function and no other organ involvement. Although most ADPKD paediatric patients are asymptomatic, a small proportion presents with early-onset disease during childhood. GANAB mutations have been recently implicated in 0.3% of ADPKD cases, typically with milder kidney involvement. The knowledge of the genetic spectrum of cystic kidney disease may prompt an earlier diagnosis. Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder that causes many fluid-filled cysts in the kidneys. The increasing number of renal cysts results in regional renal ischemia, vasoconstriction, and vascular endothelial dysfunction. Many biomarkers have been investigated for understanding these molecular alterations in ADPKD progress such as endocan. Endocan is a new soluble biomarker that synthesis from various organs as well as kidneys. It plays a key role in cell proliferation, migration, inflammation, neovascularization, and endothelial function. It is involved in endothelial dysfunction suggests that endocan may be a potential early marker in ADPKD patients. Also, an adult study showed high serum endocan levels is ADPKD patients. For this reason, we aimed to evaluate the serum endocan levels in normotensive children with ADPKD and normal renal function. Material and methods: Twenty normotensive children with ADPKD and normal renal function were accepted as PKD group, and 20 healthy children were accepted as the control group. Serum endocan levels were determined by enzyme-linked immunosorbent assay techniques and compared between the two groups. Results: The mean age of patients was 9.9±4.12 years, and the mean age of the control group was 10.2±3.83 years. There was no significant difference between the two groups in terms of gender, age, and BMI (p=0.751, p=0.813, p=0.781, respectively). The mean serum endocan level in the PKD group was 345.8±169.5 pg/ml, and the control group was 448.61±258.2 pg/ml. Serum endocan levels did not change between groups (p=0.159). Conclusions: Serum endocan level was normal in children with ADPKD without hypertension and renal failure. It could be explained by the absence of hypertension, renal failure, and mainly tubular expression of endocan. Clinical findings of RMS include severe insulin resistant diabetes, hyperinsulinemia, postprandial hyperglycemia, growth retardation and dysmorphisms. The syndrome may have renal manifestations such as nephromegaly, nephrocalcinosis, hydronephrosis and medullary sponge kidney (MSK). Here, we report a 10-years-old girl with a homozygous mutation in the INSR gene and MSK. Material and methods: A 10-years-old girl who have RMS was admitted for proteinuria in urine analysis. On physical examination, there were the classic morphologic features of RMS, including severe acanthosis nigricans of the neck, axillae external genitalia and antecubital regions, mildly decreased subcutaneous fat, polydactyly in her left hand, mental retardation and hearing loss. Blood pressure was normal and there were no signs of edema. In laboratory tests, complete blood count, serum creatinine, electrolytes, Ca, P, ALP, Mg, albumin, HCO3 and uric acid values were normal. Urine density was 1015, protein (+1), erythrocyte (-) in urine analysis, 2-3 erythrocytes in each area in microscopy. Na, P, Mg, uric acid excretions were normal, protein excretion was 5.5 mg/m 2 /hour (N: 0-4), microalbuminuria was 29 mg/day (N<30), calcium excretion was 6.9 mg/kg/day in the urine. A renal ultrasound showed nephromegaly and increased medullary echogenicity. In postcontrast series of computer tomography, papillary enhancement was observed in a brush-like pattern in the proximal part of the calyxial structures of the slightly dilated collecting system in both kidneys. The findings were consistent with the MSK. Results: Mutations in INSR can lead to abnormalities in kidney function, most prominently to hypercalciuria and nephrocalcinosis, suggesting an important role for INSR in renal calcium handling.

Conclusions: Our patient is one of the few cases with RMS and MSC coexistence in the literature. We recommend evaluation for nephrocalcinosis, MSK, and hypercalciuria in all children diagnosed with RMS.

Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is a genetic dominant disorder mostly caused by PKD1 or PKD2 gene mutations. Here we describe a family (father and two children) with ADPKD due to a new heterozygous PKD1 gene mutation. Material and methods: A five-year-old boy was admitted to ER with haematuria due to a mild abdominal trauma. Physical examination was negative, renal function was normal, whereas the laboratory analysis confirmed haematuria and pointed out proteinuria. Clinical family history disclosed that his father had polycystic disease and underwent kidney transplant two years earlier. Screening analysis was conduct in the older sister too. She had micro-haematuria and a mild proteinuria. The ultrasound confirmed the presence of bilateral renal cysts also in her case. PKD1sequencing test for was performed to confirm the hypothesis of ADPKD. Results: The PKD1 sequencing highlighted a novel splicing variation c.215+2_215+3del (NM_001009944.3). The one base deletion is located in the first intron of PKD1, in a canonical splice site and it is not present in the population databases. Bioinformatics and computational analysis predict that the associated protein had an elevated pathogenicity rank. The genetic test performed on the two children confirmed the presence of the same deletion. Conclusions: Following the American College of Medical Genomics recommendations, this variant should be considered potentially pathogenic and was submitted to the PKD1 mutation databases. This case report highlights the importance of applying genetic testing in paediatric patients with suspected ADPKD to achieve an early diagnosis, to make specific follow-ups and prevent or delay long-term complications.

Ganna Zvenigorodska 1 , Lyudmyla Starynets 2 , Galina Guminska 2 , Oleksandr Moskaliuk 1 , Tetyana Stepankevich 2 1 National Pirogov Memorial Medical University 2 Vinnytsya Regional Clinical Childrens Hospital Introduction: Autosomal recessive polycystic kidney disease (ARPKD) belongs to a group of congenital hepatorenal cystic syndromes. The majority of cases are caused by mutations in the PKHD1 gene, which encodes for fibrocystin/polycystin. There is significant variability in age and presenting clinical symptoms related degree of renal and biliary abnormalities. Material and methods: A retrospective case review of child with ARPKD at a single center diagnosed on the basis of clinical features, radiological and endoscopic evidence of portal hypertension, and genetic findings. Results: A 18-month-old male patient presented to the emergency room with a five-day history of enlarged distended abdomen. Examination showed hepatosplenomegaly. His prenatal, birth history and neonatal period were unremarkable. Family history was uneventful. His abdominal ultrasound showed bilaterally enlarged echogenic kidneys with loss of cortico-medullary differentiation and multiple cysts. His kidney function tests were normal. Hepatic findings included nonobstructed dilatation of the intrahepatic bile ducts (Caroli syndrome) and dilatation of the common bile duct. Gastroscopy visualized a low-grade esophageal varices located in the lower third secondary to portal hypertension. To confirm diagnosis genetic testing was performed. A pathogenic variant, c.107C>T (p.Thr36Met), was identified in PKHD1. It is estimated that approximately 13% of ARPKD patients of European origin have this variant, making it the most common mutation in that population. Conclusions: The majority of ARPKD patients are identified late in pregnancy or at birth. ARPKD has multisystem effects, and often requires a multidisciplinary team for follow-up and is a cause of significant renal and liver-related morbidity and mortality in children.

Introduction: Renal cysts and diabetes syndrome (RCAD) is an autosomal dominant multisystemic disorder caused by heterozygous mutation in the HNF1B gene. It is characterized by renal disease resulting from abnormal renal development and maturityonset diabetes of the young (MODY). The renal disease is highly variable and it may include renal cysts, glomerular tufts, irregular collecting systems. Some patients have hyperuricemic nephropathy with tubulointerstitial changes on biopsy. Material and methods: Presented male patient was antenatally diagnosed with renal pelvic dilatation. Postnatal sonographic evaluation revealed both kidneys with increased renal cortical echogenicity, poor visibility of the renal pyramids and numerous small cysts. Parents didnt have any history of policystic kidney disease. Ultrasound examination also showed several small echogenic foci without acoustic shadowing but with present twinkle artifact on color Doppler. Thus the computed tomography was performed but it did not showed any kidney stones. The markers of renal function were normal. Metabolic evaluation of potential causes of urolithiasis showed only hyperuricemia. Renal scintigraphy performed in the age of 12 months showed no abnormalities. Results: In the age of 8 months the boy was genetically tested for the causes of policystic kidney disease. Comparative genomic hybridisation showed a deletion of the long arm of chromosome 17 in the 17q12 region. The aberration covers a region of the RCAD deletion syndrome (OMIM: 137920), described in patients with renal cystic disease and MODY diabetes. The patient remains under constant nephrological care. At the present time at the age of 3.5 years the kidney function remains normal and the ultrasound image of the kidneys has not changed significantly. Diabetes has not yet been established. Conclusions: HNF1B -associated polycystic kidney disease should be included in the differential diagnosis of all children presenting with renal cysts. Genetic testing is necessary to confirm a diagnosis. Introduction: In 2018, 119 French children (22 below 5 years) received maintenance hemodialysis. Most of new-generation dialysis machines do not propose pediatric lines anymore but Fresenius had validated pediatric sets above 10 kg. Material and methods: We performed a retrospective single-center evaluation of daily practice with novel Fresenius 6008® dialysis machines, using either low volume pediatric sets (83mL) or standard adult lines (122mL), as compared to 5008® machines with pediatric (108 mL) or adult lines (136mL). Each child underwent indifferently online hemodialysis with both Fresenius 5008® and 6008® generators. All dialysis sessions were performed on a central venous catheter 8Fr-18 cm Medcomp Hemo-cath®LT (N=3) and 15Fr-28 cm Metronic Permcath® (N=1). Results are presented (mean±SD). Results: A total of 115 sessions were performed over 6 weeks in 4 children (body weight 13.1±4.1kg, age 3.7±1.6years). For the three smallest children (9.1, 11.1 and 13.0kg) , treated with pediatric lines, blood flow was higher with 5008® vs 6008® (86±4 versus 80±8mL/min, 87±4 versus 84±3mL/min and 95±5 versus 86±6mL/min, all p<0.05) and so was the blood volume treated per session, due to higher arterial aspiration and venous pressures requiring reduced blood flow rate. In contrast, we observed lower mean arterial aspiration (96±18 versus 130±19mmHg, p=0.003) and venous pressures (82±8 versus 96±16mmHg, p=0.018) in the 4 th child (18.8kg), when dialyzed on Fresenius 6008® with adult lines as compared to sessions performed with adult lines on Fresenius 5008®,without significant changes in blood flow, volume of blood treated per session and duration of sessions. Conclusions: These results suggest that children between 9-13kg be treated with pediatric lines on 5008® if possible to avoid higher arterial aspiration and venous pressures, and that children above 13kg be treated with adult lines on 6008®. The interest of pediatric lines with 6008® is likely below 10kg and deserves further studies.

Beáta Szebeni 1 , Zoltán Varga 3 , István Márton Takács 2 , Domonkos Pap 1 , Apor Veres-székely 1 , Attila J. Szabó 2 , GyÖrgy S. Reusz 2 , Ádám Vannay 1 1 Elkh-se Pediatrics And Nephrology Research Group 2 Semmelweis University, 1st Department Of Pediatrics 3 Elkh-ttk Biological Nanochemistry Research Group Introduction: Extracellular vesicles (EVs) have significant therapeutic potential. They can protect against myocardial infarction, acute kidney injury or liver fibrosis, as well. However, the impact of EVs derived from dialysis effluents (PDE) of PD patients on the development of peritoneal fibrosis during PD remained unclear. Our aim was to determine, whether PDE-EVs can alter progression of peritoneal fibrosis. Material and methods: PDEs were collected from children receiving continuous ambulatory peritoneal dialysis treatment in the I st Department of Paediatrics, Semmelweis University. PDE derived EVs (EVs) were isolated by size exclusion chromatography following ultrafiltration and were characterized according to the recommendations of the International Society for Extracellular Vesicles. Their impact on the proliferation and collagen production of primary peritoneal fibroblasts (pPFs) was tested by MTT or Sirius Red assay, respectively. The effect of EVs was also studied in a chlorhexidine gluconate (CG) induced mice model of peritoneal fibrosis in vivo. Submesothelial thickness was analysed after Periodic Acid Schiff-and Masson's Trichrome staining. Results: EVs showed spherical morphology in the 100 nm size range. The infrared spectrum of EVs after buffer subtraction presented typical spectral features of EVs. Flow cytometry certified their CD9, CD63 and annexin positivity and lack of calnexin. PDE derived EVs entered into the cytoplasm of pPFs and significantly reduced PDE induced proliferation and collagen production of them. Finally, EVs penetrated into the peritoneal membrane of C57/BL6 mice after their i.p. injection and reduced the peritoneal thickness of CG treated mice almost to the control level. Introduction: Peritoneal dialysis (PD) is the main renal replacement treatment for children with end stage renal disease (ESRD). Peritoneal fibrosis is a major complication in long-term PD patients. Aim of the study was to record the metabolic "fingertip" of children on PD and to investigate its correlation with PD vintage and dialysis adequacy as well as the emergence of potential biomarkers that could early detect or predict peritoneal dysfunction. Material and methods: Samples of serum, urine and peritoneal effluent collected from 15 ESRD children on PD. At zero time and 6 months later PET-test was performed as well as assessment of KT/V and creatinine clearance. Samples were subjected to targeted metabolomic analysis of amino-acids and derivatives by mass spectrometry (HLIC-MS/MS) method and high flow (LC-qTOF analysis-HPLC/MS) analysis. Univariate and multivariate non -parametric statistical analysis tests were performed while level of significance was set at 0.01. Results: We found out that PD duration, presence or absence of diuresis and PD creatinine clerance values are associated with significant differences in the levels of several metabolites, including glycine, creatinine, proline and 4-hydroxyproline, leucine, valine, glutamine and glutamic acid. Using LC-qTOF analysis-HPLC/MS, approximately 200 metabolites were analyzed and many of them showed significant differnce accordingly to PD duration, creatinine clerance and presence or absence of diuresis. Concenring serum analysis, more than 25 metabolites were statistically different between the examined subgroups. Concerning urine analysis, uridine and itaconic acid showed statistical difference based on PD vintage. Conclusions: Metabolomics may be a tool in the evaluation of patients with ESRD on PD as it appeas to reflect the clinical phenotype of the patient and the functional phenotype of the peritoneal membrane. These results are the preliminary results of an ongoing prospective study. There are also preliminary evidences that possibly may predict the decline in clearance adequacy. Introduction: Remote patient monitoring (RPM) technologies are used in peritoneal dialysis (PD) patients in order to improve patient life quality and healthcare efficacy. This is a six-moth prospective observational single-center pediatric study aiming to determine the impact of lost PD treatment recorded by RPM on peritoneal ultrafiltration volume (UF). Material and methods: Nine pediatric patients, 5 males and 4 females, with a median age of 15 years old, on automated PD were enrolled. 5 patients were oligoanuric and 4 presented residual renal function (RRF). All patients' cyclers were connected to a web-based software (Claria-Sharesource Baxter) and PD session data were obtained from this database. Weekly UF, lost PD time,as well as number of alarms were recorded for each patient. In total, 1617 PD prescribed sessions data were analyzed. Results: Lost PD sessions were observed in 2.5% of total prescribed PD sessions, while weekly mean lost PD time was 188.34 min. At least 1 lost PD session per week was significantly associated with lower weekly nocturnal UF (p<0.001). Number of alarms per week did not negatively affect nocturnal UF, except for patients with RRF (r=-0.613, p<0.001). Weekly lost PD time percentage was negatively correlated to nocturnal UF (r:-0.323, p<0.001). In detail, weekly lost PD time of 1% in oligoanuric patients (p<0.001) and of 10% in patients with RRF (p<0.001) was significantly associated with lower nocturnal UF. Conclusions: Access to PD sessions data by RPM is vital for optimal pediatric PD monitoring because it facilitates pediatric nephrologist awareness of treatment adherence and PD efficacy, which ultimately affects UF. Introduction: Juvenile pig models have proven to provide an accurate and reliable prediction of pediatric pharmacokinetic behavior. Microdialysis is currently the gold standard for studying drug concentrations in tissues. In microdialysis a small probe, consisting of a semipermeable hollow fiber membrane, is implanted into the tissue of interest. Mainly because of the invasiveness of microdialysis, data on tissue distribution of drugs remains largely understudied in children. The aim of this pilot study was to investigate the feasibility of multiple day microdialysis in awake and free moving piglets. Material and methods: Six piglets of four weeks old were individually housed in pens. During short sedation a microdialysis probe was implanted in the paraspinal musculature under ultrasound guidance. Thereafter, the microdialysis pump was connected and fixated on the body by means of an elastic band encircling the thorax. Over the course of four days intravenous antibiotics were administered and blood and microdialysis samples were taken while the piglets were awake and free moving in their pen. Results: In five of the six piglets the microdialysis catheter remained functional until the end of the fourth sampling day. In one piglet, the probe membrane broke on day 2 after intense struggling of the piglet during blood sampling. No adverse events (bleeding, infection, pain or other discomfort) were observed during the placement of the microdialysis catheter and whole study period. Conclusions: This study shows that it is feasible to use microdialysis to study tissue drug disposition in free moving piglets over multiple days, adding to the potential of the juvenile pig in pediatric drug research. Introduction: Pathogenic autoantibodies removal by immunoadsorption (IA) has been described as an effective adjuvant treatment in some bullous diseases, especially in pemphigus, but the experience is limited. Bullous pemphigoid is not listed as disease treatable by IA at the American Apheresis Society (ASFA) guidelines. Further, bullous pemphigoid occurs very rarely in children and usually exhibits good outcome and response to corticosteroids. Material and methods: We describe a very aggressive case of bullous pemphigoid refractory to conventional treatment that was treated effectively with IA associated to high-dose corticosteroids, mycophenolate, rituximab and IV immunoglobulin (IVIg). Results: A previously healthy 8-year-old boy with pruritic papular rash that progressed to papular erythematous rash, associated with multiple bullae, initially more pronounced in hands and feet but later generalized, is described. Skin biopsy and positive serum autoantibodies against BP180 confirmed the diagnosis of bullous pemphigoid. Despite treatment with systemic corticosteroids and sulphones, patient's lesions worsen to superimposed bullae and erosions with concomitant oral mucosa involvement. The patient was admitted to the pediatric critical care department and topical silver sulfadiazine and high protein diet were initiated. Further, 5 IA sessions were performed (days 1, 2, 3, 5 and 8) and treatment was completed with IVIg (2gr/kg) and 4 Rituximab doses (375mg/m2 weekly). Oral mycophenolate was initiated in order to spare corticosteroid treatment. After the first immunoadsorption session, no new skin lesions appeared, and complete remission was achieved 3 days after the last session. BP180 auto-antibodies turned weakly positive at the end of treatment. At 6-months follow up, the patient remains stable without new lesions and weakly positive BP180 antibodies. Conclusions: Even with spare evidence in uncommon diseases, immunoadsorption has to be considered in refractory and life-threating cases of demonstrated antibody mediated diseases. This case is another example of IA therapy's safety and feasibility in pediatric patients. Material and methods: 16-year-old male with stage IV CKD due to obstructive nephropathy/posterior urethral valvae and recently diagnosed with Fanconi anemia was prepared to an allogenic HSCT procedure. Adequate dosage of cyclophosphamide (Cy) used in conditioning regimen appeared challenging because of patients lowered GFR (30 ml/min/1,73m2) but also due impossible monitoring of Cy concentration in serum and tracking its pharmacokinetics. The patient received full dose of Cy provided in the protocol and he underwent CVVHDF for 90 hours (from 20 hours after first dose of Cy till 20 hours following the last dose of Cy). CRRT parameters were continuously customized according to patient's clinical and metabolic condition. No complications of CRRT were seen. As a result correct myeloablative function of Cy was obtained and the patient succeed undergoing HSCT. After the procedure he presented laboratory features of transient acute kidney injury with signs of increased catabolism managed with conservative treatment only and hemorrhagic cystitis. Typical Graft-versus-Host disease prophylaxis was administered. Results: The patient has been living over 2 years since the HSCT so far, lymphoproliferative disease and central line -associated infection have been observed as complications in post-transplant period.

Conclusions: The patient remains in good clinical condition with CKD treatment with no need of dialysis, he undergoes regular check-ups by nephrologists, his current GFR = 42 ml/min/1,73m2actually higher than before HSCT.

Aynur Gencer Balaban Esra Aykutlu 2 , Usame Takas 2 , Aylin Inal 1 , Sibel Yel 1 , Neslihan Gunay 1 , Ismail Dursun 1 , Muammer Hakan Poyrazoglu 1 1 Erciyes University Department Of Pediatric Nephrology Kayseri, Turkey 2 Erciyes University Department Of Pediatrics Kayseri, Turkey Introduction: Kocuria species are bacteria commonly found in the environment and human skin and mucosa. There are limited reported cases of Kocuria kristinae related peritonitis in the literature. Here, we would like to report a case of Kocuria kristinae infection related with continuous ambulatory peritoneal dialysis (CAPD) peritonitis leading to catheter loss. Material and methods: A 4-year-old boy was admitted to the pediatric nephrology department because of turbid dialysis effluent for 3days. He had end-stage renal disease as a result of posterior urethral valve and had been undergoing continuous ambulatory peritoneal dialysis (CAPD) for 45 days. Upon physical examination, he was afebrile, with a normalappearing catheter exit site. However,the peritoneal dialysate fluid was fibrinous and cloudy, with a total leukocyte count of 2655/microliter, PMN:1648/microliter, monocyte: 1007/microliter. Intraperitoneal administration of vancomicin and ceftazidime was started for empirical treatment of CAPD peritonitis. No microorganisms were seen on a Gram stain. Culture of the dialysate yielded a pure culture of gram positive cocci in pairs or clusters and resulted in contamination. Due to our high suspicion of bacterial peritonitis, different techniques were used for microorganism identification and Kocuria kristinae was determined. By day twenty one of treatment, the peritoneal fluid became clear, with dialysate white cell count was 22 leucocytes/μl. The patient's complaints including backpain, fatigue and loss of appetite resolved completely. At the first control visit, the peritoneal dialysate was turbid anew, and cell count revealed the presence of 422leucocytes/μl. Results: In spite of the administration of intraperitoneal vancomycin, the response remained unsatisfactory. The catheter of peritoneal dialysis was removed and the patient improved with antibiotic therapy for 7 days after catheter removal and was discharged.

Introduction: Peritoneal dialysis (PD) remains the most commonly used dialysis modality in children, and automated PD (APD) has been increasingly preferred worldwide. By application of a software (Homechoice Claria with sharesource system) that can be used with a mod-M added to the APD device, the details of the home dialysis treatment become visible for PD nurse and physician to allow for close supervision. Objective: This study was planned to evaluate patient/caregiver, PD nurse, and physician's perception and knowledge about advantages and disadvantages of the Claria resource sharing system regarding its effect on patient-oriented clinical recovery parameters. Method: A web-based questionnaire consisting of yes-no questions and multiple-choice questions was sent to 15 pediatric nephrology centers, where remote patient monitoring (RM-APD) applied with more than a year of experience with Claria. It was answered by 30 patients/caregivers, 15 PD nurses, and 22 pediatric nephrologists. Results: 86% of the nurses reported that the Claria system increased medical control over the patients. 75% of physicians thought that the Claria system increased medical supervision over the patients and therefore created a safe zone and time saving for both patients and healthcare providers, while no impact on financial burden of the family and healthcare system. Half of the physicians believe that Claria can reduce the need for frequent visits and 2/3 had a belief that it increased patients compliance with PD treatment and other medical treatments. While 60% of the patients/ caregivers stated that they had concerns about the quality-of-care delivery at the beginning, they were convinced about the system when they saw that the problems were solved through online based on an objective and reliable data. Conclusion: RM-APD application can be successfully applied to children for increasing compliance with the dialysis prescription and can be considered an important tool for early recognition of problems and their proactive interventions/solutions by the physicians and nurses. Key words: Peritoneal dialysis, remote monitoring, children, quality of life Introduction: Central venous catheter (CVC) is by far the most used vascular access (VA) in incident pediatric patients starting on Hemodialysis (HD), with considerable rates of morbimortality. We present our experience, regarding several outcomes at one year follow-up, namely hospital admissions and according to their VA type at baseline. Material and methods: A retrospective descriptive study included patients admitted to our pediatric HD Unit between 2005-2020. Patients were followed from their first HD session until one-year follow-up, or concurrent event. Results: 42 patients were enrolled, mean age at admission 10.8±5.3 years. Most patients initiated HD with a CVC (n=32, 76.2%). At the end of follow-up, 50% of patients ended up with an arteriovenous fistula (AVF), comparing to 23.8% at the beginning. Twenty-four patients (57%) had, at least, one hospitalization (total of 46 hospitalizations and 204 cumulative days). "CVC at baseline" group represents 36.9% of all admissions. Seven of 10 patients (70%) with "AVF at baseline", and 17 of 32 patients (53%) starting with CVC experienced hospitalization. There was not a statistically significant difference between total number of hospitalizations and length of stay (LOS) on group "CVC at baseline" versus "AVF at baseline". VA-related hospitalizations accounted for 36.9% of total admissions. We did not find a statistically significant difference between the type of VA and the cause of hospitalization. Admissions due to VA mechanical complications were responsible for the longest mean LOS, with 7.1±9.3 days. Conclusions: Although there has been a trend towards "Fistula First", over-all hospitalizations were significant in both VA groups. More than 75% of our patients had a CVC at baseline, but this is mainly justified by the anatomical limitations of younger and smaller patients, and is similar to several international reports. We highlight the increase in AVF placement at the end of the follow-up.

Houda Nassih, Rabiy El Qadiry , Aicha Bourrahouat , Imane Ait Sab B Pediatric Ward, Department Of Pediatrics, Child And Mother Hospital, Mohammed Vi University Hospital Center, Marrakesh, Morocco Introduction: We report the complications of PD in children from a lowincome country Material and methods: A single center retrospective study of 11 children undergoing PD for ESRD Results: The mean age was 12-year-old. We had 5 boys and 6 girls. The mean time under PD was of 2.5 years. Etiology of ESRD was severe tubulointerstitial nephritis in one case, rapidly progressive glomerulonephritis in 4 cases, nephroblastoma and contralateral hypoplastic kidney in one case, focal segmental glomerulosclerosis in one case, Alport syndrome in one case, and CAKUT with recurrent pyelonephritis in 2 cases. PD was initiated as first line renal replacement therapy in 10 cases, while one child was switched from hemodialysis to PD after a period of two years. PD type was APD/CCPD in 10 cases, and tidal PD in one case. The mean overnight treatment time was 9 hours and the mean number of cycles was 5. The mean total therapeutic volume was of 5944 ml. Dialysis fluids used in our patients were 1.36% dextrose in 11 cases, 2.25% dextrose in 2 cases. Icodextrine was prescribed as a unique daytime dwell in 3 cases with a mean duration of 14.6 hours. Complications were noted in 10 patients. Peritonitis was present in 6 patients with a mean of 3 episodes for each patient. Retention was seen in 6 patients. Catheter dysfunction was noted in 5 cases, from whom 3 had migration and 2 had obstruction of the PD catheter. One child had Sclerosing peritonitis and was switched to hemodialysis after 3 years under PD. Unfortunately, two of our patients died, one after massive alveolar hemorrhage and the second one after septic choc. Conclusions: The training on PD catheter placement technics as well as the practice of aseptic techniques by the family are the keys to limit PD complications in our population. Introduction: Distal renal tubular acidosis (dRTA) is a tubular disorder characterized by metabolic acidosis with a normal anion gap and alkaline urine. Mutations in ATP6V1B1, ATP6V0A4, SLC4A1, FOXI1 and WDR72 can cause dRTA. Since chronic metabolic acidosis and hypokalemia increase renal ammoniagenesis and ammonia reabsorption, it leads to hyperammonemia in dRTA. Treatment of acidosis and hypokalemia usually correct hyperammonemia. In this study, we described the presenting features and long-term outcomes and investigated the relationship with hyperammonemia of seven patients with dRTA. Material and methods: Biochemical and clinical results were collected at the presentation and last clinic visit. Genetic studies were performed. The estimated glomerular filtration rate (eGFR) was calculated using the original Schwartz formula. Hyperammonemia was defined as serum ammonia level >60 μmol/L. Results: Three patients (42,8%) were female. The median age at diagnosis was six months (min-max:1-114 months). The median follow-up time was 90 months (min-max:34-150 months). Median plasma concentrations of electrolytes at presentation were nonremarkable. All patients had nephrocalcinosis at presentation. Median eGFR (ml/dk/1.73 m2) at presentation was 123 (min-max:24-240) and 126 (min-max:105-192) at last visit. The most common presenting symptom was vomiting (57,2%) followed by fever (28,5%) and polyuria-polydipsia (14,2%). At the last visit, six of seven patients (85,7%) improved their weight percentiles and five of seven patients (71%) improved their height percentiles. Homozygous mutation was found in the ATP6V0A4 gene in 5 of 7 patients and in the SLC4A1 gene in one patient. No mutation was found in one patient. In our study, four patients (%57) had hyperammonemia and it resolved in all except one patient with correction of acidosis and hypokalemia. Conclusions: Early recognition of dRTA and correction of metabolic acidosis and dehydration are important. Since hyperammonemia may accompany dRTA, hyperammonemia should be kept in mind especially in patients with neurocognitive problems or persistant vomiting.

Ezgİ Ay 1 , Emre GÜrses 2 , Filiz Arslan 2 , Bora GÜlhan 3 , Asuman AlniaÇik 1 , Ali DÜzova 3 , MÜnir Demir Bajin 4 , Levent SennaroĞlu 4 , Gülsüm Aydan GenÇ 2 , Fatih Ozaltin 3 , Rezan Topaloglu 3 Introduction: Different degrees of hearing loss may accompany different mutations in distal renal tubular acidosis (dRTA). The aim of this study is to examine the characteristics of hearing loss in dRTA patients. Material and methods: A group of 21 patients with confirmed dRTA were included in the study. Clinical and laboratory evaluations of the patients were collected. Otological examination and holistic audiological evaluation of all patients were performed. Results: The population consisted of 13 females and 8 males (range; 8 months-33 years) with dRTA. A genetic analysis could be performed in 17 patients(four participants did not give consent). Among 17 patients, nine had ATP6V1B1, six had ATP6V0A4, one had SLC4A2 and one had WDR72 mutation. In the group, hearing loss configurations tended to increase towards higher frequencies. Based on pure tone average (PTA), all patients with ATP6V1B1 mutation had various degrees of hearing loss from mild to profound. We also found large vestibular aqueduct syndrome (LVAS) in 83% of the patients with ATP6V1B1 mutation. Patients with bi-allelic ATP6V0A4 mutation showed that one patient had severe sensorineural hearing loss (SNHL) in one ear and moderately-severe SNHL in the other. The rest of the patients had normal PTAs. One patient with SLC4A2 mutation had bilateral mild mixed hearing loss based on her PTA's. We found that the pure tone hearing thresholds of the patients with ATP6V0A4 mutations were statistically significantly higher than those obtained in patients with ATPV1B1 mutations for both air and bone conduction on the right and the left ears (p<0.05). Conclusions: In our dRTA patients, hearing loss in high frequencies is commonly observed in all mutations. Besides, the type of the mutation seems to have an effect on the hearing thresholds. Our study is the first to demonstrate the association of SLC4A2 mutation and hearing loss. Introduction: Bartter and Gitelman syndromes are rare inherited tubulopathies characterized by hypokalemic, hypochloremic metabolic alkalosis. Three phenotypes exist in Bartter syndrome (BS); antenatal (aBS), classical (cBS) and mixed type. Also, BS is classified genotypically into five types as SLC12A1 (BS I), KCNJ1 (BS II), CLCNKB (BS III), BSND (BS IV) and CASR (BS V). It is aimed to clarify the frequency of the phenotypic and genotypic subgroups, clinical features, long-term management and prognosis of children diagnosed with BS and GS in this study. Material and methods: Twenty seven patients with BS and six patients with GS, who were followed-up between 2004 and 2020 in Department of Pediatric Nephrology, Çukurova University Faculty of Medicine, were included in our study. Results: Fifteen (55.5%) of the patients with BS were male and two (33.3%) of the GS patients were male. The mean age of diagnosis was 14.9 months (0.5-84) in patients with in patients with GS. Fourty eight percent of BS patients had a history of polyhydramnios. Ten patients with BS had CLCNKB, 3 patients had SLC12A1, 1 patient had BSND, 1 patient had CLCNKA, and 6 patients with GS had SLC12A3 genetic mutations. Growth retardation was found in 81.8% of patients with aBS, 68.7% of patients with cBS and mixed type, and 50% of patients with GS. Chronic kidney disease (CKD) stage 3 was detected in 14% of patients with BS at the time of diagnosis, while the rate of patients with CKD stage 3 and above at the last follow-up was 25.9%. Estimated glomerular filtration rates (eGFR) of patients with GS were normal at the time of diagnosis and at the last follow-up. eGFR values were found to be statistically significantly lower in patients with aBS than in patients with cBS and GS in the last follow-up. Conclusions: Patients with BS and GS may have a different clinical course due to the underlying genetic mutation. Since BS and GS require life-long treatment, treatment compliance is important to prevent advanced stage CKD. Introduction: Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is a rare autosomal-recessive renal tubular disorder. It is characterized by renal wasting of magnesium (Mg) and calcium (Ca), subsequently leads to bilateral nephrocalcinosis, renal stones, and chronic renal failure. It is also caused by variants in the CLDN16 or CLDN19 genes. Treatment is supportive. Here, we report seven patients with FHHNC. Material and methods: We retrospectively analyzed pediatric cases of FHHNC diagnosed at our hospital between 2010-2020. Results: A total of 7 patients, 5 girls (71.4 %) and 2 boys (28.5 %) with a median age of 4 years (min:4 months, max:13 years) and a mean followup time of 4.4±3.5 years were included in the study. All patients had normal body and height percentiles. Three of them had low urine citrate levels. All of the patients had nephrocalcinosis, normal urine oxalate levels, and normal blood gas analysis. One patient had recurrent urinary tract infection and urolithiasis. Five patients had CLDN 16 mutation, and two patients had CLDN19 mutation. None of them had ocular findings. All patients had high parathormone levels (216,7 ± 169,5 (pg/mL) . At the end of the follow-up period, two patients had chronic renal failure. Conclusions: FHHNC frequently leads to renal failure during childhood or adolescence. FHHNC must be kept in mind when severe hypomagnesemia or hypercalciuria is accompanied by nephrocalcinosis.

Zehra Aydin 1 , Fatma Semsa Cayci 1 , Ibrahim Sahin 2 , Umut Selda Bayrakci 1 1 Ankara City Hospital, Department Of Pediatric Nephrology, Ankara, Turkey 2 Diskapi Yildirim Beyazit Training And Research Hospital, Department Of Medical Genetics, Ankara, Turkey Introduction: Nephrocalcinosis (NC) is a rare condition defined by the accumulation of calcium phosphate or calcium oxalate deposits in the renal parenchyma, particularly in tubular epithelial cells and interstitium. The most common form is the medullary NC form and it may be a sign of some metabolic disorders as distal renal tubular acidosis. In addition, it may be rarely associated with other anomalies.

Material and methods: We present a case of a 1-month old boy who was referred for metabolic evaluation of bilateral NC. Results: The patient had hypokalemia, hyperchloremia, and metabolic acidosis with a normal anion gap. Urine density was 1008 and urine ph was 8 with no evidence of glycosuria, proteinuria, or phosphaturia. Further investigations showed high urine anion gap and high urine potassium-to-creatinine ratio. He was diagnosed with dRTA. The patient was subsequently treated with potassium citrate, a low sodium diet accompanied by high fluid intake. After a 12-year therapy bilateral multiple parapelvic renal cysts with NC were observed by renal ultrasonography. To provide a specific diagnosis, we performed genetic analysis, and homozygous ATP6V0A4 and heterozygous PKD1 mutations have been detected in our patient. Conclusions: We conclude that dRTA should always be considered as a cause of medullary NC. Since simple cortical renal cysts are considered as a complication of the hypokalemia in dRTA, the concomitant multiple renal cysts should also aware of polycystic kidney disease and the final diagnosis requires specific genetic analysis.

EP-148 ANTENATAL BARTTER SYNROME (ABS) TYPE 1 WITH LOW URINARY CHLORIDE EXCRETION: AN UNUSUAL PRESENTATION Varvara Askiti 1 , Anastasia Garoufi 2 , Eleni-maria Papatesta 2 , Mato Nagel 3 , Andromachi Mitsioni 1 1 Pediatric Nephrology Department Athens Childrens Hospital "p&a Kyriakou" 2 2nd Department Of Pediatrics National And Kapodistrian University Of Athens, Childrens Hospital "p&a Kyriakou" 3 Center For Nephrology And Metabolic Disorders , Laboratory For Molecular Diagnostics , Weisswasser, Germany Introduction: It is known the utility of urinary chloride measurement in the differential diagnosis of Bartter syndrome. We report a case of ABS with low urinary chloride excretion. Material and methods: Premature newborn of 31 weeks of gestation with history of polyhydramnios, birth weight of 1650 gr. He remained to the neonatal intensive care unit for 3 months due to respiratory distress, acute kidney injury (Ur:230, Cre:1.13) which gradually resolved. Αt the age of 4 months he was severely growth retarded (height and weight far below the 3 rd percentile), normotensive, with polyuria, metabolic alkalosis, hypernatremia (144-154meq/l), serum chloride normal, serum potassium (3, 4mEq / L), bilateral nephrocalcinosis grade II-III. Plasma renin >31 ng/mL ( 0.32-1,84 ng/mL), serum aldosterone 1700pg/mL (20-1100). In serial spot urine, calcium to creatinine ratio 2-2,88, potassium 60-69 mEq/L, sodium 11-16 mEq/L, FE Na 0.10-0.15%, chloride 11-20 mEq/L, chloride/creatinine ratio 5.5-6.8, serial values FE Cl<0.5. Although there was suspicion of BS, the consistently low urinary chloride excretion were debated the diagnosis. Whole exome sequencing analysis was performed. Results: Two heterozygous mutations likely pathogenic were found in SLC12A1 gene (c.2168_2169delTG, c.3164+2T>G), that are not yet published. A mutation in the CLCNKB was found (c700T>C) and another variant (c.936_937insAATA) of unknown significance. The father has one of the two SLC12A1 mutations and both the CLCNKB variants, while the other SLC12A1 was found in the mother. As by parental screening have been confirmed that the SLC12A1 mutations are bi-allelic, this is consistent with ABS type 1. Therapy with indomethacin and potassium citrate was started. At the age of 4 yrs old, his height and weight have improved (10 th percentile). Conclusions: We have described a child with atypical clinical presentation of ABS type 1 confirmed with genetic testing. This demonstrates the utility of whole exome analysis in improving the diagnostic accuracy of atypical ABS.

Sevasti Karamaria 3 , Vincent Delens 2 , Lien Dossche 3 , Ann Raes 3 , Evelien Snauwaert 1 , Johan Vande Walle 3 1 Ghent University Hospital 2 Ghent University 3 Ghent University Hospital, Ghent University Introduction: Nocturnal enuresis (NE) is caused by a mismatch of nocturnal urine production and functional bladder capacity. Nocturnal polyuria (NP) is defined as nocturnal diuresis (ND) exceeding the Expected Bladder Capacity (EBC) by 130% and is well documented as pathogenetic mechanism. NP is attributed to abnormal circadian rhythm of vasopressin (AVP). However, 40-60% of patients treated with desmopressin, an AVP agonist, show insufficient response, suggesting other factors may be involved. Material and methods: We aimed to study the kidney circadian rhythm on water and solute excretion in fractionated urine samples over 24h (4 day and 4 night samples); we analyzed retrospectively data from 402 enuretic. The children were divided into 3 subgroups: a) low-normal ND (<90% EBC, n=113) b) high-normal ND (90-130% EBC, n=103) c) NP (>130% EBC, n=91). Results: Increased diuresis rate and free water clearance overnight is present in the NP and the high-normal ND group. Both groups demonstrate an abnormal circadian rhythm of diuresis (p=0,001) and osmolary excretion (p<0,001), predominantly in the two first nighttime samples. Children with NP produced more urine (p<0,003) and excreted more osmols (p<0,001) overnight but also during the daytime and in a 24h-period. Conclusions: Where the clinical indication for desmopressin is often restricted to children with NP (>130%EBC), our data suggest that: -NP is better defined as ND>100% EBC; this population might be equally desmopressin responsive -pathogenesis is more complex than an abnormal AVP circadian rhythm; in 60% of patients abnormalities of other renal circadian rhythms and/or increased nutritional intake might be involved -NP is the highest and osmolality the lowest in the early night collections; treatment should target fast rather than long-term action Introduction: The high incidence of microhematuria and predominantly latent course of nephropathies with microhematuria leads to seek for new criteria for early diagnosis and prognosis of the disease. The aim of the study was to examine the proteomic spectrum of urine in various diseases of the urinary system in children in order to predict the nature of the course of kidney pathology. Material and methods: Proteomic urine analysis was performed using proteomics methods (MALDI-TOF-MS / MS, Ultraflex II, Bruker, USA). Molecular interaction data were obtained using the STRING 10.0 database. The study included 30 children aged 1 to 18 years with various kidney pathologies, the leading laboratory symptom in which was microhematuria. Results: Isolated 39 different proteins. The most frequently detected antigen of tubulointerstitial nephritis (100%), antiepithelial membrane antigen (50%), aminopeptidase N (42%), alpha subunit of smooth muscle fiber actin (33%), sinfilin 1 A (33%), hepcidin (33%) . With the addition of proteinuria, the frequency of detection of a molecule of renal tissue damage increased (75%). In 3 patients with polycystic kidney disease in the proteomic spectrum of urine in 100% of cases, the collagen chain alpha-1 (VI), afamin, alpha-subunit of smooth muscle fiber actin, profilin-1 were determined. In a patient with gouty nephritis (Kelly-Sigmiller syndrome), the proteomic spectrum of urine was dominated by a factor stimulating prostacyclin, interleukin 16, a molecule of renal tissue damage, matrix metalloproteinase, tolloid-like protein 2, aquaporin-1, apoptosis-inducing factor. Conclusions: Thus, the study of the protein spectrum of urine opens up wide opportunities for the search for new non-invasive diagnostic markers for assessing the level of damage to the renal structures, the effectiveness of nephroprotective therapy, as well as determining the prognosis for various pathologies of the urinary system.

EP-151 PHENOTYPIC AND GENOTYPIC CHARACTERISTICS OF CHILDREN WITH BARTTER SYNDROME Serçin Güven 1 , Ibrahim Gokce 1 , Ceren Alavanda 2 , Ece Demirci Bodur 1 , Neslihan Cicek 1 , Mehtap Sak 1 , Serim Pul 1 , Ozde Nisa Turkkan 1 , Pinar Ata 2 , Nurdan Yildiz 1 , Harika Alpay 1 1 Marmara University, Department Of Pediatric Nephrology 2 Marmara University,department Of Medical Genetics Introduction: Bartter syndrome is classified into five genetic subtypes. SLC12A1, KCNJ1, CLCNKB, BSND and CASR encode proteins in the thick ascending limb of loop Henle and distal convulated tubule in BS type I, II, III, IV and V, respectively. Bartter syndrome can also be classified by phenotype (antenatal, classic). Patients with mutations in the same gene can present different phenotypes. In the present study, target gene sequencing was performed to evaluate the genotype-phenotype relationship Material and methods: Biochemical, clinical, imaging and genetic results were collected at the presentation and the last clinic visit. The findings at presentation of patients with classical BS (cBS) and antenatal BS (aBS) were compared Results: Our study included 21 patients (12 female, %57.1) from 20 families with BS. The median age at diagnosis was 8 months (minmax: 1-139 months) and the median follow-up period was 39 months (min-max: 3-236). The most frequent complaint was growth failure (10/ 21). Height persentiles were <3p in 13 (%61) patients at presentation, in 9 (%42) patients at the last follow-up. We have found 18 variants in 4 genes, including 8 CLCNKB gene, 7 in SLCA12A1 gene, 2 in KCNJ1 gene and 1 in BSND gene, 11 of them were novel. When we compare patients with aBS (11/21) and cBS (10/21), there was no difference between the two groups in terms of age of diagnosis and follow-up time. Prematurity was significantly higher in the group with aBS than the group with cBS with a rate of 90%. Median plasma potassium and chloride concentrations were significantly lower in cBS group (2.2 vs 3.0 mEq/ L; 85 vs. 94 mg/L, respectively). Conclusions: This investigation revealed the mutation characteristics and phenotype-genotype relationship of our patients and provided valuable data for genetic counseling.

Material and methods: Potassium levels were normal. Markedly elevated serum aldosterone level and elevated serum renin confirmed the diagnosis of pseudohypoaldosteronism. Renal ultrasound showed grade III hydronephrosis on the left kidney while contrast-enhanced voiding urosonography excluded the existence of vesicoureteral reflux which raised suspicion of opstructive uropathy on the level of vesicoureteral junction. Results: Serum sodium normalized after several days of intravenous fluids and antibiotic therapy after which oral supplementation of sodium was introduced. Levels of 17-hydroxyprogesterone, ACTH, cortisole and TSH were normal. Functional MR urography conducted at the age of 3 months confirmed the diagnosis of primary congenital obstructive megaureter and the infant was referred to a pediatric surgeon. Conclusions: Although a rare occurence, S-PHA can be a potentially life threatening condition in infants if not recognized and treated adequately. Therefore, serum concentrations of electrolytes should be obtained in every child with diagnosed obstructive anomaly of the urinary tract and/ or acute cystopyelonephritis. On the other hand, every child with diagnosed S-PHA should be evaluated for obstructive anomaly of the urinary tract. Introduction: Congenital disorders of glycosylation (CDG) are rare and severe inherited diseases causing glycosylation defects lead to severe growth and psychomotor retardations in patients. Material and methods: Here, we reported an infant who presented with hypokalemic metabolic alkalosis and diagnosed CDG type IIk. Results: A 7-month-old girl presented to the pediatric nephrology department due to an incidental finding of hypokalemia and metabolic alkalosis in hospitalization for pneumonia. She was born from second-degree consanguineous parent. On physical examination, she had a weight of 5300 g (−3.21 SDS), the height of 56 cm (−4.69 SDS), head circumference of 39 cm (−3.45 SDS) and blood pressure 85/50 mmHg. Examination revealed generalized hypotonia, inverted nipples, pectus carinatum, large and flap ears, and long eyelashes. In past medical history, she had seizures and was on phenobarbital treatment. Her family history was remarkable for her elder brother had mental retardation and developmental delay. Blood biochemistry revealed blood urea nitrogen 11 mg/dl, creatinine 0.21 mg/dL, sodium 129 mmol/L, potassium 2.1 mmol/L, chloride 81 mmol/L, calcium 9.6 mg/dl, phosphorus 3.7 mg/dl, magnesium 0.63 mg/ dl, albumin 34 g/L, alanine aminotransferase 23 U/L, aspartate aminotransferase 115 U/L, lactate dehydrogenase 318 U/L and creatine phosphokinase 77 U/L. Venous blood gas analysis was pH 7.58, pCO2 32 mmHg, bicarbonate 45.4 mmol/L, and base excess 21.6 mmol/L. Plasma renin activity was elevated and serum aldosterone was normal. Her urine analysis results were: pH 8, density 1010, protein (+) positive, leukocyte esterase negative, nitrite negative and leukocytes in urinary sediment were 2-3 every high-power field. Urine calcium creatinine ratio was 0.04 mg/mg. Urine chloride level was 82 mmol/l. Fractional excretion of sodium was >4%. The sweat test revealed sweat chloride concentration of 26 mmol/L. Renal ultrasonography was normal. Treatment regimen consisting of sodium chloride, potassium citrate, magnesium oxide, and indomethacin was started. She had no mutations in CLCNKB and SLC12A3 genes. Ophthalmic examination, hearing test, and echocardiography were normal. She was hospitalized in the pediatric intensive care unit due to sepsis and pneumonia at the age of 19 months, and at that time, hypokalemic metabolic alkalosis became marked and rhabdomyolysis occurred. Hemodiafiltration and plasmapheresis were done. The involvement of multiple organs comprising hypotonia, seizure, liver (elevated transaminase levels), elevated creatine phosphokinase and growth retardation with remarkable family history led us to examine an inherited metabolic disease in this case. Basic metabolic tests were all in normal limits. Transferrin isoelectric focusing test showed CDG type II. Whole exome sequencing was performed and identified a pathogenic homozygous TMEM165:c.376C>T in exon 2 of the TMEM165 gene. Conclusions: In conclusion, several studies reported that many inherited and acquired diseases could mimic Bartter syndrome. Besides these, our case showed that inherited metabolic diseases should be taken into consideration among the diseases mimicking Bartter syndrome.

EP-154 ANTENATAL BARTTER SYNDROME MIMICKING PSEUDOHYPOALDESTERONISM Muhammet Sancaktar, Mustafa Koyun, GÜlŞah Kaya Aksoy, Mehtap Adar, Ayla KaÇar, Elif Çomak, Sema Akman Akdeniz University Medical Faculty Department Of Pediatric Nephrology, Antalya Abstract: Antenatal Bartter syndrome is a rare disease characterized by unexplained polyhydramnios and a history of premature birth, polyuria, salt wasting, and severe dehydration. We present an infant with antenatal Bartter syndrome without metabolic alkalosis and hypopotasemia. An 2.5-month-old boy was admitted to our hospital due to polyuria, polydipsia and decreased nutrition. He was born 1440 grams at 30 weeks of gestation from a 24-year-old mother due to polyhydramnios. The diagnosis of pseudohypoaldosteronism was suspected due to hyponatremia (124 mEq/L) and hyperkalemia (10 mEq/L) at neonatal intensive care unit and therefore hydrocortisone and fludrocortisone treatments were administered, which was stopped at postnatal 29th day. His mother and father were first degree cousins. Physical examination was unremarkable. On laboratory examination, serum creatinine was 0.32 mg/dL, serum sodium 132 mEq/L, potassium 4.6 mEq/L, calcium 10.9 mg/dL, phosphorus was 5.8 mg/dL, bicarbonate was 12 mmol/L. Urinary analysis revealed that; pH 6.5, dansity 1004, urinary Ca/Cr ratio was 0.76 mg/ mg. Serum aldosterone was 177 ng/dl (N<86), renin 34 ng/ml/h (N<37). On ultrasonography, increased medullary echogenicity was seen. Treatments with sodium chloride, potassium citrate and ibuprofen were started. Genetic analysis yielded a homozygous p.Trp99Gly (c.295T> G) mutation on KCNJ1 gene, compatible with type 2 Bartter syndrome. Antenatal Bartter syndrome should be considered in patients with polyuria with a history of severe polyhydramnios and prematurity in the antenatal period; metabolic alkalosis may not be present. Introduction: In salt-wasting syndromes, adrenal pathology and tubulopathy should be the main differential diagnoses. Tubular maturation in the neonate can make it difficult to initially develop the classic biochemical pattern. We propose the differential diagnosis between two entities that in the first weeks may be indistinguishable: primary pseudohypoaldosteronism(PHA) and type II Bartter syndrome(BS) Clinical observations: A 15-month-old patient(non-consanguineous parents), second pregnancy of a 35-year-old mother with a previous cesarean section with intrauterine death of one of the fetuses. Severe polyhydramnios.In amniotic fluid biochemical study, high levels of chlorine and extremely high levels of aldosterone are found, orienting itself from the beginning as a salt-wasting syndrome. Urgent cesarean section at 28 weeks after sustained bradycardia in context of placental abruptio. During first 2 weeks, presented severe dehydration with sustained polyuria(18ml/Kg/h), hyponatremia(minimum of 128mmol/l), hyperkalemia(up to 7.3mmol/l), metabolic acidosis(treatment with bicarbonate and frequent corrections needed). A response test with hydrocortisone is performed, changed to fludrocortisone on 4th day of life without response, oriented to tubular origin. Serial analyzes show an increase in renal losses of chlorine and calcium(calciuria up to Ca/Cr 3.02 mg/mg), hyperaldosteonic hyperreninema and a finding of moderate nephrocalcinosis(grade 2), considering at this point the differential diagnosis between primary type 1 PHA and BS. From the 2nd week, the acidbase balance changes with a progressive tendency to hypokalemia and metabolic alkalosis, requiring treatment with increasing amounts of sodium(up to 17mEq/kg/d) and potassium(up to 3.5mEq/Kg/d), being discharged at 21 days pending the genetic study that will result in a type II Bartter Syndrome(ROMK mutation), initiating indomethacin with good subsequent metabolic control Comments: Type II Bartter syndrome can simulate a pseudohypoaldosteronism picture during the first weeks of life, which can make it difficult to manage and diagnose

Gabriele Malgieri 1 , Giulia Ranucci 2 , Giovanni Russo 2 , Rossella Colantuono 3 , Ilaria Luongo 1 , Daniela Molino 1 , Luigi Annicchiarico Petruzzelli 1 , Ilaria Battagliere 1 1 Pediatric Nephrology And Dialysis Unit, Santobono Childrens Hospital, Naples, Italy 2 Department Of Translational Medical Science, Section Of Paediatrics, University Of Naples Federico Ii, Naples 3 Pediatrics Section, Department Of Medicine, Surgery And Dentistry "scuola Medica Salernitana", University Of Salerno, Baronissi, Italy Introduction: to describe a case of a child suffering from hypomagnesemia with secondary hypocalcemia, presenting with recurrent generalized seizures. The cause of hypomagnesemia in this patient is still unknown and she continues to require oral magnesium supplements to maintain normocalcemia. Material and methods: A 2-month-term healthy girl was brought to the emergency department because of generalized seizures. On admissionshe was found to have hypocalcemia (total blood calcium: 6.3 mg/dL). Further investigations revealed normal level of creatinine, inorganic-phosphorus, alkaline phosphatase, vitamin D3, parathyroid hormone, but low serum magnesium (0.6 mg/dL). Urinary electrolytes prior to magnesium repletion found an inappropriately elevated fractional excretion of magnesium at 4.6% with age-appropriate excretions of potassium, sodium, and phosphate. There was no hypercalciuria (calcium to creatinine ratio 0.56). Renal ultrasound was normal. After initial treatment with parenteral calcium and magnesium, followed by oral magnesium at 3.28 mmol/kg/ day seizure disappeared completely over the next few days. Results: After 6 months of follow up, there has been no seizure recurrence. The patient had normal height and weight for age and neurologic examination and electroencephalogram were normal. Her serum and urinary calcium and magnesium levels were in range. However she required oral supplementation to maintain normocalcemia. Other causes of primary hypomagnesemia were excluded. A next-generation sequencing panel for known mutations associated with hypomagnesemia including 22 genes was negative. Conclusions: Magnesium levels should always be measured when trying to determine the etiology of seizures. Although rare, genetic causes of hypomagnesemia should be considered, once common causes of hypomagnesemia are ruled out. Despite the identification of several genes with rare Mendelian disorders our understanding of renal Mg2+ homeostasis remains still incomplete. Introduction: Idiopathic infantile hypercalcemia (IIH) is characterized by severe symptomatic hypercalcemia. It is caused by mutations in CYP24A1 and SLC34A1 resulting in increased vitamin D sensitivity and elevated serum 1,25(OH)2D3 with subsequent hypercalcemia and hypercalciuria. SLC34A1 mutations additionally lead to primary renal phosphate wasting and hypophosphatemia. Contrarly, neurofibromatosis (NF) is associated with vitamin D deficiency, so supplementation of vitamin D is beneficial. Yet, NF is sometimes complicated by hypophosphatemic osteomalacia and hyperparathyroidism. Material and methods: We report a case of a 14 years old male who initially presented at the age of 5 months with profound hypercalcemia, vomiting, dehydration, weight loss, hypotonia, and hypercalciuria. He was born at term after an uncomplicated pregnancy as the first and only child of healthy parents without known consanguinity. He was exclusively breastfed and received 1000 IU of vitamin D for prophylaxis. At admission his serum 25-OH vitamin D and 1,25(OH)2D3 levels were normal, while parathyroid hormone level was undetectably low. Besides, he had hypophosphatemia. A low calcium/vitamin D diet was initiated. Ultrasound showed increased echogenicity of the renal pyramids at the age of 3 years and kidney stones at the age of 5. Serum calcium and phosphate levels and the urine calcium/creatinine ratio were normal. Furthermore, he fulfilled clinical criteria for neurofibromatosis type 1 and started prophylaxis with 600 IU vitamin D. After two months of prophylaxis, he developed hypercalciuria with suppressed PTH and hyperphosphaturia, so vitamin D was restricted again. By the age of 7, he suffered from recurrent renal colic. The kidney stones were fragmented with extracorporeal shock wave lithotripsy and excreted in the urine. Since then the patient has been treated with hydrochlorothiazide. His urine calcium/creatinine ratio and renal ultrasound are normal. Moreover, catch-up in growth and development was observed. Results: Finally, genetic analysis has recently been done. Homozygous missense variant CYP24A1 c.1186C>T,p. (Arg396Trp) was identified. Conclusions: IIH has not yet been described in individuals with NF1. Both conditions adversely affect complex phosphocalcic metabolism. Hydrochlorothiazide is a useful treatment option. Further investigation is required to facilitate appropriate management and treatment of these challenging patients.

Blood Pressure in Children and Adolescents", "2016 European Society of Hypertension guidelines"), on the prevalence of hypertension and associations with Left ventricular hypertrophy in children and adolescents. Material and methods: We searched bibliographic databases (MEDLINE, Web Of Science, CENTRAL) for studies evaluating the impact of the 2017 AAP guidelines on the prevalence of hypertension and left ventricular hypertrophy compared to the 4 th Report or the 2016 ESH guidelines. Meta-analysis was performed to compare the overall risk of LVH between the two guidelines. We used a random-effects model to synthesize quantitative data. Results: We included 18 observational studies in our systematic review with an overall moderate to high risk of bias. The AAP guidelines resulted in higher prevalence of HTN than the ESH guidelines. In the metaanalysis of three observational studies, the two guidelines revealed similar associations with LVH (OR=3.89, 95% [CI] = 1.68-8.99 for AAP -OR =3.19, 95% [CI]= 1.14-8.88 for 4 th Report/ESH). Likewise, a qualitative analysis of two observational studies revealed similar predictive capacity of the two guidelines for LVH in adult life. Conclusions: The incorporation of the new AAP guidelines increased the prevalence of Hypertension in children and adolescents. However, the new nomograms did not yield any advantage in identifying children and adolescents with LVH. Introduction: In adults, albuminuria is a recognized marker for cardiovascular risk, and it is associated with obesity and hypertension. In children, however, the association between albuminuria and cardiovascular risk has not been demonstrated, nor is it clear whether albuminuria persists throughout childhood. We aimed to determine whether albuminuria at 12 years is associated with concurrent cardiovascular risk factors and whether albuminuria at 2 years sustained until the age of 12. Material and methods: In the population-based GECKO (Groningen Expert Center for Kids with Obesity) cohort, urine was collected from 1352 children at the age of 2 years and 1311 children at the age of 12 years (random urine and first morning void urine, respectively). In a cross-sectional analysis, we determined the association of urinary albumin concentration (UAC) and urinary albumin-creatinine ratio (UACR) at 12 years with blood pressure (BP), Body Mass Index (BMI) and Waist Circumference (WC). In a longitudinal analysis we evaluated in 835 individuals whether albuminuria at 2 years persisted until 12 years. Results: Both UAC and UACR at 12 years were negatively associated with BMI and WC (UACR: ß-0.45 and ß-1.06, respectively; both p<0.001). UAC was positively associated with systolic BP (ß0.69, p=0.046), UACR with diastolic BP (ß0.58, p=0.047). UACR ≥3 mg/ mmol was present in 23.4% of children at 2 years, but only in 3.3% at 12 years. Only 10.7% of the children with UAC ≥ 20 mg/L at 2 years had UAC ≥ 20 mg/L at 12 years (p=0.43). Conclusions: In contrast to the hypothesized positive association, albuminuria at 12 years is negatively associated with BMI and WC, and the positive association with BP is weak and barely statistically significant. Albuminuria at age 2 does largely not persist at the age of 12 years, indicating that many children at 2 years of age have transient albuminuria. Introduction: The diagnosis of hypertension in adolescents aged ≥13 and <16 years is based on the percentile according to age, gender, and height in the European Society of Hypertension guidelines (ESHG2016) guideline; whereas the American Academy of Pediatrics guideline (AAP2017) uses blood pressure above 130/80 mmHg as a single criterion. Therefore, this study aimed to evaluate the compatibility of these two guidelines in adolescents aged ≥13 and <16 years. Material and methods: This study was designed by retrospectively screening the records of 395 adolescents with both office and 24-hour ambulatory blood pressure measurements. Each blood pressure measurement was classified according to both the ESGH2016 and AAP2017 guidelines. Patients were divided into 3 subgroups according to body mass index. Cohens kappa analysis was used to evaluate the agreement of the two guidelines. Results: The majority of adolescents were normotensive according to both guidelines, 55.9% by ESHG2016 and 43.1% by AAP2017. For the whole group, the frequency of hypertension was 32.4% with ESHG2016 and 34.4% with AAP2017; while, in obese patients, hypertension frequencies were 38.8% and 43.3%, respectively. The diagnosis of hypertension demonstrated with the two guidelines, and there was significant agreement at a substantial level, both for the obese subgroup and the whole study group (kappa value=0.738 and 0.785, respectively). The frequency of white-coat hypertension was higher with the AAP2017 guideline (29.1% vs 19.4%,p<0.001) Conclusions: With our experience in this single-center study, it seems that both the AAP2017 and the ESHG2016 guidelines can be used in the diagnosis of hypertension in adolescents. Introduction: The metabolic syndrome (MetS) is a cluster of risk factors including insulin resistance, dyslipidemia and hypertension, which are often found in chronic kidney disease (CKD). Left ventricular (LV) hypertrophy (LVH) is a major target organ damage in hypertension and an important cardiovascular risk factor. The study aimed to identify risk factors that contribute to LVH in children with (CKD). Material and methods: The study was conducted in a group of 71 children (28 girls and 43 boys) with CKD stage 1 to 5. The patients' mean age was 12,8 years and mean GFR was 64,8±38 ml/min/1.73m 2 . Serum creatinine and lipids levels were measured. MetS was diagnosed according to De Ferranti (DF) criteria. Ambulatory blood pressure measurements (ABPM) were performed. Echocardiographic examinations were carried out with a HP 5500 device. The 95 th percentile of LV mass index relative to height age was used to define LVH. Results: LVH was detected in 21 (29,6%) children. MetS (DF) was diagnosed in 20 pts (28,2%). Glucose ≥ 110 mg/dL was present in 3 pts (4,2%); waist circumference ≥75 th pc in 16 pts (22,5%); triglycerides ≥ 100 mg/dL in 35 pts (49,3%); high-density lipoprotein < 50 mg/dL in 31 pts (43,7%) and blood pressure ≥ 90 th pc in 29 pts (40,8%), respectively. In multivariate analysis with logistic regression model (logit) the most important risk factors for LVH in CKD children were: diagnosis of MetS based on DF criteria (OR= 24.11, Chi2=8.38, p=0 .0038); low HDL according to DF criteria (OR= 0.066, Chi2=6.38, p=0.0116); high mean arterial pressure standard deviation score (SDS) (OR=2.812, Chi2=5.91, p=0.015) and low height SDS (OR=0.078, Chi2=25.01, p<0.001). Conclusions: In children with chronic kidney disease LVH is associated with the individual components of the metabolic syndrome, and a cluster of these factors significantly increases the risk. Introduction: This study is to present the changes of target organ damage (TOD) and arterial stiffness parameters after treatment in children with primary hypertension (HTN) who were managed in accordance with the European Society of Hypertension Guidelines 2016. Material and methods: The patients included in the study were newly diagnosed and untreated ones and they had a follow-up period of minimum 6 months. All patients underwent the following assessments: Anthropometrical measurements, 24-hour ambulatory blood pressure monitoring (ABPM), left ventricular mass index (LVMI), plasma creatinine, urea, electrolytes, uric acid, fasting plasma glucose, blood lipids, urinalysis, urine culture, first morning urine albumin: creatinine ratio. The ABPM device was able to perform measurements like central blood pressure (cBP) and pulse wave velocity (PWV). At the end of the study, patients were divided into normotensive and hypertensive. Pre-and post-treatment parameters of the patient groups were compared. Results: Thirty-two of 104 patients were enrolled. Seventeen of the patients were male and the frequency of obesity was 53%. Compared with pretreatment, creatinine, urea, systolic blood pressure (SBP), diastolic blood pressure (DBP), central SBP (cSBP) , cSBP z-score, cDBP, and PWV z-score decreased, whereas LVMI z-score and BMI z score were not changed. When the normotensive and hypertensive were compared, while there was cSBP and PWV z score regression in the normotensive group, both parameters increased in the hypertensive group. However there was no change in LVMI z score in hypertensive patients (Table 1) . Conclusions: The finding suggest that vascular function tests may detect an earlier response of BP regression in the cardiovascular system. For hypertensive group, it seems that both obesity and HTN presence have a greater impact on arterial stiffness than does cardiac remodeling. Finally, in a short-term follow-up, in children with low CVD risk as BP normalizes, regression of cSBP and PWV may occur without LVMI reversal. Introduction: The aim of the study was to detect complications and associated risk factors in patients with renal scarring (RS) secondary to recurrent urinary tract infections (UTI). Material and methods: Fifty patients with RS with a mean follow-up time of 9.69 years were compared with 25 patients without RS by means of, serum creatinine, 24-hour urinary creatinine clearance, and 24-hour urinary albumin levels. Office blood pressure (BP) examination and ambulatory BP monitoring (ABPM) were also performed. Results: Vesicoureteral reflux was detected in 50 patients and its grade was correlated with the severity of RS (r=0.45, p=0.01). Glomerular filtration rate (GFR) <90 mL/min/1.73 m 2 was observed in 5 patients with RS but in no patient without RS. Urinary albumin excretion was significantly higher in patients with bilateral RS and severe RS. Patients with albuminuria had a significantly lower GFR than those without albuminuria. All patients with ambulatory hypertension (HT) were in the RS group, and 60% of those had isolated nocturnal HT. Compared to those without RS, patients with RS had significantly higher standard deviation score (SDS) values for all BP readings, 24-hour and nighttime systolic and diastolic BP loads with significantly lower systolic dipping. GFR was negatively correlated with diastolic BP SDS and diastolic BP load in patients with RS. Daytime diastolic BP load was significantly higher in those with severe RS than in those with mild RS.

Conclusions: Isolated nocturnal HT could be an early indicator of complications in RS of UTI. Albuminuria is related to increased BP and impaired renal function. Therefore, ABPM and assessing albuminuria should be a routine part of the follow-up. Diastolic BP elevations could be associated with worse outcomes in these patients.

Introduction: In the recent years, the effect of blood pressure (BP) on cognitive functions of the brain has gained increasing interest. The aim of the present study was to study if hypertensive children and adolescents present lower cognitive function scores. Material and methods: Children and adolescents aged 5-18 years with diagnosis of primary arterial hypertension underwent 24-hour ambulatory BP monitoring and assessment of cognitive functions with WISC-III test.

Results: Hypertensive children showed statistically significantly lower performance on the scales of similarities, cube patterns, as well as practical intelligence and general intelligence scales, compared to children with normal BP on 24-hour ambulatory BP monitoring. Night systolic BP z score showed a negative correlation with the verbal intelligence quotidient (r=-0.439, p<0.05), and the general intelligence quotidient (r=-0.429, p<0.05), while night diastolic BP z score showed a negative correlation with the practical intelligence quotidient (r=-0.356, p<0.05) and the general intelligence quotidient (r=-0.394, p<0.05). For each standard deviation (SD) increase of systolic and diastolic night BP intelligence quotidient was reduced by 0.462 and 0.421 respectively (image 1,2)

Conclusions: Night BP is closely correlated with cognitive function in children and adolescents as shown by the associations with intelligence quotidients in WISC-III test. 24-hour ambulatory BP monitoring in children and adolescents with hypertension is important for identifying children at increased risk for lower cognitive performance. Introduction:Serum levels of traditional (TnT and BNP) and novel (GDF15 and ST2) CV biomarkers increase after start of dialysis and decrease after kidney transplantation (KTx). The aim of this analysis was to analyse covariates associated with these changes.

Material and methods: CV biomarker levels were measured in children before and after dialysis (n=53) or pre-emptive KTx (n=42). Association between the changes (Δ) of biomarkers and various covariates (including left ventricular mass index (LVMI), pulse wave velocity z-score (PWVz) and carotid intima-media thickness z-score (cIMTz)) was analysed by linear regression adjusted for time between biomarker measurements and baseline biomarker level.

Results: Median age and estimated glomerular filtration rate (eGFR) was 13.6 years and 13.5 ml/min/1.73 m 2 before the start of dialysis, and 12.9 years and 13.0 ml/min/1.73 m 2 before KTx, respectively. GDF15, TnT and BNP but not ST2 increased after the start of dialysis (median change 24%, 50%, 201% and 3%, respectively) and decreased after KTx (-58%, -27%, -73% and -3%, respectively). The biomarker changes after initiation of dialysis associated inversely with ΔeGFR (ΔTnT and ΔBNP) and Δhigh-density lipoprotein cholesterol (ΔTnT and ΔGDF15), and directly with Δserum phosphate (ΔTnT and ΔGDF15), Δferritin (ΔTnT, ΔBNP and ΔGDF15) and ΔLVMI (ΔTnT and ΔBNP). ΔST2 was inversely associated with Δserum albumin and Δhemoglobin.

In children who underwent pre-emptive KTx, ΔBNP, ΔGDF15 and ΔST2 associated inversely with Δhemoglobin. In addition, ΔBNP was directly associated with Δferritin and ΔLVMI, while ΔGDF15 was inversely associated with ΔeGFR and ΔST2 directly with Δtotal cholesterol. ΔTnT was inversely related to Δserum calcium and directly to ΔPWVz. Conclusions: Changes of serum CV biomarker levels following the start of KRT are only partially explained by changes in kidney function and additionally associate with markers reflecting uremic and CV risk burden. Change of CV endpoints associated only with traditional CV biomarkers (TnT and BNP).

Introduction: Mid Aortic Syndrome (MAS) is a rare vascular malformation characterized by segmental narrowing of the abdominal aorta and stenosis of its principal branches. Patients affected by MAS typically present malignant renovascular hypertension, with variable clinical symptoms like claudication, abdominal angina, headache. Material and methods: A newborn was admitted to our hospital with systemic shock. At the clinical resolution patient showed hypertension with systolic blood pressures ranging from 110-150 mmHg (greater than 99% percentile) and absence of femoral pulses. An echocardiogram showed mild left ventricle (LV) hypertrophy (Z score 2.7) with increased LV mass index (130 g/m2, vn 49-115 g/m2) and aortic coarctation was excluded. Diagnostic imaging of the abdominal vessels showed narrowing of abdominal aorta to the proximal tract of superior mesenteric artery, right filiform renal artery and left stenotic renal artery with size prevalence of right kidney confirming the diagnosis of MAS. Results: Our patient was successfully treated with right percutaneous transcatheter renal angioplasty (PTRA) and left nephrectomy. Progressively blood pressure values improved with beta-blockers, calcium channel blockers and angiotensin-converting enzyme inhibitors. Furthermore, in our case cerebral MRI angiography showed a tortuous course of the A2 tracts of the internal cerebral arteries raising the suspicion of Moyamoya Disease. Genetic testing is still ongoing.

Conclusions: Patients can develop hypertensive encephalopathy, vascular brain accidents and systemic shock as occurred in our patient. MAS may be acquired, caused by Takayasus or temporal arteritis, neurofibromatosis, Williams syndrome and Moyamoya disease, or congenital, ascribed to a developmental anomaly in the fusion and maturation of the paired embryonic dorsal aortas. Therefore, in patients with multidrug resistant hypertension, vascular causes such as MAS, isolated or syndromic, should be suspected. Renovascular hypertension often requires a surgical approach to treat clinical symptoms and prevent or avoid organ damage.

Introduction: Pulse wave velocity is a method of functional vascular evaluation. The gold standard is the carotid-femoral pulse wave velocity measurement. However, the software allows measurement among radial, carotid and femoral artery. The goal of our prospective pilot study was to compare pulse wave velocity measurement among different arteries, not only carotid-femoral, in children and adolescents to find out, if the measurement can be performed in a simplified version with comparable results which would be especially important in younger children.

Material and methods: 58 children were analyzed using SphygmoCor Cardiovascular Management Suite® and PWV was measured in three different ways: carotid-femoral pulse wave velocity (cfPWV), carotidradial pulse wave velocity (crPWV) in lying position and crPWV in sitting position PWV results and pulse wave analysis with central hemodynamic data were collected. Results: There was statistically significant difference between: cfPWV and crPWV in lying position and cfPWV and crPWV in sitting position (p<0.0001 for both). There was no significant difference between crPWV in lying or sitting position (p=0.158). Analysis of central hemodynamic data showed statistically significant differences between subendocardial viability ratio (p=0.001), end systolic pressure (p=0.001) and central diastolic pressure (p=0.001) when central hemodynamic data of carotid-radial measurements lying and sitting were compared, but there were no differences when the same parameters were compared between hemodynamic data of both lying positions, except for subendocardial viability ratio.

Conclusions: The site of measurement significantly affects pulse wave velocity and can not be interchangeable. On the contrary, the position of the child does not affect pulse wave velocity, but could be important in hemodynamic data analysis.

Introduction: The hypothalamic-pituitary-adrenal (HPA) axis abnormalities and insulin resistance are involved in the pathogenesis of obesityassociated hypertension in adolescents. The aim of this study was to assess the correlation between serum cotisol levels, presence of insulin resistance and presence of hypertension in adolescents with obesity. Material and methods: Height, body weight, waist circumference, office blood pressure measurements of the patients were recorded. Ambulatory blood pressure monitoring (ABPM) was performed in each patient. Fasting glucose, insulin, total cholesterol, high density lipoprotein (HDL) cholesterol, triglyceride, troid stimulating hormone (TSH), free T4, cortisol and adrenocorticotropic hormone levels and 24 hour urine cortisol and creatinine levels were studied. The patients were grouped according to the presence of hypertension and/or insulin resistance. Results: Seventy five adolescent patients with obesity (37 girls, 38 boys) were enrolled in the study. Twenty-one (28%-group 1) patients had hypertension and insulin resistance, 24 (32%-group 2) patients had only hypertension; 14 (18.7%-group 3) patients had only insulin resistance and 16 (21.3%, group 4) patients had neither hypertension nor insulin resistance. There were statistically signicant differences in body weight sds, body mass index sds, systolic blood pressure, waist circumference, insulin, ACTH and triglyceride levels between patient groups. The patients in group 1 had higher values of these parameters than patients in other groups. Also the patients without hypertension had lower values of insulin, ACTH, cortisol and 24 hour urine cortisol than patients with hypertension.

Conclusions: Primary hypertension is often associated with obesity and insuline resistance. The disturbance in HPA axis may relate to hypertension in children with obesity. There is a need for further studies with higher number of patients and controls.

Introduction: CKD detected in 20-50% of children who had HUS. Arterial hypertension (AH) is one of the most frequent complications of HUS. AH is not only complication of HUS but also factor of formation and progression of CKD. The aim of the study was to determine frequency and role of AH in formation of CKD in children with HUS. Material and methods: Materials and methods: we had retrospective analyze of 75 case reports of children with HUS and had prospective study of these patients. All children were underwent 24h BPM. Results: 3 years children (81%, p0,05) prevailed in patients with HUS. AH was diagnosed in 35% (n = 26) of patients with HUS, in 100% of children with atypical HUS. Children with AH underwent RRT in 92.3% (n = 24) in acute period of HUS. AH was stopped together with acute renal injury in 25 patients. AH was diagnosed in 8 (11%) patients after HUS in their prospective study. 1 patient had AH from acute period of HUS till present time. 2 children who had stopped AH in acute period of HUS have AH in present time. 5 children had AH after stopped HUS. All children treated by antihypertensive drugs. 58% (n = 15) of children with AH in acute period of HUS have CKD in present time.

Conclusions: AH is predictor of formation and progression of CKD in children with HUS. Introduction: Behcets disease is a chronic recurrent systemic inflammatory disease characterized by inflammation in the vascular wall. We aimed to present an adolescent with Behçets Disease whose first presentation was with hypertension. Material and methods: A fifteen-year-old girl was admitted with complaints of dyspnea, palpitations, right arm numbness and cough. Rash, fever, oral aphthae or myalgia were not described. Her family history was unremarkable. On physical examination, her blood pressure was 219/126 mmHg (99 th p: 124/80mmhg) in the right arm, lower-extremity blood pressure was normal (110/70 mmHg). Laboratory results were as follows: hemoglobin 11.3 g/dL, leukocyte 9780/mm 3 , erythrocyte sedimentation rate 24 mm/hour, C-reactive protein 2.07 mg/dL, serum creatinine 0.64 mg/dL, serum sodium 138 mEq/L, serum potassium 4.1 mEq/L. Anti-nuclear antibody and antineutrophil cytoplasmic antibodies were negative. No proteinuria or hematuria was observed on urinalysis. A renal Doppler ultrasonography (US) showed a stenosis of 90% of the abdominal aorta. Fluorodeoxyglucose (FDG)-positron emission tomography was applied for large vessel vasculitis, showing diffuse wall thickening and accompanying significant pathological activity in the proximal abdominal aorta (L1 level) was observed. Propranolol and captopril were administered for antihypertensive treatment.

Results: At follow-up, doppler US was performed due to pain and hyperemia at right arm, revealing a thrombus in the vena basilica. Low molecular weight heparin and pulse methyl prednisolone were given to the patient with the diagnosis of vasculitis. Genetic analysis yielded a heterozygous "p.Thr68Met (c.203C> T) mutation on PSTPIP1 gene, which was previously reported to be associated with Behcets Disease. Conclusions: Although Behçets disease usually presents with arteriovenous thrombus, it should be kept in mind that it may present with hypertension. Introduction: The aim of our study was to evaluate correlations between body composition and several clinical parameters. Material and methods: 206 children and adolescents (120 male, 86 female) have been prospectively included in this study. Body impedance measurement has been performed in all participants. During the hospital work-up several clinical parameters were obtained and correlated to body composition measurement. Results: Body composition parameters were significantly associated with anthropometric measurements, systolic blood pressure, insulin levels, serum creatinine, urate, liver function tests, triglycerides, cholesterols and apolipoproteins, homocysteine, vitamin D and proteins in 24-hour urine. Body composition differed between boys and girls, between participants with hepatic steatosis and normal liver parenchyma as well as between left ventricular hypertrophy and normal left ventricular wall. Interestingly, body composition did not correlate with diastolic blood pressure, pulse wave velocity and intima media thickness. Conclusions: Several clinical parameters are associated with body composition and fat mass in children. Obesity and body composition play an important role in development of other cardiovascular risk factors, not dependent on fat mass alone, and the latter might be used for cardiovascular risk determination. Introduction: Blood pressure is influenced by adipose tissue in obesity. We aimed to investigate the relationship between blood pressure and body composition in normotensive and hypertensive children.

Material and methods: Children who underwent ambulatory blood pressure monitoring were grouped as hypertensive (+) (Group 1) and normotensive (Group 2). Bioelectric impedance analysis (Bodystat Qudscan 4000, Bodystat Limited, British Isles) were performed to all patients and the following parameters were recorded: body mass index (BMI), body fat mass index (BFMI), lean mass index (LMI), fat free mass index (FFMI), total body water (TBW%), extracellular fluid (ECF%), intracellular fluid (ICF%). Groups were compared for these parameters and age, gender, waist and hip circumference, waist-hip ratio, uric acid and lipid levels. In addition, the correlation of these parameters with mean blood pressure (BP) (systolic, diastolic and total) and BP loads (day and night) was evaluated.

Results: There were 32 children in Group 1, 16 in Group 2. The age and gender were similar in both groups. The waist and hip circumference, BMI, BFMI, LMI, FFMI and uric acid level were higher in Group 1 than Group 2, while ECF% was lower in Group 1. There was a positive correlation between uric acid level and systolic or total mean BP during the day and night. In addition, there were a positive correlation between BFMI, LMI, waist circumference with systolic or total mean BP during the day or night (p<0.05). There was a negative correlation between ECF% and BMI (r= -0.58, p<0.05).

Conclusions: The waist circumference, uric acid, fat and fat free mass may have an impact on BP.

Ganna Zvenigorodska 2 , Galina Guminska 1 , Lyudmyla Starynets 1 , Oleksandr Moskaliuk 2 1 Vinnytsya Regional Clinical Childrens Hospital 2 National Pirogov Memorial Medical University

Introduction: Renovascular hypertension is not very common in the pediatric population. Because high blood pressure in children is rare and most of these patients are asymptomatic, many are overlooked until they present with a hypertensive crisis. The aim of this study was to review a case of a child with malignant hypertension caused by renal artery stenosis (RAS). Material and methods: We have a follow up of the patient with congenital adrenal hyperplasia (CAH) and uncontrolled hypertension caused by bilateral renal artery stenosis, determined clinically in a Vinnytsya Regional Children's Hospital. His clinical course was retrospectively reviewed and results analyzed. Results: A 3 years old child presented with vomiting, headache. Blood pressure (BP) was discovered 260/180 mmHg. Opthalmological examination revealed retinal exudates. Drugs couldn't control his BP. From the history it was known that the child had CAH, deficiency of 21-hydroxylase. The diagnosis was confirmed by neonatal screening test and replacement therapy with fludrocortisone and glucocorticoid started.

Hypertension was thought to be the adverse effect of drugs. Changing of doses of these medications gave no effect. Medical treatment with nifedipine, amlodipine, moxonidin failed to control his BP. Biochemical analysis showed impaired kidney function. GFR decreased

progressively. An ultrasound scan showed two normal-sized kidneys. Echocardiography showed hypertrophy of left ventricle. Because of resistant high grade hypertension we suspect renovascular origion. CT angiography revealed right renal artery high grade stenosis, which was the cause of near total occlusion, as well as left artery stenosis. Bilateral RAS with renal insufficiency was diagnosed. The child was sent for surgical revascularization.

Conclusions: Systemic hypertension in children is usually secondary to a specific pathology, and RAS is the most common cause in children. Surgical revascularization has been an effective therapy. Hypertension may persist despite endovascular or surgical management of childhood RAS highlighting the importance of close monitoring and ongoing medical management. Introduction: A 9-year-old male was referred to the emergency department of our hospital for headache and vomiting, his blood pressure was 203/130 mmHg. He was admitted to the pediatric nephrology unit for investigation.

Material and methods: The family history was negative for hypertension but positive for renal stenosis (maternal uncle). His weight and height were normal for his age. Physical examination was unremarkable with no cardiac or abdominal bruits and normal peripheral pulses. Routine laboratory and urine examination were normal. An abdominal ultrasound showed the left kidney to be smaller than the right one (right 9,2 and left 7,9 cm) with regular corticomedullary differentiation. Fundoscopic examination and electrocardiogram were normal, where the echocardiogram showed no left ventricular hypertrophy. A bilateral renal stenosis was detected by a renal doppler. Further analysis revealed a significant increase of renin activity and aldosterone levels. Clonidine, amlodipine and furosemide were administrated with clinical benefit. At 48 hours of admission the patient was asymptomatic and his blood pressure reduced to 150/100 mmHg. An ambulatory blood pressure monitoring (ABPM) was performed showing an average 24h value of 147/104 mmHg, being daytime and nighttime values 149/105 and 141/100 mmHg respectively. Results: An abdominal magnetic resonance documented ostial bilateral renal artery stenosis with post-stenotic dilatation, ectasia of abdominal aorta (24 mm) associated with increased intima and media thickness, ectasia of celiac trunk, and narrowing of superior mesenteric artery. We performed a percutaneous transluminal angioplasty of both renal arteries, with ultrasoft SV Boston-Scientific 4 x 20 with no complications. Two days later ABPM was performed. At discharge, ABPM showed average 24h value of 117/75 mmHg, daytime and nighttime blood pressure values were 117/75 and 115/75 mmHg respectively. Conclusions: We suspected a middle aortic syndrome (MAS) related to Takayasu arteritis. One month later his blood pressure values were 110/ 60, under treatment with amlodipine.

Bernardica Valent Moric, Tomislav Krpan, Josipa Josipovic Sestre Milosrdnice University Hospital Center Introduction: The most common pattern of kidney vascularisation is a single renal artery originating from the abdominal aorta. However, in 20-30% of general population an accessory renal artery can be found being more frequently present (up to 80%) in patients with essential hypertension. A possible pathomechanism of hypertension is the impaired renal perfusion since the diametar of a single renal artery is usually larger than when multiple arteries are present. Whether an accessory renal artery could be a cause of hypertension is still controversial. Material and methods: We describe a case of a 16-year old girl who presented with hypertension crisis. She was previously healthy with no record of abnormal blood pressure (BP). At admission she reported nausea and severe headache while her BP was 220/120 mmHg. Her body mass index was normal and physical examination unremarkable.

Results: Initial workup showed normal renal function with normal serum electolytes and plasma glucose. Urin dipstick and urin toxicology screen were also normal. She had hypercholesterolemia and mild proteinuria but no signs of other target organ damage (electrocardiogram, echocardiography, fundoscopy and computed tomography of the brain were normal). Ambulatory blood pressure monitoring confirmed severe ambulatory hypertension. Further evaluation was aimed at determining the possible cause of secondary hypertension. Urine metanephrines, urinary free cortisol, plasma cortisol, ACTH and thyroid function tests were within reference ranges. High normal plasma renin with elevated plasma aldosteron led to a suspicion of renovascular hypertension. Magnetic resonance imaging revealed no pathology of the adrenal glands. Although renal ultrasonography with Doppler was normal, magnetic resonance angiography and later CT angiography showed two nonstenotic right renal arteries.

A satisfactory blood pressure control was eventually achieved with combination therapy including ACE inhibitor. Conclusions: Although nonstenotic, an accessory renal artery should be considered as a possible cause of renovascular hypertension in children and adolescents. .4 years (range 7.9-17) with a 1:1 sex ratio. All patients presented with oedema and nephrotic syndrome +/-macroscopic (n=2) or microscopic (n=1) hematuria, and normal eGFR. Four patients had a positive PLA2R serology. Initial treatment included steroids and tacrolimus, in addition to ACE-inhibitors. B-cell depletion was added in 5 patients at onset and after relapse in the 3 others. Complete remission was obtained in all patients after a median time of 3.7 months (range 2-6). Five patients experienced >1 relapse, following tacrolimus discontinuation or B-cell recovery. At last follow-up (median 60 months), all were in complete remission, receiving ACE-inhibitors +/-B-cell depletion. One patient with negative PLA2R-Ab was diagnosed 5 years after with systemic lupus with skin involvement and arthritis. Conclusions: In this small series, all patients went into complete remission within 6 months with a combined induction therapy with steroids and tacrolimus +/-B-cell depletion, but 60% relapsed. There are no guidelines for the treatment of pediatric primary MN, and there is a real need for larger data. Therefore, a European survey and registry initiative is currently in process. Mean age at diagnosis of interstitial nephritis was 14 years old. Ten patients presented with fever, 12 with digestive symptoms and 13 weight loss. Only 1/19 had a prior diagnosis of sarcoidosis. At presentation, mean serum creatinine level was 242 μmol/L and proteinuria 0.83 g/L. Granulomas were detected on renal biopsy in 6 cases, on salivary gland biopsy in 9 and both tissues in 4 patients. Extrarenal involvement included uveitis in 6/19 and lung in 6 patients with only asymptomatic test dysfunction in 5. All patients received steroids, after methylprednisolone pulses in 15/ 19. Mean duration of oral prednisone was 16 months and 15 received Mycophenolate mofetil as maintenance therapy. At 2 years follow-up, GFR was 88mL/min/1.73m 2 .

Conclusions: The prevalence of renal involvment in pediatric sarcoidosis is unknown but this series highlights that renal granulomatous sarcoidosis is mostly inaugural, associated to general signs and/or uveitis rather than pulmonary or multiorgan disease. All patients had a favorable renal outcome with this intensive treatment strategy. Longer follow-up and larger series are required to better describe the disease's course and evaluate treatment options.

Introduction: Sjögren syndrome (SS) is a chronic autoimmune disease primarily affecting lachrymal and salivary glands with varying degrees of systemic involvement. Clinical manifestations differ in children and do not meet currently available adult criteria (American European consensus group -AERCG). Recurrent parotid swelling is often observed in children unlike oral and ocular involvement (sicca syndrome) which are specific for adults. Extraglandular involvement ia rare, only 9.9% patients having renal involvement. Pathologic and laboratory findings include lymphocytic infiltration of the exocrine glands, presence of rheumatoid factor (RF) and specific antinuclear antibody (ANA). We present a case of primary SS with renal involvement. Material and methods: A 12- year-old girl with history of recurrent left-sided parotid enlargement episodes and sicca syndrome was admitted to our Department for evaluation. Her mother was diagnosed with systemic lupus in adolescence.

Results: Laboratory screening showed highly positive ANA (1:1280), anti-SS-A 122 U/mL, anti-SS-B 176 U/mL and RF (762 U/mL). Schimmer's test verified moderate hypolacrimation. Salivary gland biopsy confirmed pSS diagnosis. Since there was persistent proteinuria in a 24-hour urine (247 mg/24h) renal biopsy was performed and acute tubulointerstitial nephritis was confirmed by pathohystological evaluation. The patient received pulse corticosteroid therapy. On her last follow there was no proteinuria with low dose prednisone and hydroxichlorochine therapy. Conclusions: pSS is rare and often unrecognized condition in children. The lack of pediatric diagnostic criteria and underdiagnosed extraglandular involvement can affect course of disease. Early renal involvement recognition and adequate therapy can prevent progressive disease. Additional studies in children are needed in establishing clasification criteria and therapeutic algoritams to enable further clinical and translational research. Introduction: Concurrent membranous glomerulonephritis (MGN) and ANCA vasculitis, commonly associated with necrotizing/crescentic glomerulonephritis, is rarely described.

Material and methods: We report a case of MGN and ANCA vasculitis in a pediatric patient.

Results: A 4 year-old boy was admitted to a local public hospital for acute febrile infection of lower respiratory tract, with bilateral interstitial lung infiltrates at chest X-ray. On 3 rd day, he presented nephrotic syndrome, necessitating prednisolone therapy initiation. C3, C4 titers and antistreptolysin levels were normal, while antinuclear and anti-DNA antibodies were negative. He was discharged on 20 th day, but eight days later, he presented acute respiratory distress and was transferred to our hospital. Pulmonary CT scan revealed scattered ground-glass opacities throughout the pulmonary parenchyma and disperse alveolar infiltrates indicative of alveolar hemorrhage. Kidney function and serum albumin were normal, while moderate proteinuria (527 mg/m 2 /24h) without hematuria was present. Positive serum cANCA antibodies indicated granulomatosis with polyangiitis (GPA) vasculitis. Nevertheless, kidney biopsy revealed MGN with IgG, IgM and IgA, C3 and C1q subepithelial deposits, moderate mesangial proliferation and minimal endocapillary hypercellarity, without glomerular necrotizing lesions or crescent formation. Induction therapy included methylprednisolone pulses (3 doses) switched to prednisolone therapy for 6 months and cyclosphophamide infusions (6 doses), while rituximab therapy (4 doses) was added due to respiratory function deterioration 4 days after admission. One week after therapy onset, cANCA levels turned negative, proteinuria resolved, and respiratory function was improved. 10 months later, the patient remains in remission under maintenance therapy with mycophenolate mofetil. (11.3-16.2) in the patients with renal artery involvement. All of the patients presented with hypertension, 3 of 6 patients had bilateral renal artery involvement. During initial evaluation, functional renal asymmetry was revealed in 4 patients with MAG3, DMSA and DTPA scintigraphy. The median follow-up period was 26 months . During follow-up, two patients underwent surgery (both thoracic aorta to abdominal aorta bypass and aortorenal bypass). Radiological findings of 2 patients with single renal artery wall irregularities improved on follow-up. eGFRs were >60 ml/min/1.73 m 2 during the follow-up in all patients. At last visit, need for antihypertensive persisted in all of the patients. Conclusions: In TA renal arteries are mostly affected, and patients frequently manifests with hypertension. In addition to immunosuppressive drugs used for primary disease, surgical procedures and multiple antihypertensive drugs may be required in the management of hypertension. Imaging of kidney differential functions at the time of diagnosis may be a guide for the surgical plan. 2.4-3.6) g/dL, median proteinuria 2.84 (IQR 1.08-6.30) g/per day. Children with nephrotic (n=22) and nonnephrotic (n=17) proteinuria differed in Hb level (P < 0.05), serum albumin level (P < 0.001), daily proteinuria (P < 0.0001), eGFR (P < 0.01) and occurrence of hypertension (P < 0.01). We did not observe statistically significant differences in the age at the onset of LN, WBC count, platelet count, C3 level, C4 level and SLEDAI between the nephrotic group and non-nephrotic group.

Conclusions: Proliferative forms of LN in children may have a varying clinical presentation. Children with LN with nephrotic range proteinuria have lower Hb level, lower eGFR and higher occurrence of hypertension. Introduction: Associated vasculitis-ANCA (AAV) are rare in pediatric age (incidence 10.6 cases / 100,000 / year). Renal involvement is common in up to 90% of cases. Material and methods: In this study, the cases of AAV diagnosed in the last 15 years at the Pediatric Nephrology of the AORN Santobono Pausilipon in Naples were retrospectively analyzed, describing the clinical characteristics, renal involvement, treatment and outcome of the disease.

Results: 9 patients were identified. Five (55%) were affected by microscopic polyangiitis (MPA) and 4 (44%) by granulomatosis with polyangiitis (GPA) according to the EULAR / PReS classification criteria.All patients received steroid boluses as induction therapy and in addition cyclophosphamide was used in 6 patients while rituximab in 2 others. Plasma exchange was performed in two patients for a total of 10 sessions in combination with steroid boluses and rituximab. The median follow up of the entire population is 88 months. Maintenance therapy involved the use of prednisone with gradual decalage and mycophenolate.

Conclusions: The analysis of therapeutic efficacy showed that patients treated with rituximab and plasmapheresis did not relapse after remission, although one of the two patients had chronic kidney disease stage V D KDOQI residual. Introduction: We describe an unusual presentation of Gougerot-Sjögren syndrome (GSS) associated with celiac disease (CD) in a child Material and methods: A 14-year-old girl with CD presented with nephrogenic insipidus diabetes, distal tubular acidosis and peripheral neuropathy Results: A non-consanguineous 14-year-old girl with a medical history of several family cases of CD and a type 1 diabetic father; was diagnosed at tenyear-old with celiac disease. At that time, the girl had an alternation of diarrhea and constipation, evolving for two years, associated with abdominal bloating, and stunting. Her anti-transglutaminase antibodies were positive. Her jejunal biopsy showed total villous atrophy. A gluten-free diet was started, but unfortunately, the child was not compliant. A year later, she presented to the hospital for polydipsic-polyuria syndrome with ataxia evolving for three months. Physical examination noted a failure to thrive, and pubertal delay. Laboratory workup revealed an Iron deficiency anemia, hypocholesterolemia, associated with features of hypogonadotropichypogonadism. Pelvic sonography showed no ovaries and a small bladder strip corresponding probably to the uterus. The girl had polyuria. Her water restriction test showed a nephrogenic insipidus diabetes pattern. Serum electrolytes showed metabolic acidosis, with hyperchloremia, hypokalemia, and normal plasma anion-gap. Her urinary PH was alkaline, and her urinary anion gap was positive. Neurological examination showed a peripheral neurogenic syndrome. The electromyogram showed a motor polyneuropathy. Also, the girl reported a dry syndrome of the mouth and eyes. Biopsy of salivary glands showed a chronic sialadenitis. Keratoconjunctivitis was found on ophthalmological examination, and the Schirmer test was positive. The presence of distal tubular acidosis, dry syndrome, and polyneuropathy was very suggestive of Gougerot-Sjögren syndrome. Serological tests were done, and the rheumatoid factor came positive along with anti-nuclear antibodies. Therapeutic management consisted of a strict gluten-free diet, physical rehabilitation, artificial tears, oral steroids and amiloride-hydrochlorothiazide association. Evolution was marked by normalization of stool and gait, with remarkable improvement of polydipsic-polyuria syndrome within three months Introduction: Lupus nephritis (LN) in children has a more severe clinical course than in adults, is a factor that worsens the prognosis, and its course is difficult to predict. The aim of the study was to assess the course of childhood-onset lupus nephritis in pediatric nephrology centre.

Material and methods: The study included 10 patients (9 females and 1 male) hospitalised in the tertiary pediatric nephrology centre between 2006-2020, with systemic lupus nephritis diagnosed at the average age of 14 ± 4 years. Nephropathy was confirmed by renal biopsy in all patients. Results: In five patients (50%), lupus nephritis was the first symptom of cSLE. At the time of cSLE diagnosis, one of the patients was in the 20th week of pregnancy In the renal biopsy class IV LN was diagnosed in 60% of the patients. Treatment comprised glucocorticoids (GCS) (100%), mycophenolate mofetil (MMF) (50%), cyclophosphamide (33.3%) and azathioprine (0.16%). Patients diagnosed with class III (20%) were treated with GCS (100%) and MMF (100%). Two patients (one with class II lupus nephritis -10% and one with class I lupus nephritis -10%) were treated only with GCS. The course of the disease in one of the patients was associated with the need for renal replacement therapy. In 90% of the patients a remission was achieved. One patient died as a result of disseminated infection with Aspergillus spp. The treatment with glucocorticoids was associated with the occurrence of adverse reactions in half of the patients. In one of the patients, the use of GCS intensified psychiatric symptomsparanoid personality disorder was diagnosed.

Conclusions: Clinical course of LN in chidren varies between cases. In most subjects, early diagnosis and treatment of cSLE leads to the remission, although the disease and its treatment may have serious complications. Objectives: Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis is a rare but severe condition in childhood. Clinical presentation is often heterogeneous and treatment is not well defined. Methods: We describe three cases of ANCA vasculitis in children with renal involvement. Results: First case is a 16-month-old girl with a history of preterm birth, large interatrial communication and resistant hypertension since the first month of age. Glomerular filtration rate (GFR), blood biochemistry and renal ultrasound were normal. Positive A-ANCAs were found, her moth-er´s serology was negative. After five plasmapheresis sessions and four weekly doses of rituximab, she was clinically better but A-ANCA persisted. Currently, hypertension is well controlled with captopril. Next case is a 2-year-old boy with end stage renal disease (ESRD) because of rapidly progressive glomerulonephritis. He was diagnosed when he was 3 months old during a hospital admission because of a suspected urinary tract infection. He started with oliguria, hematuria, proteinuria, elevated serum creatinine and refractory hypertension with positive A-ANCA. Eventually, he required continuous hemodiafiltration. He had a bilateral nephrectomy and kidney biopsy showed pauci-immune extracapillary proliferative glomerulonephritis. Despite treatment with intravenous bolus of methylprednisolone, oral prednisone and rituximab he is on peritoneal dialysis and is awaiting a kidney transplant. Last case is a previously healthy 5-year-old patient who presented with nephritic syndrome of torpid evolution and low C3 levels. Renal function worsened progressively and he needed extrarenal depuration techniques. P-ANCA was positive and kidney biopsy showed glomerular crescents in above 70% glomeruli. He received five doses of rituximab (last one in April 2020), ten plasmapheresis sessions and intravenous and oral corticoids tapering regimen until July 2020 with clinical improvement. Currently, he has normal GFR and is not taking medication.

Conclusions: Treatment of pediatric ANCA-vasculitis is based on adult guidelines. More studies in children are needed to establish better therapies. Introduction: Intravenous nicardipine is an efficient drug for severe arterial hypertension and belongs to the standard treatments in pediatric nephrology and intensive care units. We report the case of a boy with atypical HUS who developed severe macroglossia and angioedema while treated with intravenous nicardipine. Material and methods: A 1-year-old boy presented with generalized oedema, asthenia, pallor and poor dietary intake at the clinical examination. Blood sampling revealed mechanical hemolytic anemia (hemoglobin 4.4 g/dL), low platelets (12,000/mm3), low serum albumin with nephrotic proteinuria and acute renal failure (serum creatine 91 umol/L, urea 21 mmol/L). The search for shigatoxin in a rectal swab and stool were negative twice, ADAMTS 13 was normal, vitamins B9/B12 normal, ANF, ANCA, anti dsDNA were all negative. C5b9 activity was increased (638 ng/mL; normal value 420) and C3 was decreased, allowing the diagnosis of atypical HUS. Serum levels of Factor H, I, B and CD46 were normal. Mutation analysis of respective genes is still ongoing. Eculizumab injections were performed and resulted in a rapid clinical and biological improvement. He received 5 blood transfusions, hemodialysis and loop diuretics to manage fluid overload and severe arterial hypertension was managed using intravenous nicardipine between 2 and 4.5 mc/kg/min. Results: Thirteen days after initiation of nicardipine therapy, the child developed facial swelling and significant macroglossia. Nineteen days after nicardipine initiation, he was transferred to the intensive care unit for respiratory distress secondary to obstructive macroglossia. At that time, the antihypertensive treatment was changed, nicardipine was interrupted and intravenous urapidil (alpha-1 antagonist) was introduced with good blood pressure control and without recurrence of angioedema. Within one day after the withdrawal of nicardipine, the boy's macroglossia/angioedema had completely resolved and never relapsed.

Conclusions: Severe angioedema may be related to the treatment with intravenous calcium antagonists. As soon as this association is detected, nicardipine should be immediately withdrawn and replaced by other intravenous drugs such as alpha-1-antagonists. Awareness about this rare association may help to switch the treatment quickly and avoid potentially life threatening situations. Post-infectious GN with activation of classical pathway of complement cascade is also an infrequent presentation (<10%). The aim is to discuss differential diagnosis in patient with fluid overload, nephrotic proteinuria and hematuria. Clinical observation: 5-year-old patient admitted with facial edema and increased abdominal perimeter. Intermittent fever was referred for the last 2 weeks. He presented hypertension, tachypnea and respiratory distress, anasarca and bad general condition. Radiological signs of pulmonary edema were observed. Blood test showed anemia (hemoglobin 8.7g/dl), hypocomplementemia C3 (<110mg/l) and C4 (94mg/l), hypoalbuminemia (24mg/l), hypocalcemia (8.3 mg/dl) with normal kidney function. The urinary test showed microscopic hematuria (25-50 erythrocytes/field) and nephrotic proteinuria (protein/creatinine index 5.4 mg/mg). He received intravenous albumin and furosemide; hypertension was corrected once the fluid overload was controlled. Autoimmunity test was normal but ANA 1/180. Kidney biopsy was performed: all glomeruli (17) had endocapillary proliferation, none with extracapillary proliferation or sclerotic lesions. Positive staining for C3 (+++), IgA (+) and IgG (+++) was informed with granular mesangiocapillary pattern. He was diagnosed of post-infectious GN and symptomatic treatment was decided. During follow-up patient improved all biomarkers (anemia, biochemical nephrotic syndrome and complement) and remained asymptomatic. Due to activation of classical pathway of complement (C3 and C4 decreased), therefor we performed a genetic and functional complement test with no findings. Conclusion: The approach to patients who consult for edema and hematuria can be difficult because of atypical presentations of frequent entities. Renal biopsy is essential to reach the diagnosis and to adopt the appropriate therapeutic measures.

Introduction: Primary CoQ10 deficiency, a mitochondrial disorder caused by recessive mutations in components of the CoQ10 biosynthesis pathway, leads to a wide spectrum of organ involvement, including steroid-resistant nephrotic syndrome (SRNS Results: Median (interquartile range) age at kidney disease onset was 1 (0.5-2), 2 (0.9-4.5) and 9.9 (5.3-14.4) 

The ADPedKD registry is a unique source of clinical observational data that will provide deep phenotyping of children with ADPKD and will allow to define unified diagnostic and follow-up recommendations. Age of presentation (years) 6.6 (5.0,11.7) 4.7 (3.4,9.2) 7.5 (4.9,12.8) 5.4 (4.1,11.8) 0.70

Length of follow-up (years) 3.5 (2.0,8.2) 1.4 (0.5,4.9) 2.6 (1.4,3.0) 4.8 (1.6,8.5) 0.30 Age at last follow-up (years) 13.8 (11.8,14.7) 10.2 (5.3,11.9) 10.5 (6.7,15.1) 14.2 (7.7,16.1) 0.28 104. 8 (97.4,135.-1) 142. 6 (97.6,168.-4) 106.0 (100. 5,132.-7) 0.60 Introduction: FSGS is an inavitable stage of progressive glomerulopathies. The aim of the study was to determine the frequency of FSGS in children with Alport syndrome (AS).

Material and methods: The study included 60 children (age Me 11 (8,5;13) yrs; 40M) with AS; Х-linked AS had 43 pts. The inclusion criteria were: availability of light and immunofluorescence renal tissue microscopy, genetic/morphological verification of AS; the exclusion criteria were: the presence of concomitant kidney disease/podocytic genes' mutation and <10 glomeruli for analysis. The clinical (gender, age, deafness, blood pressure (BP)), laboratory (eGFR, proteinuria) data at the moment of biopsy, and renal tissue morphology (% of FSGS) were analyzed. The criteria for proteinuria was urine protein excretion (Pr) >100 mg/m 2 /day; the high-level proteinuria and nephrotic proteinuria were defined as Pr≥500 mg/m 2 /day and >1000 mg/m 2 /day, respectively. Blood hypertension (BH) was defined as BP≥95‰ for sex, age, height.

Results: FSGS was reveled in 35 (q=0.58) children. The pts were divided into 3 groups: gr1 (FSGS ≤10%, n=28), gr2 n=13) , gr3 (FSGS≥20%, n=19). The groups did not differ in age (11[8.5;13] vs 11[8;13] Introduction: Tuberous sclerosis complex presents with variety of symptoms than begin in childhood and increase with age. Renal manifestations are the leading cause of mortality in patients with tuberous sclerosis. Renal impairment includes mostly cystic renal disease and angiomyolipomas. The aim of our study was to determine the extent of renal impairment and other clinical characteristics as well as treatment of children with tuberous sclerosis complex, followed-up in our department. Material and methods: Ten patients with tuberous sclerosis (median age of 13.5 years) were in our cohort. Their history, clinical characteristics, including renal manifestations and treatment regime were highlighted.

Results: Renal manifestations, mostly angiomyolipomas, were present in six of our patients. In 2 patients renal impairment was found to be substantial. However, at the moment decreased renal function is present in only one. From extra renal characteristics: two thirds of patients had skin pathology, both cardiac rhabdomyomas and retinal hamartomas were present in 3 and brain lesions in 7 patients. In 7 patients' epileptic seizures and in 3 cognitive disorders were diagnosed, with 4 and 2 of them necessitating antiepileptic or psychiatric therapy, respectively. In 2 patients systemic everolimus was used in one because of angiomyolipoma size and other because of astrocytoma. In one patient embolization due to renal haemorrhage in angiomyolipoma was performed. In 2 patients topical everolimus for skin lesions was also prescribed. Until now, genetic analysis was performed in 7 patients and was positive in 5 and negative in 2 of them. Conclusions: Our results confirmed common renal involvement in patients with tuberous sclerosis complex. However, in most of the paediatric patients' renal function is stable and the treatment in rarely needed. Extra renal characteristics were present according to literature. Material and methods: We report the case of a 9 month old girl referred because of fever, vomiting, dehydration and electrolyte abnormalities despite fluid administration. Medical history revealed unexplained maternal polyhydramnios, prematurity (34weeks) and dysmaturity (birth weight 1,75kg). She was admitted in a neonatal unit and after a smooth course, was discharged after 36 days (weight 2,2kg). At 4months she presented with feeding difficulties and failure to thrive with no biochemical abnormalities or polyuria were .At admission, laboratory examination revealed plasma potassium (K) level <3.0 mmol/L, combined with inappropriately high excretion (44%), metabolic alkalosis and hypernatremia (154 mmol/l). Despite IV fluids the biochemical abnormalities persisted but polyuria became prominent Blood pressure ( Introduction: Renal tubular dysgenesis (RTD) is a lethal, developmental anomaly of the fetal kidney characterized by a defect in differentiation of the proximal and distal convoluted tubules. Inherited RTD is genetically heterogeneous and linked to mutations in the genes encoding the renin-angiotensin system (RAS). We describe a neonate with typical clinical features of RTD whose definitive diagnosis was confirmed by genetic analysis. Material and methods: Clinical presentation, investigations, management and outcome of the baby were followed from the health records. Results: Our patient was a male born to first degree consanguineous parents. Oligohydramnios appeared after 26 weeks gestation, leading to anhydramnios and lung hypoplasia. The baby was delivered via emergency C section at 32 weeks gestation with severe lung hypoplasia, potters facies and skull ossification defects. He had severe systemic hypotension unresponsive to triple inotropes. He was anuric since birth with gradually increasing edema and deranged renal functions. Ultrasound kidneys showed normal kidney size and echogenecity with normal bladder. The baby expired on day 6 of life. Family refused autopsy but whole exome sequencing showed mutation in AGT gene {homozygous G to A substitution at nucleotide position 1124 (c.1124, G>A) in exon 3} confirming the diagnosis of inherited RTD.

The diagnosis of RTD should be considered in a neonate who presents with late onset oligohydramnios, normal or near normal kidneys on ultrasound examination, skull ossification defects and refractory hypotension. Diagnosis of RTD is important for its severe clinical course and the risk of 25 % recurrence in case of the inherited form. Identification of the genetic defect allows for precise genetic counselling and early prenatal diagnosis. Material and methods: 10 children (5M/5F) with biallelic (n=5) and monoallelic (n=5) SLC34A1 mutations were examined. The median age at the first evaluation was 3.0 (2.0; 6.0) months. Molecular genetic analysis was performed in all children using NGS. Introduction: Schimke immuno-osseous dysplasia (SIOD) is a multisystem disorder characterized by a poor prognosis due to immunodeficiency and end-stage kidney disease. Material and methods: We summarized the data of 10 children (9 families) with SIOD syndrome observed in several Russian federal medical centers. Results: Renal disease was diagnosed at Me 3 [2] [3] [4] [5] yrs; 6 pts were treated with prednisone/calcineurin inhibitors (q=0.4); 5 pts progressed to end-stage kidney disease at Me 7 [5;8] yrs. In all cases SIOD was diagnosed by nephrologists at Me 4 [3;5] Introduction: The aim of the study was to assess the atypical retroaortic left renal vein as a cause of hematuria and proteinuria in children.

Material and methods: The study group consisted of 13 children (6 girls, 7 boys), aged 12,5 (7-16 ys) , with haematuria or proteinura, which were diagnosed having the atypical retroaortic location of left renal vein. This group was a part (6,2%) of bigger study in 209 children presenting with haematuria and/or proteinuria of unclear origin. Every patient underwent abdominal ultrasound with Colour and Spectral Doppler of renal vessels, both in supine and standing position. Aloka Prosound alpha 6 with convex transducer 2-6MHz was used. Ultrasound results were correlated with clinical and laboratory data. Results: Patients were evaluated 1-72 months (mean 24 months) after first diagnosis of haematuria or proteinuria. Proteinuria measured in a spot urine reached 2,4 g/l, mean 0,74 g/l; in 24h-urine up to15 mg/kg/d. In 3 children positive orthostatic test was observed. 2 children presented with left flank pain. In 2 children kidney biopsy was performed due to proteinuria >1,5 g/l with coexisting heamaturia. In one of them unspecific slight mesangial proliferation was found suggesting possible glomerulopathy. In ultrasound the diameter of left renal vein was similar in both positions, 6-11mm, mean 8,38mm vs. 6-10mm mean 7,88mm; with similar flow velocity 12-30 mean 21,1 cm/s vs. 5-28 mean 14 cm/s respectively. Flow spectrum analysis showed severe obstruction of left renal vein in 6 cases (46%). Retroaortal velocity increased significantly both in supine (50-150 mean 97 cm/s) and standing position (40-240 mean 110 cm/s) in all cases. In 2 children retroperitoneal anastomoses led to scrotal or periuteral varices Conclusions: Atypical anatomical variant of retroaortal left renal vein may lead to vein compression independent from body position, which may be the cause of heamaturia and/or proteinuria in childhood. Doppler ultrasound evaluation of renal and retroperitoneal vessels in supine and standing position is crutial to set this diagnosis. In children with nephrotic range proteinuria and hematuria kidney biopsy should be considered to rule out coexisting glomerulopathy.

Introduction: Nephropathic cystinosis usually presents in infancy with failure to thrive and acidosis with features of Fanconi's syndrome. Our case at presentation had features of Bartter's syndrome along with generalised proximal tubular dysfunction. Material and methods: Clinical presentation, investigations, and management of the patient were followed from the health records. Results: Our case is a 3 year old male child who presented at 2 years of age with vomiting, failure to thrive and dyselectrolytemia. He had triangular facies, polyuria and had normal blood pressure. At presentation, he had normal renal functions with hyponatremia, hypokalemia, hypochloremia, hypophosphatemia, hypomagnesemia mild metabolic alkalosis, and hypercalciuria. He had high urine chloride with elevated renin and aldosterone levels suggestive of Bartter's syndrome. He also had features of generalised proximal tubular dysfunction with proteinuria, glycosuria, aminoaciduria, and phosphaturia. His initial ophthalmologic evaluation was normal. Ultrasound KUB showed normal size echogenic kidneys. He required large doses of electrolyte supplements to correct his dyselectrolytemia. At 21/2 years of age, he developed photophobia, ophthalmologic evaluation revealed cystine crystals in the cornea suggesting a diagnosis of cystinosis. At 3 years of age, he now has developed mild metabolic acidosis with slight rise in creatinine and he is being considered for cysteamine therapy.

Conclusions: Till date,10 cases with nephropathic cystinosis have been reported that initially presented as Bartter's syndrome. Patients who present with hypokalemic metabolic alkalosis along with other features of Fanconis sydnrome should be re-evaluated and followed up regularly to diagnose cystinosis early. Early diagnosis and specific treatment of cystinosis is effective in slowing down or preventing complications. Introduction: Primary hyperoxaluria type 1 (PH1) is a rare autosomal recessive disorder which leads to increased production of oxalates with development of nephrocalcinosis / urolithiasis and end stage renal disease (ESRD). Combined liver-kidney transplantation (CLKT) allows saving lives of children with PH1 and ESRD. Material and methods: We present two clinical cases of children from the same family with identical homozygous mutation in AGXT gene, but different phenotypic manifestations: in an older childsevere nephrocalcinosis with onset of hemodialysis at 9,5 y.o., in a younger child recurrent urolithiasis. Results: The first child at 11,5 y.o. underwent CLKT from a deceased donor. There was a delayed renal graft function, which required hemodialysis. Despite several surgical complications (intraabdominal bleeding, stenosis in hepatic artery anastomosis), which were successfully solved, the function of kidney graft recovered on the 14 th day, and on the 30 th day the child was discharged from the hospital. For the last 3,5 postoperative years the child has a satisfactory function of the grafts. In the second child, since the diagnosis of PH1 at the age of 7,7 y.o. and the beginning of conservative therapy, there is a regular discharge of calculi with episodes of renal colic and obstruction of the urinary tract. Despite this, stable kidney function has been maintained over the past 5 years.

Conclusions: These clinical cases showed different phenotypes with the same mutation of AGXT gene. The clinical case confirms the possibility of a successful simultaneous liver and kidney transplantation in a child with ESRD.

Introduction: Neonatal nephrocalcinosis isn't a disease itself, but the sign of underlying pathological condition. When nephrocalcinosis is associated with metabolic acidosis and electrolyte imbalance, distal renal tubular acidosis (dRTA) must be investigated. dRTA occurs with hypokalemia, hypercalciuria, nephrocalcinosis, with alkaline urinary pH and sometimes deafness. We describe a case of dRTA with neonatal onset. Material and methods: genetic investigation, blood gas analysis, urine tests, kidney ultrasound Results: G.F is a one-month-old infant, hospitalized for severe hyperchloremic metabolic acidosis with normal anion gap and electrolyte imbalance. He appeared consciousness, dehydrated, inappetent and showed poor weight gain. After the lack of response to hydration, he was referred to intensive care unit. On admission he had blood pH = 7.1 and HCO3 = 3.34 mmol / L, K 2.2 mEq/ L, normal anion gap, urinary pH 8.Renal ultrasound showed bilateral nephrocalcinosis. Intravenous therapy with Sodium bicarbonate and Chloride Potassium was started, and clinical condition promptly improved. Therapy was switched to oral route within 72 hours. Later the genetic analysis revealed a genomic variant c2089C>T in heterozygosity of the ATP6V0A4 gene responsible of dRTA. At subsequent post-discharge checks, the patient has regular weight gain, blood pH and electrolytes within the norm.

Conclusions: metabolic acidosis associated with nephrocalcinosis can be a sign of dRTA. It's important to diagnose it in order to set the most appropriate therapy. The early diagnosis and treatment of dRTA can prevent renal and growth failure. Material and methods: The files of patients suspected of SIOD due to clinical and laboratory findings and genetically confirmed were retrospectively analyzed.

Results: In this study, all of the patients except one had SIOD mutations which were already defined with Sanger sequencing method. This patient had a novel homozygous mutation in the SMARCAL1 gene (c.1177C>T). Since her father lived in Syria, genetic analysis could not be obtained from the parents. All patients had nephrotic syndrome. The patients did not respond to steroid therapy or other immunsupressive agents. But in one patient we had been continued to give Cyclosporin-A (Cy-A) because she had been suffering from severe hypoalbuminemia and edema when Cy-A was withdrawn. Three patients had cerebral ischemia. Three patients died at follow-up while the survived ones were in end-stage renal disease. Two of our cases had an auto-immune disease; one had coombs positive hemolytic anemia and the other had bone marrow failure. Although the patient with coombs positive hemolytic anemia responded to steroid therapy, she died from bacteriemia and acute respiratory distress syndrome in follow-up. Similarly the other patient with bone marrow failure also died because of septicemia.

Conclusions: SIOD is a rare, multisystemic disorder and it may be diagnosed late or underdiagnosed. As in our cases, SIOD should be considered in all children of growth failure with unclassifiable bone dysplasia. A urine test for proteinuria should be performed in all cases with growth failure to help the correct diagnosis. All patients diagnosed with SIOD should be evaluated for cerebrovascular complications, prompt management and renal transplantation should be considered in the earlier period. Introduction: Renal tubular dysgenesis (RTD) is an ultra-rare disease that is associated with pathogenic variations in the genes of the reninangiotensin system (RAS), including AGT, REN, ACE and AGTR1 genes. The condition is associated with a very high mortality during the pregnancy and in the early postnatal period. There are only a few individuals surviving beyond the perinatal period. Here, we present two siblings with a homozygous AGTR1 pathogenic variation related RTD, who have survived for longer period than the previously reported individuals with AGTR1 mutation. Material and methods: We had two siblings of a consanguineous parents with a similar clinical picture recognized in the early postnatal period that is characterized by oligohydramnios, multiple joint contractures, central hypotonia, wide cranial sutures, severe arterial hypotension, impaired kidney functions, hyperkalemia, and metabolic acidosis. We performed whole exome sequencing to both siblings and the parents to uncover the underlying genetic abnormality. Results: We identified homozygous pathogenic variation in AGTR1 [c.376C>T (p.Arg126*)], thereby diagnosed as RTD in the course. In addition, both patients also had a homozygous variation in platelet derivated growth factor D (PDGFD) [c.737A>G (p.His246Arg)] variation, which has previously been reported to be associated with kidney fibrosis in humans and mice. Conclusions: Although rare, RTD should be considered in a pregnant woman who has severe oligohydramnios without any apparent fetal urinary tract defect. Such patients should be evaluated for the mutations in the genes encoding the RAS. Additional genetic/epigenetic factors might also affect the prognosis. In our cases, we thought that variation in PDGFD may modulate the clinical course and explain our patients' prolonged survival. Introduction: Schimke immune-bone dysplasia is a rare multisystemic disease, with a large spectrum of manifestations, its aetiology and physiopathology remain unknown. Different forms can be found from where diagnosis difficulties. Material and methods: We report a case of a girl of Algerian origin presented with a severe spectrum form of schimke syndrome complicated with prenatal growth retardation and End Stage renal failure (ESRF) Results: It's about a 5 years old girl, was referred to our pediatric department for a cortico-resistant nephrotic syndrome. She's a second child of a healthy consanguineous couple, her personal history was marqued by unexplained intrauterine growth retardation with a short stature followed since the age of 2 years. On first examination, she had short stature and a distinctive physical feature : fine hair, thin upper lip, low nasal bridge and excessive inward curvature of the lumbar spine Initial biological check-up revealed nephrotic syndrome (high proteinuria=175mg/kg/24H), renal failure with a rapid worsening of the renal function, Cell Blood count showed severe leucopenia. Peripheral blood lymphocytes showed a significant decreased number of total CD3 T cells. Skeletal X rays were normal, Renal biopsy showed segmental and focal hyalinosis of the "collapsing" type. Genetic study confirmed Schimke syndrome with homozygous mutation in exon 12 of the SMARCAL1 gene.

In view of the rapid evolution towards end-stage renal failure, Renal replacement therapy was required 3 months later, renal transplantation was indicated but our patient was lost of follow up.

Conclusions: Although it is likely a primary immune disease, schimke disease may affect kidneys with rapid progression to ESRF, it is more difficult to accept that it may interfere with bone growth starting before birth as happens to our patient.

Material and methods: We report here a fifth case of CNS with biopsyproven thrombotic microangiopathy (TMA) and a mutation in the WT1 gene.

Results: A 14 day-old girl from unrelated healthy parents with past medical history of intrauterine growth restriction and anamnios was admitted for grunting and anorexia. She had no dysmorphic features. Lab investigations showed kidney injury (creatinine 108μmol/L) with nephrotic syndrome (hypoalbuminemia 11g/L, proteinuria >30g/L) and uncountable erythrocytes in the urine. Kidney ultrasonography showed no thrombosis. Her kidney function only slightly improved despite optimized hemodynamic conditions and she remained oliguric on high dose diuretics. She quickly developed thrombocytopenia and mechanical hemolytic anemia (schistocytes 1-2%) needing recurrent erythrocyte transfusions. She had no severe hypertension. The kidney biopsy revealed signs of TMA without diffuse mesangial sclerosis. The search for shigatoxin and anti-factor H autoantibodies was negative. ADAMTS13 activity, homocysteinemia and analysis of a comprehensive panel of genes involved in atypical HUS were normal. Eculizumab and plasma infusions had no effect. Screening for genetic causes of CNS revealed a de novo monoallelic pathogenic variant in the WT1 gene. The evolution was pejorative with sepsis and worsening of anasarca leading to death. Material and methods: Renal transplant recipients aged 7-20 years and having at least post-transplant 3 months of follow-up were included in the study. The study was carried out between March and July 2019. The "Immunosuppressive Therapy Compliance Scale" was used to assess immunosuppressive therapy compliance and score <12 was defined as non-adherence. "Pediatric Quality of Life Inventory (PedsQL)" was administered to all patients. Evaluation of parental attitude was based on "Parental Attitude Research Instrument" and 5 main parent characteristics were discussed in this scale (factor 1: over-parenting, factor 2: democratic approach, factor 3: hostile and rejective approach, factor 4: marital discordance, factor 5: authoritarian approach Introduction: Chronic kidney disease and kidney transplantation (KT) are associated with an increased risk of cardiovascular disease. The aim of this study was to examine the cardiovascular health after KT compared to matched controls, to relate the results to physical activity, blood pressure and biochemical findings and to follow the cardiovascular health over time.

Material and methods: Patients with KT (n=38, age 7.7-18 years), with a mean time from transplantation of 3.7 years (0.9-13.0) were examined at inclusion and annually for up to four years. Matched healthy controls (n=17, age 7.3-18.6) were examined once. All subjects underwent a cardiopulmonary exercise test, ultra-high frequency ultrasound (UHFUS), pulse wave velocity (PWV) assessment, resting blood pressure measurement, anthropometry and activity assessment. Patients also underwent echocardiography, Dual-energy X-ray absorptiometry (DXA), 24-h ambulatory BP measurements (ABPM), assessment of glomerular filtration rate (GFR) and blood sampling annually. Results: As compared to healthy controls, KT patients showed significantly decreased exercise capacity measured as VO 2peak (34.5 vs 43.9 ml/kg/min), also when comparing z-scores. The KT patients were shorter and had higher BMI z-score than controls, as well as increased resting SBP and DBP z-scores. There was a significant difference in activity score (1.7 vs 2.5) and a tendency towards higher aortic PWV (5.9 vs 5.4 m/s), but no significant differences in arterial wall thickness measured by UHFUS, compared to matched healthy controls. Within the KT group, low exercise capacity was associated with high fat mass index (FMI), low activity score, low GFR and high blood lipids.

Conclusions: Patients with KT showed decreased exercise capacity and increased BP as compared to matched healthy controls, but morphological vascular changes are minimal. Low exercise capacity was associated with low activity score, high FMI, low GFR and high blood lipids. There were no changes in exercise capacity or vascular measurements in patients over time. Introduction: we aimed to determine the prevalence of anemia in pediatric kidney graft recipients and patients with CKD predialysis group, investigate the results of these patients and the factors that may play a role in the pathogenesis of anemia, to evaluate the effect of inflammation on the development of anemia, to determine the anemia-related markers in pediatric renal transplant patients and to investigate the relationship between graft function and anemia. Material and methods: This prospective study was done with 29 CKD patients with GFR value <30 ml/min/1,73 m2 (group 1) and 31 kidney transplant patients (group 2) and 20 healthy controls (group 3). Anemia and inflammation paramethers including hepcidin were measured and compared between groups, then, the affecting factors of Hb levels in kidney transplant recipients were determined.

Results: The frequency of anemia was statistically significantly higher in group 1 compared to group 2. Average serum phosphorus, ALP, PTH, BUN, creatinine, triglyceride levels were significantly lower in group 2.

whereas Hb, Htc, iron binding capacity, total protein, albumin, HDL and GFR values were significantly higher in group 2. Blood hepcidin levels were higher in group 1 than group 2 and 3. It was determined that both the group 1 and the group 2 patients had high inflammation indicators in the pre-transplant period and the inflammation improved after transplantation. The blood hepcidin levels in patients with anemia and those without anemia were similar in both groups during the study. It was determined that the blood hepcidin level of transplant patients was related with ferritin and PTH value. In contrast, blood hepcidin levels of predialysis patients were found to be moderately negatively associated with Hb, Htc, iron binding, Ret Hb, delta Hb, HDL and GFR, positively associated with ferritin level, hCRP and erythrocyte sedimentation rate.

Conclusions: In patients with CKD, anemia frequency and hepcidin level decreases in post-transplant period compared to predialysis period. While the blood hepcidin level was positively correlated with ferritin in both predialysis and kidney transplant patients, it is negatively correlated with Hb, Htc and GFR, positively correlated with hCRP and erythrocyte sedimentation rate. (10), graft intolerance syndrome (8) and unsalvageable acute graft thrombosis (5) . Neoadjuvant renal artery embolization (RAE) was performed in 1. One patient (3.6%) suffered intraoperative hemorrhage without hemodynamic instability. Incidence of postoperative complications was 21% (6): bleeding (3), hematoma (2) and seroma (1) . Symptoms disappeared in all but one patient who remained hypertensive. No mortality related with TGN was seen after median followup of 124.5 months (IQ(25-75): 81.5-158). We observed an increase in Panel Reactive Antibody (PRA) value after the procedure in 50% of patients studied by CDC. Although, in all patients studied by SAB appeared Donor Specific Antibodies (DSA) or suffered a rise in MFI values after the surgery.

Conclusions: Surgical morbidity of TGN in our series was low and clinical symptoms improved overall. However, our data suggested that allosensitization often occurs, a complication better identified due improving diagnostic immunologic tools. Introduction: EBV-PCNSPTLD is a rare complication of kidney transplantation, usually within the first months, during peak immunosuppression, that often bodes poor prognosis. Most children have significant elevations in serum EBV PCR before or at the time of diagnosis. We describe an EBV-PCNSPTLD, 8 years after kidney transplantation with negative blood EBV PCR. Material and methods: A boy (primary diagnosis hypoplastic-dysplastic kidneys) underwent living-related renal transplantation at six years of age. Immunosuppression included prednisone, tacrolimus, MMF. There was EBV mismatching (recipient negative, donor positive). Serial blood EBV PCR were negative. Eight years after transplantation, with baseline creatinine at 3.5mg/dl, he presented with status epilepticus. After the episode, he was asymptomatic with unremarkable neurologic examination. Brain MRI showed multiple lesions in white matter and hippocampus enhanced with gadolinium. CSF cytology was normal. CSF EBV PCR was positive (2,25x10 3 IU/ml), while blood EBV PCR was negative. Brain biopsy showed lymphoproliferative lesion CD20 positive, with EBER ½ (in situ hybridization) in nucleus of large and medium lymphocytes, consistent with polymorphic EBV-PCNSPTLD. MMF was discontinued and tacrolimus was decreased. He received four cycles of rituximab intravenously (375mg/m 2 /dose) despite of concern over limited penetration of rituximab across the blood-brain barrier. Follow-up MRIs showed a gradual decrease in size and number of lesions. After three months, he received two additional doses of rituximab, due to lack of further improvement on imaging. Eight months after diagnosis, he had almost complete resolution of his brain lesions in MRI. His graft function further deteriorated. Results: We report the occurrence of polymorphic EBV-PCNSPTLD with negative blood PCR EBV before or at diagnosis and its successful treatment with reduction of immunosuppression and rituximab intravenously.

The negative blood EBV PCR does not exclude EBV-PCNSPTLD. Once the diagnosis is confirmed, immunosuppression should be reduced and rituximab should be used as first-line treatment.

Introduction: Calcineurin inhibitors (CNI) are the mainstay of current posttransplant immunosuppression. They provide excellent allograft and patient outcomes. However, CNI exhibit a number of adverse effects. Calcineurin-inhibitor induced pain syndrome (CIPS) has been recently described as a rare complication of CNI therapy after organ transplantations. CIPS is clinically characterized by severe disabling bone pain, the diagnosis is made on the basis of clinical symptoms and imaging techniques. While the bone X-ray is normal, magnetic resonance imaging (MRI) shows edema of bone marrow and the skeletal scintigraphy exhibits increased radiotracer uptake. Material and methods: We report a 10-year-old boy with renal cysts and diabetes syndrome, who developed CIPS after kidney transplantation. After 5 months on hemodialysis he received a kidney allograft from a deceased donor. Induction regimen with basiliximab was used along with maintenance therapy consisting of mycophenolate mofetil, tacrolimus and corticosteroids with early withdrawal. The perioperative period was uneventful, but on day 4 posttransplant severe pain of his right leg occured. He presented with complaints of hyperesthesia with maximum pain localized to the right thumb, limitation in movements and pain irradiation to the thumb while walking. Results: Neurologic examination did not explain the cause of the pain.

The plain X-ray of the leg and the spine MRI were normal. Finally, MRI of the right thumb showed localized bone marrow edema. As the pain sustained for 2 weeks despite the adequate tacrolimus dosing, we switched tacrolimus to sirolimus with successful prompt pain relief. Six months later, sirolimus was switched back to tacrolimus because of the suspicious drug induced liver enzymes elevation with no recurrence of CIPS and subsequent normalization of transaminases.

Conclusions: Clinicians should be aware of CIPS as a very rare adverse effect of CNI therapy. CNI discontinuation results in prompt pain relief. Tacrolimus may be restarted later without recurrence of CIPS. Introduction: Although renal transplantation is the best treatment option in advanced CKD patients, many problems such as poor bone health and growth retardation may be seen at follow-up. The aim of this study was to evaluate and determine the factors affecting the bone health parameters of patients who had undergone renal transplantation Material and methods: 30 kidney transplant patients and healthy controls were included into study. This study had both retrospective and prospective properties. Anthropometric measurements and serum biochemical parameters of the pre-transplant period were obtained retrospectively from the hospital records. Retrospective date including anthropometric measurements and serum biochemical These variables were compared to post-transplantation period of the patients. The data obtained from the patients after transplant were compared with healthy controls. Patients were grouped according to serum levels of iPTH, vitamin D and also status of steroid treatment. DEXA parameters of patients were compared between these groups. Finally, correlation analysis between all clinical and laboratory parameters of patients and DEXA parameters were studied in order to determine bone health related factors in kidney transplanted children.

Results: Nineteen (63.4%) patients were male. There was no difference for the age of transplantation between the genders. The most common cause of CKD was CAKUT (46.7%) in patient group. In the pretransplant period, approximately 50-60% of the patient's height and body weight percentiles were less than three percentiles. Height SDS, weight SDS and BMI of patients after transplantation period were found to be higher than those of before transplantation. in 40 % of the patients, the bone age was found to be lower than the chronologic age. The anthropometric parameters of patient group were significantly lower than the control group. When the serum parameters were compared between the study groups, it was found that iPTH, Cr, hCRP values were significantly higher, eGFR, Mg, albumin and HCO3 values were significantly lower in patient group than the control group. There was no difference between two groups in terms of bone specific ALP (bALP). According to height age-matched lumbar vertebra Z score (LVZS), 3,6% of the patients were osteoporotic and 21,4% of the patients had osteopenia. When the DEXA parameters were compared between groups according to the cumulative steroid dose, the lumbar vertebra (LV) BMD was found to be higher in the low cumulative steroid dose group. There was a negative correlation between height age-matched LVZS and duration of steroid treatment and cumulative dose. There was a positive correlation between height age-matched femur neck Z score (FBZS) and duration of tacrolimus and MMF treatment, a negative correlation between height age-matched FBZS and serum iPTH, duration of steroid and calcium treatment. There was a negative correlation between LV, FB and forearm BMD and the duration and dose of steroid treatment in the post-transplant period.

Conclusions: Although height SDS, weight SDS and BMI values of the patients after transplantation were better than the pre-transplant values, there was still significant growth retardation compared to healthy children. Serum bALP levels were not predictive for renal osteodystrophy. DEXA parameters of patients showed improvement after transplantation. In this study, corticosteroid treatment was found to be the most important factor of bone health and growth in renal transplant patients. In addition, we need more research for the use of forearm DEXA application routinely in this population. Introduction: Phthalates, parabens and bisphenols are added to a wide variety of consumer products including medical equipment, pharmaceuticals and personal care products. These contaminants are classified as chemicals of emerging concern because of the ubiquitous occurrence and their endocrine disrupting properties. Pediatric renal transplant recipients (RTR) might be at increased risk of exposure of these potentially harmful chemicals due to frequent health care and their lifelong medication. The aim was to measure urinary concentration of phthalate metabolites, parabens and bisphenols in pediatric RTR.

Material and methods: Morning urine samples were collected from 30 RTR (aged 4.5 -18 years, 17 males) and phthalates metabolites, parabens and bisphenols were measured and adjusted for urinary creatinine. Associations with age, time since transplantation, anthropometrics, glomerular filtration rate (GFR) and previous dialysis were examined. Results: The preservatives, methylparaben and ethylparaben, the sunscreen oxybenzone and all the phthalate metabolites were detected in 100% of the urine samples, whereas bisphenol A (BPA), propylparaben and triclosan were found in more than 90% of the samples. The BPA analogs (substitutes), bisphenol S and bisphenol F were detected in the 70% and 20% of the urine samples, respectively. The concentrations of phthalate metabolites and bisphenols measured in this study are comparable with the levels detected in the general Norwegian population. However, the levels of methylparaben, propylparaben and ethylparaben were substantially higher than the general population in 25%, 15% and 10% of the study participants, respectively. In univariate analysis were 11 of 26 compounds negatively associated with age and monoethyl phthalate was positively associated with GFR (r=0.506, p=0.005). Other significant associations were not found.

Conclusions: The source for the higher levels of parabens in 25% of the patients compared to the general Norwegian population is unknown, but personal care products, drugs and medical equipment may be suspected. There is widespread exposure to bisphenol S which is a BPA substitute. Introduction: Schimke immuno osseous dysplasia (SIOD) is a rare autosomal recessive disease caused by mutations of SMARCAL1, which is an encoding gene for a chromatin remodelling protein. This multi system disorder is characterized by disproportionate short stature, T cell immune deficiency, progressive CKD due to FSGS, and recurrent CVA/TIA. Classical renal involvement starts with nephrotic range proteinuria around the age of 5 years and progresses to ESRD in 1 to 11 years, at median age of 8.7 years. Renal transplant remains the key therapeutic option for ESRD, with excellent allograft survival. However, optimal immunosuppressive is challenging with high risk of death from severe infections. Material and methods: We retrospectively studied 3 patients diagnosed with SIOD referred to our transplant centre with ESRD in the period between 2015 and 2017. Genetic diagnosis was established in all patients. We studied the length of the period of progression to the ESRD, infection rate post transplant, rejection episode and eGFR at one month, 6 months, 18 months and the current eGFR. Results: All patients achieved stable renal function without any episode of rejection during the follow up. Infection episode required hospital admission was report in one patient for which mycophenolate mofetil was discontinued in view of severe neutropenia and lymphopenia. Patient 2 was admitted to the intensive care 6 months post-transplant with hypertensive crisis and TIA, but retained normal neurological function with good blood pressure control.

Conclusions: SIOD patients with significant T cell immunodeficiency, selecting appropriate immunosuppression remains a challenge as there is high risk of infection such as BKVAN, severe disseminated cutaneous papilloma, EBV, and CMV. In this case series, all patients were given Basiliximab as induction along with maintenance of Tacrolimus, mycophenolate mofetil 300 mg/m2/dose twice daily, and a 6-month course of prednisolone. All 3 patients achieved excellent graft survival with low infection rate. Introduction: Azathioprine, an antimetabolite drug interfering with purines synthetisis, is frequently used in solid organ transplant or dysimmune disease. In pediatric kidney transplant, immunosuppressive (IS) maintenance therapy usually combines 2 or 3 IS drugs: a calcineurine inhibitor (e.g. tacrolimus, ciclosporin), an antimetabolite (e.g. mycophenolic acid, azathioprine) and potentially oral steroids. Material and methods: We report the case of a 6 year-old-girl who developed hepatic peliosis due to azathioprine use 9 months after kidney transplant.

Results: A girl with stage 5 chronic kidney disease due to Denys-Drash syndrome received a kidney transplant at the age of 6 years. IS maintenance therapy initially consisted in the association of tacrolimus and mycophenolate mofetil (MMF). Seven months post transplant, MMF was switched to azathioprine, because of persistant diarrhea attributed to this treatment.Two months later, hepatomegaly with micronodular liver infiltration and moderate portal hypertension with splenomegaly was fortuitously discovered on abdominal sonography. Liver fonction was normal, aspartate transaminase (AST) and gamma-glutamyltransferase (GGT) were moderately increased (respectively 53 UI/L and 105 UI/L). Complete infectious investigations were negative. A hepatic biopsy was performed. Histopathology study found nodular regenerative hyperplasia with severe peliosis, i.e. multiple, randomly distributed, blood-filled cavities, without central venous occlusion. The biopsy lead to hemoperitoneum which required blood transfusion.Hepatic peliosis was attributed to azathioprine, which was interrupted and switched to mycophenolic acid.One year later, control sonography found a persistent non dysmorphic micronodular hepatomegaly. Splenomegaly and portal hypertension had resolved. Biological liver tests were unchanged. Conclusions: Hepatic peliosis is a rare but known complication of azathioprine treatment. Its long-term outcome and the reversibility remain uncertain, even after interruption of the causal treatment. Objectives: The optimal urological management of pediatric kidney transplant recipients (pKTR) with longstanding anuria resulting in defunctionalization of a previously normal bladder remains controversial. Current practices vary from pretransplant bladder augmentation, to suprapubic catheter placement at the time of surgery. We aimed to evaluate postoperative urological complications and graft function following the implementation of a more conservative urological approach in pKTR with normal lower urinary tracts prior to their anuric ESKD. Methods: Five children with ESKD of non-urological etiology and protracted anuria underwent LRD transplantation; donor ureter was anastomosed onto native bladder with subsequent JJ stent and urethral catheter (UC) placement. No bladder reconstructive surgery, preoperative bladder cycling or suprapubic drainage were implemented. Results: Median age at transplant was 12.9 years with bladders defunctionalized for a median of 9 years (range 6 to 11) representing 73.6% of the patients total lifetime. JJ stents and UC were removed at 28 and 7 days post transplant respectively as per protocol in all but one patient with bladder capacity (BC) of 20 ml and vesicoureteral reflux in the pretransplant MCUG, in whom the UC was maintained for 25 days while bladder cycling was undertaken until a BC of 180 ml was reached. During a median follow-up of 15.6 weeks no hydroureteronephrosis or urinary leaks were detected; only one patient developed recurrent UTIs despite an improving BC z-score of -0.67 and satisfactory bladder emptying likely related to underlying diabetes and persistent urothelial colonization. At last follow-up, median BC z-score and eGFR decline were 0 (range -1.65 to 0.3) and 0ml/min/1.73m 2 (range -10 to 0) respectively. Conclusions: We suggest that invasive urological procedures can be avoided in pKTR with anuric ESKD of non-urological background with successful natural postoperative rehabilitation of a priorly defunctionalized bladder. Conclusions: It is difficult to explain why some of our patients with IH reduced, usually in adolescence and early adulthood, both calcium and citrate excretion, which has an impact on lithogenetic risk. The interpretation of these results is complex. Bone is the largest reservoir of alkaline salts in the body. We hypothesise that the late hypocitraturia observed in patients with IH would be an indirect sign of high functional osteoblastic activity. Increased proximal citrate reabsorption would denote an increased body production of bicarbonate which is necessary as osteoblastic activity increases, thus requiring increased inputs of alkali, calcium (normalised calciuria) and phosphate. Another option would be an acidification defect. Conclusions: With the exception of the small PH2 group, ßCaOx is similar in PH and non-PH patients. In PH1 this miscalculation is related to a rather lowish urinary calcium excretion. Therefore, calculation of ßCaOx using computed programs is not a reliable parameter to define the definitively extreme CaOx supersaturation of urines from PH patients. Introduction: To describe the characteristics of ophthalmologic involvement in children with primary hyperoxaluria type 1 (PH1). Material and methods: This was a retrospective study over a period of 20 years. The patients included were those followed up for primary hyperoxaluria confirmed by biochemical assays or by molecular study in whom ophthalmological involvement was demonstrated. Ophthalmic examination included best corrected visual acuity (BCVA) testing and multimodal retinal imaging, including fundus photography and optical coherence tomography (OCT). In selected cases, fundus autofluorescence imaging was performed. Results: A total of 11 patients from 70 children with primary hyperoxaluria were included, among them 8 girls and 3 boys. Infantile PH1 was diagnosed in 5 patients, and non-infantile PH1 in 5 children. The mean age at diagnosis of PH was 3.43±3.22. The most frequent mutation was I244T in 6 cases, followed by G190R and the c.406_410 in one case respectively. A mutation of the AGXT gene could not be identified in 3 cases. The mean creatinine clearance was 29.8 ml/min/1.73 m 2 BA. All eyes (n = 22) of PH1 patients revealed severe retinal alterations and oxalate deposits, including macular crystals and hyperpigmentations. Deposits appeared as focal hyperreflective subretinal lesions on OCT imaging and were hyperautofluorescent on autofluorescence images. Conclusions: Severe ocular alterations may occur in patients with PH1, the natural history of (sub)retinal oxalate deposits, the pathogenesis of subretinal fibrosis, and exact factors influencing the overall severity of Introduction: The studies on the prevalence of kidney stones in Iranian children are very limited and only two studies have examined this issue and reported its prevalence of about 1%. Children with nephrolithiasis have a high chance of developing recurrent stones, so they should be thoroughly evaluated. Due to little information in Iranian children, the aim of this study was to investigate the prevalence of kidney stones in this population. Material and methods: This cross-sectional study investigates the prevalence of kidney stones in different university centers among outpatients and inpatients from March-December 2019 in Iran. Twenty-six pediatric nephrologists from 13 centers were participated in this study and completed questionnaire containing information on the total number of inpatients and outpatients and the number of kidney calculi in them. The diagnosis of the stone was based on radiological findings. Results: A total of 97912 patients were examined, of which 20327 were hospitalized and the rest were outpatients. The prevalence of kidney stones was 1.5% among hospitalized patients and 3.2% among outpatients. Conclusions: In this study, we examined a large population of children and assessed the prevalence of kidney stones in them. Also, we showed that the prevalence of kidney stones in Iranian children has an increasing trend compared to the previous two studies and most of them are outpatients. The total prevalence of stone in Iranian children was report-ed%2.86. According to the few studies that have been done in this field and also to justify this upward trend ,it is recommended that more extensive studies should be performed in collaboration with more centers and demographic characteristics such as age, sex, stone composition, family history and diet.

Introduction: Urolithiasis is a medical condition marked by presence of calculi in the kidney or urinary tract. These are composed of chemical substances that are normally or pathologically found in urine. About 2% of children are affected by the kidney stone disease. Another serious health issue is the prevalence of obesity that reached epidemic proportions among children and adults. The increasing incidence of urolithiasis in developed countries may be partially due to greater overweight and obese population. American studies revealed a relationship between obesity and incidence of urolithiasis in adults, especially among men. Metabolic disturbances predisposing to urolithiasis linked to excessive body weight include: low urine pH, hypercalciuria, hyperoxaluria, hyperuricosuria and hypocytraturia. Material and methods: The study consisted of 134 children (69 girls, 65 boys) aged 9-18 years with diagnosed urolithiasis. Patients with urolithiasis associated with urinary tract infection, urinary tract malformations, significant urinary retention and rare genetic determinants were excluded. Two study groups were distinguished: group I (95 children :45 girls, 50 boys) consisted of patients with BMI <85 centile, group II(39 children: 24 girls, 15 boys) included children with BMI ≥85 centile. Urolithiasis was diagnosed using abdominal ultrasound. All children underwent anthropometric measurements and laboratory tests. Excretion of following crystalloids was evaluated in 24hour urine collection and from a fasting second-void morning urine. All patients underwent height, body weight. Results: Following results were obtained using the collected data: -group with excessive body weight had statistically significant higher serum uric acid concentration compared to children with normal body weight (p=0.000009). Uric acid concentration correlated statistically positively with the body weight of the subjects (p=0.0001), -children with excessive body weight had statistically significant lower serum concentration of liver-produced 25-hydroxyvitamin D compared to children with normal body weight (p=0.007), -children with normal body weight had higher daily urinary calcium excretion (mean 3.42 mg/kg/day) than children with excessive body weight (mean 2.75 mg/kg/day). This may be considered a trend (p=0.059). No statistically significant differences were noted in the Ca/ Cr ratio between the examined groups, -children with excessive body weight had significantly higher urinary uric acid concentration in the second morning urine compared to children with normal body weight (0.26 vs. 0.23) (p=0.04). No statistically significant differences were noted in the daily urinary excretion of uric acid between the examined groups, -there was a negative correlation between body weight and daily urinary uric acid excretion (p=0.002), -children with normal body weight had significantly higher daily urinary oxalate excretion compared to children with excessive body weight (0.39 vs. 0.31) (p=0.049), -daily urinary citrate excretion was significantly lower among children with excessive body weight compared to children with normal body weight (201.89 vs 277.72) (p=0.040), -there was a negative correlation between body weight and Ca/Cr ratio in the second void urine (p=0.003). No statistically significant differences were noted in the daily urinary calcium excretion between the examined groups, -there was a negative correlation between body weight and daily urinary magnesium excretion (p=0.001) as well as Mg/Cr ratio in the second morning urine (p=0.0001), -there was no statistically significant correlation between the concentration of liver-produced 25-hydroxyvitamin D and daily urinary calcium excretion, -furthermore, there was no statistically significant correlation between the concentration of liver-produced 25-hydroxyvitamin D and the daily urinary calcium excretion and Ca/Cr ratio once patients were divided into groups with normal and excessive body weight. Conclusions: 1. In the examined material, urolithiasis was more often observed in children with normal body weight, which may indicate that excessive body weight is not a risk factor for the disease. 2. Excessive body weight promoted the occurrence of hyperuricemia and reduced hepatic metabolite of vitamin D. Low excretion of citrates, which are crystallization inhibitors, was more frequently observed in this group. 3. Hypercalciuria and hyperoxaluria were found more frequently in children with normal body weight, and higher magnesium excretion than in overweight children, which did not protect against deposits. 4. Vitamin D concentration did not affect urinary calcium excretion, regardless of body weight. Introduction: The purpose of this study is to investigate the demographic, etiological, clinical characteristics and prognosis of UL in children under 2 years of age. The mainly etiological factors in pediatric patients with UL can be categorized as metabolic, urinary system infection related, anatomical anomalies causing urinary stasis and idiopathic. Material and methods: Sixty children were diagnosed with UL under the age of 2 years were recruited to study. All patients have been completely evaluated for etiological factors. Patients have been classified as age at diagnosis, sex, presenting symptoms, family history, physical examination findings, localization and size of urinary stones, laboratory and radiological findings, urinary biochemical examinations, medical and surgical treatments and prognosis. Results: The average age at diagnosis is 8.5 ± 4.5 months and the male to female ratio was 1.6. Forty one of the cases (68.3%) were diagnosed less than 1 year of age. The family history of stone disease was found in 41 (68.3%) cases. Restlessness was noted as the main symptom. Hypercalciuria was found to be the most common metabolic factor. Eight (15%) of patients receiving surgical treatment. Sixteen of the patients (26.7%) received medical treatment and eight patients received both surgical and medical treatments. The recurrence rate was found 15%.

The most important thing is to identify the high-risk populations and take measures if necessary. In all patients with infantile stone disorder, anatomical and metabolic tests must be done. Introduction: We analyzed children with urolithiasis with age-and gender-matched healthy children as a retrospective study to ascertain any differences in urinary stone formation. Material and methods: We used 24-h urine of Ca mmol/mmol creatinine), Ox (mmol/mol cr), Cit (mmol/mol cr), GAGs (mg/mmol cr), Ca/ Cit (mol/mmol), Ox/GAGs (mmol/g), Ox/Cit (mmol/mmol), Ox/ (Cit×GAGs) (mol Ox × mol cr) / (mol Cit × g GAGs), and Cit/GAGs (mmol/g) were analyzed. Data analysis was performed by using Statistica for Windows version 8 and GraphPad Prism version 5. Additionally, J48 classifier was used to construct classification model for discrimination between subgroups. Results: Calcium (mmol/mmol creatinine) and the calcium/citrate ratio (mol/mmol) are the only variables that differentiate children before puberty from healthy children (ROC analysis confirmed only calcium/ citrate as a significant variable with cut-off value > 0.84). Pubertal /postpubertal children are distinguished from age-and gender-matched healthy children by the following variables: citrate (mmol / mol creatinine), calcium / citrate (mol / mmol), oxalate / glycosaminoglycans (mmol / g), oxalate / citrate ratios ( mmol / mmol) and oxalate / (citrate × glycosaminoglycans) (mol oxalate × mol creatinine) / (mol citrate × g glycosaminoglycans), all were confirmed by ROC analysis with cut-off values ≤ 327.87, > 1.02, > 11.24, > 0.12, > 0.03, respectively. Conclusions: These results indicate a different risk of urinary stones development before puberty vs. pubertal/postpubertal children and increasing importance (deficiency) of citrate and glycosaminoglycans in such children. J48 classifier confirmed the importance of the oxalate/ (citrate × glycosaminoglycans) and the calcium/citrate ratios with the practically applicable classification tree for distinguishing between pubertal/postpubertal children with urolithiasis with age-and gendermatched healthy children. Introduction: PH1 is a group of rare inherited diseases, linked to autosomal recessive transmission. It's characterized by excessive production of oxalate leads to exessive urinary oxalate excretion. The clinical presentation ranges from asymptomatic through to isolated or recurrent renal stones, nephrocalcinosis and renal impairment. Insoluble oxalate is progressively stored by all organs, gastrointestinal involvement remains rare,this work has to illustrate the characteristics of digestive impairment during HP1 Material and methods: Cross sectional observational study of the paediatric cases of PH1 managed in the department of paediatrics in the University hospital (Sousse -Tunisia) Results: 60 cases of PH1 were followed up during study period, 5 patients (15.1%) had gastro-intestinal involvment, mean age of digestive signs was 16.1 years with an average time of 35+/-27months compared to diagnosis. the desease was more frequent in girls (3 girls Vs 2 boys), clinical manifestations were recurrent vague abdominal pain in 3 cases, abdominal bloating in one case and chronic diarrhea in the last case. Physical examination found no abnormalities outside of abdominal bloat in one case. Oesophago-gastro-duodenoscopy was performed in all patients show no abnormalities. The abdominal ultrasound and abdominal scan locate calcium deposits in the gastric wall, colic or ileal loops. All children were symptomatically treated with an evolution towards death Conclusions: Systemic impairment in HPI appears at an advanced stage of the disease, Digestive involvelent of HP Is a serious impact during the évolution of the disease, it schoud be researched in all systemic forms of the disease. Introduction: The main etiological factors in pediatric patients with UL can be categorized as metabolic, urinary tract infection, anatomical anomalies causing urinary stasis, and idiopathic for which the cause cannot be demonstrated. The aim of this study is to investigate the effect of nutritional factors on those diagnosed with idiopathic infantile urolithiasis. Material and methods: The study group included 44 infants without a predictable etiologic factor for urolithiasis. The control group consisted of 60 ages and gender matched full healthy infants. Each infant in the patient and control groups was carefully questioned by the same researcher for their nutritional characteristics. Results: Forty-four patients included in the study had a total of 65 stones were detected in urinary system. None of the patients in study group had bladder stone. In 20 of the patients, there were stones in both kidneys. The duration of intake of breast milk in children with urolithiasis was found to be longer than those without urolithiasis. No statistical differences were observed between the study and control groups during the duration of breast milk consumption. In the study groups, the duration of use of the formula was longer than in control groups (p=0.003). The daily intake of cows milk and dairy products was much higher in the group of infants with urolithiasis (p=0.033 and p=0.001). Conclusions: We concluded that dietary conditions could also be a risk factor for idiopathic urolithiasis at the conclusion of our research. We believe that nutritional factors for infantile urolithiasis should be better described, in addition to genetic, anatomical, and metabolic factors.

Silvia Acuñas-soto, Ana Castellano-martinez, Virginia Roldan-cano, Moises Rodriguez-gonzalez Puerta Del Mar University Hospital

Introduction: X-linked hypophosphataemia (XLH) is a rare genetic disorder with x-linked dominant inheritance caused by mutation on the PHEX gen, which increases fibroblast growth factor 23 causing loss of phosphorus at the proximal tubule. Low height and bone deformities, especially at the lower limbs, are typical. Conventional treatment consists of oral supplements with phosphorus and calcitriol. Since 2018, burosumab is approved as a novel therapeutic option with promising results. Our objective is to describe two cases of XLH treated with Burosumab. Material and methods: Data collection from medical records of two paediatric patients with XLH under burosumab therapy in a tertiary hospital. Results: The first case is a boy diagnosed with XLH at 22 month-old during the study of low height and bowing limbs. He had hypophosphataemia with hyperphosphaturia and a mutation in hemizygosis on the PHEX gene. Conventional treatment was initiated, with poor biochemical and radiographic control, requiring hemiepiphysiodesis at 4 years-old due to the significant deformity in the lower limbs. At 6 years-old, burosumab therapy was started. After three years of treatment, serum phosphorus values have increased to near normal values with radiological improvement and better quality of life. The second case is a girl diagnosed with XLH at 24 month-old during genu varus study. She had hypophosphataemia with hyperphosphaturia and a mutation in heterozygosis on the PHEX gene. She received conventional treatment, with persisting hypophosphataemia and worsening deformity of the lower limbs, requiring hemiepiphysiodesis at 5.5 yearsold, which was effective, but hypophosphataemia persisted with poor tolerance to oral treatment. Therefore, burosumab treatment was started at 9 year-old. After 1.5 years, hypophosphataemia has improved with radiological progress. Conclusions: Our two patients have very different phenotypic expression. It is important to know the disease in order to suspect it and start early treatment, with special interest in new therapies. In our short-term experience, burosumab is an excellent therapeutic option for XLH in children, as it improves their quality of life and allows rapid biochemical stabilization without significant side effects.

Perceived QoL in pediatric caregivers was reduced due school absenteeism and learning difficulties, whereas in adult patients absence to work, professional limitations and social issues predominated. Conclusions: This patient driven research project describes the contemporary clinical picture of patients with cystinosis in Spain, characterized by earlier diagnosis, later progression to renal failure and better multidisciplinary care over time, both in children and adults. Introduction: Primary hyperoxaluria type 1 (PH1) is a rare, progressive, serious, and life-threatening autosomal recessive disease, resulting in increased production of oxalate, the key toxic metabolite in PH1. Excretion of excess oxalate by the kidneys leads to recurrent kidney stones, nephrocalcinosis, progressive kidney disease, and multiorgan damage from systemic oxalosis. Lumasiran, a subcutaneously administered RNAi, is the first therapy to be approved by the EC and FDA for the treatment of PH1. Here, we present the study design of BONAPH1DE TM , an observational study to characterize the long-term real-world safety and effectiveness of lumasiran in patients of all ages with PH1. Material and methods: BONAPH1DE is a global, multicenter, prospective, observational, longitudinal study designed to characterize the longterm, real-world safety of lumasiran in patients with PH1. This study will also evaluate the natural history and progression of patients with PH1, and characterize the long-term, real-world effectiveness of lumasiran. Patients at participating sites are eligible to enroll in this study with a documented diagnosis of PH1, regardless of treatment status, provided they are not enrolled in a clinical trial for any investigational agent. Patients will be managed and treated per routine clinical practice; the protocol does not recommend the use of any specific treatments, visits or procedures. No medication is provided as a part of study participation. Data collected will include patient characteristics (general and PH1-related), laboratory assessments (including urinary oxalate excretion and plasma oxalate concentration), clinical outcomes, and safety outcomes of interest. Results: BONAPH1DE is expected to begin enrollment in Q3 2021. Conclusions: BONAPH1DE will collect real-world data in patients of all ages to further evaluate the long-term safety and effectiveness of lumasiran for the treatment of PH1. In addition, these data are expected to complement existing disease registries that describe the natural history of PH1 and characterize factors that affect the course of disease. Introduction: Urolithiasis (UL) and nephrocalcinosis (NC) are rare in children, but their incidence and prevalence continue to rise. For the majority of individuals NC / UL has a multifactorial etiology involving genetic factors. This study aims to describe the clinical presentation of UL / NC in children. Material and methods:A retrospective study of all children (0-18 years) referred to Vilnius University Hospital Santaros Klinikos for NC / UL between 2016-2020 was performed. Patients were stratified into 3 age categories: <1, 1-7 and 8-18 years. The following data was analyzed additionally: (i) symptoms; (ii) urinary tract infections (UTI); (iii) potentially predisposing conditions; (iv) family history; and (v) results of genetic testing for NC / UL (if performed). Results: Analysis included 279 children (52% boys). Mean age of the patients was 3±4.98 years: 153 were <1 year, 64 were 1-7 years and 62 were 8-18 years old. Presenting symptoms encompassed abdominal pain in 56 (20%), hematuria in 62 (22%), UTI in 27 (9.6%), non-specific symptoms in 10 (3.5%) and asymptomatic / incidental finding in 124 (44%) patients. Abdominal pain and hematuria were more frequent in older children while infants were mostly asymptomatic (Table) . The most common potentially predisposing condition was hypervitaminosis D (n=60, 21%). Family history of NC / UL was reported in 28 (10%) cases and genetic mutations were detected in 13 (6%) patients. Introduction: Urolithiasis is an important disease that can lead to permanent kidney dysfunction and severe clinical symptoms in pediatric patients. We aimed to present our findings of rigid ureteroscopy combined with Ho:YAG laser lithotripsy in pediatric patients . Material and methods: We retrospectively reviewed the ultrasonography (US), and medical records of pediatric patients with a urolithiasis of pediatric patients.

Results: Sixty-one pediatric patients (M/F=38/23) with urolithiasis were enrolled in this study. The mean age was 6.7±4.9 years (range 3 month-17 years). Thirteen (34.2%) male patients need an urgent operation while the corresponding number was 4 (17.4%) in female patients. The difference between two sexes was statistically non-significant (p=0.156). Thirty-two male patients (84.2%) and 12 (52.2%) females patients had a successful operation. The difference between the two sexes was statistically significant (p=0.019). The ratio of female patients with right-sided stone was greater than the corresponding rates of male patients (p= <0.001).

Conclusions: Considering that more than one operation can be performed in infants and children with mini ureteroscopy and holmium laser, safe and effective stone treatment can be performed. Flexible or PNL may be preferred in kidney calyces. Introduction: Urolithiasis is an important disease that can lead to permanent kidney dysfunction and severe clinical symptoms in pediatric patients. We aimed to present our findings of rigid ureteroscopy combined with Ho:YAG laser lithotripsy in pediatric patients .

Material and methods We retrospectively reviewed the ultrasonography (US), and medical records of pediatric patients with a urolithiasis of pediatric patients.

Results: Sixty-one pediatric patients (M/F=38/23) with urolithiasis were enrolled in this study. The mean age was 6.7±4.9 years (range 3 month-17 years). Thirteen (34.2%) male patients need an urgent operation while the corresponding number was 4 (17.4%) in female patients. The difference between two sexes was statistically non-significant (p=0.156). Thirty-two male patients (84.2%) and 12 (52.2%) females patients had a successful operation. The difference between the two sexes was statistically significant (p=0.019). The ratio of female patients with right-sided stone was greater than the corresponding rates of male patients (p= <0.001). There was no difference between infants (<3 years of age) and toddlers (>3 years of age) with respect to gender, side of stone, procedural success, and need for urgent surgery (p>0.05) ( Table 2 ). Regression analysis showed that female gender was a risk factor for a failed attempt (OR=-0.313, 95% CI: 0.052 -0.528; p=0.0018).

Conclusions: Considering that more than one operation can be performed in infants and children with mini ureteroscopy and holmium laser, safe and effective stone treatment can be performed. Flexible or PNL may be preferred in kidney calyces. Introduction: X-linked hypophosphatemia (XLH), a disorder caused by mutations in PHEX, impairs the inactivation of FGF-23 resulting in renal wasting of phosphorus, hypophosphatemia and rickets. Early diagnosis and treatment are important to prevent subsequent sequelae. We report a severe case of XLH due to a novel PHEX mutation. Our aim is to raise awareness about this disease and the potential factors contributing to its severity. Material and methods: Clinical case description. Results: A five-year-old girl from Guinea-Bissau was referred to our tertiary hospital for evaluation of progressive limb deformities since the age of two. Physical examination showed enamel defects, absent superior incisive teeth, genu valgum, severe tibial curvature in the sagittal plane, widening of metaphyseal ends and height-for-age index below -3 z-score. Laboratory workup revealed elevated alkaline phosphatase (1251 U/L), hypophosphatemia (2.8 mg/dL), borderline low serum calcium levels (total calcium 9.1 mg/dL; Ca++ 1.08 mmol/L); low 25-hydroxyvitamin-D (18 ng/mL), high 1,25dihydroxycholecalciferol (124.18 pg/mL) and PTH (231.7 pg/mL); tubular reabsorption of phosphate (57%) and TmP/GFR (2.22 mg/ dL) were low. The x-rays showed metaphyseal widening, diaphyseal trabeculation, rarefaction and pseudofractures. The patient was started on phosphate and calcium supplementation, alfacalcidol, and cholecalciferol. Additionally, she underwent orthopedic surgery twice resulting in partial improvement of the genu valgum. At the age of eight, a novel heterozygous PHEX mutation (c.156_174del) was identified. She started receiving treatment with burosumab, showing clinical improvement.

The patient was referred to us only three years after the identification of bone deformities, which led to a significant delay in the genetic diagnosis and appropriate treatment initiation. The coexisting vitamin D deficiency may have also contributed to the severity of the disease presentation. Additionally, we question whether the truncate mutation may have played a role in this case severity. Considerable controversy exists regarding the correlation between truncating mutations and a more severe phenotype in XLH. Introduction: Hematuria is a rare condition defined by the side effect of botulinum toxin injection when it is used for overactive bladder. However, there are few reports of hematuria when it is used for limb spasticity.

Material and methods: Here we report a rare case of hematuria following a botulinum toxin injection for lower limb spasticity in a 6-year-old male patient with a history of cerebral palsy. Results: He had a history of recurrent nose bleeding. Of note, he had no hematuria in the past. The patient had normal hemogram, biochemical analysis, C3 and urinary ultrasonography. ANA and dsDNA were negative. Macroscopic hematuria started three days after botulinum toxin injection (35 units for right Adductor muscles, 15 units for right Gracilis muscle, 35 units for left Adductor muscles, 15 units for left Gracilis muscle) and resolved without any additional treatment. However, microscopic hematuria continued for 3 weeks. Further hematological investigations showed high levels of collagen ADP and collagen epinephrine.

Although studies on the effect of botulinum toxin treatment on coagulation are needed, there are studies showing that it may play a role in the coagulation cascade by preventing the formation of fibrin.

Introduction: The diagnosis "idiopathic multidrug resistant nephrotic syndrome" (MDRNS, Orphacode 567550) was recently introduced to describe patients in whom proteinuria neither responds to steroid nor to other immunosuppressive therapies. The recent IPNA SRNS Guideline recommends performing comprehensive genetic screening in these cases to rule out a genetic disease cause. Material and methods: Adherence to this recommendation is monitored in the European Rare Kidney Disease Registry (ERKReg) as one of 55 key performance indicators (KPIs) at 47 pediatric and adult nephrology centers. At a first assessment in 12/2020, NGS panel or exome screening had been performed in a surprisingly low fraction of MDRNS patients (1/18 adult and 2/46 pediatric) reported at 14 expert units. We subsequently inquired the centers about the causes and circumstances of this apparent diagnostic performance issue.

Results: Updates were received on 59 of the 61 cases. In 38 of these, genetic screening had not or incorrectly been reported or performed after the initial data entry. A genetic diagnosis had been established in 7 patients. In 24 patients MDRNS was confirmed by negative genetic screening. 13 patients showed late responsiveness to 2nd-line immunosuppressive therapy and 3 were re-classified as secondary nephrotic syndrome. One patient was deceased. The documentation of genetic testing and/or reclassification of diagnosis increased KPI compliance from 4.3% to 82.1% in the pediatric and from 5.5% to 30.7% in the adult MDRNS cohort. In 8 of the 11 remaining patients genetic testing was scheduled for the next patient visit, which will improve KPI compliance even further.

Conclusions: This proof-of-concept study demonstrates how guideline adherence can be prospectively monitored and optimized by case documentation in an international registry. It illustrates the potential of online KPI monitoring for quality improvement, but also the substantial effort required to monitor data quality and alert treating physicians in a clinical network setting. Introduction: The most common type of nephrotic syndrome in children is minimal change disease (MCD). one of the suggested mechanisms in its pathogenesis is the presence of circulating factors that cause damage to podocytes. One of these circulating factors is the CD80 (B7-1) molecule which is said to be expressed in kidney tissue in MCD patients. The aim of this study was to assess whether urinary level of CD80 is different in histopathological types of INS and also between responsive and nonresponsive types and by this way specify whether CD80 can be used as a diagnostic and prognostic biomarker. Introduction: We present a case of nephrotic syndrome revealing a neuroblastoma in an infant Material and methods: A case report of an 18-month-old nonconsanguineous boy presenting with generalized edema evolving for 7 days Results: The infant was well-appearing. Medical history was unremarkable. The child wasn't under any medication. Clinical examination found a massive hepatomegaly of 11 cm. Meanwhile, there were no signs of heart failure, nor chronic diarrhea or undernutrition. Dipstick found massive proteinuria and microscopic hematuria. Laboratory tests found hypoalbuminemia of 11 g/L, proteinuria of 3 g/24h, and low PTT of 37%. The child had subclinical cholestasis (GGT of 156 ui/L) and mild hepatic cytolysis (transaminases of three times the upper normal limit). Renal function was normal with urea of 0.24 g/L and creatinine of 3 mg/L. Abdominal ultrasound found a mass enveloping the neighboring vessels.

Abdominal scan showed a retroperitoneal calcified tumor resulting in the encasement of the inferior vena cava and a partial extrinsic obstruction of the vessel. Puncture biopsy of the mass followed by pathological study confirmed the diagnosis of neuroblastoma. The child was managed by symptomatic measures (IV albumin with diuretics), and neoadjuvant chemotherapy followed by surgery and maintenance chemotherapy. Evolution was marked by complete resolution of the generalized edema, negative proteinuria, and normal PTT by the second month of treatment.

Conclusions: Neuroblastomas can present with features of inferior vena cava syndrome. That is why abdominal ultrasound is mandatory in every infant with nephrotic syndrome. Treatment is based on chemotherapy followed by surgery. Complete remission of the nephrotic syndrome is usual.

Material and methods: Herein, we present a pediatric patient who developed severe acute kidney injury soon after the diagnosis of NS, as a case report. Results: Nine year-old previously healthy girl was admitted with the clinical and laboratory findings of NS (serum albumin: 1,7 g/dl, spot urine protein/creatinine: 27). She had recent history antibiotic and ibuprofen use for acute pharyngitis. Despite albumin and furosemide treatment, as she became anuric on the third day of hospitalization, hemodialysis was immediately started and pulse methylprednizolone was given. Renal biopsy revealed minimal mesangial proliferation with widespread acute tubular injury findings. She remained completely anuric for seven days. Urine output restarted beginning from the 11 th day of hospitalization. Overall 11 sessions of hemodialysis were performed. She was discharged after 15 days of follow-up with normal daily urine volume. After six weeks of oral prednisolone, complete remission in NS was achieved. Steroids were discontinued at the end of fifth month. On the 10 th month of follow-up, she was in good clinical condition with normal serum creatinine, albumin and urine protein levels.

Conclusions: Acute tubular necrosis was the histopathologic diagnosis underlying anuric AKI in the setting of NS. We believe that heavy proteinuria leading to tubular obstruction, presence of decreased effective intravascular volume due to severe hypoalbuminemia, and use of nonsteroid anti-inflammatory drug (ibuprofen) may have caused acute tubular necrosis. This case emphasizes the importance of awareness for possibility of severe AKI in NS due to multifactorial causes.

Introduction: Nivolumab is increasingly used in the treatment of many cancers. The kidney damage related to nivolumab is usually caused by acute interstitial nephritis. However, glomerulonephritis (GN) associated nivolumab has been encountered with increasing frequency. Here, we report a patient who developed IgA nephropathy (IgAN) after using nivolumab. Material and methods: A seven-year-old male patient was admitted with proteinuria. In his history, it was learned that two years ago malignant melanoma developed on the scalp, tumor excision was performed, various chemotherapy drugs were used, finally nivolumab treatment was initiated and proteinuria was determined after four cycles. On physical examination, blood pressure was normal and there were no edema. In laboratory tests, complete blood count, serum creatinine, electrolytes, HCO3 values were normal, albumin was 3.4 g/dL. Urine density was 1020, protein (+3), erythrocyte (-) in urine analysis, 5-6 erythrocytes in microscopy. Na, P, Ca, Mg, uric acid excretions were normal, protein excretion was 130 mg/m 2 /hour in the urine. Tests (C3/4, ANA, ANCA) performed for proteinuria were normal. Nivolumab-associated proteinuria was considered and the treatment was discontinued. Renal biopsy was performed because of the persistence proteinuria and development of microcopic hematuria. In the light microscopy; enlargement of mesangial matrix, increase in mesangial cellularity, endocapillary proliferation, mesangial IgA (+3), IgG (-), IgM (minimal), C1q (-), Kappa (-), Lambda (+3) was detected. The patient was diagnosed with IgAN with these findings and prednisolone was started. Proteinuria decreased and hematuria regressed in the first month. Complete recovery occurred in the sixth month.

Results: The mechanisms of IgAN due to nivolumab remain unclear. For treatment, while only drug discontinuation is sufficient in some cases, others may recovery with immunosuppressives.

Conclusions: Close monitoring of kidney function, proteinuria and hematuria, as well as early biopsy and intervention in renal involvement are important during the use of nivolumab. Introduction: The aim of the study was to assess age at onset and time to first relapse of steroid sensitive nephrotic syndrome (NS) in children who developed and didn't develop steroid dependency. Material and methods: The retrospective and prospective study was carried out to assess age at onset and time to first relapse in 118 children with infrequent and frequent relapsing steroid sensitive at onset NS.

Results: Median age at onset of steroid sensitive NS in 118 children was 3,5 years [2, [3] [4] [5] 2] , male 75 (64%) and female 43 (36%). Out of 118 children with steroid sensitive at onset NS 60 (51%) and 58 (49%) had infrequent and frequent relapsing course of NS, respectively. Out of 118 children with steroid sensitive at onset NS 75 (64%) had steroid dependency. Statistically significant differences were established: median time to first relapse from onset in 75 children with NS who developed steroid dependency was 4 months [4] [5] , while median time to first relapse from onset in 43 children with NS who didn't develop steroid dependency was 11 months [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] , (p<0,0001); median age at onset in children with NS who developed and didn't developed steroid dependency was 3,4 years [2, [2] [3] [4] 8] and 4,2 years [3, [0] [1] [2] [3] [4] [5] 8] , retrospectively (p<0,05), median age at first relapse in children with NS who developed and didn't develop steroid dependency was 3,8 years [2, 1] and 5,7 years [4,0-7,4] , respectively (p<0,001).

Conclusions: Age at onset and first relapse in children with NS who developed steroid dependency was younger than in those who didn't develop steroid dependency. Children with NS, who relapsed within first half a year after disease onset, more often developed steroid dependency. Laboratory studies: HbA1C 6.6%, peptide C 0.9 ng/mL, anti-GAD 98.2 U/mL and HLA-DQ2. Due to poor glycaemic control and partial remission of SNI, he received mycophenolate mofetil (MMF), allowing steroid withdrawal. He is currently in remission of INS with MMF and adequate metabolic DM1 control with insulin therapy. Case 2: 15-year-old-girl without prior medical history. At 3 years of age was diagnosed with steroid-dependent INS, treated with MMF for three years without subsequent relapses. At the age of 10, after 3 years of remission without treatment INS, she debuted with cardinal symptoms of DM1. Laboratory results: anti-GAD 73.9/mL, anti-IA2 3054U/mL, anti-insulin 2.17U/mL, anti-ZnT 324U/mL and HLA-DQ2-DQ4. No genetic mutation was identified. After starting with subcutaneous insulin therapy with an insulin therapy pump, the patient now has good glycaemic control and is currently in remission for his SNI.

Conclusions: Association of INS and DM1 in paediatrics is extremely rare, although it may be a temporal coincidence. In patients with long-follow-up of DM1, kidney damage is well documented. In our cases, SNI preceded DM1 diagnosis. A common genetic and immunological background that predisposes patients to both disorders may be possible. Introduction: Children with nephrotic syndrome predominantly respond well to corticosteroid therapy, nonetheless 30% of those patients have frequent relapses and a steroid-dependent course of disease. Immunosuppressive drugs are being used in treatment of steroid-dependency, including rituximab in the last years-a chimeric monoclonal antibody, which selectively binds CD20 antigen on lymphocytes B, causing apoptosis of those cells. The aim of thy study was asssessment of efficacy and safety of rituximab in patients with steroid-dependent nephrotic syndrome, in whom previous, long-standing, multidrug immunosuppressive therapy (prednisone, CsA, MMF) gave no grounds for drug dose reduction and/or resulted in significant side effects. Material and methods: 12 patients, who met the criteria of steroid-dependent, cyclosporin-dependent, MMF-dependent nephrotic syndrome were enrolled in the study. Rituximab was given in single, recommended dose of 375mg/m 2 . Evaluation included treatment effect at 6 months, as well as indications for subsequent doses.

Results: The mean time of remission after first rituximab infusion was 9,21±3,89 months. 11 patients remained with no relapse for at least 6 months. In 8 patients within a month after RTX infusion CsA and prednisone treatment was discontinued completely, in others the doses were significantly reduced. In all patients the dose of MMF was reduced. Moreover a relevant reduction of serum creatinine, cystatin C concentration and BMI has been achieved. None of the patients had significant adverse effects of the given treatment.

Conclusions: Rituximab appears to be an effective and safe drug for patients with steroid-, cyclosporin-and MMF-dependent nephrotic syndrome in the aspect of long-term remission, and withdrawal of steroid therapy and calcineurin inhibitors. Introduction: Congenital and infantile nephrotic syndrome is a rare disease with edema, proteinuria, hypoalbuminemia, and may cause end-stage renal failure. They may occur due to perinatal infections and mutation of genes involving structural and functional proteins in the glomerular filtration barrier. Although PLCE1 is the major gene for diffuse mesangial sclerosis, its mutation has also been reported in patients with steroid-resistant nephrotic syndrome with focal segmental glomerulosclerosis. This report presents a case with infantile nephrotic syndrome with PLCE1 gene mutation treated with Cyclosporine. Material and methods: A four-month-old female was referred to our clinic after detected incidental proteinuria. Her parents were first-degree cousins, and her mother's grandmother had a history of dialysis due to kidney failure of unknown origin. Physical examination was normal at admission. Initial laboratory evaluation; creatinine 0,19 mg/dl, albumin 1.9 g/dl, 24-hour urine protein 147 mg/m 2 /h, complement three and com-plement four levels were normal, viral tests were negative. Biopsy was detected as focal segmental glomerulosclerosis. A genetic test was sent, and steroid therapy was initiated. There was no response to full-dose steroid treatment for eight weeks, and the steroid treatment was tapered and stopped. We started enalapril. A homozygous mutation (Exon 23: C.5276C> T (p. S1759L), Homozygous) was detected in the Phospholipase C epsilon 1 (PLCE1) gene. During the follow-up, cyclosporine was added to her treatment. In the first year of cyclosporine treatment, the spot urine protein/creatinine ratio decreased to 1.1 mg/mg creatinine, and albumin increased to 3.7 g / dl. Our patient was considered to have a partial response to cyclosporine. Results: At the last control, she was three years old, using enalapril and cyclosporine, creatinine 0,5 mg/dl (GFR 75,1 ml/min/1,73 m2), albumin 3.1 g/dl, 24 hour urine protein was 67 mg/m 2 /h. Conclusions: Most PLCE1 mutation cases are not responsive to treatment with steroid and cyclosporine. In our case we had a partial response with cyclosporine.

Introduction: This study aimed to determine the characteristics and outcomes of nephrotic syndrome patients with sphingosine-1-phosphate lyase (SGPL1) mutation. Material and methods: Nephrotic syndrome patients with SGPL1 mutation diagnosed in Hacettepe University, Department of Pediatric Nephrology, Nephrogenetics Laboratory were included in the study. The patients medical records were retrospectively evaluated, and characteristics of the patients and outcomes were presented. Results: There were 6 nephrotic syndrome patients (3 female, 3 male) with SGPL1 mutation. Four of the patients (%67) were diagnosed with nephrotic syndrome before the age of one. The median age of nephrotic syndrome diagnosis was 5 months (0.5-63).

Renal biopsy was performed on 4 patients, 2 had focal segmental glomerulosclerosis, one had diffuse mesangial sclerosis, and one had mesangial cell increase and hyaline degeneration in arterioles. Three patients who were given steroid were steroid-resistant. All 6 patients progressed to renal failure and renal replacement therapy (RRT) was initiated in all but one (median age of RRT onset was 6 months, 1-41). Deceased kidney transplantation was performed in a patient at the age of 3 years. All 6 patients also had adrenal insufficiency. Five patients were diagnosed with adrenal insufficiency before 6 months of age; one was diagnosed at 29 months old. Besides, 3 of the patients had hypothyroidism, 2 had ichthyosis, 4 had immunodeficiency, 4 had various neurological findings, and 2 had genitourinary system anomalies. Four patients died at a median age of 30.5 months (1-103); 2 patients are still being followed up with RRT (peritoneal dialysis and kidney transplantation).

Conclusions: The prognosis of nephrotic syndrome seen in SGPL1 mutations is poor, and many extrarenal organ/system involvement, especially adrenal insufficiency, can be seen in patients with this mutation. SGPL1 mutation should be considered in patients with nephrotic syndrome accompanied by adrenal insufficiency. Introduction: Thrombosis is one of the most important complications of nephrotic syndrome (NS) . Renal vein, pulmonary artery, deep veins of lower extremities, inferior vena cava and femoral artery are affected most commonly while cerebral venous thrombosis is extremely rare. A patient with NS and superior sagittal sinus thrombosis is presented to draw attention to this rare complication. Material and methods: . Results: CASE REPORT:An 18 year-old girl who was diagnosed with steroid-sensitive-NS one year ago, admitted to hospital with severe headache. She was using steroid treatment for 25 days for her second attack of NS. On physical examination she had periorbital and pretibial pitting edema. Neurological examination was normal. Laboratory findings showed albumin level of 1.8 g/dl and 3+ proteinuria in urine dipstick. Fundus examination of the eye was normal. Cranial MRI showed hyperintense pathological signal changes of superior sagittal sinus and left sigmoid sinus. In MR venography, defects and contour irregularities were detected in the posterior part of the superior sagittal sinus, left transverse sinus and left sigmoid sinus suggesting of thrombosis. Subcutaneous low molecular weight heparin was started for venous thrombosis and acetazolamide was started for headache. Lumbar puncture was performed to reduce the intracranial pressure. She responded to steroid treatment with remission of the NS and her headache was also resolved. One month later, control imaging of MRI and MR venography showed a complete resolution of the thrombosis. She continued to use anti-thrombotic treatment for the next 6 months and has been followed for 2 years without any problem.

Conclusions: Cerebral sinus thrombosis should be considered in patients with NS with symptoms such as headache, vomiting, and behavioral disorders especially in acute attack period. Imaging methods such as cranial MRI and MR venography should be used for diagnosis. Early diagnosis and treatment prevents the development of neurological deficits in most patients. Cerebral sinus thrombosis should be considered in patients with NS with symptoms such as headache, vomiting, and behavioral disorders especially in acute attack period. Imaging methods such as cranial MRI and MR venography should be used for diagnosis. Early diagnosis and treatment prevents the development of neurological deficits in most patients. Despite the treatment, thrombotic changes progressed with the occurrence of left pulmonary embolism. A central catheter was urgently inserted into the left pulmonary artery and thrombolytic treatment with alteplase was continued in an ICU simultaneously with continuous unfractionated heparin infusion. Treatment was monitored in terms of coagulation system parameters, echocardiographic assessment of right ventricle function and pulmonary arterial flow. For a few days, the patient was kept in pharmacological coma, ventilated. Occasional episodes of hypertension required additional treatment. Bleeding complications necessitated RBC transfusion.

Results: Nephrotic syndrome relapse treatment was first continued with methylprednisolone; later, CsA was introduced. When thrombolytic therapy was completed and the patient's general condition stabilized, she was returned to the Paediatric Nephrology Department. Regression of thrombotic changes (femoral and iliac veins, VCI), improvement of left lung aeration and remission of nephrotic syndrome were achieved. The patient was discharged in good general condition with no symptoms of post-thrombotic syndrome; LMWH treatment was continued for 12 months after the thrombotic episode, followed by antithrombotic prophylaxis with acenocoumarol. Steroids and CsA were discontinued and replaced with mycophenolate mofetil. Introduction: Schimke immuno-osseous dysplasia (SIOD) is a rare autosomal recessive multisystem disorder caused by biallelic mutation in SMARCAL1 gene. Material and methods: We describe a clinical case of SIOD identified by Next Generation Sequencing (NGS). Results: A boy is the first child of unrelated parents with negative family history of bone and kidney disease. He was born full-termed with intrauterine growth retardation, 44sm of birth height and 1980g weight. Patient's characteristic features were a broad low nasal bridge on the triangular face and disproportionate short stature (short neck and trunk) with protruding abdomen and long arms. He also had pigmented macules and microdontia. At the age of 3, he was diagnosed with nephrotic syndrome (morphologically: focal segmental glomerulosclerosis) resistant to steroids and cyclosporine A (treatment 6 months) which led to the end-stage renal disease and required peritoneal dialysis by the age of 5. Among endocrine disorders hypothyroidism and partial deficiency of growth hormone were detected. Hypothyroidism was corrected with L-thyroxine, whereas body length was not improved by growth hormone supplementation for 4 months. At the age of 6 he received kidney graft from a deceased donor. Seizures and neutropenia, frequent herpes infections appeared after transplantation. At the age of 11, SIOD was suspected, which was confirmed by NGS. Compound heterozygous mutations in 15 and 17 exons in SMARCAL1 gene: c.C2290G (p.R764G) and c.G2542T (p.E848X) were identified. Conclusions: Schimke immuno-osseous dysplasia is an extremely rare diseasethis is the first patient described in Belarus. The existence of steroid-resistance nephrotic syndrome and short stature should make doctors suspect Schimke diagnosis. Introduction: Schimke immuno-osseous dysplasia (SIOD) is a rare autosomal recessive genetic disease caused by mutations in SMARCAL1 gene. It is charaterized by spondyloepiphyseal dysplasia, T-cell immunodeficiency, hypercromic nevi, hypercholesterolemia and steroid-resistant nephrotic syndrome caused by a focal segmental glomerulosclerosis with a progressive renal failure to end-stage kidney disease. Our objective is to describe two cases of SIOD in two sisters. Material and methods: Data collection from the medical records of two paediatric patients admitted to a tertiary hospital for debut of nephrotic syndrome. Informed consent were obtained from parents. Results: We report two cases of SIOD in two sisters, diagnosed after the debut of steroid-resistant nephrotic syndrome. Both had personal history of short stature, acetabular hip dysplasia and hypercholesterolemia. Laboratory data were compatible with nephrotic syndrome, immunophenotypes were normal, skeletal radiography showed spondyloepiphyseal dysplasia and physical exam revealed characteristic hypercromic nevi. The first case, a 6-year-old girl, presented peripheral refractory edema, severe arterial hypertension and progressive decrease of the glomerular filtration rate. Steroid-resistance of nephrotic syndrome was confirmed, so tacrolimus was started without response. Renal function progressively worsened over the following 4 months, so haemodialysis was started while awaiting renal transplantation. Her sister, a 5-year-old girl, had a steroid-resistant nephrotic syndrome currently with good edema control, normal blood pressure and normal renal function under enalapril treatment. In view of the suspicion of SIOD, the genetic studies were carried out which revealed the same mutation in homozygosis in SMARCAL1 gene.

Conclusions: SIOD has a variable expression with multi-systemic involvement and short life expectancy. It is important the early diagnosis, which can encourage early start of treatment and anticipation of possible complications that may be life-threatening. Introduction: It has been recently identified that mutations in the gene encoding diacylglycerol kinase epsilon (DGKE) lead to hemolytic uremic syndrome (HUS) and/or membranoproliferative glomerulonephritis (MPGN). There are few cases in the literature with DGKE mutations with MPGN. Here, two sibling cases who presented with the clinic of nephrotic syndrome in which a novel mutation was identified in the DGKE gene were reported. Material and methods: Case Report: A 4-year-old girl presented with complaints of swelling around the eyes. In her physical exam four positive pitting pretibial edema. Her past medical history was unremarkable. Her parents were first-degree cousins, and her parents cousins suffered from chronic kidney failure. When her six-year-old brother was screened for familial nephrotic syndrome, hypoalbuminemia and non-nephrotic range proteinuria was found. They underwent kidney biopsy which demonstrated mild mesangial and endocapillary cell proliferation and basement membrane thickening without any immunofluorescence staining. The genetic testing for nephrin, podocin, and WT1 and genes was unremarkable. She was given multiple immunosuppressive medications including cyclosporine, tacrolimus, MMF and rituximab but reached at CKD 5 at the 5 th year of follow-up. Her brother was followed up with steroid and cyclosporine treatment.

Results: Clinical exon sequencing was performed. A c.1383-1384 ins28p.Met462 nonsense homozygous mutation was detected in the DGKE gene. The DGKE mRNA expression and gel electrophoresis supported the pathogenicity of variant (Figure 1 ). At the 6 th year of the follow-up, the immunosuppressive treatments were stopped and peritoneal dialysis was initiated to her. Her brothers non-nephrotic proteinuria continued, and he is being followed up with supportive therapy.

Conclusions: Clinicians should keep in mind that patients with nephrotic syndrome who do not respond to immunosuppressive therapy may rarely have DGKE nephropathy. Even in patients in whom common genetic mutations are not detected, DGKE mutations should be investigated as a part of genetic screening of SRNS. Introduction: Children with nephrotic syndrome predominantly respond well to corticosteroid therapy, nonetheless 30% of those patients have frequent relapses and a steroid-dependent course of disease. Immunosuppressive drugs are being used in treatment of steroid-dependency, including rituximab in the last years. The aim of thy study was asssessment of efficacy and safety of rituximab in patients with steroid-dependent nephrotic syndrome, in whom previous, long-standing, multidrug immunosuppressive therapy (prednisone, CsA, MMF) gave no grounds for drug dose reduction and/or resulted in significant side effects. Material and methods: 12 patients, who met the criteria of steroid-dependent, cyclosporin-dependent, MMF-dependent nephrotic syndrome were enrolled in the study. Rituximab was given in single, recommended dose of 375mg/m 2 . Evaluation included treatment effect at 6 months, as well as indications for subsequent doses.

Results: The mean time of remission after first rituximab infusion was 9,21±3,89 months. 11 patients remained with no relapse for at least 6 months. In 8 patients within a month after RTX infusion CsA and prednisone treatment was discontinued completely, in others the doses were significantly reduced. In all patients the dose of MMF was reduced. Moreover a relevant reduction of serum creatinine, cystatin C concentration and BMI has been achieved. None of the patients had significant adverse effects of the given treatment.

Conclusions: Rituximab appears to be an effective and safe drug for patients with steroid-, cyclosporin-and MMF-dependent nephrotic syndrome in the aspect of long-term remission, and withdrawal of steroid therapy and calcineurin inhibitors. Introduction: Congenital nephrotic syndrome (CNS) is characterized by severe proteinuria, hypoalbuminemia, and edema seen within the first three months after birth. CNS can occur due to perinatal infections or mutation of genes encoding structural or regulatory proteins of the glomerular filtration barrier. Treatment includes albumin infusions, nephrectomy, dialysis, and transplantation. In this study, we aimed to evaluate the demographic, clinical, and follow-up results of patients with CNS who were followed up in our center between 2010 and 2020. Material and methods: Demographic, clinical, laboratory values of 8 patients diagnosed with CNS between 2010 and 2020, kidney biopsy results, genetic examinations, and follow-up results were retrospectively evaluated.

Results: A total of 8 patients (4 girls) were included in the study. The median age at diagnosis was 36 days (3 days-8 months) and the follow-up period was 34 months (7-114 months) . There was a history of prematurity and consanguinity in 5 patients in the history. Edema (expected in 5 patients) was detected at the admission of all patients. Albumin infusion and captopril therapy were started from the diagnosis. No pathology was seen in the tests and ultrasonographic examinations sent for perinatal infection. In the genetic analysis, NPHS1 (Nephrin) homozygous mutation was detected in six patients, and coenzyme Q2 mutation was detected in one patient. Peritoneal dialysis treatment was performed in four patients during the follow-up, and unilateral nephrectomy was completed in one patient. During the follow-up, four of our patients (three due to sepsis while on dialysis, one on the postoperative first day after transplantation) died. Three of our patients are followed up with kidney transplantation and one with supportive treatment.

Conclusions: According to our results, most CNS cases are due to genetic reasons, and nephrin mutation is the most common cause. Management of complications in CNS is crucial for patient survival. Introduction: Denys-Drash syndrome (DDS) is a rare disease caused by mutations in exons 8 and 9 of the Wilms tumor suppressor gene (WT1). Since the WT1 gene is a transcription protein that plays a role in the development of kidneys and gonads, patients can present with steroidresistant nephrotic syndrome (NS) , Wilms' tumor, and sexual differentiation disorders. In this article, a patient with DDS presented with infantile NS is reported Material and methods: Case Report:A previously healthy 16-monthold female patient was referred to our clinic because of proteinuria while being examined with fatigue, fever, and rash. Clinical findings were compatible with the sixth disease without any edema. Laboratory investigations revealed massive proteinuria, hypoalbuminemia (1.7 g / dl). Renal functioning test and electrolytes were within normal range. On pelvic ultrasonography, uterus didelphys was observed, and bilateral ovaries were absent. The karyotype analysis was detected as 46 XY. WT1 gene mutation was studied in terms of differential diagnosis with Frasier syndrome. Mutation in exon 8 of the WT1 gene was detected. All findings were consistent with DDS. Enalapril and L-thyroxine treatments were initiated to reduce proteinuria and for hypothyroidism, respectively. During follow-up, proteinuria decreased, and albumin levels were increased. No wilms tumor image was found in the abdominal laparoscopy of the patient. Biopsy taken from streak gonads and reported compatible with gonadoblastoma.

Results: By this case, we emphasize the necessity to consider DDS, which is a rare condition, in the differential diagnosis of patients with steroid-resistant infantile nephrotic syndrome. Conclusions: DDS should be considered in the differential diagnosis, especially in children presenting with steroid-resistant nephrotic syndrome in the first years of life. Ultrasound can be used as an early diagnostic tool in the evaluation of the pelvic area. Early diagnosis of this syndrome is essential to avoid unnecessary immunosuppressive treatment, and periodic assessment is required about the risk of gonadal tumor. Introduction: The purpose of this retrospective study is to determine the efficacy of cyclosporine A (CyA) in children with steroid-resistant nephrotic syndrome (SRNS). Patients with genetic mutations were excluded. Material and methods: We reviewed the data of 41 nephrotic children with primary SRNS who received CyA between 2010 and 2020. Ten patients were treated with cyclophosphamide prior to CyA therapy without clinical effect. CyA starting dose was 5 mg/kg/day and was readjusted to maintain a C2 blood level of 600-800 ng/ml. The drug was received for 6-165 months (mean: 39.16 months). The observational period was 5 -168 months (mean: 41.04 months).

Results: Complete long lasting remission (proteinuria <4 mg/h/m 2 for more than 12 months), complete remission with relapses of the disease, partial remission (proteinuria 4.0-40 mg/h/m 2 ) and resistance to CyA (proteinuria >40 mg/h/m 2 ) were observed in 36.5%, 19.1%, 19.1% and 24.4 % of patients, respectively. A combination with MMF was usually the next-line immunosuppressive treatment. Only two out of ten patients (20%) achieved remission additionally. During the observational period hypertrichosis, elevated uric acid and anemia occurred in 36.6%, 43.9% and 29.3 % of patients, respectively. Gingival hyperplasia was not observed. Arterial hypertension was found in 16 children (39 %). Renal function impairment (7.3%) was a part of the disease progression toward CKD and not related to CyA treatment. CyA was discontinued in 72.5 % of patients. Among them long lasting remission was observed in 60 %, while 40% showed CyA dependency. Conclusions: CyA was able to induce complete remission in only half (55.6%) of the children with SRNS. The rest of the patients needed prolonged steroid treatment or a combination of two or more immunosuppressants still. Hypertension, elevated uric acid and anemia required additional therapy. Introduction: We evaluated demographic and clinical characteristics of children with steroid sensitive idiopathic nephrotic syndrome (SSINS) who experienced one or more relapses.

Material and methods: 26 patients with SSINS who were followed-up for ≥12 months were included. The patients were divided into two groups: group 1; the patients with infrequent relapse (IFR) and group 2; those who had frequent relapse (FR) and steroid dependence (SD).

Results: A total of 26 patients, 17 boys (65.4%), with a mean age of 7.4±2.8 years (range; 3-12.6 years) and mean follow-up period of 3.3±1.8 years were enrolled. All patients had normal renal function and received prednisolone (12 weeks) for the treatment of the first episode. The mean follow-up period was 3.3 ±1.2 vs 2.9 ±2.8 years for group 1 (n=19,73%) and group 2 (n=7, 27%). Time to first relaps was 10.4 ±8.8 and 5.1 ±2.6 weeks for group 1 and 2, respectively. There was no statistically significant difference between two groups with respect to sex, follow-up period, age at the onset of disease, time to diagnosis, time to first remission, time to first relapse and laboratory findings (serum albumin, creatinine, triglyceride, cholesterol, platelet, complement 3, IgA levels, eGFR, urine protein/creatine ratio (pr/cr), the presence of microscopic hematuria) (all p> 0.05). The time to first remission was significantly higher in those with urine pr/cr >10 mg/mg compare to those who had urine pr/cr between 5-10 mg/mg (p= 0.015).

Conclusions: Demographic, clinical and laboratory findings were not statistically significant between two groups. The time to first remission correlated with the severity of proteinuria.

NEPHROTIC SYNDROME: ABOUT 9 CASES Kaoutar Danaoui, Radia Laanait, Rabiy Elqadiry, Houda Nassih, Aicha Bourrahouat, Imane Ait Sab B Pediatric Ward, Mohammed Vi University Hospital Center, Marrakesh, Morocco

Objectives: to analyze the etiologies, clinical features and evolution of the patients with congenital and infantile nephrotic syndrome (NS) Methods: A retrospective single center study during a period of 5 years including 7 cases of congenital and infantile NS Results: we had 5 boys and 4 girls. The mean age at presentation was of 20-day-old, with extremes of age at diagnosis of 1 month and 9 months. Four patients were from an inbred marriage, and 1 patient had a sibling with neonatal NS who died from anasarca. Generalized oedema was present at diagnosis in all our cases. All our patients had hyperlipemia and hypocalcemia. Meanwhile, 7 patients had hypothyroidism. Growth delay was found in 5 patients and infection in 2 patients. Five patients had congenital NS and four had infantile NS. The NS was related to the congenital Finnish-type NS and the diffuse mesangial sclerosis disease in 6 patients, congenital CMV infection in one case, congenital rubella infection in one case, and congenital syphilis infection in one case. All patients received symptomatic treatment, with regular IV albumin infusions, high protein diet, and calcium and iron supplements. Oral Levothyroxine was started in 7 patients. ACE inhibitors (captopril starting at 1 m/kg/day) and anticoagulant therapy (aspirin at 3 mg/kg/day) was given to all our patients. Penicillin G was prescribed in the case of syphilis infection and ganciclovir was given for a total period of six weeks in the case of CMV infection. Two of our children died, one of massive anasarca, and the other one of septic shock. Four of our cases are lost to follow-up and one patient had evolved to ESRD.

Conclusions: Genetic forms of congenital and infantile NS are the most frequent. Symptomatic measures awaiting for a renal transplantation are the key of treatment. Introduction: Steroid-resistant nephrotic syndrome (SRNS) in children, due to its aggressive nature, requires follow-up renal biopsy for histological study. However, limited resources for genetic testing, as well as low test availability invites us to start calcineurin inhibitors (CNI) before attempting kidney biopsy. Genetic testing now allows screening for mutations which could help determine treatment response expectation without a kidney biopsy. Our objective is to know if detected mutations can influence SRNS patient care, and substitute kidney biopsy. Material and methods: A retrospective study was done on children diagnosed with SRNS within the last five years. Clinical, histological, genetic and therapeutic data were collected from debut up to the last follow-up. Results: 12 patients (7 female) with a mean age at debut between 9 months -13 years old were included. Patients were treated either with standard oral prednisone therapy for 4 weeks or 6-8 weeks. In both groups, 9 were additionally treated with methylprednisolone pulses. Kidney biopsies showed: 5 focal segmental glomerulosclerosis (FSGS), 4 minimal changes disease (MCD), 2 IgM mesangial glomerulonephritis (MGN). Genetic tests revealed mutations in APOL1 in one patient, INF2, NPHS2 and cubillin gene in another each. At the end of follow-up: 7 cases were in complete remission, 4 patients in partial remission, and only 1 without answer. Regarding patients with detected mutations: 3 cases are in partial remission (1 FSGS, 1 MCD and 1 MGN) and 1 patient with a genetic mutation associated with FSGS evolved to end-stage renal disease.

The presence of a genetic mutation confers a poorer prognosis in our patients regardless of histological diagnosis. Our study suggests CNI response may allow, according to some current recommendations, to delay or avoid kidney biopsy in patients with SRNS.

Introduction: Schimke immuno-osseous dysplasia (SIOD) is associated with steroid resistant nephrotic syndrome with focal segmental glomerulosclerosis and usually progresses to end-stage renal disease. We describe a case where Tacrolimus had an early beneficial effect in achieving partial remission with normalisation of albumin and reduction of proteinuria in a child with SIOD. Material and methods: A 5-year-old female was referred with steroid resistant nephrotic syndrome for assessment and management of oedema. Extra-renal features included short stature (<<0.4 th centile for height), truncal lentigines, platyspondyly with ovoid vertebrae and lymphopaenia associated with combined immunodeficiency syndrome. Despite having reduced T-cell population, she had no history of recurrent infection and had adequate vaccine responses. Results: Genetic testing revealed a homozygous deletion in exon 3 & 4 in SMARCAL1 mutation confirming our clinical diagnosis of Schimke immune-osseous dysplasia. Renal histopathology showed focal segmental glomerulosclerosis and 15% chronic change. Urine albumin to creatinine ratio peaked at 4172 mg/mmol, an albumin of 20 g/l and a creatinine of 34 umol/L. Estimated GFR was 90 ml/ min/1.73m 2 . A trial of Tacrolimus was initiated at 0.1mg/kg/dose twice a day.

Following the introduction of Tacrolimus, the patient's albumin normalised with a reduction in albuminuria to 429 mg/mmol by month 6 from a peak of 4172 mg/mmol. Relapse occurred at month 8 with hypoalbuminaemia and oedema, following which, renal function declined with current eGFR at 15 ml/min/ 1.73m 2 .

Conclusions: Tacrolimus was associated with partial remission of steroid-resistant nephrotic syndrome associated with SIOD was achieved for 7 months. Introduction: Strict and complex lifelong treatment and monitoring requirements in pediatric patients with cystinosis often lead to caregiver burn-out and exhaustion. Prevalence of anxiety-depression (AD) and care overload manifestations in caregivers of pediatric patients with cystinosis are thought to negatively impact QoL perception, and to increase healthcare budget. Aims: 1) to evaluate and compare QoL perception and AD symptoms in caregivers of pediatric patients with cystinosis 2) to compare QoL and overload perception between asymptomatic caregivers and those with AD Material and methods: Hypothesis: caregivers with AD have lower QoL; presence of AD in caregivers is associated with larger care overload perception and reduced QoL Population: 9 patients (6 boys) of 12.6 (±4.2) years with nephropathic cystinosis. Their chronic kidney disease (CKD) stage was 1 (4 patients), 2 (1 patient), 3 (4 patients). 4 had a kidney transplant (KT). All studied caregivers were patients' mothers. Methods: validated scales for caregiver overload (HADS, ZARIT) and QoL (SF-36) were used after inform consent and ethical committee approval. Statistics tests were applied as corresponded.

Results: Only 3 out of 9 caregivers did not suffer AD; 4 caregivers manifested care overload (which was intense) whereas 5 did not. Health perception was reduced in all cases. Decreased physical activity, increased pain, reduced social life, mental health issues, negative emotional impact and decreased vitality were observed in nearly half mothers (5, 3, 4, 6, 5, 4 out of 9 , each one respectively). QoL perception was significantly better among caregivers without AD (p=0.02).

Conclusions: Pediatric cystinosis patient caregivers mental health issues, were associated with larger care overload perception and reduced QoL. Those results remark the need of detection and treatment of caregivers' psycho-social issues to mitigate family stress and facilitate patient empowerment, adherence, transition, and emotional health. Introduction: The healthcare transition (HCT) is a vulnerable time in the lives of adolescents with chronic conditions. HCT requires readiness measurement, however, there was no instrument to evaluate HCT readiness in Russia. We aimed to develop the Russian version of the UNC TR x ANSITION Index™, a tool that assesses HCT readiness among adolescents with chronic kidney disease (CKD) and type 1 diabetes mellitus (DM). Material and methods: The UNC TR x ANSITION Index™ is a provider-administered/verified 32-question HCT measure with ten domains and a maximum score of 10. In accordance with international guidelines, the following steps of translation, cross-cultural adaptation, and linguistic validation were conducted: preparation, two forward translations, reconciliation, back-translation, revision, cognitive interviewing, pilot testing, final review, and proofreading. This process was carried out by an international multidisciplinary team. Cognitive interviewing was conducted with 5 adolescents and pilot testing was conducted with 15 adolescents with CKD and 15 adolescents with DM. Results: Through the iterative process of translation and cultural adaptation, a Russian test version of the UNC TR x ANSITION Index™ was developed. The cognitive interviewing of adolescents did not lead to any significant revisions but helped obtain qualitative data about patients' perspectives on HCT readiness. The test version was then administered through semi-structured interviews during pilot testing. The most difficult questions for Russian adolescents were about reproduction, health insurance, and new adult healthcare providers. The median transition score was 5.86 ). Based on the pilot testing we developed an algorithm for automated score calculations. After the final review and proofreading, the Russian version was finalized.

Conclusions: In this study, we developed a Russian HCT readiness assessment tool, based on the UNC TRxANSITION Index™. The median scores in our adolescents with CKD and DM were low, indicating the need for HCT preparation.

Introduction: To describe clinicians' perspectives on communication and decision-making in pediatric chronic kidney disease (CKD) and investigate to what extend their intensions on care and management interfere with the interests of children with CKD and their parents. This to identify opportunities to improve shared decision-making, care and outcomes for children with CKD and their families.

Material and methods: Forty-three semi-structured interviews with clinicians, including pediatric nephrologists, nurses, social workers, surgeons, dietitians, and psychologists, with at least one year of experience providing care to children with CKD, from multiple centers (18 hospitals and 4 University research departments) across eleven (United States of America, Canada, Australia, China, United Kingdom, Germany, France, Italy, Lithuania, New Zealand and Singapore) countries were analyzed thematically.

Results: We identified four themes: striving to blend priorities (minimizing treatment burden, emphasizing clinical and long-term risks, achieving common goals), focusing on medical responsibilities (carrying decisional burden and pressure of expectations, working within system constraints, ensuring safety is foremost concern), collaborating to achieve better long-term outcomes (individualizing care, creating partnerships, encouraging ownership and participation in decision-making, sensitive to parental distress) and forming cumulative knowledge (balancing reassurance and realistic expectations, building understanding around treatment, harnessing motivation for long-term goals). Conclusions: Clinicians strive to blend priorities, minimize treatment burden and collaborate with their patients to support decision-making, manage expectations, and achieve the best outcomes and common goals despite many varied challenges (the conclusion is not finalized yet... this is not the finale version!)

Introduction: Urinary tract infection (UTI) is one of the most common bacterial infection in the pediatric population. The main etiological factor for UTI is Escherichia coli, regardless of sex and age and presence of congenital anomaly of kidney and urinary tract (CAKUT). The aim of the study was to analyse epidemiology and risk factors of UTI in children admitted to the tertiary pediatric hospital between 2015-2017. Material and methods: A total of 1,195 positive urine cultures were analysed. In 1,143 patients with positive urine cultures UTI was diagnosed, in the remaining 52 patients vulvovaginitis, vulvitis or sample contamination were diagnosed. The demographic data, epidemiology and risk factors in patients with UTI were further analysed. Results: 540 patients (325 ♀, 215 ♂, mean age 2.17 years) were diagnosed with acute pyelonephritis, 401 patients (204 ♀, 197 ♂, mean age 4.51 years) with cystitis and 202 patients (101 ♀, 101 ♂, mean age 4.14 years) with asymptomatic bacteriuria. The most frequently isolated bacterial strains were Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis both in patients without risk factors (84.76%; 6.69%; 2.97%; 0.93%, respectively) and in patients with risk factors (59.75%; 11.5%; 7%; 8.5%, respectively).

Minimum one risk factor of UTI was presented in 43% patients with pyelonephritis or cystitis. The main risk factor of UTI were: CAKUT (26.1%; 246), bladder dysfunction (neurogenic bladder 5.7%; 54; non-neurogenic bladder 4.8%; 45), constipation (5.6%; 53), immunosuppressive drugs (1.5%; 14), urolithiasis (1.1%, 11) , diabetes mellitus (1.06%; 10). Conclusions: Acute pyelonephritis was more common in hospitalized girls and cystitis in boys. Escherichia coli was the most common etiologic agent of UTI in children with/without risk factors, while Klebsiella pneumoniae, Pseudomonas aeruginosa and Proteus mirabilis were more frequently in children with risk factors. CAKUT and neurogenic/non-neurogenic bladder dysfunction were significant risk factors of UTI in children. Introduction: Acute focal bacterial nephritis (AFBN) is a rare infection in children. AFBN shows an inflammatory intrarenal lesion without evidence of an abscess wall and is therefore considered as an intermediate condition between pyelonephritis and intrarenal abscess. We describe an illustrative case of a recurrent AFBN and a literature review on AFBN.

Material and methods: We performed a literature review using pubmed, EMBASE and google scholar. Data extraction was done for the following variables: patient demographics, antimicrobial duration, underlying conditions and details on relapses or recurrences. Results: Illustrative case: An 11-year-old Swiss girl presented with multiple episodes pyelonephritis followed by AFBN. After initial oral antimicrobial courses for first five episodes of pyelonephritis, evidence of a pronounced bilateral nephritis on magnetic resonance imaging (MRI) during her 6th episode prompted treatment with intravenous antimicrobial treatment, followed by prophylactic oral therapy and physiotherapy for a coexisting micturition disorder. Despite this management and a normal uroflow examination, she presented with new focal lesions on a repeated MRI 4 weeks after treatment cessation, prompting us to resume a prolonged intravenous antibiotic therapy over 4 weeks. The literature search identified 24 studies. No single study reported about recurrent AFBN with event-free intervals of several weeks. One prospective study reported about 7 out of 41 individuals with non-further specified treatment failure following a 2-week antimicrobial protocol, whereas no one out of 39 patients treated with a 3-week protocol experienced therapeutic failure. The overall data of the studies showed no clear association between risk of AFBN or relapse and treatment duration or vesico-urethral reflux.

Conclusions: This case highlights a rare presentation of a patient with recurrent AFBN, several weeks following treatment cessation. Despite heterogeneity of the studies, a minimum treatment duration of 3 weeks, investigation for underlying conditions and repeated imaging might be safe approaches in the management of AFBN. Introduction: Urinary tract infections are among the most common infections of childhood and the development of resistance to antibiotics causes treatment failure. Therefore, the aim of this study is to evaluate the resistance patterns of uropathogens by years and to find risk factors affecting the development of antibiotic resistance.

Material and methods: This study retrospectively assessed 1852 patients (1308 females) between 1 month and 18 years of age with a diagnosis of urinary tract infection and 2340 urine cultures of these patients with uropathogen growth above 10 5 CFU/mL from January 2010 to December 2019. Results: The mean age was 73 ± 61 months (1-215 months) and the number of urinary tract infection episodes was 2.5±3.8 . Urinary tract anomalies were found in 15.7% of the patients, among which hydronephrosis (8.8%) was the most common. The most common uropathogens in urine culture were respectively E.coli (59.6%) Klebsiella spp. (11.5%) and Enterococcus spp. (9.5%). There was a statistically significant increase in the growth rate of E.coli, Klebsiella pneumoniae and Acinetobacter spp. by years (p <0.001). The frequency of ESBL positive uropathogens was 16.2% at ten-year follow-up. ESBL positivity was higher in infants, patients with recurrent UTIs, urinary anomalies, and those who had used prophylactic antibiotics (p<0.05). Antibiotics with the highest resistance were penicillin (60.8%), ampicillin (55.7%) and trimethoprim-sulfamethoxazole (40.8%). While there was no increase in resistance to carbapenems in ESBL positive E.coli, it was found that imipenem and meropenem resistance increased in Klebsiella strains (p <0.05).

Conclusions: In the treatment of UTI, especially in infants younger than 12 months, and those with urinary anomalies and a history of recurrent UTIs, appropriate antibiotic should be chosen in accordance with local studies. Introduction: Obesity has become a serious health problem with increasing frequency in children and adolescents. Besides metabolic problems, it can also cause bladder-bowel dysfunction (BBD). It is known that both obesity and BBD have negative effects on the quality of life. In this study, we aimed to investigate the effect of BBD on the quality of life in obese children and adolescents. Material and methods: Obese children and adolescents aged 5 to 17 years who were admitted to pediatric outpatient clinics between April 2019 and December 2019 were included in the study. The cases with normal weight, similar age and sex to the other groups, who came for respiratory tract infection and presented to the Pediatric Nephrology outpatient clinic with signs of bladder-bowel dysfunction were included. The cases who scored 11 or above according to the Bladder Bowel Symptom Score (BBSS) were considered as BBD.

Results: A total of 289 patients, 148 obese and 141 normal weight, with a mean age of 11.7 ± 3.1 years were included in the study. In the obese group, the quality of life subscale and total scores were significantly lower than the control group with normal weight. In obese cases, the quality of life subscale and total scores were significantly lower in the group with BBSS≥11 (p <0.001). There was a statistically significant difference in the physical health total score and the total scale score in the obese patients with BBSS≥11. Conclusions: In this study, while the negative effects of both obesity and BBD on the quality of life were revealed, it was seen that BBD affects the quality of life even more negatively, and both of them are comorbid situations with each other. In addition, it was concluded that the quality of life is most affected when both MBD and obesity coexist. Introduction: The esquistosomiasis (bilharziasis) is a parasitic disease produced by the Schistosoma. It is endemic of sub-Saharan Africa, Latin America and Asia, affecting more than 200 million people/year. Moreover, the immigration and the international trips have contributed to the growing prevalence in European countries. Schistosoma haematobium predominantly leads to genitourinary complications. Material and methods: We present 3 cases of African children diagnosed with schistosomiasis who presented with hematuria. Results: We present three children aged 8, 11 and 13 years from Mali. They consulted for recurrent macrohematuria during the last months. Physical examination was normal. All presented significant eosinophilia (35%, 28%, 17%). All presented ultrasound images of segmental thickening of the bladder wall. Clinical and complementary tests were suggestive of bladder squistosomiasis, which was confirmed by isolation of Schistosoma haematobium in urine. All had positive Schistosoma serology. They received treatment with praziquantel with good response. Hematuria disappeared with absence of squistosomes in urine, and subsequently, in the bladder ultrasound a normalization of lesions was observed in the first year of follow-up. Conclusions: Although schistosomiasis is a typically tropical disease, the large number of migratory movements and the international tourism make necessary to take it into account in the differential diagnosis of hematuria, and in the comprehensive assessment of the reception of an immigrant child. At present, there is no effective preventive drug. Preventive measures are recommended, avoiding bathing in endemic areas. A serological screening should be done in travelers or immigrants who are in contact with contaminated water, and in positive cases, a determination of parasites in stool and urine should be done. Patients with parasitism should be treated even if they are asymptomatic. Introduction: Bladder-bowel dysfunction (BBD) is a common problem in childhood. Due to the existing anatomical and physiological conditions and chronic functional constipation (FC) can accompany to voiding disorders. Constipation should be questioned and treated frequently in children presenting with voiding dysfunction, because it is known that BBD does not improve before constipation improves. However, in patients presenting with the complaint of constipation, BBD is generally not considered and can be overlooked. We aimed to determine the frequency of BBD in pediatric cases presenting with FC and evaluate it with the Bladder-Bowel Symptom Scoring questionnaire. Material and methods: Children ages of 5-18 diagnosed with functional constipation completed the Bladder Bowel Symptom Score (BBSS). Children with BBSS above 11 were considered bladder-bowel dysfunction. Rome IV criteria were used for diagnosis of FC. Results: Eighty-four patients with FC included into the study. Mean age of participants was 9.03 (5.0-16.0) years. Forty-eight(57.1%) of the participants were girls, and 36(42.9%) were boys. The mean duration of constipation of the patients was between 2 -168 months. Presence of painful and hard defecation (79.8%) and abdominal pain(75.0%) were the most common constipation symptoms. In 39 (46.4%) patients, BBSS was found above 11 points and they were diagnosed with bladder-bowel dysfunction. The most common urinary tract symptoms were urgency (63.1%) and frequency (50.0%). A significant positive correlation was detected between the BBSS and the duration of constipation (p:0.042). Significant negative correlation was also found between constipation age and BBSS score (p:0.008). Patients with a younger age of constipation had higher BBSS. Abstract: In this study, our aim was to evaluate psychosocial risk factors, functional bladder and bowel problems, bladder bowel dysfunction (BBD) and other related parameters in children who admitted to child psychiatry outpatient clinic based on the underlying psychiatric disorders. This study was performed in patients who applied to Erciyes University Medical Faculty Child Psychiatry Outpatient Clinic. Patients with organic problems and autistic spectrum disorders were excluded. Bladder intestinal dysfunction questionnaire, depression and anxiety scales, prepared on the basis of international standardized scales, were administered to children aged 6-14. In our study, 440 patients between the ages of 6 and 14 who applied to Child Psychiatry outpatient clinic between March 2019 and December 2019 were evaluated. 227 (51.6%) of the patients were attention deficit and hyperactivity disorder (ADHD), 23 (5.2%) of the patients were anxiety disorder, 23 (5.2%) of the patients were adjustment disorder, 89 (20.2%) of the patients were grouped as other psychopathologies besides 72 (16.4%) were considered as no psychopathology. A statistically significant relationship was found with ADHD in all three urinary incontinence patterns including daytime incontinence, nighttime incontinence and diurnal incontinence. A significant relation was found between anxiety disorders and nighttime urinary incontinence. Other psychopathologies were not being associated with incontinence. A statistically significant relationship was found between cigarette exposure and all three urinary incontinence patterns. There was a significant relationship between having a new sibling and daytime urinary incontinence and between lower urinary tract symptoms and BBD. To the best of our knowledge, this is the first study evaluating children with broad spectrum of psychiatric disorders in terms of BBD. We found a strong relationship between ADHD, anxiety, social stressors, and BBD and urinary incontinence. In some patients, this situation should be considered in diagnosis and treatment since functional bladder and intestinal disorders and psychiatric problems may be intertwined. Introduction: Emphysematous pyelonephritis (EPN) is a necrotizing infection with gas formation, affecting the renal parenchyma and, in some cases, perirenal tissue. Here, a patient presenting with a typical upper urinary system clinic but diagnosed with emphysematous pyelonephritis is presented. Here, we present a case that presents with a typical upper urinary system clinic but diagnosed with emphysematous pyelonephritis is presented. Material and methods: Case: A 6-year-old girl was brought with fever, vomiting and burning pain while urinating 3 days ago. It was learned that amoxicillin-clavulanate treatment was initiated with the initial diagnosis of urinary tract infection, but persistent fever (39 o C), weakness, nausea, vomiting, deficient oral intake, flank pain and widespread abdominal pain continued despite the treatment. On physical examination she had tenderness on the left costovertebral angle and in the left lower abdominal quadrant on palpation. Laboratory test showed that leucocytosis, high acute phase reactants high D-dimer and fibrinogen levels. Kidney and liver function test results and electrolytes were within normal limits. In urinalysis, there was protein +1, leukocyte +3, erythrocyte +3, abundant leukocytes and bacteria. Renal ultrasonography were normal. The COVID-19 PCR test result was negative. In contrast-enhanced abdomen MRI T1-weighted coronal sections showed in the upper pole of the left kidney and millimetric hypointense air signals.

Results: The presence of gas supported the diagnosis of EPN due to gas formation. Empirical treatment with meropenem and amikacin was initiated. At the end of the treatment, control MRI imaging revealed that the lesion had completely healed. Dimercaptosuccinic acid (DMSA) examination performed after 4 months revealed normal. No scar or signs of infection were seen Introduction: Neonatal hypertension is an uncommon clinical problem. The main cause is renovascular followed by other vascular causes, congenital disorders, pulmonary, iatrogenic and endocrine causes. The authors present a rare cause of transitory hyperaldosteronism secondary to renal infection. Material and methods: Case report and systematic review. Results: A 22 day-old boy, term newborn, without any prenatal or postnatal complications presented to paediatric emergency due to poor weight gain. After blood and urine workup he was diagnosed with urinary tract infection (UTI) and mild hyponatraemic dehydration associated with hyperkalaemia and immediately initiated ampicillin and cefotaxime and fluid therapy. During hospitalization, persistent high blood pressure (BP) levels (>P97) were observed. Promptly renal ultrasound and eco-Doppler showed no alteration as well as normal hormonal study and renal analytical function so congenital adrenal hyperplasia was excluded. At D9 of hospitalization, he presented normalization of BP values. Further laboratory tests revealed aldosterone levels 335.4 ng/dl (N 2-70 ng/dl) and renin 1684 mUI/L (N <46), renal function and electrolytes were normal. No medication was introduced. 4 weeks later he presented a UTI relapse (multisensible Escherichia coli) with normal BP and renal function. Follow-up paediatric outpatient revealed a decreasing level of aldosterone and renin, normal BP and renal function. No further UTI, no imaging evidence of renal sequalae and good weight evolution.

Conclusions: Transitory hyperaldosteronism is more frequent in premature neonates due to renovascular system immaturity; some studies reveal that aldosterone levels gradually reach normal levels around 12 months of age. Transitory hyperaldosteronism is rarely seen in post term neonates and secondary to neonatal pyelonephritis. This case enhances the importance of a accurate information of normal range plasma aldosterone and renin based on gestational age and day of life as well as a proper approach to this pathology. Introduction: We determined the frequency of the overactive bladder (OAB) in children during the COVID-19 isolation quarantine measures.

Material and methods: The study was conducted in 2282 patients of 3-17 years old in April-December of 2020 and 2019 years.

Results: The frequency of OAB has been twice more in April-June of 2020 than 2019 year. It was the biggest in May and June of 2020. Girls and children after 7 years old were dominated.

Conclusions: Increased amount of children with OAB was noticed after COVID-19 lockdown in 2020 under the influence of stressful factors and anxiety.

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Branchio-Oto-Renal Syndrome: A Case Report and Review of Literature

Bilateral Preauricular Pits

Branchio-Oto-Renal Syndrome

Branchiootorenal/Branchiootic Syndrome -Genetics Home Reference -NIH

Branchiootorenal/Branchiootic Syndrome -Genetics Home Reference -NIH

NORD (National Organization for Rare Disorders), rarediseases.org/rare-diseases/ branchio-oto-renal-syndrome

Branchiootorenal Spectrum Disorder

Branchiootorenal/Branchiootic Syndrome -Genetics Home Reference -NIH

Branchiootorenal/Branchiootic Syndrome -Genetics Home Reference -NIH

Genetic and Rare Diseases Information Center

NORD (National Organization for Rare Disorders), rarediseases.org/rare-diseases/ branchio-oto-renal-syndrome

NORD (National Organization for Rare Disorders), rarediseases.org/rare-diseases/ branchio-oto-renal-syndrome

Constantinou Deltas; A family with the branchiooto-renal syndrome: clinical and genetic correlations

NORD (National Organization for Rare Disorders), rarediseases.org/rare-diseases/ branchio-oto-renal-syndrome

NORD (National Organization for Rare Disorders), rarediseases.org/rare-diseases/ branchio-oto-renal-syndrome

Required Courses (and Encouraged Electives) | Department of Anatomy and Cell Biology

Branchiootorenal Spectrum Disorder

NORD (National Organization for Rare Disorders

NORD (National Organization for Rare Disorders), rarediseases.org/rare-diseases/ branchio-oto-renal-syndrome/. Conclusions: For those that present with features of BOR, swift recognition and supplementary investigations might prevent the potential severe long-term effects of hearing impairment and end stage renal disease

Due to the 90% chance of BOR being inherited in an autosomal dominant manner, genetic counseling and screening is recommended for affected individuals and their relatives to inhibit disease progression. The patient and their siblings should have hearing and renal function examination. The patient should then be reevaluated every 6 months[2] to monitor for disease advancement

Patients with BOR syndrome who receive sufficient treatment and follow up can lead natural and healthy lives

Therefore, it is imperative to provide early diagnosis and multidisciplinary team approach and to include the patient and their families in the medical management and planning. Further studies are needed to shed light on genetic pathways and transcriptional regulators that may be involved in the development of the varying clinical picture of the BOR spectrum and whether or not any other factors may contribute or have an association to the de novo mutations of BOR syndrome

Branchio-Oto-Renal Syndrome: A Case Report and Review of Literature

Bilateral Preauricular Pits

Branchio-Oto-Renal Syndrome: Comprehensive Review Based on Nationwide Surveillance in Japan

Branchio-Oto-Renal Syndrome

Constantinou Deltas; A family with the branchio-oto-renal syndrome: clinical and genetic correlations

NORD (National Organization for Rare Disorders), rarediseases.org/rare-diseases/ branchio-oto-renal-syndrome

Genetic and Rare Diseases Information Center

Branchiootic Syndrome 3 -Conditions -GTR -NCBI

Branchio-Oto-Renal Syndrome: A Case Report and Review of Literature

Required Courses (and Encouraged o gy

Branchio-Oto-Renal Syndrome

Branchio-Oto-Renal Syndrome: Comprehensive Review Based on Nationwide Surveillance in Japan

Bilateral Preauricular Pits

Branchiootorenal Spectrum Disorder

Riedhammer 8 , Julia Hoefele 9

No significant differences were seen between urinary CD80 in patients with MCD in remission compared to those with non-MCD. Using ROC (receiver operating characteristic) curve a cutoff value of 83.5 ng/g creatinine was obtained, with a sensitivity of 87 % and specificity of 100% to differentiate between MCD-relapse and non-MCD-relapse and AUC (the area under the ROC curve) was 0.98. Using ROC curve, a CD80 cutoff level of 108.7ng/gr Cr with a sensitivity of 71% and specificity of 100% was obtained to differentiate between MCD-relapse and MCD-remission and AUC was 0.85. the mean urine CD80 level between the steroid-responsive patient in relapse (511.78ng/gr cr) compared to non-responsive patients in relapse (161.83) was statistically significant (p=0.00). No significant differences were seen between urinary CD80 in responsive (15.25) and nonresponsive groups (6.31) in remission phase

Corticosteroids is the first treatment of choice but many children relapse and need repeated or prolonged courses of steroids and are defined as frequently relapsing (FRNS) or steroid dependent (SDNS) nephrotic syndrome. To reduce the risk of side effects of steroids alternative treatment with cyclophosphamide (CYP), cyclosporin, tacrolimus, mycophenolate mofetil and rituximab has been used. The objectives of this study were to determine the long-term outcome after CYP and factors associated with remission. Material and methods: Retrospective note review of children with biopsy-proven MCNS at the Queen Silvia Children´s Hospital, Sahlgrenska University Hospital between 2004 and 2016. We correlated time to first relapse to gender, steroid-dependence, age at presentation, age at start of treatment and cumulative dose of CYP. Results: 16 boys and 13 girls were treated with CYP during the period. Median age at presentation of nephrotic syndrome was 4.1 years and CYP was introduced at a median age of 6.6 years. The median follow-up period after CYP was 6.5 years. 13 children (45 %) remained in remission during the follow-up period. 16 (55 %) children had by the end of follow-up at least one relapse. Median time to relapse was 11 months. The last noted relapse occurred after 3.5 years. There was no difference in median age at presentation or cumulative dose of CYP between the group with or without relapse. Children with FRNS had a higher remission rate than patients with SDNS although the difference was not significant (p=0.07). Conclusions: Almost half of the children were in long-term remission at the end of follow-up after treatment with CYP

EP-279 NEPHROTIC SYNDROME: DISEASE IMPACT BEYOND CHILDHOOD Laura Bucchino

Regina Margherita Childrens Department Introduction: Long term outcome of childhood nephrotic syndrome

Material and methods: Data from a retrospective cohort of childhood onset steroid-sensitive (SS), steroid-dependent (SD) and steroid-resistant (SR) NS over 18 at January 2021 were collected. Results: 46 subjects were identified

15 remained SD (33%) and 5 SR (11%) under other maintenance therapy (CNI, RTX or MMF). 22 patients (48%) suffered from at least one complication among arterial hypertension, obesity, adult height impairment, sterility, the most frequent being height impairment (18 patients; 39%). Conclusions: NS pediatric onset has a strong impact in adult life, due to disease relapses, prolonged therapy or permanent long term complications: it is remarkable that in our cohort relapses continued over 18 in SS and SD. Long-term follow up multicenter studies are

EP-280 SCLEROSTIN LEVELS IN CHILDREN WITH IDIOPATHIC NEPHROTIC SYNDROME Argyroula Zampetoglou 1

Kyriakou Children Hospital

Our aim was to study sclerostin in INS children and adolescents and its relation with various metabolic bone markers and BMD. Material and methods: In this cross-sectional study various bone metabolism markers of 65 pediatric INS patients [mean±SD age: 9.0±3.9 years, median INS (IQR) durationx-ray absorptiometry (DEXA). Results: Patients with INS had significantly lower sclerostin

There was a positive correlation of sclerostin with alkaline phosphatase (r=0.33, p=0.008) and PTH (r=0.26, p=0.038) in INS patients. Sclerostin was correlated negatively with time since diagnosis (r=-0.36, p=0.004) and positively with age at diagnosis (r=0.42, p=0.001). Moreover, sclerostin was lower in INS patients treated with cyclosporine A

Introduction: Colistimethate sodium(CMS) is an antibiotic with neurological and nephrological side effects. They have a narrow antibacterial spectrum limited to some gram-negative bacilli, they have an important role in the treatment of pan-resistant infections. We present a case of CMS toxicity developing iatrogenically for pan-resistant urinary tract infection. Material and methods: A 5-month-old male patient, who was followed up with a diagnosis of operated posterior urethral valve (PUV), was hospitalized for positive urine culture obtained before control cystoscopy. Physical examinations were normal. Laboratory investigations revealed as serum urea 34mg/dL

Blood gas analysis revealed as pH7.35, HCO3 21.2mmol/L. Urine analysis was nitrite positive with Klebsiella pneumonia(100000KOU/mL) growth. Bacteria was resistant to carbapenems, so CMS was initiated(5mg/kg/day) intravenously. On the 8 th day of CMS treatment, the patient developed sudden restlessness, sleepiness, vomiting, intolerance to feeding, anuria, hypertension and tachycardia. Results: It was observed that CMS treatment, was applied as 50mg/kg/day. Laboratory findings displayed, abnormal liver function tests, acidosis, acute kidney injury and the patient progressed to anuric, hypertensive, tachycardiac

EP-307 FIBROSIS IN VISCERAL TISSUES DUE TO NITROFURANTOIN IN RAT PUPS Ilke Beyitler

North Cyprus Introduction: Nitrofurantoin used for prophylaxis of urinary infections methods: 64 rat pups were grouped and given 1: drinking water, 2: 60 mg/kg nitrofurantoin and 3: 120 mg/kg nitrofurantoin for 60, 90 and 120 days. Fibrosis was investigated histopathologically in lung

In group 3, lung fibrosis in 90. day (mean=1,5) was higher than 60. day (mean=1) (p=0,04). Fibrosis on 120. (mean=3,3) was higher than 90. and 60. days (p<0,0001)

Introduction: There are many challenges in the treatment of viral infections in pediatric solid organ transplantation recipients. Norovirus (NoV) is a self-limiting disease in the general population, but it may cause chronic infection with an increased risk of prolonged diarrhea complicated by malabsorption, weight loss, organ failure, and even death in immunocompromised patients. Material and methods: We present a kidney transplant patient with prolonged and persistent symptoms due to NoV infection. Results: An 18-year-old male kidney transplant recipient was admitted to the hospital with the complaints of recurrent diarrhea attacks, abdominal pain, vomiting, loss of appetite, and weight loss (5 kg in 6 months) for two years. Physical examination revealed short stature, cachexia, and dehydration. Stool tests by PCR revealed positive results for Adenovirus, NoV Genotype II (GII), and C. jejuni. Symptoms did not improve after the use of azithromycin for C. jejuni and the modification of immunosuppressive therapy. Diarrhea and intermittent vomiting persisted; dehydration attacks and acute kidney injury occurred. NoV GII was detected by a PCR assay in the gastroscopic biopsy materials. A significant decrease in stool frequency and volume was observed after oral intravenous immunoglobulin therapy. No side effects were observed during or after the treatment. The patient had a good appetite and appropriate hydration, diarrhea resolved entirely, and he gained weight. Conclusions: Norovirus gastroenteritis should be kept in mind in kidney transplant children with persistent and intractable diarrhea. Oral administration of intravenous immunoglobulin seems to be an easy and effective treatment option. Conclusions: We want to emphasize the importance of the evaluation of children for the underlying hematological disorders in patients who develop hematuria after Botulinum toxin injection for limb spasticity. 

Conclusions: Microalbuminuria was the earliest event observed in the progression of AS, most significant in male X-linked and autosomalrecessive AS patients. Majority of children had normal serum albumin and eGFR during the study period. Eight patients have been identified for consideration of clinical trials. Introduction: Hyperimmunoglobuline D syndrome (HIDS) is an autoinflammatory hereditary disorder caused by mutations in mevalonate kinase (MVK) gene. HIDS is characterized by recurrent attacks of fever lasting 4-7 days and accompanied by lymphadenopathy, abdominal pain, arthralgia, diarrhea, vomiting, skin lesions, aphthous ulcers and splenomegaly. Amyloidosis is a rare but serious long-term complication of HIDS and can cause end stage kidney disease (ESKD) . In this report 10 year old patient who was admitted with steroid resistant nephrotic syndrome (SRNS) and had amyloidosis at the time of HIDS diagnosis is presented. Material and methods: . Results: CASE REPORT: A 10- year old girl admitted to hospital with fever, cough, wheezing and edema. Laboratory evaluation revealed hypoalbuminemia, massive proteinuria and normal creatinine level. Complement levels of C3 and C4 were normal, anti-nuclear antibody, anti-dsDNA, anti-neutrophil cytoplasmic antibodies were negative. In her medical history recurrent lower respiratory tract infections were noteworthy since infancy period. Fever was not a prominent symptom. On physical examination, her weight and h e i g h t p e r c e n t i l e s w e r e n o r m a l . S h e h a d c l u b b i n g , hepatosplenomegaly, periorbital and pretibial edema. First, a diagnosis of nephrotic syndrome (NS) was made and 2 mg/kg/day methylprednisolone treatment was started orally. No response to steroid therapy was seen. Genetic analysis for SRNS showed no mutation. Kidney biopsy was performed and showed AA amyloidosis. Steroid therapy was stopped. Genetic investigation for hereditary periodic fever syndromes were performed. Analysis of MVK gene revealed a homozygote mutation in exon 11, c.1129G>A (p.Val377Ile), diagnosing the HIDS. Canacinumab, an interleukin-1 antagonist, was started. Despite therapy, she eventually progressed to ESKD. Conclusions: Although allele frequancy for V377I mutation in patients with MKD is much more common than other mutations, AA amyloidosis has not been reported previously secondary to the p.V377I homozygous mutation. To our knowledge, this patient is the first case of amyloidosis due to homozygous p.V377I mutation. Introduction: Present the case of a 5-year-old patient with severe hypertension that required kidney transplant and led to diagnosis of a rare inherited glomerular and cystic kidney disorder. Material and methods: Patient´s medical history review. Results: Five-year-old healthy boy who went to his primary healthcare centre because of a week of severe headache and asthenia. Physical examination showed paleness, enlarged liver and hypertension (blood pressure 194/134mmHg) . Blood test showed hemolytic anemia, mild increased liver enzymes and impaired kidney function (creatinine 1.56 mg/dL, urea 124 mg/dL). He was referred to an intensive care unit with the diagnosis of hypertensive emergency. On our centre we started hypertension treatment, requiring six antihypertensive medications, and began etiological study. We requested ocular fundus, echocardiogram, immunological study (without abnormalities), abdominal ultrasound (unspecified hepatomegaly with normal kidneys) and complement study (normal C3 and C4) . Renal biopsy showed tubulointerstitial fibrosis, atrophic tubules, global glomerular sclerosis and vascular changes that suggest thrombotic microangiopathy, vascular predominance. With the diagnostic suspicion of atypical hemolytic uremic syndrome, patient started treatment with eculizumab and we requested complement system genetic test, but only risk polymorphisms in CFH y MCP were detected. Therefore, the genetic study was extended to the analysis of a gene panel associated with glomerular and cystic kidney diseases: two pathogenic variants in TTC21B gene in compound heterocygosis [c.626C&gt;T, p.(Pro209Leu); c.1276C&gt;G, p.(His426Asp)] were detected, which explained impaired kidney function and increased liver enzymes. Despite treatment he developed end-stage chronic kidney disease, requiring peritoneal dialysis until deceased donor kidney transplant in January 2021. He also maintained refractory hypertension, requiring bilateral native nephrectomy. Conclusions: Increasing availability of next generation sequencing techniques has revolutionized nephrogenetics, allowing to diagnose a wide variety of inherited kidney disorders. Alterations in TTC21B gene are associated with glomerular and cystic kidney diseases and it can imply liver involvement. Introduction: Bartter syndrome (BS) is an inherited tubulopathy characterized by hypokalemic metabolic alkalosis. BS type 2 is caused by ROMK disorder due to loss of function mutations in KCNJ1 gene. These patients typically present during early infancy with polyhydramnios, prematurity, polyuria, dehydration and failure to thrive. Hypercalciuria and nephrocalcinosis are also common, but marked parathyroid hormone (PTH) abnormalities have not been described. Although rare patients with BS type 2 present with late-onset isolated nephrocalcinosis, they also have typical hypokalemic metabolic alkalosis. We describe a child with BS type 2 presenting with nephrocalcinosis and normal serum electrolytes mimicking primary hyperparathyroidism. Material and methods: A 7- year-old girl presented with bilateral nephrocalcinosis. She had a history of obstructive calcium-oxalate stones at 1.5 years of age. Past and family history was normal otherwise. She was normotensive with borderline growth retardation. Serum creatinine, electrolytes and HCO 3 were normal; phosphate and 25(OH)D 3 were decreased; calcium, 1,25(OH)D 3 and PTH were elevated. Urine tests revealed hypercalciuria and hyperphosphaturia. Wrist x-ray, parathyroid ultrasonography and parathyroid scintigraphy were normal ruling out primary hyperparathyroidism. Tubular diseases panel showed homozygous likely pathogenic variation (c.658C> T; Chr11: 128709538, L220F, rs200320892) in exon 2 of KCNJ1. This variant was reported to cause functional changes in ROMK in vitro and described in adults with BS type 2 previously. Results: Absence of hypokalemia after newborn period is atypical in patients with ROMK dysfunction. Since the positive transepithelial potential in lumen created by ROMK enables paracellular calcium reabsorption, hypercalciuria is observed in type 2 BS patients. Similarly, high PTH levels can be seen in type 2 BS due to persistent hypercalciuria. High level of 1,25(OH)D3 has been attributed to increased prostaglandin E2 mediated 1-a-hydroxylase activation. Conclusions: The present case suggests that the KCNJ1 gene should be included in genetic analysis even in older children and adults with isolated nephrocalcinosis.EP-207 A RARE PHENOTYPE OF X-LINKED ALPORT SYNDROME. TIME TO RETHINK? Cristina Julia Blazquez Gomez, Lara Sanchez-trujillo, Joao Pedro Vieira Dos Santos, Juan De Dios García Hospital Universitario Príncipe De Asturias Introduction: Alport syndrome(AS) is caused by a mutation in one of the type IV collagen chains. It is characterized by glomerular basement membrane disorder, along with hearing loss and eye abnormalities. Material and methods: Two-year-old girl, with no prior medical history, undergoing follow-up consultation due to gross haematuria coinciding with respiratory infections, with a presumed diagnosis of IgA Mesangial glomerulonephritis. Two years later, the episodes of haematuria present farther apart; however, proteinuria in the non-nephrotic range was detected. Family history reveals that her mother was suddenly diagnosed with end-stage chronic kidney disease(ESRD) in the second decade of life and a left ventricular haemangioma stands out as the only extrarenal presentation. Results: Given the mother's medical history and the persistent prognosis risk factor detected in our patient, the performance of a renal biopsy and genetic study was recommended, as well as initiating treatment with enalapril. Ocular and audition tests showed no defects. The histological study of the kidney showed a a slight expansion of the mesangial matrix without an increase in mesangial cellularity, direct immunofluorescence were negative and electronic microscopy could not be performed. The patient´s proteinuria progressed; therefore losartan was added. The molecular genetic study revealed the mother was a carrier of the heterozygous c.3257G> A mutation in the COL4A5 gene, transmitting it to her daughter.Conclusions: This is an atypical presentation of X-linked AS, due to late diagnosis and severe renal impairment in the absence of extrarenal disorders in female patients. The etiological search for ESRD in early life can determine long-term prognosis and is decisive for preconception genetic counselling.Introduction: Discoloration of theeth(DT) and black hairy tongue(BHT) are frequent in our society because of the poor oral hygiene, physical agents, environmental chemicals, mouth rinses, some dental procedures, general systemic conditions and drugs. In case of suddenly developing DT and BHT, the etiology should be carefully evaluated. Material and methods: A six-year-old boy was admitted to the emergency room with acute renal injury(AKI) due to nausea, vomiting and diarrhea. The patient, who was anuric and hypertensive, had acidosis, uremia, and hyperpotasemia. Renal replacement therapy(RRT) was planned for the patient and a catheter was placed. The patient received hemodialysis(HD) and renal biopsy was performed for etiology. Immediately after biopsy, intravenous pulse methylprednisolone(PMP) treatment was initiated for the patient who has a rapidly progressive course and had a serum creatinine level of 0.6 mg/dL 6-months ago. While the patient was receiving daily HD, he had fever on the 4 th day of prednisolone treatment and became septic. Laboratory tests of predialysis revealed serum urea 98mg/dL(N:10-38); creatinine 3.4mg/ dL(N:0.5-1.2); uric acid 4.6mg/dL(N:2-5.5); albumin 2.4g/ dL(N:3.5-5.5); sodium 131mmol/L(N:134-150), potassium 4.8mmol/L(N:3.5-5.5), calcium 8.3mg/dL(N:8.8-10.8), phosphorus 4.9mg/dL(N:4-7) ; CRP 44mg/L(N:0-5); procalcitonin 185μg/L(N:0.04-0.1). Results: Meropenem and linezolid treatment was initiated. Methicillin sensitive staphylococcus aureus grew in blood culture. Therefore, meropenem treatment was discontinued on the 5 th day. On the 8 th day of antibiotic treatment DT and BHT developed. Treatments were reviewed. It has been observed in the literature that linezolid and prednisolone can cause reversible DT and BHT. First, we stopped linezolid treatment. 72 hours after the cessation of treatment, all findings regressed with the effect of regular tooth brushing. Conclusions: Antibiotic side effects are important in patients using medication. It should be kept in mind that sudden situations can be iatrogenic. Introduction: Hemolytic Uremic Syndrome (HUS) is the leading cause of acute renal failure in children and is mainly caused by infection with Shiga toxin-producing Escherichia coli (STEC). We report the surveillance results of the Italian HUS Registry, established by the Italian Pediatric Nephrology Society and the National Reference Laboratory for E. coli (NRL-ISS), for the years 2016-2020. Material and methods: Stool and blood samples from HUS patients were submitted from all over Italy nephrology units to NRL-ISS for STEC testing, through Real-Time PCR targeting stx genes, isolation and serology. 125 isolates were subjected to whole genome sequencing (WGS) and analyzed through IRIDA-ARIES bioinformatic platform (https://irida.iss.it/irida-aries), engaging an IRIDA instance and Galaxy cluster ARIES, respectively working as web-based interface for data collection and workflow engine for automatic analysis, including serotyping, virulotyping and core genome Multi Locus Sequence Typing. IRIDA-ARIES is connected with the Italian HUS Registry, automatically collecting clinical information and returning typing results. Results: 322 HUS cases were identified, corresponding to 0.72 mean annual cases per 100,000 (0-15 years). The top-5 STEC serogroups O26 (N=107), O111 (N=39), O157 (N=29), O145 (N=27) and O103 (N=12) were identified in 214 cases and prevailed among the 247 STEC positive HUS cases. WGS allowed to identify other serogroups, in particular STEC O80 (10 cases between 2016 and 2020 vs 1 case in the six previus years). All but 2 isolates were stx2-positive. The subtype stx2a was present in 86,4% of these. Furthermore, 14 clusters (<15 allelic difference) were identified, nine including strains from patients without clear epidemiological links. Conclusions: HUS increased of 22% compared with the six previous years. The developed integrated system for surveillance allows fast communication of STEC-HUS diagnosis and the STEC detailed typing through genomics. The identification of isolates with high genetic similarity in different years suggests circulation of certain clones leading to persistent contamination of the sources. Introduction: Childhood end stage kidney disease (ESKD) is a rare disease, with clinical characteristics and underlying etiologies of patients that may vary between countries and populations. We aimed to study secular trends in incidence of childhood ESKD and to study the etiologies, treatments, and prognosis by population group in Israel, over a period of 30 years. Material and methods: In this nationwide, population-based, historical cohort study we collected and analyzed medical and demographic data of all children treated with renal replacement therapy and reported to the Israeli ESKD Registry from 1990 to 2020. Statistical analysis was performed with incidence rate corrected for age, ethnicity and calendar year, using as denominator the appropriate population as reported by the Israeli Central Bureau of Statistics. Results: During 30 years of follow-up, childhood ESKD 5-year average incidence decreased from 12.1 to 10.6 cases per million age related population (pmarp). Arab and Druze children exhibited higher incidence rates of ESKD compered to Jewish children (23. 4 and 19.4 vs. 7 .0 cases pmarp, respectively). The most common etiologies for ESKD among Jews and Arabs were congenital anomalies of the kidney and urinary tract (27.2% and 26.6%, respectively), followed by glomerulonephritis among Jews (16.1%) and renal cystic diseases among Arabs (11.3%). The most common etiology among Druze children was Hyperoxaluria (33.3% of ESKD). Arabs had a lower rate of living donor transplantations compared to Jews and thus longer waiting time for transplantation. Patients survival has improved during the study period, however, Arab and Druzes patient survival rates were lower than Jews survival rates (5- Introduction: Many children with chronic diseases survive into adulthood, meaning that there is an increasing need for an appropriate transition from a pediatrician to adult care. The goal of the transition is an integrated, developmentally appropriate and coordinated transition from pediatric to further treatment, which requires a lot of patient education. The aim of our study was to investigate the readiness of our patients of age for transition. Material and methods: A questionnaire about patient readiness for the transition was sent to all patients aged 18 years and older. The questionnaire included different questions about their readiness for the transition, such as knowing the disease they are being followed and treated for, the medications they are taking, etc. SPSS Statistics (IBM, version 22) was used for basic statistical analyses. Results: 100 questionnaires were returned. The average age of participants was 19.1 years. They were mostly high school (55%) or college students (39%), living with their parents (94%). 15% do not know, what disease they have, and 14% are not aware of its long-term consequences. About one third regularly takes medications and mostly they know what they are taking on their own, but 15% of them do not know the side effects of the medications. 42% visit doctors with their parents and 18% will do the same after transition. They are mostly aware of alcohol and drug effects on their health, but one third does not know how the disease is affecting their profession choice and reproductive health. 46% of the asked do not know who will continue with their care and 44% still have a primary pediatrician.

Conclusions: Regular education about the transition is the key for successful transfer of pediatric patients to adult care. Introduction: The Flemish Collaborative Glomerulonephritis Group, FCGG, was founded in 2016 as a collaboration to collect all native kidney biopsies in Flanders. Uniform renal biopsy request and report forms, and a new comprehensive list of renal pathology diagnoses for coding were introduced. The 2017-2019 epidemiological data of the pediatric patients are presented Material and methods: Following informed consent and complying to GDPR, basic patient and categorical renal data, semi-structured medical information of renal histopathology and clinical renal disease were collected. Results: In 2017-2019, 127 renal biopsies in children were reported in Flanders [3.3/100,000 children per year] -6% of all biopsies; boys N=73, girls N=54. Three "clinical" patterns were equally represented: proteinuria >1g/day; hematuria; and combination of both. Acute or chronic renal failure were present in 25%. In each age/gender group glomerulopathy was most common. In the youngest age group (0-5years; N=33) minimal change disease/nephrotic syndrome predominated (50%), followed by Henoch-Schönlein nephritis and Alport's disease. The middle age group (6-11years; N=47) mainly presented with diseases with hematuria (47%): IgA nephropathy, Henoch-Schönlein nephritis, Alport's disease; followed by minimal change disease (28%). Greater impact of gender was noted in teenagers (12-18years; N=47): IgA-and GBM mediated nephritis was present in 50% of the boys, whereas a more diverse palette of kidney diseases was present in girls. Children of Western-European descent presented with hematuric renal diseases (50%) and nephrotic diseases (25%), while the reverse was noted in the group without a Western-European descent. Conclusions: FCGG network provides a structured format for cross-talk between renal pathologists and nephrologists. Reliable estimates of pediatric renal diseases based on histology are now available in our region. Due to the diverse renal spectrum of the teenager group, a renal biopsy may have an added value. Introduction: International guidelines regarding urinary tract infections (UTIs) in children state that the choice of the initial empirical antibiotic should be based on local resistance data. To guide this clinical decision in Flanders (Belgium), a multicentre data-analysis was performed. Material and methods: Prevalence and resistance patterns of all urinary isolates of children <16 years from 9 centres in Flanders during a one-year (2020) period, were retrospectively analysed regarding age, sex and one vs multiple urine collections (samples) per patient. Results: 3512 isolates from 3156 samples and 2636 unique patients (male/female ratio 1/2, 57% <2 years, 18% with multiple samples) were analysed. E. coli was the most prevalent uropathogen (58%; girls 65.5% vs boys 43.5%; boys <2 years 48.5% vs boys >2 years 29%), comparable with a smaller 2015-multicentre study in Flanders (overall prevalence 61%). In patients with multiple samples vs one sample, prevalence of Klebsiella and Pseudomonas species was higher (9.73% vs 6.79% and 7.15% vs 3.35% respectively). E. coli showed a resistance-rate to coamoxiclav of 46%, with an increasing resistance for 2 centres that were included in the 2015-and 2020-analysis (29% to 52% and 32% to 39%). For patients with multiple samples vs one sample, resistance to ampicillin, co-amoxiclav and co-trimoxazol was higher (64% vs 54%, 52% vs 42% and 35% vs 28% respectively).Conclusions: E. coli remains the most prevalent uropathogen in children, but with an increasing co-amoxiclav resistance-rate. In patients with multiple samples, the prevalence of Klebsiella and Pseudomonas species and the antibiotic resistance-rate for E. coli is higher, probably reflecting a patient group with more uropathies and more frequent antibiotic use. This needs to be taken into account when selecting the empirical antibiotic to treat UTIs in children in Flanders. A regular multicentre data-review in the future will further demonstrate the local trends in time. Introduction: In this study, we aimed to investigate the frequency of voiding dysfunction (VD) in the pediatric outpatient clinics and to determine the risk factors that were related with this disorder. Material and methods: The study included children aged 5-18 years who were admitted to the pediatric outpatient clinic of Ankara University Children's Hospital with any complaints. Patients with known anatomical and neurological defects of the lower urinary system and those who had chronic diseases were excluded. A questionnaire with 18 items including demographical information and possible risk factors for VD and Dysfunctional Voiding and Incontinence Scoring System were applied to the patients. Results: The study included 1000 patients (54,1% girls; mean age 9,52 ±3,57 years). Voiding dysfunction was detected in 115 (11.5%) patients (53 boys, 62 girls). Voiding dysfunction was most frequently detected in the age group of 7 (18,6%) and its frequency decreased with increasing age. The most common symptoms were urgency (75%), holding maneuvers (71%), night-time incontinence (69%) and urge incontinence (60%). Quality of life was affected in 84% of the patients with VD. Living in a crowded family, having ≥3children in the family, having a housewife mother, presence of VD in the other members of family, history of urinary Pediatr Nephrol tract infection (UTI) and constipation were found to be risk factors related with VD (p<0,05). Although statistically insignificant, the prevalence of VD was found to be higher in obese children and in children of mothers who gave birth under the age of 20. Conclusions: Voiding dysfunction was detected in one out of every ten children who applied to the pediatric outpatient clinic and the quality of life was affected in majority of these children. Some familial risk factors, history of UTI and constipation were found to be associated with the increased prevalence of VD.

Magnus Lindén, Per Brandström Institute Of Medical Sciences, Sahlgrenska Academy, University Of Gothenburg, SwedenIntroduction: Several paediatric guidelines on UTI suggest a cut-off for bacterial colony count ≥50 000 or 100 000/mL in urine culture required for the diagnosis. The objective of this study was to investigate if clinical parameters and imaging results differ in infant UTI with low versus high bacterial counts. Material and methods: In a prospective nationwide study at paediatric hospital departments in Sweden, 1165 children <1 year of age treated for their first UTI were included. No predetermined diagnostic criteria were required and instructions to the managing paediatrician were to treat and investigate according to the Swedish national guidelines and local practice. Clinical parameters, urine collection method, bacterial data and results from imaging investigations were reported. Three groups of infants with bacterial colony counts <10 000, 10 000-100 000 and >100 000 CFU/mL respectively were compared regarding age, gender, CRP, non-E. Coli, dilatation on renal sonography, VUR and kidney involvement on DMSA scan. Results: Reports on urine cultures with growth of a single urinary pathogen were available in 1122 cases (522 boys and 600 girls). Clean catch was used as urine collection method in 93% of cases. The frequency of high, medium and low bacterial numbers were 932, 156 and 34 respectively. Girls had lower bacterial numbers than boys. No significant difference in age, diagnostic rate of pelvic dilatation on ultrasound, abnormality on DMSA-scintigraphy or dilating VUR was seen between the groups. Non-E.Coli infection was significantly more prevalent in lower bacterial numbers (p<0.001) whereas CRP was higher in high bacterial numbers (p=0.039). Conclusions: Significant renal abnormalities are present in infants with UTI in similar rate regardless of bacterial count in urine culture. These may be undetected, and adequate treatment delayed, if a high threshold of bacterial numbers is required for diagnosis and subsequent action. Introduction: The aim of the study was to investigate the effectiveness of combination therapy for vulvovaginis (VV) in preschoolers with urinary tract infections (UTI). Material and methods: We examined 52 girls aged 3-6 years with VV and UTI. The patients were divided into groups: 1 (n=22)standard treatment and 2 (n=30) -combined treatment. Inclusion criteria: established diagnosis of VV, UTI, preschool age, absence of other extragenital diseases, enterobiosis, informed parental consent. Standard treatment: capsules, containing neomycin+polymyxin B+nystatin, intravaginally once a day for 6 days. Combination therapy: candles Viferon 150 000 IU rectally twice a day for 5 days, then once a day -5 days; gel with bacteriophages Phagogin 2-3 ml per area of the vestibule of the vagina twice a day for 7 days, then once a day -7 days; Kanefron H 15 drops 3 times daily, 14 days. Monitoring of the state of the vaginal microflora was carried out after treatment, the frequency of relapses was evaluated during 12 months of follow-up. The program "SPSS Statistics 17.0 for Windows" is used for statistical processing. Results: The high efficiency of combined therapy of VV was revealed. After treatment, the patients of group 2 in the vagina decreased microbial colonization of E. coli from 6.0±0.05*10 6 to 1.7±0.03*10 2 GE/S, (p<0.05), the presence of a variety of obligate anaerobic microflora, with no growth (less than 10 2 GE/S) and pathogenic properties, while in group 1, a significant decrease in microbial colonization was not detected. After 1year follow-up, relapses were observed in 46% of patients in group 1 and 4.8% in group 2 (p<0.05). Conclusions: Combination therapy of VV in girls with recurrent UTIs, including recombinant interferon alpha 2b, a complex of bacteriophages and a drug of phytoniring nature, reduces relapses, the need for antibacterial therapy, preserves the vaginal microbiome, improving reproductive health.

Introduction: To determine the diagnostic value of β2-MG (β2microglobulin) in urine to determine the severity of tubulointerstitial fibrosis (TIF) in children with vesicoureteral reflux (VUR), depending on nephroprotective therapy. Material and methods: We examined 117 patients aged 3 to 16 years (mean age 10.2 ± 4.5, 70.1% girls) with VUR. The control group consisted of 20 healthy children. All children underwent a complete nephrological examination. Β2-MG levels were determined in morning urine by ELISA and calculated as urine creatinine. DMSA static scintigraphy was performed to determine the degree of damage to the renal parenchyma. Depending on the therapeutic approach, the children were divided into 2 groups: 1 gr. -74 p. (63.2%) who received enalapril -(0.1 mg / kg) and 2 gr. -43 p. (36.8%) did not receive enalapril. Each group was divided into subgroups according to the degree of TIF according to DMSA: A subgr. -no signs of sclerosis (15.4%), B prep. -1-2 lesions (44.74%) and C subgr -> 3-4 lesions of sclerosis (40.1%). Results: After six months of treatment and follow-up, data were collected and analyzed in both groups. Patients of both groups with sclerosis showed a high urinary excretion of β2-MG compared to the control group and the group of children without sclerosis (p <0.05). Patients gr. 1 (subgr. B) had a statistically significantly lower level of β2-MG excretion compared to patients from subgr. C (p <0.05). In gr. 2, in children with sclerosis (B and C subgr.) without enap therapy, a significantly high level of β2-MG in urine was revealed when compared with children on enalapril therapy. Conclusions: A significant dependence of β2-MG excretion in urine on the severity of TIF was established according to DMSA scintigraphy in children with VUR. A high level of β2-MG was revealed in children with sclerosis in the absence of enalapril therapy. Therefore, the study of urinary β2-MG excretion as non-invasive markers can be used as a criterion for the effectiveness of nephroprotective therapy and for determining the degree of tubulointestinal fibrosis. Introduction: International guidelines agree that stratifying enuresis into non-monosymptomatic (NMNE) and monosymptomatic (MNE) based on the presence or absence of Lower Urinary Tract Symptoms (LUTS) respectively, is mandatory at intake to optimize therapy. To identify LUTS, a checklist (Clinical Management Tool (CMT)) and/or voiding diaries can be used. However, home recordings are time-consuming for the family. Moreover, the added value to CMT is rather expert-opinion than evidence-based. Material and methods: We conducted a study in 7 Belgian Hospitals to document the prevalence of MNE and the added value /correlation of CMT and/or diary in differentiating enuresis in treatment-naïve patients >5 years. At visit 1 CMT following thorough medical history was used to set a diagnosis. Afterwards, a 2day voiding diary was registered at home. During a second visit, this diary was evaluated and used to differentiate enuresis. Results: 109 children included, 19 lost to follow-up. Mean age 7,7years (±2); 62 boys (68,9%) and 27 girls (30%). Based on the CMT 13 children had MNE (16,7%) and 75 NMNE (83,3%). Based on the diary 16 children had MNE (17,8%) and 74 NMNE (82,2%). 25 (27,8%) had the same diagnosis with both methods. Regarding the presence of LUTS we observed significant inconsistencies between CMT and diary. There was fair agreement between the two modalities for urge (κ=0,219), moderate for daytime incontinence (κ=0,432) and none for abnormal voiding frequency (κ=-0,057). Conclusions: NMNE is frequenter than MNE in treatment-naïve patients. CMT alone versus CMT+diary had a different sensitivity and specificity of identifying LUTS: in absence of validation of the importance by a therapeutic trial-outcome, we state that MNE can only be considered when both methods do not demonstrate LUTS. Introduction: Urinary tract infections (UTI) is one of the most common bacterial infections in children. When UTI is accompanied by bactermia, it can lead to more serious complications. Therefore, prompt decisionmaking on the initial management of young infants suspected of having bacteremia is important but not feasible because UTI without bacteremia and bacteremic UTI are clinically indistinguishable. This study was conducted to evaluate the initial clinical and laboratory risk factors of concomitant bacteremia in very young children with febrile UTI. Material and methods: We performed a multicenter retrospective study of very young children aged 0 to 24 months who admitted with febrile UTI from January 2000 to December 2019. Results: We analyzed 2178 patients with febrile UTI, of whom 40 (1.8%) patients were classified into bacteremic UTI. No significant differences in gender and pasts medical histories including previous UTI, hospitalization, or antibiotic therapy were observed between children with bacteremic UTI and non-bactermic UTI. Although the rates of vesicoureteral reflux were not significantly different between two groups, higher rates of abnormal findings of ultrasonography such as hydronephrosis or pyelonephritis were significantly associated with increased risk of bacteremic UTI. Bacteremic UTI group had a significantly younger age (≤ 3month) and low levels of lymphocyte, hemoglobin or albumin on admission. The C-reactive protein (CRP) levels were significantly higher in bacteremic UTI group (P < 0.001 Introduction: The goal is to establish the development of tubulointerstitial fibrosis (TIF) in rats and the level of collagen formation (free (FO) and peptide-bound (PBO) oxyproline) in experimental nephrosclerosis (NS) and to determine the effects of antibiotic therapy and ACE inhibitors to prevent scar development.

Wistar rats by urethral scarification with the development of intravesical obstruction and inoculating E.coli in the cavity of the bladder and 2 groups were formed: gr.1 -9 rats (antiobiotic -cefepim -40 mg/kg), gr.2 -15 rats (antiobiotic+ enalapril -0.1 mg/kg). Аntibacterial therapy was used 2 days after the development of acute pyelonephritis (for 5 days), enalapril a month later (for 6 months). The level of FO and PBO in the urine (method ELISA) was determined at 1, 3, 6 months of the experiment. The level of TIF was determined histologically after decapitation of animals in 1, 3, 6 months of the experiment. Results: Аt 1 month urinary FO and PBO levels were not significant difference between the groups. The urinary level of FO was significantly higher in gr.1 at 3 (p<0.05) and 6 months (p<0.001), the level of PBO in urine was statistically lowest in gr. 2 at 6 month (p<0.05). the development of TIF for 1 month of the experiment did not differ in both groups. Significant low development of TIF was detected in individuals of gr. 2 at 3 and 6 months of the experiment. Conclusions: Antibiotic does not prevent the development of TIF. The combined use of an antibiotic and enalapril reduces the activity of the urinary level of FO, which is involved in the active synthesis and breakdown of collagen and also prevents further sclerosis of the renal tissue.Introduction: Urinary tract infections are one of the most common diseases in childhood and appropriate antibiotic treatment should be started as early as possible. However, the use of antibiotics results in increasing antibiotic resistance. In this study, we aimed to investigate the relationship between antibiotic resistance and prophylactic antibiotics in children with recurrent urinary tract infections. Material and methods: Patients with urinary tract infections ages between 1-24 months were retrospectively analyzed. Results: 219 patients had been diagnosed with urinary tract infections, 113 (51.6%) were girls and 106 (48.4%) were boys. The mean age of all patients was 9.68 ± 5.74 months. The mean age of girls was significantly higher than the boys (p <0.001). 133 of all patients were using the antibiotic prophylaxis (female/male: 63/70), 86 of all patients were not using antibiotic prophylaxis (female/male:50/36). The mean age of patients with prophylaxis was significantly higher than the patients without prophylaxis. (10.33 ± 5.88 months, and 8.66 ± 5.38 months, respectively p = 0.036). The most frequently isolated microorganisms in urine culture were; Escherichia coli (65.8%), Klebsiella spp. (21.9%) and Enterobacter spp. (4.6%). Klebsiella was significantly higher in patients with prophylaxis (p=0,001). The highest antibiotic resistance was observed in; Ampicillin (74%), TMP-SXT (66%), and ceftazidime (64%), and the lowest was fosfomycin and imipenem (7%), and amikacin (6%). Although the resistance of ampicillin and amikacin is higher in patients with prophylaxis, there was no significant difference between patients with and without prophylaxis according to total antibiotic resistance (p>0.05). Conclusions: We would recommend that antibiotic resistance should be investigated for each institution and treatment plans should be revised according to these reports. Introduction: Urinary tract infections (UTI) are very common in pediatric age. Cases of recurrent UTI with other risk factors should lead to the suspicion of an underlying disease. The objective of this work is to raise awareness of an unusual cause of recurrent UTI. Material and methods: Information gathering on a patient with recurrent UTI that lead to the diagnosis of a rare disease. Results: A 16-year-old male was admitted to the emergency department with fever, dysuria, pollakiuria and macroscopic hematuria that started the day before. He was a nonsmoker, with no previous history of kidney/ urologic diseases. Urine culture revealed an Escherichia Coli, that was treated with oral Amoxicillin-Clavulanate. Within the next 2 months, he was admitted several times with similar complaints, always with the diagnosis of UTI (Escherichia Coli for two times and Enterobacter cloacae with multiple antibiotic resistances in the last time). The bladder ultrasound revealed an 18mm exophytic and branched mass adjacent to the right ureteric meatus, that was later confirmed and removed with cystoscopy. The anatomopathological analysis revealed a well differentiated papillary urothelial carcinoma of low malignant potential. After cystoscopy, no more UTI were reported, and the patient remains asymptomatic. Conclusions: The authors present this case to warn that recurrent UTI in male adolescents should lead to further investigation. Although bladder cancer is a common disease, it is very rare in young, nonsmoking individuals. The most common presentation is gross and painless hematuria, like in this case. However, hematuria has a wide range of differential diagnosis, with the most likely being UTI, which can delay the diagnosis. Moreover, a relationship between recurrent UTI and bladder cancer has been described. We intend to draw attention to this rare but potentially fatal disease to avoid a late diagnosis and poorer prognosis. Introduction: Acute focal bacterial nephritis (AFBN), formerly known as lobar nephronia, is a localized, bacterial and inflammatory involvement of the renal lobules without liquefaction and is a process located between pyelonephritis and renal abscess. Here, a case is presented with MERS and AFBN. Material and methods: A nine-year-old male patient was brought to the emergency room with complaints of convulsion for 5 minutes. On physical examination, her body temperature was 38.4°C and the other were in norrmal area. Hyperemic and hypertrophic tonsils were present on oropharyngeal examination, and there was significant tenderness on the left side of the abdomen. Blood biochemistry tests were normal except for hyponatremia and high acute phase reactants. Urinalysis was negative for protein, occult blood, and leukocytes. Lumbar puncture was performed and CSF was found normal. Abdominal ultrasound (US) and abdominal tomography (CT) were performed because of the patients high C-reactive protein (CRP) level, high fever and septic appearance. Abdominal CT showed hypodense patches in the upper and lower poles of the left kidney consistent with AFBN ( Figure 1 ) Cefotaxime treatment was started in the patient. Results: Brain diffusion-weighted magnetic resonance imaging (DW-MRI) was obtained to exclude other pathologies affecting the central nervous system. Hyperintensity and diffusion restriction were noted in the corpus callosum splenium (Figure 2 ). The pathological signal change in the splenium region of the corpus callosum disappeared in the brain DW-MRI repeated on the 14th day of treatment ( Figure 3 ). The patient was discharged after 21 days of antibiotic therapy. Conclusions: AFBN should be kept in mind in cases with toxic appearance, resistant fever, and high acute phase reactant findings. It could be together with MERS.